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Ode to the liver
ere, inside,
you lter and apportion,
you separate and divide,
you multiply and lubricate,
you raise and gather
the threads and the grams of life,
the nal distillate,
the intimate essences.
From you I hope for justice,
I love life.
Do not betray me!
Work on!
Do not arrest my song.
Pablo Neruda
(Translated by Oriana Josseau Kalant)

Preface
Taking a look back
At the end of this PhD, I would like to stand still for a moment and take a
look back at the past four years.e course of a PhD is like an adventurous
journey. At the start, you don’t know exactly where the journey will lead you
or where the scientic adventure will guide you. Along the way, however,
you meet a lot of people. Some of them guide and join you on your trip,
while others give you advice on which road to take, where to stop or what
to do. In this respect, I would like to share with you the most important
and inspiring people I met on my journey and acknowledge them for their
contributions.
A 4-year scientific adventure
First and foremost, I would like to thank my promotor, prof. dr. ir. Patrick
Segers, for givingme the opportunity to start as a PhD student at bioMMeda.
Although Patrick has a busy agenda, the door of his oce was always open.
I always felt welcome when I knocked on his door to ask or discuss some-
thing. I really appreciated his enthusiasm, motivating words and enormous
scientic insights and expertise. In the end, I have an enormous respect for
Patrick and, honestly, cannot think of a better promotor. Patrick, thank you
for guiding me on my 4-year trip towards this dissertation.
Being a biomedical engineer, it was extremely enriching to collaborate
with medical doctors. In that respect, I would like to thank my copromotor,
prof. dr. Diethard Monbaliu, for submerging me in the topics of liver trans-
plantation and preservation, for the interesting discussions and his enor-
mous enthusiasm. Similar to some parts of the journey being rather di-
cult to predict, the moment at which a human liver becomes available for
research is highly unpredictable. erefore, I would like to dedicate a spe-
cial thank you to Diethard and his team for all logistical arrangements and
support enabling the human liver perfusion experiments.
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While digging deep in a PhD research topic, one may lose touch with
the research that is going on outside. However, I was able to join the Belgian
National Committee on Biomedical Engineering as a youngster member,
which allowed me to zoom out to the larger picture capturing biomedical
research at national level. Hence, I would like to thank prof. dr. ir. Pascal
Verdonck for this opportunity.
As none of this journey would have been possible without nancial sup-
port, I also want to thank the Agency for Innovation by Science and Tech-
nology (IWT) for funding this project by a doctoral grant Strategic Basic
Research.
Meeting people along the way
Next, I would like to thank all other people with whom I had the pleasure to
collaborate and who joined me during part of my trip.
I would like to thank Organ Recovery Systems for the liver perfusion
machine they supplied, and especially Bert for the technical assistance. Jur-
gen, thank you for your technical support during a number of long days to
perform all required perfusion measurements. Pieter, Christophe and other
colleagues at theDepartment ofMorphology, thank you for the vascular cor-
rosion casting and for adjusting your agenda at the moment that a human
liver was available, even on days like ‘Sinterklaas’. Denis, Manuel and other
colleagues at the UGCT, thank you for performing the challenging micro-
CT scans of our liver casts. Jan, Jennifer and Rodolfo, thank you for the in-
teresting discussions on how to optimise the liver microcirculation models.
Ye-Dong, thank you for the interesting discussions on the impact of partial
hepatectomy procedures. Benedict, thank you for the support concerning
the bumper cluster. Prof. em. Valeer Desmet, thank you for your input on
how to interpret our data on the human liver (micro)vascular architecture.
David, Geert, Alexandre, Laurent and Nathan, thank you for your interest-
ing master theses.
Furthermore, I thank my previous and current oce mates (Abigail,
Benjamin, Bram, Francisco, Geert, Joris, Nic, Paula, Sebastian,omas &
Tom) for joining me along the way, for the pleasant atmosphere and for the
nice conversations. Additionally, I would like to thank all other colleagues
and ex-colleagues for their support: Alessandra, Annette, Ayfer, Daniel, Da-
nilo, Darya, David, Dieter, Francesco, Frederic, Gianluca, Guillermo, Guivey,
Iris, Jan, Koen, Liesbeth, Luis, Lynn, Margo, Mathias, Matthieu, Michele,
Peter, Soe, Sander, Tim, Tomas & Wouter. Additionally, I would like to
dedicate a special thank you to Saskia for all administrative and practical
arrangements.
At some point during the trip, you might decide to change directions
and go looking elsewhere to learn new things and come back with a bunch
of new ideas. erefore, I want to thank everybody who made it possible
for me to go to Toronto (Canada) for an internship. John and all other col-
leagues at MICe, thank you for all the advice and interesting discussions.
David, Dolores and Luc, thank you for the warm welcome and your gener-
ous hospitality.
Additionally, I thank all the members of the jury for their interest and
for reading this dissertation.
The walk of life
On your way called life, you meet lots of people of whom some in particular
deserve special attention. Without these supporters, I would probably not
have reached the point where I am today.
First of all, I would like to thank my parents and my brother for their
unconditional support, for giving me a good foundation on how to handle
life, teaching me about right and wrong and about how to persist, while al-
ways stimulating what I was going for.ank you so much for all eorts. By
providing me with the necessary luggage, you brought me up to the point
where I was able to start a PhD. I also want to thank my grandparents, who
- unfortunately - cannot share this moment with us anymore. is brings
me to also thank my family and friends, who were always supportive and
interested in my research.
Finally, there is one more person that I would like to thank, being the
person to whom I’m indebted the most: my husband. Bob, I want to thank
you for your unconditional love and support, for your never-ending encour-
agements, for being my listening ear, for being my soundboard, for just al-
ways being there for me, even during dicult times. In this respect, I would
like to mention that - in antiquity - the liver was perceived as being the seat
of soul, life, intelligence, passion and love, illustrating its importance.ere-
fore, Bob, instead of saying “I love you with all my heart!”, I would like to end
by saying: “I love you with all my liver!”
Charlotte Debbaut
Gent, September 2013
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Samenvatting
Inleiding
Het blijvend tekort aan geschikte donorlevers voor transplantatie hee on-
derzoekers ertoe aangezet omnieuwemogelijkheden te zoekenomdedonor-
pool te vergroten. De donorpool bestaat hoofdzakelijk uit overleden dono-
ren en een kleiner aandeel levende donoren. Hoewel er volgens de standaard-
criteria gewerktwordtmet hersendode donoren, worden steeds vaker donor-
levers gebruikt afkomstig van donoren die overleden aan de gevolgen van
circulatoir arrest of van hersendode donoren met contra-indicaties (bijv. le-
versteatose). Aangezien deze organen gevoeliger zijn aan ischemie-reper-
fusieschade en koude temperaturen (zoals het geval is bij de huidige gouden
standaard van statische koude bewaring) dan organen van standaardcriteria
donoren, werd er gezocht naar betere bewaringstechnieken. Bijgevolg kende
machineperfusie (MP) gedurende de laatste decennia een snelle opmars als
alternatieve bewaringsmethode voor donorlevers met een betere en langere
preservatie dan statische koude bewaring. Desondanks zijn de optimaleMP-
instellingen om beschadiging te voorkomen (bijv. mogelijke beschadiging
van de sinusoïdale endotheelcellen) en om homogene perfusie te waarbor-
gen nog niet eenduidig bepaald (vooral voor hypothermischeMP;HMP), en
wordt MP nog steeds geconfronteerd met een aantal logistieke problemen
(vooral bij normothermische MP; NMP). Verder werden ook alternatieve
transplantatietechnieken voorgesteld om het orgaantekort te verhelpen, zo-
als levertransplantaties met levende donoren (LDLT), waarbij een gezonde
persoon een deel van zijn lever afstaat aan een patiëntmet leverfalen. Helaas
lopen deze donoren en ontvangers het risico om complicaties te ontwikkelen
zoals het ‘small-for-size’-syndroom. Daarnaast is er het aanhoudende debat
omtrent de optimale hoeveelheid bij de donor te verwijderen leverweefsel
alsook omtrent de resectielocatie. Binnen deze klinische context zouden
modellen van de leverperfusie dus ingezet kunnen worden om meer in-
zicht te verschaen in de hemodynamische impact van MP alsook van een
partiële hepatectomie.
De unieke bouw en de complexe vasculaire architectuur van de lever
spelen ongetwijfeld een belangrijke rol in de hierboven aangehaalde proble-
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men. Daarom wordt er in deel I eerst een overzicht gegeven van de ana-
tomie, fysiologie, pathologie en transplantatie van de lever, gevolgd door
een samenvatting van de beschikbare literatuur omtrent het modelleren van
de (perfusie van de) lever. Vervolgens focussen deel II en deel III op het
onderzoek dat binnen dit doctoraat uitgevoerd werd. Deel II bespreekt hoe
een stromingsmodel van de globale leverperfusie ontwikkeld werd om de
interne hepatische stromingspatronen te bestuderen, bijv. tijdens MP. Aan-
gezien demicrocirculatie een sleutelrol speelt bij leverbeschadiging, handelt
deel III over het ontrafelen en modelleren van de perfusie-eigenschappen
van de hepatische microcirculatie. Tenslotte worden in deel IV de belang-
rijkste conclusies en toekomstperspectieven opgelijst. Hieronder wordt de
inhoud van ieder hoofdstuk kort samengevat.
Deel I. De lever: van anatomie tot model
Hoofdstuk 1. Anatomie en fysiologie van de lever
Hoofdstuk 1 gee een overzicht van de macro- en microscopische anatomie
van de lever met de focus op de unieke vasculaire architectuur van de lever.
Zo is de lever voorzien van twee aerente vatensystemen (de hepatisch ar-
teriële (HA) en de portaal veneuze (PV) vaatboom) en één eerent vatensys-
teem (de hepatisch veneuze vaatboom (HV)). Op hetmicroscopische niveau
bestaat de lever uit leverlobules (opgebouwd uit o.a. hepatocyten), die de
sinusoïden (kleinste hepatische bloedvaten afgelijnd door endotheelcellen)
bevatten.
Verder worden de belangrijkste leverfuncties aangehaald, zoals de regu-
lerende functies van de lever in de bloedcirculatie, de lymfe- en galproductie,
de metabolische rol, detoxicatie, leverregeneratie enz.
Hoofdstuk 2. Pathologie van de lever
Leverpathologieën worden onderverdeeld in hepatocellulaire en cholesta-
tische ziektes. Hepatocellulaire ziektes (bijv. steatose, brose, hepatitis en
cirrose) zijn de frequentste leverpathologieën en worden gekenmerkt door
inammatie en necrose van de levercellen. Deze ziektes worden vaak ge-
compliceerd door vasculaire aandoeningen zoals portale hypertensie. Cho-
lestatische ziektes (bijv. cholestasis en biliaire cirrose) duiden op een inhi-
bitie of obstructie van de galafvloei. In een vergevorderd stadium kunnen
leverziektes leiden tot leverfalen. In het geval van ongeneeslijke leverziektes
is levertransplantatie op dit moment de enige behandeling.
Hoofdstuk 3. Levertransplantatie
De donorpool voor levertransplantatie bevat zowel overleden als levende
donoren. Hierbij worden de overleden donoren onderverdeeld in hersen-
dode donoren (standaardcriteria), donoren overleden aan een circulatoir
arrest en hersendode donorenmet bijkomende complicaties (bijv. leverstea-
tose of een hoge leeijd). De transplantatieprocedure start met de identi-
catie en aanmelding van een donor bij Eurotransplant, gevolgd door de
toewijzing van de beschikbare donororganen aan de ontvangers. Vervolgens
worden de organen gepreleveerd en getransporteerd om nadien getrans-
planteerd te worden. Er bestaan verschillende technieken voor levertrans-
plantatie, zoals de standaardtechniek van orthotope levertransplantatie en
alternatieve technieken zoals LDLT en gesplitste levertransplantatie. Daar-
naast wordt ook een vergelijking gemaakt tussen verschillende preservatie-
technieken voor donorlevers, zijnde de gouden standaard van statische kou-
de bewaring en de opnieuw ontdekte MP-techniek.
Vervolgens worden een aantal HMP-experimenten besproken ommeer
inzicht te verwerven in het perfusiegedrag van geïsoleerde (varkens)levers,
en in het bijzonder in de stromingscompetitie tussen de HA and PV. Aange-
zien dit fenomeen kan leiden tot een onevenwichtige perfusie en de HMP-
stabiliteit in gevaar kan brengen, is het essentieel om de determinanten van
stromingscompetitie te onderzoeken. Zo werd in deze studie de invloed van
HMP-randcondities op het gedrag van de geperfundeerde lever onderzocht.
De resultaten toonden aan dat stromingscompetitie kon uitgelokt worden
door de HA-druk te verhogen alsook door een obstructie aan te brengen
ter hoogte van de hepatische outow. Deze fenomenen konden gerelateerd
worden aan veranderingen van de intrasinusoïdale druk en zouden in reke-
ning moeten gebracht worden bij het ontwerp van HMP-protocollen.
Hoofdstuk 4. Modelleren van de lever
Hoofdstuk 4 gee een overzicht van de reeds ontwikkelde modellen van de
lever (experimentele modellen en computermodellen van de leveranatomie,
-perfusie, -mechanica en -functies), die relevant zijn voor dit manuscript.
Verschillende technieken enmodellen werden eerder aangewend om de he-
patische vasculatuur te bestuderen op zowel het macroscopische als het mi-
croscopische niveau (bijv. vasculaire afgietsels, classicatie van de vertak-
kingstopologie gebaseerd op bloedvatengeneraties enz.). Hoewel de vascu-
laire architectuur reeds het onderwerp was van vele studies, werd er nooit
eerder een analyse uitgevoerd van het complete spectrum van bloedvaten
gaande van de macrocirculatie tot de microcirculatie van één en dezelfde
lever.
Verschillende experimentele diermodellen (gebruikmakende van ratten,
muizen, varkens, honden enz.) werden reeds ontwikkeld om de normale
alsook verstoorde leverperfusie (bijv. na een partiële hepatectomie, in het
geval van cirrose enz.) te karakteriseren, maar hierbij valt op te merken
dat diermodellen niet altijd representatief zijn voor de mens. Verder wer-
den ook verschillende computermodellen ontwikkeld om leverperfusie te
simuleren: compartimentele modellen, elektrisch analoge modellen en nu-
merieke vloeistofdynamische (Computational Fluid Dynamics; CFD) mo-
dellen.
Naast de levervasculatuur en -perfusie werden ook andere aspecten van
de lever gemodelleerd. Zowerd demechanica van leverweefsel reeds experi-
menteel (bijv. trek- en compressietesten) alsook numeriek bestudeerd (bijv.
poroviscoelastische materiaalmodellen). Verder focusten verschillende stu-
dies op het modelleren van leverfuncties zoals het verwijderen van chemi-
caliën en leverregeneratie.
Deel II. De hepatische macrocirculatie: van experiment tot
elektrisch analoog model
Hoofdstuk 5. Analyse van de vasculaire architectuur van de humane
lever aan de hand van vasculaire afgietsels en micro-CT beeldvorming
Hoewel een goed inzicht in de hepatische circulatie belangrijk is voor le-
vertransplantatie, -chirurgie en -pathologie, is er nog steeds weinig geweten
omtrent de topograsche organisatie van de levervasculatuur. Daaromwerd
in dit hoofdstuk de humane hepatische vasculatuur gematerialiseerd, gevi-
sualiseerd en morfologisch geanalyseerd op verschillende schalen, zijnde de
macro- en mesocirculatie.
Een vasculair afgietsel (replica van de bloedvaten) van een humane lever
werd verkregen door een simultane injectie van polymeervloeistof in de HA
en PV. Een micro-CT-scan van de volledige replica op hoge resolutie (110
µm) liet toe om gedetailleerde data te verzamelen van de macrovasculatuur,
zijnde de grootste bloedvaten. Vervolgens werd een sample gedissecteerd
(representatief voor de mesocirculatie startende bij bloedvatengeneratie 5;
88 mm x 68 mm x 80 mm) en gescand met een resolutie van 71 µm. Seg-
mentaties en drie-dimensionale (3D) reconstructies maakten het mogelijk
om de topologie (volgens de waargenomen vertakkingspatronen en dus niet
volgens de anatomische segmentatie) en geometrische eigenschappen van
de HA-, PV- en HV-vaatboom te kwanticeren tot op het niveau van de 13e
bloedvatengeneratie (stralen varieerden van 13.2 mm tot 80 µm; lengtes van
74.4 mm tot 0.74 mm).
Door de techniek van vasculaire afgietsels te combineren met micro-
CT scans konden de vertakkingstopologie en geometrische eigenschappen
van de hepatische vasculatuur gekwanticeerd worden aan de hand van een
multischaalaanpak.
Hoofdstuk 6. Studie van de humane leverhemodynamica en -perfusie:
van vasculaire replica tot elektrisch analoog model
Niettegenstaande HMP gezien wordt als een potentieel betere preservatie-
methode (in het bijzonder voor levers afkomstig van donoren overleden aan
een circulatoir arrest of donorenmet contra-indicaties zoals steatose) in ver-
gelijkingmet statische koude bewaring, zijn de optimale perfusieprotocollen
momenteel nog niet eenduidig gedenieerd voor deze niet-fysiologische be-
waringsmethode, waarbij hypothermie in se een potentieel probleem vormt.
Hierbij worden o.a. demogelijke beschadiging vande sinusoïdale endotheel-
cellen en heterogene perfusie gezien als hinderpalen. Daarom werd in dit
hoofdstuk een elektrisch analoog model ontwikkeld van de humane hepati-
sche bloedcirculatie om interne druk- en debietverdelingen in de lever te be-
studeren tijdens HMP en om verschillende HMP-condities uit te testen. De
gedetailleerde geometrische eigenschappen van de hepatisch humane vas-
culatuur, verkregen in hoofdstuk 5, werden gebruikt om de componenten
van het elektrisch model te berekenen.
Het model kon de eecten van drukgestuurde HMP op de leverhemo-
dynamica simuleren en kon observaties zoals stromingscompetitie tussen
de HA en PV reproduceren. Onze simulaties tonen verder ook aan dat,
gezien vanuit een puur biomechanisch (schuifspanning) standpunt, drukge-
stuurde HMPmet lage drukken niet resulteert in endotheelschade en dat de
vloeistofviscositeit geen eect hee op de schuifspanning die tijdens druk-
gestuurdeHMP heerst ter hoogte van de levermicrovasculatuur. Deze resul-
taten impliceren een mogelijke toepasbaarheid van deze techniek om per-
fusiecondities virtueel uit te testen.
Hoofdstuk 7. Validatie en kalibratie van een elektrisch analoog model
van de hepatische perfusie op basis van HMP-experimenten
In hoofdstuk 6 werd een elektrisch analoog model ontwikkeld van de hu-
mane hepatische perfusie tijdensHMP.Hierbij dienden een aantal veronder-
stellingen gemaakt te worden als gevolg van enkele ongekende parameters.
Om het elektrisch analoog model te toetsen aan experimentele data wordt
er in dit hoofdstuk een methodologie toegelicht om het initiële elektrische
model (ontwikkeld in hoofdstuk 6) te valideren en te tunen voor een spe-
cieke lever. Een aantal HMP-experimenten werden uitgevoerd om het per-
fusiegedrag van humane levers te karakteriseren aan de hand van simultane
druk- en debietmetingen. De berekening van HA- en PV-ingangsimpedan-
ties liet toe om compacteWindketelmodellen te tten aan de globale hepati-
sche perfusie-eigenschappen. Vervolgens werden deze globale eigenschap-
pen gebruikt om het leverspeciek elektrisch analoog model te tunen.
Hoofdstuk 8. Modelleren van de impact van partiële hepatectomie op
de hepatische hemodynamica gebruikmakende van een rattenmodel
LDLT biedt een mogelijkheid om de donorpool uit te breiden, maar kan
tevens leiden tot het ‘small-for-size’-syndroom, waarbij een te klein levervo-
lume als het ware te veel bloedstroming te verwerken krijgt. Aangezien de
hemodynamische eecten van een partiële hepatectomie nog niet volledig
duidelijk zijn, ontwikkelden we een elektrisch model van de bloedcirculatie
doorheen de rattenlever (gebaseerd op het model van hoofdstuk 6) om de
hemodynamica van de normale lever te vergelijken met die van een lever
waaruit een deel geresecteerd werd.
Gedetailleerde 3D-reconstructies en geometrische data van de levervas-
culatuur van twee rattenwerden verzameld door vasculaire afgietsels te com-
bineren met micro-CT scans en beeldverwerking. Deze data lieten toe om
een druk- en een debietgestuurd elektrisch model te ontwikkelen van de
totale rattenlever. Vervolgens werden virtuele resecties uitgevoerd om een
70%, 80% en 90% partiële hepatectomie te modelleren en de impact hiervan
op de hemodynamica te voorspellen. De resultaten demonstreerden duide-
lijke hyperperfusie met portale hypertensie en verhoogde PV-debieten per
lob. De vergelijking van twee 90% resectietechnieken demonstreerde ver-
schillen in totale HA-debieten, portale en sinusoïdale drukken, wat moge-
lijks zou kunnen resulteren in betere overlevingskansen voor lagere portale
en sinusoïdale drukken. Naar de toekomst toe kunnen deze nieuwe model-
len geëxtrapoleerd worden naar de humane context en kunnen ze mogelijks
bijdragen tot een betere planning van partiële hepatectomieën.
Deel III. De hepatische microcirculatie: van visualisatie van de
sinusoïdale geometrie tot microschaal-CFD-modellen
Hoofdstuk 9. Perfusiekarakteristieken van de humane hepatische
microcirculatie gebruikmakende van 3D-reconstructies en CFD-analyse
De hepatische microcirculatie bezit een unieke en complexe structurele or-
ganisatie en is gevoelig voor abnormale omgevingsfactoren (bijv. een ver-
hoogde schuifspanning tijdens HMP of na een partiële hepatectomie). Aan-
gezien demicrocirculatie daarenboven een sleutelrol speelt in het proces van
leverbeschadiging en aangezien relatief weinig geweten is omtrent de hepa-
tisch microvasculaire hemodynamica, was het aangeraden om de perfusie-
karakteristieken van de levermicrocirculatie verder te bestuderen. Hoewel
de hepatischemicrostructuur door vloeistofdynamischemodellen tot nu toe
vaak geanalyseerd werd als zijnde opgebouwd uit geïdealiseerde functionele
eenheden gebaseerd op poreuze media, is uitgebreider onderzoek essentieel
om de validiteit van deze aanpak te onderzoeken en om een adequate en
kwantitatieve karakterisatie van de levercirculatie toe te laten. In dit hoofd-
stuk onderzoeken we daarom de perfusiekarakteristieken van de humane
levermicrocirculatie.
Een microvasculair staal met drie leverlobules werd gedissecteerd uit
de vasculaire replica van een humane lever. Het staal werd vervolgens in-
gescand met een micro-CT scanner op een resolutie van 2.6 µm. Na de
beeldvorming werd een kubusvolume, gevuld met tortueuze en intergecon-
necteerde sinusoïden, uit de 3D-gereconstrueerde beelden geïsoleerd om
het vloeistofdomein te deniëren. Aan de hand van deze kubus werden
drie computationele vloeistofdynamische (CFD) modellen bestudeerd om
de stroming langs drie orthogonale richtingen te simuleren (i.e. parallel aan
de centrale vene, radiaal en in de circumferentiële richting van de lobule).
Verwerking van de resultaten liet toe omde perfusiekarakteristieken van
de microvasculatuur te visualiseren en te kwanticeren, alsook om de 3D-
porositeit en de permeabiliteitstensor met bijhorende permeabiliteitshoofd-
richtingen te berekenen. De CFD-simulaties resulteerden o.a. in data over
drukverschillen, stroomlijnen en wandschuifspanningen. Deze nieuwe data
tonen aan dat de humane hepatischemicrocirculatie gekarakteriseerd wordt
door een hogere permeabiliteit in de richting van de centrale vene, en een
ongeveer tweemaal kleinere permeabiliteit in de radiale en circumferentiële
richting ten opzicht van een lobule. Aangezien de permeabiliteitscoëciën-
ten afhangen van de stromingsrichting, zouden (poreuze media) modellen
van de levermicrocirculatie deze sinusoïdale anisotropie in rekeningmoeten
brengen.
Hoofdstuk 10. Een 3D poreus mediummodel van een leverlobule: het
belang van vasculaire septa en anisotrope permeabiliteit voor
homogene perfusie
Gebruikmakend van de perfusiekarakteristieken verkregen in hoofdstuk 9
ontwikkelden we in dit hoofdstuk een 3D-micromodel van een leverlobule
om de rol van vasculaire septa en de invloed van anisotrope permeabilitei-
ten te onderzoeken. De lobulewerd gemodelleerd als een hexagonaal prisma
(met of zonder vasculaire septa) en het leverweefsel werd behandeld als een
poreus medium (isotrope of anisotrope permeabiliteit). De modellen wer-
den opgelost met CFD.
De inclusie van vasculaire septa resulteerde in een betere perfusie van de
zones tussen de portale triades in vergelijking met modellen zonder vascu-
laire septa, alsook in een spatiaal homogenere perfusie van de lobule. Aniso-
trope permeabiliteit resulteerde in duidelijk verschillende stromingspatro-
nen met stroomlijnen die, in vergelijking met een isotrope permeabiliteit,
een grotere axiale snelheidscomponent hadden. Eenparameterstudie toonde
aan dat de resultaten het gevoeligst zijn aan de circumferentiële lobuledia-
meter en de radiale drukval. Ons model verscha inzicht in de hepatische
microhemodynamica en suggereert dat vooral de inclusie van vasculaire
septa leidt tot perfusiepatronen die de fysiologische werkelijkheid hoogst
waarschijnlijk beter benaderen. Verder hee het model potentieel om ook
aangewend te worden voor andere doeleinden zoals de microhemodyna-
mica in niet-fysiologische en pathologische situaties.
Deel IV. Conclusies
Hoofdstuk 11. Conclusies en toekomstperspectieven
Dit hoofdstuk gee een overzicht van de belangrijkste bevindingen en con-
clusies van dit manuscript. De hoofdboodschap van dit werk is dat er ver-
schillende modellen (anatomische modellen van de hepatische vasculatuur,
elektrisch analoge modellen van de hepatische perfusie en CFD-modellen
van de hepatische microcirculatie) ontwikkeld werden om de hepatische
perfusie te simuleren op verschillende niveaus (macro-, meso- en micro-
circulatie). Dit geheel aan modellen werd toegepast binnen het kader van
levertransplantatie en resulteerde in unieke morfologische en geometrische
data van humane levers en rattenlevers, alsook in nieuwe inzichten in de he-
modynamische impact vanMP-preservatie en partiële hepatectomieën (bijv.
bij LDLT procedures) en in de perfusiekarakteristieken van de hepatische
microcirculatie. Op deze manier waren we in staat om een aantal stukjes
van de puzzel omtrent leverperfusie te verzamelen. Verder onderzoek (zoals
validatie van de micromodellen en het bestuderen van meer levers) is onge-
twijfeld nodig om de volledige puzzel op te lossen. De veelzijdige modellen
die binnen dit doctoraatswerk ontwikkeld werden, zijn niet enkel toepas-
baar voor hemodynamische vraagstukken gerelateerd aan levertransplanta-
tie, maar ook voor leverpathologieën (bijv. cirrose), chirurgische ingrepen
(bijv. de Fontanprocedure) enz. Deze laatste zijn slechts enkele voorbeelden
van mogelijke toekomstige onderzoeksrichtingen.
Summary
Introduction
e substantial shortage of suitable donor livers for transplantation has forc-
ed researchers to investigate possibilities to increase the donor pool. e
donor pool contains mainly deceased donors and a smaller amount of liv-
ing donors. Although the standard criteria donors are donation aer brain
death donors (DBD), more and more livers from donation aer circulatory
death donors (DCD) and extended criteria donors (ECD; e.g. liver steatosis)
are being used. As DCD and ECD livers are more succeptible to ischaemia-
reperfusion injury and cold temperatures (as is the case for the golden stan-
dard of static cold storage) thanDBD organs, alternative preservationmeth-
ods were explored. As such, machine perfusion (MP) revived during the last
decades and was proposed as an alternative preservation method for donor
livers, allowing for better and longer preservation compared to cold storage.
However, liver MP encountered some problems (e.g. occasional endothelial
cell damage) and the most optimal perfusion settings to prevent microcir-
culatory damage, while assuring a sucient homogeneous perfusion, are
still unknown (especially for hypothermic MP; HMP). In addition, MP is
still confronted with logistical problems (especially for normothermic MP;
NMP). Furthermore, alternative transplantation techniques have been sug-
gested to help overcome the organ shortage. In living donor liver transplan-
tation (LDLT) for instance, a healthy person donates part of his liver to a
patient with liver failure. Unfortunately, LDLT donors and patients are suc-
ceptible to the ‘small-for-size’ syndrome and the most optimal amount of
liver tissue to resect as well as the resection planes are still a matter of de-
bate. Within this clinical context, models of liver perfusion would help to
gain more insight into the haemodynamic impact of MP as well as partial
hepatectomy procedures.
ese open questions are unevitably linked to the unique and complex
vascular architecture of the liver. erefore, part I provides a background
overview of liver anatomy, physiology, pathology and transplantation, fol-
lowed by a summary of previous modelling studies on the liver (perfusion).
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Parts II and III focus on the original research performed within the frame-
work of this PhD. Part II deals with the development, validation and appli-
cation of an electrical analog model of the global liver perfusion, e.g. during
MP. As the microcirculation plays a key role in liver damage, part III goes
deeper into unraveling and modelling the perfusion characteristics of the
hepatic microcirculation. Part IV ends this dissertation by listing the main
conclusions and future perspectives. Below, the content of each chapter is
briey summarised.
Part I. The liver: from anatomy to model
Chapter 1. Anatomy and physiology of the liver
Chapter 1 starts by discussing themacro- as well as themicroscopic anatomy
of the liver with the focus on its unique vascular organisation.e liver has
two aerent vessel systems (the hepatic arterial (HA) and the portal venous
(PV) tree) and one eerent vessel system (the hepatic venous tree (HV)). At
the microscopic level, the liver contains liver lobules (containing a.o. the he-
patocytes) including the sinusoids, being the smallest hepatic blood vessels
lined by endothelial cells.
In addition, the most important liver functions are addressed, such as
the liver’s regulatory functions in the blood ow, its lymph and bile produc-
tion, its metabolic role, detoxication, liver regeneration etc.
Chapter 2. Liver pathology
Liver pathologies are divided in hepatocellular and cholestatic diseases. He-
patocellular diseases (e.g. steatosis, brosis, hepatitis and cirrhosis) are the
most frequent liver pathologies and are characterised by inammation and
necrosis of liver cells. ese diseases are oen complicated by hepatic vas-
cular disorders such as portal hypertension. Cholestatic diseases (e.g. cho-
lestasis and biliary cirrhosis) are characterised by an inhibition or obstruc-
tion of the bile ow. In an advanced stage, they may lead to end-stage liver
failure. In the case of incurable liver diseases, liver transplantation is the
only possible treatment at this moment.
Chapter 3. Liver transplantation
e donor pool for liver transplantation contains deceased as well as living
donors. Deceased donors are classied in DBD (standard criteria), DCD
and ECD donors (with contraindications such as steatosis or advanced age).
e transplantation procedure starts with the identication and registration
of the donor to Eurotranplant, followed by the allocation of the available
donor organs to recipients. Subsequently, the donor organs are prelevated
and transported to be transplanted aerwards. Several types of liver trans-
plantation procedures exist, such as the most frequently applied orthotopic
liver transplantation technique and alternative techniques such as LDLT or
split liver transplantation. Next, dierent preservation techniques for donor
livers are discussed, comparing static cold storage with the reviving tech-
nique of MP.
Furthermore, a set of HMP experiments are presented to gain more
knowledge on the perfusion behaviour of isolated (porcine) livers, more
specically in the ow competition between the HA and PV. Since this phe-
nomenon may lead to unbalanced MP and thus aects HMP stability, it is
essential to gain more insight into the determinants of ow competition.
To this end, we investigated the inuence of HMP settings on the isolated
liver behaviour. e results showed that ow competition could be evoked
by increasing the HA pressure as well as by obstructing the hepatic outow.
ese phenomena could be related to intrasinusoidal pressure alterations
and should be taken into account for the design of liver HMP protocols.
Chapter 4. Modelling the liver
Chapter 4 lists the previously developed models of the liver (experimental
models and computer models of liver anatomy, perfusion, mechanics and
function), relevant to the work performed in this manuscript. As such, sev-
eral techniques and models (vascular corrosion casting, branching topo-
logy classications based on blood vessel generations etc.) have been used
to study the hepatic vasculature on both the macroscopic and microscopic
scale. Although the hepatic vascular architecture has been the topic of many
studies, a vascular analysis of the complete spectrum of blood vessels rang-
ing from the macrocirculation to the microcirculation of one and the same
liver has not yet been performed.
Previous studies are almost exclusively based on experimental animal
models (using rats, mice, pigs, dogs etc.). ese models were developed to
assess normal liver perfusion as well as disturbed liver perfusion character-
istics (e.g. aer a partial hepatectomy, in the case of cirrhosis). Note, how-
ever, that animal models are not always representative for humans. Several
modelling approaches have been applied to simulate liver perfusion: com-
partment models, electrical analog models as well as computational uid
dynamics (CFD) models.
Besides the liver vasculature and perfusion, liver mechanics have been
studied experimentally (tensile and compression tests etc.) as well as nu-
merically by e.g. poroviscoelastic material models. Finally, the literature
overview also briey adresses studies focussing onmodelling liver functions,
such as the removal of chemicals and liver regeneration.
Part II. The hepatic macrocirculation: from experiments to
electrical analog models
Chapter 5. Analysing the human liver vascular architecture by
combining vascular corrosion casting and micro-CT scanning
ough a full understanding of the hepatic circulation is important for liver
transplantation, surgery and pathology, relatively little is known about the
topographical organisation of the liver vasculature. In this chapter, the hu-
man hepatic vasculature was materialised, visualised and morphologically
analysed at dierent scales (being the macro- and mesocirculation).
A unique human liver vascular corrosion cast was obtained by simulta-
neous resin injection in the HA and PV. A high resolution (110 µm) in globo
micro-CT scan of the cast allowed gathering detailed data on the macrovas-
culature. Subsequently, a sample representing the mesocirculation (starting
at blood vessel generation 5; 88 mm by 68 mm by 80 mm) was dissected
and imaged at a 71 µm resolution. Segmentations and three-dimensional
(3D) reconstructions allowed quantifying the macro- and mesoscale topo-
logy (according to the observed branching patterns; not according to the
anatomical segments) and geometrical features of the HA, PV and HV trees
up to 13 generations (radii ranging from 13.2mm to 80 µm; lengths from 74.4
mm to 0.74 mm).
Combining vascular corrosion casting and micro-CT imaging allows
quantifying the branching topology and geometrical features of the hepatic
vasculature by using a multiscale approach.
Chapter 6. From vascular corrosion cast to electrical analog model for
the study of human liver haemodynamics and perfusion
While HMP is experiencing a revival in organ preservation (especially for
DCD and ECD livers), perfusion protocols are still poorly dened for this
non-physiological preservation method, for which hypothermia is a poten-
tial problem. Hereby, potential sinusoidal endothelial cell injury and hetero-
geneous perfusion are concerns. In order to enlighten internal pressure and
ow distributions duringHMP and test dierent HMP settings, an electrical
model of the human liver blood circulation is presented in this chapter.e
detailed human hepatic vascular data, obtained in chapter 5, were used to
set up the electrical model.
e model was able to simulate eects of pressure-driven HMP on liver
haemodynamics and reproduced observations such as ow competition be-
tween the HA and PV. Our simulations further indicated that, from a pure
biomechanical (shear stress) point of view, pressure-controlled HMP with
low pressures should not result in organ damage, and that uid viscosity has
no eect on the shear stress experienced by the livermicrocirculation during
pressure-driven HMP.ese ndings imply that this modelling technique
may be applicable to virtually test perfusion conditions.
Chapter 7. Validation and calibration of an electrical analog model of
hepatic perfusion based on human liver HMP experiments
In chapter 6, an initial electrical analog model was developed to investigate
the human hepatic perfusion during HMP. Due to unknown parameters, a
number of assumptions had to be made. To test the electrical analog model
against experimental data, this chapter presents a methodology to validate
and tune the initial electrical model (as developed in chapter 6) for a specic
liver. A number of HMP experiments were aimed at capturing the perfusion
behaviour of human liver gras by performing simultaneous pressure and
ow measurements. e calculation of HA and PV input impedances en-
abled tting compactWindkesselmodels to represent the global hepatic per-
fusion properties. Subsequently, these global properties were used to tune
an extended liver-specic electrical analog model.
Chapter 8. Modelling the impact of partial hepatectomy on the hepatic
haemodynamics using a rat model
LDLT may help expanding the donor pool, but is oen confronted with the
‘small-for-size’ syndrome, in which a small liver has to deal with too much
blood ow. Since the haemodynamic eects of partial hepatectomy are not
fully understood, we developed an electrical model of the blood circulation
through the rat liver (derived from the model discussed in chapter 6) in
order to compare the normal liver haemodynamics with those of partially
resected livers.
Detailed geometrical data and 3D reconstructions of the liver vascu-
lature of two rats were gathered by combining vascular corrosion casting,
micro-CT scanning and image processing. Data extrapolations allowed ob-
taining a total liver pressure- and ow-driven electrical analog model. Sub-
sequently, virtual resections led to 70%, 80%, or 90% partial hepatectomy
models. Results demonstrated hyperperfusion eects such as portal hyper-
tension and elevated lobe-specic PV ows. Comparison of two 90% re-
section techniques demonstrated dierent total arterial ows, portal and si-
nusoidal pressures, possibly resulting in better survival for lower portal and
sinusoidal pressures.esemodelsmay be extrapolated to human livers and
help to optimise hepatectomy planning.
Part III. The hepatic microcirculation: from imaging the
sinusoidal geometry to microscale CFD models
Chapter 9. Perfusion characteristics of the human hepatic
microcirculation based on 3D reconstructions and CFD analysis
e hepaticmicrovasculature has a unique and complex organisation, and is
susceptible to abnormal stressors, possibly arising during MP or aer a par-
tial hepatectomy procedure etc. As the microcirculation plays a pivotal role
in liver perfusion and function, and since relatively little is known about the
microvascular haemodynamics, it is advisable to put more eort in unravel-
ing the microcirculation perfusion properties. Previously, perfusion mod-
els of the liver microcirculation were oen analysed in terms of idealised
functional units (e.g. hexagonal liver lobules) based on a porous medium
approach, while more elaborate research is essential to assess the validity of
this approach and to provide amore adequate and quantitative characterisa-
tion of the liver microcirculation. erefore, we investigated the perfusion
characteristics of the liver microcirculation in this chapter.
A microvascular sample representing three liver lobules, was dissected
from a human liver vascular corrosion cast and scanned using a high resolu-
tion (2.6 µm) micro-CT scanner. Following image processing, a cube repre-
senting a sample of intertwined and interconnected sinusoids, was isolated
from the 3D reconstructed dataset to dene the uid domain.ree compu-
tational uid dynamics (CFD) models were studied to simulate ow along
three orthogonal directions (i.e. parallel to the central vein and in the radial
and circumferential directions of the lobule).
Post-processing allowed visualising and quantifying the microvascular
ow characteristics, calculating the permeability tensor and corresponding
principal permeability axes, as well as the 3D porosity.e CFD simulations
provided data on pressure dierences, preferential ow pathways and wall
shear stresses. Our data indicate that the human hepatic microcirculation is
characterised by a higher permeability along the central vein direction, and
an about two times lower permeability along the radial and circumferential
directions of a lobule. Since the permeability coecients depend on the ow
direction, (porous medium) liver microcirculation models should take into
account sinusoidal anisotropy.
Chapter 10. A 3D porous media liver lobule model: the importance of
vascular septa and anisotropic permeability for homogeneous perfusion
Using the perfusion characteristics acquired in chapter 9, we developed a 3D
microcirculatory liver lobule model to investigate the role of vascular septa
(VS) and anisotropic permeability.e lobule was modelled as a hexagonal
prism (with or without VS) and the tissue was treated as a porous medium
(isotropic or anisotropic permeability). Models were solved using CFD.
VS inclusion resulted in better perfusion of the zones lying between
portal tracts as well as amore spatially homogeneous perfusion of the lobule
compared tomodels neglecting the VS. Anisotropic permeability resulted in
clearly dierent ow patterns with streamlines that are oriented closer to the
lobule axes compared to isotropic permeability. A parameter study revealed
that results are most sensitive to the lobule circumferential diameter and
radial pressure drop. Our model provides insight into hepatic microhaemo-
dynamics, and suggests that especially the inclusion of VS in themodel leads
to perfusion patterns that are likely to better reect physiological reality.e
model has also potential for other applications such as unphysiological and
pathological conditions.
Part IV. Conclusions
Chapter 11. Conclusions and future perspectives
is chapter gives an overview of the key ndings and most important con-
clusions of this manuscript. e take home message of this work is that a
multi-level modelling framework (anatomical models of the hepatic vascu-
lature, electrical analog models of the hepatic perfusion and CFDmodels of
the hepatic microcirculation) was developed to simulate hepatic perfusion
at dierent scales (macro-, meso- en microcirculation). is framework
was applied in the context of liver transplantation and resulted in unique
3D morphological and geometrical data on human and rat livers, as well as
novel insights into the haemodynamic impact of MP preservation of donor
livers, partial hepatectomy procedures (such as LDLT), and into the per-
fusion characteristics of the liver microcirculation. Doing so, we collected
some missing pieces of the puzzle on liver perfusion, but further research
(such as validation of themicromodels and investigatingmore livers) is nec-
essary to reveal the complete picture.e versatile modelling tools that were
generated within this PhD work, are not only applicable to hepatic haemo-
dynamic issues related to liver transplantation, but also to liver pathologies
(e.g. cirrhosis), surgical interventions (e.g. the Fontan procedure) etc.ese
represent only a few of the potential future research directions to go from
here.
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Introduction
The liver: a mythical organ
e rst reports on the liver and its anatomy date back from many centur-
ies ago.e ancient Greek culture already provided two tales involving the
liver. One of them is the myth of Prometheus, written by the poet Hesoid
(700-750 BC). According to one of the versions of this myth, Prometheus,
who created mankind, oered the best meat of a cow to mortal humans,
while giving only bones and fat to the gods. Zeus, king of the gods, was furi-
ous about this and punished mankind by taking their re. Prometheus stole
the re back, but he was caught. Zeus punished Prometheus by chaining
him to a rock on the mountain Caucasus and making an eagle eat from his
liver daily (Fig. 1). His liver grew back overnight and the hungry eagle re-
turned each morning, leaving Prometheus in eternal pain [282, 336]. While
the myth of Prometheus is generally well-known, less is known about the
myth of Tityus. Tityus, son of Zeus, was another mythical gure who was
so gigantic that his body was believed to cover nine acres. Tityus made the
mistake of attempting to rape Leto, mother of Apollo. She cried for help re-
sulting in Apollo trying to kill Tityus with his arrows, but he could not kill
the immortal Tityus. Nonetheless, Zeus punished Tityus by exiling him to
Hades, kingdom of the dead, where he was tied down. Two vultures (or a
snake according to another version of this myth) were released to fed on his
regenerating liver.is resulted in eternal torture, similar to the punishment
of Prometheus [406, 468].
ese mystical tales illustrate that the ancient Greek already had some
knowledge of the liver and its ability to regenerate (see section 1.2.12). How-
ever, as stated by Lehman et al. [282], the liver remains - to some extent - ‘a
fragile bleeding mystery’. . .
Clinical context and research goals
Since liver transplantation became a true and successful treatment for liver
failure, a substantial discrepancy arose between the supply of donor livers
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Figure 1: Prometheus Bound, 1611-1612. Photographic reproduction of an oil painting by Peter
Paul Rubens (Flemish painter who lived from 1577 to 1640). Source: [10].
and the demand for liver transplantation during the last decades. As a con-
sequence, there is now a substantial shortage of liver gras for patients with
liver failure and waiting lists are becoming longer. Patients die while waiting
for a transplant liver.is urged research, aiming to reduce the waiting list
and increase the number of available liver gras.
Machine perfusion
One of the proposed options to expand the donor pool is the use of organs
that are currently uncommonly used for transplantation (e.g. livers from
donation aer circulatory death donors or extended criteria donors with
contraindications such as liver steatosis, advanced age etc.) [345]. Com-
pared to standard criteria organs (donation aer brain death), these organs
are more succeptible to ischaemia-reperfusion injury, which is partly ag-
gravated by the current gold standard of static cold storage. Consequently,
machine perfusion (MP) preservation (see also section 3.3.2) was proposed
lii
as a potential alternative preservation technique for donor organs, dier-
ent from and better than static cold storage. MP can be hypothermic (non-
physiological cold perfusion) or (sub)normothermic (with normothermic
MP mimicking normal in vivo liver perfusion) [341]. Experimental studies
gave evidence of a better organ viability aer MP preservation, especially in
the case of extended criteria donor livers (see section 3.1.3). Other advan-
tages of MP are the possibility of longer preservation periods compared to
static cold storage, as well as the possibility to monitor the behaviour and vi-
ability of the organ by measuring perfusion parameters. Nonetheless, liver
MP also encountered some non-negligible disadvantages. As such, the two
blood inlets of the liver may start to compete during MP. Furthermore, it
is known that the unique and complex hepatic microvasculature is prone
to abnormal stressors which may arise due to hyperperfusion and lead to
endothelial injury. In the end, the challenge is to dene the most optimal
perfusion settings to prevent microcirculatory damage while assuring suf-
cient and homogeneous perfusion. It would thus be insightful to clarify
the intrahepatic haemodynamics at both the macro- and microscale during
(hypothermic) MP and to develop a liver perfusion model to test dierent
settings.
Alternative transplantation techniques
Another possibility to circumvent the donor liver shortage is to use alter-
native transplantation techniques, such as living donor liver transplantation
(LDLT; see section 3.2.3.2) and split liver transplantation (SLT; see section
3.2.3.1). In LDLT, a healthy living person donates a part of his liver to a pa-
tient with liver failure, while SLT stands for a deceased donor liver being
split into two liver gras to be transplanted into two recipients. e dis-
advantage of these transplantation techniques is the risk of developing the
small-for-size syndrome (SFSS). SFSS is characterised by a liver that is too
small compared to the patient’s body and may lead to serious complications
or even liver gra failure. In this context, it is for instance not completely
clear how much liver tissue can be safely removed from a living donor, or
what the optimal resection planes are. More insight into the haemodynam-
ics before and aer partial hepatectomy is thus desired.
Research goals
Since hepatic haemodynamics are shown to play an important role in dif-
ferent liver transplantation strategies, this dissertation focused on clarify-
ing and modelling hepatic haemodynamics and perfusion across dierent
length scales.ree major research goals were dened:
liii
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Goal 1. Development of a methodology for the quantitative anal-
ysis of the human liver vasculature from the macro- down to the
microscopic level.
Goal 2. Development of computer models to study the intrahepa-
tic haemodynamics and quantify biomechanical stressors on the
macro- and microscale level.
Goal 3. Validation and application of the acquired models.
Structure overview
is dissertation is divided into four major parts.
Part I gives a background overview starting with the liver anatomy and
physiology (chapter 1). Subsequently, the dierent categories of liver patho-
logies are discussed followed by the treatment options, of which liver trans-
plantation is the ultimate treatment for patients with end-stage liver failure
(chapter 2). Chapter 3 deals with the donor pool for liver transplantation,
the transplantation procedure and liver preservation techniques with the
focus on MP. Chapter 4 gives a literature overview of previous modelling
approaches to study the hepatic vasculature and perfusion as well as a short
overview of liver mechanics and function models.
In part II, chapter 5 rst focuses on acquiring detailed data on the he-
patic vascular architecture. ese data are used in chapter 6 to develop an
electrical analog model of the human liver perfusion in order to study the
internal hepatic ow patterns during MP. Chapter 7 discusses how the elec-
trical analog model is validated and tuned to a specic liver based on MP
experiments to acquire the hepatic perfusion characteristics. Subsequently,
the electrical liver model is adapted to the rat liver in order to investigate the
eect of partial hepatectomy on the hepatic haemodynamics (chapter 8).
While part II mainly focuses on the hepatic macrocirculation, part III
goes deeper into the hepatic microcirculation. In chapter 9, a CFD model,
based on a real 3D geometry of sinusoids, is developed to quantify the perfu-
sion characteristics of the hepatic microcirculation. Chapter 10 applies the
acquired permeability data to develop a porous media model of the blood
ow through a liver lobule.
Finally, part IV sums the most important conclusions of this disserta-
tion, as well as the future perspectives (chapter 11).
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The liver:
from anatomy to model
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Anatomy and physiology
of the liver
Before adressing the research and ndings of this PhD dissertation (part II-
IV), it is important to give a general background overview. In this chapter,
the anatomy of the liver will be discussed from the macroscopic to the mi-
croscopic level. We will further discuss its major regulatory and metabolic
functions.
1.1 Anatomy of the liver
1.1.1 Macroscopic anatomy of the liver
1.1.1.1 General characteristics
e liver is the largest organ in the human body.e human liver accounts
for approximately 2-2.5% of the body weight, which corresponds to a liver
weight of 1.4 kg for the average adult. At birth, however, the liver is pro-
portionally larger, occupying approximately 5.5% of the body weight. e
wedge-shaped liver typically has a brown-reddish colour and is located in
the right upper quadrant of the abdominal cavity, just below the diaphragm
(Fig. 1.1). Due to its location, the liver is partially protected by the rib cage of
the thorax. Furthermore, the liver is embedded in the visceral peritoneum,
except for the locationwhere the liver touches the diaphragm (bare area; Fig.
1.2). e liver is also covered by a thin layer of connective tissue: the liver
capsule (also called the capsule of Glisson).e gallbladder is located at the
3
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Liver
Gallbladder
Large intestine
Stomach
Small intestine
Figure 1.1: e human liver is located in the upper right quadrant of the abdominal cavity.
Adapted from [4].
inferior side of the liver and acts as a storage location for bile produced by
the liver and the bile ducts [118, 122, 164, 278, 311, 351, 400, 496].
e human liver is traditionally divided into four primary anatomic liver
lobes (Fig. 1.2). e right lobe (lobus dexter) is the largest lobe, and has
approximately six times the size of the le lobe (lobus sinister). e two
Superior
Superior
Posterior
Anterior
Right
Inferior
Vena cava inferior
Bare area
Right lobe        Left lobe Left lobe       Right lobe
Ligamentum
falciforme
Ligamentum
teres
Gallbladder
Porta hepatis
Vena cava inferior
Gallbladder
Gallbladder
Caudate lobe
Quadrate lobe
Caudate lobe
Quadrate lobe
(a)
(c)
(b)
(d)
Figure 1.2: Dierent views of the human liver based on the classical view of four lobes: (a)
superior, (b) posterior, (c) anterosuperior and (d) posteroinferior view of the liver. Adapted
from [122].
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smaller lobes are visible in a posteroinferior view of the liver: the caudate
lobe (lobus caudatus) and the quadrate lobe (lobus quadratus). e liver is
attached to its surrounding structures by a number of ligaments. e liga-
mentum falciforme (visible on the anterosuperior view of the liver) attaches
the liver to the diaphragm and separates the right from the le lobe. Below
the ligamentum falciforme lays the remnant of the foetal umbilical vein: the
ligamentum teres.e gallbladder is situated between the right lobe and the
quadrate lobe. It is a thin-walled greenish muscular sac having a length of
approximately 10 cm and a volume of approximately 50 ml [311, 377].
In addition to the traditional division of the human liver in four ana-
tomic lobes, there is a more functional schematisation dividing the liver
in lobes and segments. Several hepatic functional classications [78, 79,
133, 176, 177, 437, 443] have been proposed, such as the system described
by Couinaud (and later rened by Bismuth [38] by dividing segment 4 in
segment 4a and 4b) which is accepted by the transplantation community
in Europe, North America and Asia [213]. Couinaud divided the liver into
a functional le and right liver by a main portal scissurae containing the
middle hepatic vein running from themiddle of the gallbladder fossa anteri-
orly to the inferior vena cava posteriorly. Typically, each segment has its own
blood supply and biliary drainage, without anastomoses between these seg-
ments (Fig. 1.3). In the centre of each segment there is a branch of the portal
vein, hepatic artery and bile duct. In the periphery of each segment, there is
vascular outow through the hepatic veins. Hereby, the liver is divided into
eight main segments (or nine segments when dening the caudate lobe as a
separate posteriorly located segment). is compartmental segmental sub-
division is applied clinically, e.g. in liver surgery to help planning segmental
resections of the liver [122, 176, 213, 409, 460].
1.1.1.2 Macroscopic hepatic vasculature
At rest, 25-30% of the total cardiac output ows into the liver. e human
liver receives a total ow of approximately 1.5 l/min or 100-130 ml/min/100
g liver tissue [377].is corresponds to an oxygen consumption of approxi-
mately 25% of all oxygen consumed in the body.e liver has a unique vas-
culature with a dual aerent vascular system. Blood is supplied to the liver
through the hepatic artery (arteria hepatica; HA) and the portal vein (vena
portae; PV) as illustrated in Fig. 1.4. Both vessels enter the liver through the
porta hepatis (hilum) and branch into vessels with smaller diameters to form
vascular trees, supplying the liver parenchyma with blood [55, 169, 233].
e vessels of the HA and PV vascular trees typically run parallel in the
so-called portal tracts or portal triads (PTs; Fig. 1.5). e PTs also contain
vessels of the biliary tree, running parallel to the HA and PV vessels. Note,
however, that the bile ow in the biliary tree is directed opposite to the blood
5
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Figure 1.3: Segmental subdivision of the human liver in correspondence to (a) the portal
veins and (b) the hepatic veins: the caudate lobe (1), the lateral superior segment (2), the
lateral inferior segment (3), the medial superior (4a) and medial inferior segment (4b), the
anterior inferior segment (5), the posterior inferior segment (6), the posterior superior seg-
ment (7) and the anterior superior segment (8). Adapted from [122].
Liver 
microcirculation
Liver
Heart
Vena cava 
     inferior
Aorta
Hepatic artery
Portal vein
Capillaries of the digestive tract
Hepatic
     veins
Figure 1.4: Schematic overview of the macroscopic vasculature of the human liver and its
relation to the systemic circulation.
ow through theHA and PV vascular trees. Aer passing the livermicrocir-
culation, blood leaves the liver via the hepatic veins (venae hepaticae; HV)
and drains into the vena cava inferior (VCI).e VCI leads the deoxygen-
ated blood to the right atrium of the heart (Fig. 1.4) [311, 377].
As one of the aerent vessel systems of the liver, the common hepatic
artery is a side branch of the coeliac trunk which directly originates from
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Portal triad containing a branch of the hepatic arterial tree, 
the portal venous tree and the biliary tree
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Figure 1.5: e vascular trees of the human liver: the hepatic arterial (HA) tree, the portal
venous (PV) tree and the hepatic venous (HV) tree.e biliary tree is also visible. Adapted
from [5].
the aorta. e coeliac trunk gives rise to the splenic artery, the le gas-
tric artery and the common hepatic artery. Along its course, the common
hepatic artery gives rise to the gastroduodenal artery, and enters the porta
hepatis as the proper hepatic artery. Usually, aer the origin of a side branch
(right gastric artery), it splits into a le and right branch, bringing oxygen-
rich blood to the liver (Fig. 1.5) [122, 213].eHA assures approximately 25%
of the total blood ow to the liver, resulting in a pulsatile HA inow with a
mean value of 350-400 ml/min at a mean pressure of 100 mmHg (compara-
ble to the aortic pressure). In this way, the HA accounts for 50-80% of the
oxygen supply to the liver. In addition to the perfusion of liver parenchyma,
the HA tree also includes a subtree providing blood ow to the gallbladder.
Unlike liver tissue, the gallbladder has only one aerent vascular system.e
HA vascular tree also nourishes the bile ducts by a network of capillaries,
called the peribiliary plexus [377].
e PV supplies the remaining 75% of the blood ow into the liver, as
well as the remaining oxygen. e nutrient-rich PV blood originates from
the gastro-intestinal tract: the small and large intestines (superior and in-
ferior mesenteric veins), the spleen (splenic vein), the stomach (coronary
and pyloric veins), the pancreas (pancreaticoduodenal veins) and the gall-
bladder (cystic vein). e PV blood is partially deoxygenated and carries a
lot of nutrients as well as waste products. e PV has a length of approxi-
mately 6-8 cm and a diameter of 1-1.2 cm.e PV is characterised by amean
continuous blood ow of 1.1 l/min at a pressure of 7-10 mmHg.e PV vas-
cular tree has no valves, resulting in the pressure being freely transmitted
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to the aerent vessels. Aer passing through the porta hepatis, the PV also
splits into le and right branches and further splits into segmental branches
(Fig. 1.5) [42, 169, 309, 377, 382].
Deoxygenated blood is removed from the liver through the HV tree by
its major HV draining into the VCI.e continuous outow is characterised
by a mean ow of approximately 1.5 l/min and a 3-5 mmHg pressure [377].
e HV vascular tree counts three major vessels (the right, le and middle
hepatic vein), complemented by a number of accessory hepatic veins. Usu-
ally, the middle hepatic vein drains into the le vein just before its termina-
tion in the VCI [377].e HV tree also lacks valves [169, 254].
e unique vascular organisation of the human liver is studied in detail
in chapter 5, as the hepatic vascular architecture is important to take into
account when modelling liver perfusion.
Next to the vascular trees of the hepatic blood circulation, there is also
the biliary tree.e intrahepatic bile ducts, which drain the bile produced by
the liver, merge into a right and le hepatic duct, which in turn fuse together
at the porta hepatis into the common hepatic duct. is duct receives the
cystic duct from the gallbladder. From the conuence of the cystic duct,
the hepatic duct is termed the common bile duct or ductus choledochus,
draining bile both from the gallbladder and intrahepatic bile ducts into the
duodenum at the papilla of Vater [311].
1.1.2 Microscopic anatomy of the liver
1.1.2.1 Liver lobules and sinusoids
In literature, the microscopic anatomy of the liver is usually schematically
represented in terms of structural units, called classic liver lobules. Classi-
cally, these liver lobules are proposed to have the shape of a hexagonal prism
and have a circumscribed diameter of 0.7-2 mm and a length up to several
millimetres (Fig. 1.6 and 1.7a). Of interest, a more recent quantitative study
revealed that pentagonal lobules predominate over hexagonal ones in pigs
[118]. Liver lobules are assumed to be congured in a tessellating pattern,
similar to the organisation of hexagonal wax cells in the honeycombs of bees
(Fig. 1.6 and 1.7b). Every lobule consists of plates of hepatocytes (main liver
parenchymal cells; see also section 1.1.2.3), which account for 80%of the liver
mass and 65% of the liver cells (Fig. 1.6 and 1.8a) [305, 309, 311]. In chapter
10, a liver microperfusion model is developed based on liver lobules.
At every corner of a lobule, there is a PT, containing three structures: a
hepatic artery , a portal vein branch and a portal or interlobar bile duct (Fig.
1.7 and 1.8a). However, Crawford et al. [81] showed that variations in PTs
are possible (e.g. a portal vein branch and a portal bile duct accompanied
by three instead of one hepatic artery branch).ere are also lymph vessels
and nerves running along the PTs, but these are dicult to distinguish. A
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Figure 1.6: Representative histological image of liver lobules.e delineation of a lobule and
its neighbouring lobules is clearly visible, demonstrating the tessellating organisation of liver
lobules. Adapted from [2].
fraction of the blood from the PTs enters the vascular septa (VS), which are
the continuous vascular surfaces between neighbouring lobules, bordered
at opposite edges by two PTs. As such, the VS supply blood to the tissue
between PTs by a number of microvessels (septal branches) branching o
the PTs.
Hepatic arteriole
Central vein
Sinusoids
Portal
tract
Vascular septum
Bile duct
Portal venule
(a) (b)
Figure 1.7: Schematic representation of the liver microcirculation: (a) liver lobule, (b) or-
ganisation of liver lobules in a tessellating pattern.
Subsequently, blood ows from the PTs and VS into the interconnected
network of tortuous hepatic-specic capillaries, called the sinusoids (Fig. 1.7
and 1.8). e hepatic arterioles in the PTs do not always drain directly into
the sinusoids.e hepatic arterioles either drain into the peribiliary plexus,
the periportal plexus or the sinusoids. Hereby, the peribiliary plexus sup-
plies blood to the intrahepatic bile ducts before draining into the sinusoids.
In the periportal plexus, the arterioles rst nourish the PV branches before
draining into the sinusoids. As a third option, arterial blood can directly
9
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Figure 1.8:Microanatomy of the liver: (a) segment of a liver lobule and (b) illustration of the
space of Disse between the sinusoidal endothelial cells and the hepatocytes. Adapted from
[143, 311].
enter the sinusoids through arteriosinus twigs which terminate in the sinus-
oids close to the origin of portal venules [237, 322, 324, 409, 465, 496].
Blood ow through a sinusoid can be portal venous, hepatic arterial
or a mix of both. e sinusoids are located between the plates of hepa-
tocytes, and are lined by endothelial cells of which the at extensions are
provided with pores or fenestrations (fenestrae) (Fig. 1.8b). Fenestrations
are clustered together (typically 10-15 pores per cluster) forming sieve plates.
Human sinusoids have a diameter of 7-15 µm and a length of 223-477 µm
[309, 382, 496, 517]. Blood solutes (nutrients, toxic substances etc.) can pass
through the fenestrations ending up into the space of Disse. e space of
Disse is the region between the endothelial cells lining the sinusoids and the
hepatocytes (Fig. 1.8b). Proteins as well as blood plasma are able to enter into
the space of Disse through the fenestrae (typically having a diameter of ap-
proximately 175 nm [509]) contrary to the larger red blood cells. As such,
the endothelial cells with fenestrations act as a lter. Due to these char-
acteristics, the hepatocytes are able to take up nutrients, oxygen etc. from
blood. Furthermore, the space of Disse contains a low density extracellular
matrix (supporting the overall structure of the liver) and is responsible for
approximately half of the lymph production.e exchange of uids, solutes,
particles etc. between sinusoidal blood and the microvilli of hepatocytes is
bidirectional. Next to endothelial cells, the sinusoids also contain Kupf-
fer cells (Fig. 1.8b). ese liver-resident macrophages remove bacteria and
worn-out blood cells, and play an important role in inammation processes
of the liver [309, 311].
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Figure 1.9: Schematic illustration of the sphincters in the liver microcirculation. Adapted
from [409].
Sinusoids also contain two types of sphincters at their inlets (Fig. 1.9).
e portosinusoidal sphincters contain large endothelial cells combinedwith
hepatic stellate cells. ey are located at the connection between the ter-
minal portal venule and sinusoid. e arteriosinusoidal sphincters are lo-
cated at the connections of terminal hepatic arterioles with sinusoids and
are contractile smooth muscle sphincters [53, 324, 382, 409]. In addition,
aer owing through the sinusoids, blood passes through the outlet or ef-
ferent sphincters composed of sinusoidal endothelial cells (Fig. 1.9) [216].
e blood ow in the sinusoidal network is heterogeneous. As such, the
periportal sinusoids form an interconnected polygonal network, while the
pericentral sinusoids are more organised as parallel vessels provided with
intersinusoidal connections and draining radially into the central vein (CV;
also called centrolobular vein) [323, 409].e haemodynamics in the sinus-
oids are characterised by a low pressure (2-5 mmHg) and a low blood ve-
locity. As a consequence, this enables hepatocytes to interact metabolically
with blood that slowly passes by [169]. At the centre of every lobule, there is
a central vein, oriented along the longitudinal axis of the lobule (Fig. 1.6-1.9).
e blood is drained from the sinusoids into the CV, and from there into the
HV and VCI [311].
1.1.2.2 Bile secretion
e hepatocytes produce bile, playing an important role in the digestion of
lipids. Bile is drained into the bile canaliculi lining the hepatocytes (Fig.
1.8), and subsequently into the canals of Hering.rough these canals, bile
ows towards the portal bile duct in the PTs and leaves the liver through
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the biliary tree, guiding bile towards the porta hepatis. Furtheron, bile is
transported either to the gallbladder, where it is stored and concentrated up
to 20-fold the original concentration, or to the duodenum. Note, however,
that bile ows in the opposite direction of the HA and PV blood ow in the
PTs [82, 272, 309, 311, 409].
1.1.2.3 Liver cells
e liver counts six major types of cells, of which a few were already men-
tioned earlier in the text. Here, we give a short overview of the major cell
types and their functions [509].
• Hepatocytes are the main liver parenchymal cells. ese polygonal
epithelial cells are organised in plates with a thickness of one or two
cell layers. At their sinusoidal side, they line the interstitial space of
Disse by their microvilli. On the other side, at the middle of their in-
tercellular surface, a groove is formed representing a so-called hem-
icanaliculus which together with a similar groove from the adjacent
hepatocyte forms a separate biliary compartment which is the begin-
ning of the bile canaliculus.e functions of hepatocytes include pro-
cessing of nutrients, bile production, storage of fat-soluble vitamins,
and detoxication [309, 351, 377].
• Endothelial cells form the lining of the sinusoids. In this way, paren-
chymal cells are separated from the sinusoidal blood. In contrast to
other capillary endothelia, the sinusoidal endothelial cells have no vis-
ible basement membrane and are perforated at their at extensions by
fenestrations [382].
• Kuper cells are star-shaped mobile macrophages, attached to the si-
nusoidal endothelial lining, and are mainly located in the periportal
area.ese phagocytes remove debris such as bacteria, old blood cells,
viruses etc. by the process of endocytosis. Kuper cells can become
activated by several agents (endotoxins, interferon-gamma etc.) as
well as by shock or sepsis. Activated Kuper cells can produce pro-
inammatory cytokines (inammation initiators) [377].
• Pit cells (also called the hepatic specic natural killer cells) are located
in the space of Disse. ese liver-associated lymphocytes play an ac-
tive role in the immune system [41, 377, 409].
• Stellate cells (also called perisinusoidal cells, fat storing cells or Ito
cells) contain lipid dropletswhich store vitaminA.eirmain features
are the long cytoplasmatic extensions which may regulate blood ow.
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ey contain actin andmyosin to contract in response to endothelin-1
etc. Hepatic stellate cells play an important role in brogenesis (syn-
thesis of extracellular matrix) and are found in the space of Disse.
ey produce extracellular matrix proteins (both in normal condi-
tions as well as excessively in the brotic liver) and play a role in liver
regeneration. Stellate cells account for 5-8% of all liver cells [377, 382,
409].
• Cholangiocytes (or bile ductular cells) are epithelial cells lining the
bile ducts [41].
1.1.2.4 Liver units
Although the classic hexagonal liver lobule (Fig. 1.10a; used in chapter 10)
as rst described by Kiernan [252] is probably the most frequently used liver
unit, there is an ongoing debate about the most suitable morphological or
functional liver unit. is has to do with the fact that the peripheral poly-
gonal boundaries of classic liver lobules are not easy to recognise (partially
due to sinusoidal anastomoses between lobules), except for a few species.
As such, the liver lobules of pigs, camels and polar bears are well-dened by
interlobular septa of connective tissue, while connective tissue is sparser in
the human liver. Furthermore, liver lobules are not always perfect prisms,
and variations are frequently observed in the number of PTs per lobule as is
also observed in chapter 9 (e.g. polyhedral lobules with four, ve or seven
corners instead of six). Consequently, other units have been proposed in the
past. Below, we give an overview of a number of alternative functional units
[118, 119, 303, 309, 377, 409, 417, 466, 496].
Mall [305] favoured the portal lobule (also called the portal unit) as the
true structural unit of the liver. Hereby, the portal lobule is centred around
Classic
lobule  Portal
lobule
Hepatic
 acinus 3   2   1   1   2   3
(a)           (b)            (c)
Primary
 lobule
Hepatic
microvascular
subunit
Inlet
venule
SinusoidsCentral
vein
Figure 1.10: Schematic illustration of several structural and functional liver units: (a) the
classic hexagonal lobule centred around a central vein (CV) and the portal lobule centred
around a portal tract (PT); (b) the primary lobule with sickle zones and the hepatic acinus
with its corresponding zonation (periportal zone 1, intermediate zone 2 and pericentral zone
3); (c) the hepatic microvascular subunit.
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a PT and extends to the closest three CVs. Hence, a portal lobule has a
triangular shape (Fig. 1.10a).
e hepatic acinus proposed by Rappaport et al. [394] is probably the
secondmost used liver unit (aer the classic lobule). It was dened as a unit
related to the aerent vessels of the microcirculation. e simple hepatic
acinus represents a parenchymal mass having an irregular size and shape,
bordered by two PTs and two CVs (Fig. 1.10b). Its shortest axis is the con-
nection between twoPTs, including connective tissue and a vascular septum.
An acinus is arbitrarily divided in three zones implying zonal heterogeneity:
zone 1 lies closest to the PTs (periportal), zone 3 is closest to the CVs (peri-
central) and zone 2 lies in between zones 1 and 3 (intermediate). In this inter-
pretation, zone 1 is thought to receivemost nutrients and oxygen, while zone
3 receives partially deoxygenated blood carrying fewer nutrients. However,
there are a number of papers, in which metabolic activity is experimentally
measured, stating that the acinar zonation is not the most optimal zonation
method [466, 532]. e simple acinus occupies parts of two neighbouring
lobules in 2D.e locations of the terminal aerent vessels of neighbour-
ing acini are called the nodal points of Mall. e concept of simple acini
was also extended to complex acini, containing at least three simple acini
and the parenchyma around the preterminal portal venule accompanied by
its arteriole and bile duct. On its turn, the acinar agglomerate consisted of
three or four complex acini [271, 377, 382, 394].
e primary lobule of Matsumoto et al. [317, 318] contains a group of
sinusoids that are supplied by a single portal inlet venule (and its neighbour-
ing terminal hepatic arteriole) and drain into a CV (Fig. 1.10b). e classic
lobule consists of 6-8 primary lobules, and is consequently named the sec-
ondary lobule.e concept of the primary lobule seems to give evidence of
another type of zonation, called sickle zones. Sickle zones seem to corres-
pond better with the actual liver physiology than the zonation based on the
hepatic acinus [317, 465]. Furthermore, Matsumoto clearly highlighted the
role of VS [317, 322, 409].
Bloch [40] and McCuskey [320] proposed the hepaton as the hepatic
functional unit, as they suggested that the functional liver unit should be
the minimum amount of tissue required to perform liver function. As such,
the hepaton was dened as a single sinusoid with a cylinder of surround-
ing tissue including aerent and eerent blood vessels, biliary vessels and
lymphatic connections [309, 377, 409].
Later, the choleon was introduced by Homan [202] as the exocrine se-
cretory unit consisting of a group of hepatocytes drained by a single portal
bile duct [409].
Following the report of the hepaton, Ekataksin and Wake [119] came
to a similar conclusion that most terminal portal vessels preferentially per-
fused a certain column of sinusoids. ese can be interpreted as having a
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conical shape with a wider base at the lobule perimeter and a point end at
the lobule centre.ey called this pyramidal group of sinusoids the hepatic
microvascular subunit (Fig. 1.10c) [119, 409]. Furthermore, Ekataksin and
Wake [119] showed that the choleon spatially overlaps with the pyramidal
column of sinusoids of a hepatic microvascular subunit. e parenchymal
mass of liver cells associated with this overlap is thus equipped with all nec-
essary structures to perform exocrine and endocrine liver functions. Hence,
this conguration was called the choleohepaton, being a combination of a
hepaton and a choleon [116, 119, 409].
In his turn, Teutsch et al. [465, 466] introduced the primary unit or
primary module and the secondary unit or secondary module based on
three-dimensional reconstructions using serial cryosections.e livermod-
ule is compatible with the primary lobule of Matsumoto, but with more ir-
regularities in shape. In the modular concept of Teutsch, the complexity of
the real shapes in liver units is represented in the marked variation of size,
in shape, in number of facets, in concavity or convexity of the facets, and
also in the number of primary units assembled into the secondary modules
[465]. One should realise that hexagons and pentagons are considered as
geometrically idealised perfections of the real lobular shape [104].
In addition to the described liver units, a number of other units were
proposed during the last decades, but never really permitted acceptance (e.g.
the metabolic lobule of Lamers, the modied zonal microcirculatory unit,
the hepatom, the billion, the porton etc.) [119, 271].
1.1.3 Individual and interspecies hepatic anatomical dierences
Although the general characteristics of the hepatic macro- as well as mi-
croanatomy are similar among individual humans and dierentmammalian
species, there are individual variations as well as interspecies anatomical dif-
ferences. Since human and rat livers are being used in this PhD dissertation
(part II and III), it is worth having a look at these dierences.
1.1.3.1 Individual anatomical variations
Macroscopically, individual human livers dier in size, weight and shape.
Additionally, a lot of variations have been observed previously when analys-
ing the branching patterns of the hepatic vasculature as well as the biliary
tree [255, 301]. Below, we briey discuss a few of these variations.
For the HA tree, Gruttadauria et al. [172] reported HA anomalies in 42%
of 701 individuals. In most cases, the HA arises from the coeliac artery (or
trunk as mentioned earlier) and provides blood ow to several arterial ves-
sels (see section 1.1.1.2). Anatomical variations have been described of which
themost frequent ones are a replaced or accessory right HA arising from the
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superior mesenteric artery, or a replaced or accessory le HA arising from
the le gastric artery [172, 377].
e PV tree also displays a substantial degree of variations. Gupta [176]
reported that the PV of approximately 80% of the individuals splits into a
right and le branch at the porta hepatis. In contrast, about 10% of the indi-
viduals have a PV dividing into three branches (two to the right and one to
the le [133]).
Concerning the HV tree, the middle hepatic vein usually drains into the
le hepatic vein just before its termination, but variations of this organisa-
tion have been described. In addition, there are variations of the number of
accessory hepatic veins [122, 177].
ese individual variations and dierences in vascular anatomy are es-
pecially relevant in the context of surgical planning (e.g. for living donor
liver transplantation or segmental liver resection; see also chapter 8) [255].
1.1.3.2 Interspecies anatomical dierences
Next to individual dierences between humans, it is important to take into
account the more outspoken anatomical dierences between species. Tre-
mendous dierences between species (e.g. pigs, dogs, rats, primates, hu-
mans) have been reported when studying the hepatic anatomy, histological
features and vasculature [377]. Caution is thus needed when extrapolating
results obtained in animals to the human setting. A few examples of species-
dependent hepatic variations are provided showing that animal models may
not always be a good tool to compare with human liver properties [80, 117,
203, 305, 312, 400, 417, 465, 526].
Macroscopically, the liver size and weight as well as the number of liver
lobes and their relative sizes dier between species (Fig. 1.11). For instance,
the rat liver has a small size and a dierent division in liver lobes compared
to the human liver [257, 258, 312, 323, 466]. Its VCI is completely intrahepa-
tic, which is not the case for human livers. Furthermore, the PV of the rat
trifurcates while in the normal human liver, the PV only bifurcates. Also,
the rat (as well as the horse and deer) has no gallbladder, in contrast to hu-
mans, dogs, pigs, mice etc. [312]. e external morphology of the porcine
liver also clearly diers from the human liver morphology. e pig liver
has three main lobes (the right lateral, the median and the le lateral lobe),
while the human liver is known to count four main lobes (see section 1.1.1.1).
e segmental anatomy is similar to that of the human liver, albeit there are
substantial dierences in the relative volumes of segments compared to the
human liver [80, 526].
Also microscopically, there are a number of remarkable interspecies dif-
ferences. For instance, the lobules of the porcine liver are clearly delineated
by septa of connective tissue between the portal tracts, while the human liver
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(a)           (b)           (c)
Figure 1.11: Comparison of the liver of dierent species: (a) human liver, (b) porcine liver
(adapted from [80]), (c) rat liver (adapted from [533]).
typically contains less connective tissue [417]. In addition, the frequency
of arterioportal anastomoses in the microvasculature is said to be species-
dependent. For instance, the presence of arterioportal anastomoses is fre-
quent in rats, but not in hamsters and humans [322, 324, 417]. Teutsch [465]
reported that sinusoids are typically longer in humans than in rats, and that
the branching pattern of the CV tree is dierent.
1.2 Liver functions
e metabolic activity of the liver is without any doubt a very complex phe-
nomenon.e liver is responsible formore than 500 functions, contributing
to the homeostasis of the body. ese functions range from the synthesis,
storage and breakdown of proteins and cholesterol to the degradation of
toxic substances. All these activities depend on the well-functioning of the
blood circulation, which is the main topic of this manuscript. Below, a short
overview of the most important liver functions is given [311, 409].
1.2.1 Regulation mechanisms of hepatic blood ow
1.2.1.1 Sphincters
e sinusoids contain inlet and outlet sphincters, as mentioned in section
1.1.2.1. ese sphincters are able to regulate the sinusoidal blood ow. e
arterial inow regulation is possibly triggered by the need for oxygen: if the
oxygen concentration is too low, sphincters may react by altering the ratio
of arterial to portal blood inow [169, 321, 377].
1.2.1.2 Stellate cells and endothelial cells
Hepatic stellate cells have been suggested to play a role in controlling the
hepatic vascular resistance to blood ow due to their cytoplasmic processes
and contractility [267, 409]. Endothelial cells are able to expand or contract
as a response to a variety of vasoactive substances. Hereby, the diameter
of the sinusoidal lumen is changed, resulting in alterations of the vascular
resistance and blood ow [377].
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1.2.1.3 Hepatic arterial buer response (HABR)
e hepatic arterial buer response (HABR) is the compensatory response
of the HA to changes in PV blood ow. For instance, an increase of the PV
ow will lead to a decrease of the HA ow. is mechanism is thought to
be based on the adenosine washout: themetabolic washout hypothesis [114].
Adenosine is produced at a constant rate and released into the space ofMall,
surrounding the HA resistance vessels and the PV branches.e adenosine
concentration in the space ofMall depends on the adenosine washout by the
blood ow through the neighbouring PV andHAvessels. When PVowde-
creases, less adenosine will be washed away, resulting in higher adenosine
concentrations surrounding the HA vessels. is will trigger the HA ves-
sels to dilate, resulting in a higher HA ow. Also, the opposite response is
present: when the PVow rises, more adenosinewill bewashed away, result-
ing in more constricted HA vessels and a lower HA ow.is mechanism is
thus intended to preserve a nearly constant hepatic blood ow, maintaining
the hepatic clearance functions and adequate blood levels of nutrients, hor-
mones, oxygen etc. In addition to the adenosine washout hypothesis, some
studies report that other mediators may also play a role in the HABR regu-
lation (e.g. nitric oxide, carbon monoxide, H2S etc.). It is also believed that
- in physiological conditions - a similar response does not exist for the PV.
As such, it is thought that the PV ow doesn’t change as a response to an
altered HA ow [114, 169, 216, 275, 276, 278, 377, 401, 409, 496].
e HABR is, to some extent, related to the ow competition phenom-
enon between the HA and PV that we observed during previous perfusion
experiments with isolated porcine livers (see section 3.3.3). For instance, the
PV owwas altered as a response to HA pressure changes and this phenom-
enon was reversible when decreasing the arterial inow. is PV response
is not accounted for by the HABR. An elevated pressure in the VCI was also
able to provoke ow competition in our experiments. Note, however, that
we observed ow competition ex vivo in isolated organs, while the HABR
has been observed in vivo under physiological conditions [342].
1.2.1.4 Nervous control
Two plexuses of nerve bres are found near the PTs of the liver: parasym-
pathetic (hepatic branches of the vagus nerve) and sympathetic bres [41].
e bres extend into the parenchymal tissue and tend to run along sinus-
oids (mainly sympathetic bres). Neurotransmitters may be released from
the intrasinusoidal bres and may aect the lipid and carbohydrate meta-
bolism as well as the intrahepatic haemodynamics by changing the vascular
resistance. However, transplanted livers also have the ability to function sat-
isfactorily, while they are denervated during the transplantation procedure
and not reconnected aerwards. Consequently, some authors suggest that
the neural regulatory mechanisms are less important [377, 409].
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1.2.2 Hepatic lymph ow
In normal circumstances, the liver produces about 1 to 2 litres of lymph
per day by which the liver is the largest source of lymph in the body. He-
patic lymph typically has a high protein content and a high content of cells
(mainly lymphocytes andmacrophages).e hepatic lymph ow rate is pro-
portional to the hepatic blood ow rate: approximately 0.5 ml lymph for
every litre of blood ow. Hepatic lymph production is mainly situated in the
space of Disse between the hepatocytes and the endothelial cells (protein-
rich lymph), supplemented by a small amount of lymph production in the
peribiliary capillary plexus of the PTs (protein-poor lymph).
e terminal vessels of the lymphatic tree are a ne plexus associated
with the nest arterial ramications in the interstitium of the small PTs. Lar-
ger lymph vessels are also associated with PV and biliary branches, result-
ing in a fourth element in the PTs (Fig. 1.12). In addition, two other types
of smaller (and less important) lymphatic plexuses have been described:
one associated with hepatic veins and one with the capsule of Glisson. e
lymphatic vessels exit the liver at the porta hepatis and drain into the hepatic
lymph nodes or alternatively via the falciform ligament or the bare area.
e lymph system is responsible for several functions including the for-
mation of lymphocytes and antibodies, the removal of dead bacteria and
waste products, the transportation of fats and fat-soluble vitamins etc. If the
pressure in the sinusoids rises, the lymph production will increase. Doing
so, the excess uid and proteins of the interstitial spaces are drained, result-
ing in a protein-rich ascitis uid [277, 309, 369, 377, 409].
Lymph
 vessel
Hepatic
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Bile
duct Sinusoids
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 vessel
Figure 1.12: Illustration of the microscopic liver anatomy showing a lymph vessel in the in-
terstitial tissue of a portal tract (PT). Adapted from [369].
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1.2.3 Bile production and secretion
e hepatocytes of the liver produce bile for export to the duodenum. In
normal conditions, 600 to 1200 ml bile is secreted daily. Bile is a yellow-
greenish uid composed of water, bilirubin, bile salts, phospholipids, pro-
teins, cholesterol etc. [311, 377].
Bilirubin, the major bile pigment, is a product of the breakdown of nor-
mal haeme - a component of haemoglobin present in red blood cells - which
takes place in the spleen, liver and bonemarrow. Daily, 250-300mg bilirubin
is produced. Free bilirubin is not water-soluble. Most of the free bilirubin
is attached to albumin proteins for transport. e rest is partially attached
to glucuronic acid. is form of bound bilirubin is water-soluble and can
be secreted in bile. Aer transport by bile into the small intestine, bilirubin
is transformed by bacteria into urobilinogen, which is responsible for the
brown colour of faeces [311, 409].
Bile salts are derived from cholesterol and play an important role in the
digestion of fats by emulsifying them. In this way, fats are decomposed into
smaller particles, which are easier to handle by the digestive enzymes. Fur-
thermore, bile salts are important for the absorption of cholesterol.e con-
version of cholesterol into bile acids by the liver is themost important way of
cholesterol decomposition in the human body. ough several substances
in bile leave our body through faeces, there is a recycling process for bile
salts: the enterohepatic circulation. About 90% of the bile salts are reab-
sorbed in this process at the level of the intestines. Subsequently, the bile
salts are brought back to the liver through the PV and can be resecreted in
the newly formed bile [233, 434].
1.2.4 Immunological barrier
e Kuper cells of the liver are important for the immune system because
of their phagocytosis function. Kuper cells are able to remove 99% of the
bacteria in PV blood coming from the intestines when it reaches the sinus-
oids and before it enters the blood circulation. is ltration system pre-
vents e.g. colon bacilli from contaminating the systemic circulation before
entering the general circulation [309].
1.2.5 Detoxication
e liver is able to remove hormones, medication, alcohol and other biolo-
gical active molecules from the blood through bile production and by pha-
gocytosis by Kuper cells as well as through chemical reactions at the level
of the hepatocytes [309, 311]. For instance, the liver possesses an enzyme to
transform ammonia into urea. Subsequently, the liver secretes urea, aer
which urea is cleared from the blood by the kidneys and removed via the
urine [434]. Moreover, the liver inactivates steroid hormones, dierent types
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ofmedication andother xenobiotics bymodications of their chemical struc-
ture. As a result, these substances are less active,morewater-soluble and thus
easier to excrete by the kidneys.
1.2.6 Carbohydrate metabolism
e liver helps regulating the blood glucose homeostasis. Keeping the glu-
cose concentration within a narrow range is important for the human body
to ensure adequate glucose delivery to the cells [409]. Aer a meal rich in
carbohydrates, the liver is able to remove glucose from the PV blood. First,
the glucose is transformed into glycogen (glycogenesis) to ll up the glyco-
gen supply, and secondly into triglycerides for storage (lipogenesis). Hepa-
tocytes can store up to 8% of their weight as glycogen and an average adult
liver stores approximately 80 g of glycogen. Aer a period of fasting, the
liver will secrete glucose into the blood by the conversion of stored glycogen
(glycogenolysis) or the conversion of other molecules (lactate, amino acids,
glycerol and pyruvate) if no more glycogen is available (gluconeogenesis)
[311]. e carbohydrate metabolism is regulated by hormones (e.g. insulin,
glucagon, adrenaline) and the nervous system [409].
1.2.7 Lipid metabolism
e liver is essential for the lipid metabolism in the body, e.g. because of
its ability to emulsify fats, to store fats, to produce lipoproteins and to syn-
thesise fats from proteins and carbohydrates. Lipids (e.g. triglycerides, fatty
acids, cholesterol esters) are not soluble in water and need lipoproteins for
transport in the plasma. According to the density, three types of lipoproteins
are distinguished: very low (chylomicrons), intermediate and high density
lipoproteins. Chylomicrons (containing dietary fats) lose their triglycerides
due to the action of lipoproteins. e rest of the chylomicrons (including
cholesterol) is further metabolised by the liver. High density lipoproteins
transport cholesterol from the tissues to the liver [409]. Concerning the fatty
acid metabolism, the liver is active in the oxidation of fatty acids to acetyl
coenzyme A for the production of energy. Alternatively, the acids are used
to form triglycerides, phospholipids or cholesterol esters. When there is an
excess of energy, glucose is converted by the liver to fatty acids.ese acids
are used to synthesise triglycerides (lipogenesis; also mentioned in section
1.2.6) [311, 409].
1.2.8 Protein metabolism
e hepatic protein metabolism assures the breakdown of amino acids (de-
amination), the formation of urea to remove ammonia (highly toxic) from
the human body, the synthesis of most plasma proteins, coagulation factors
and non-essential amino acids as well as the conversion of amino acids into
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other amino acids (transamination).e hepatic synthesis of proteins (main-
ly plasma proteins) accounts for 15% of the proteins produced in the human
body. is synthesis is inuenced by several factors such as the nutritional
state (when fasting, protein synthesis drops), hormones (e.g. insulin), tissue
injury or inammation etc. e most important proteins secreted by the
liver are albumin, transferrin, ceruloplasmin etc. Albumin accounts for ap-
proximately 70% of the plasma proteins and is an important constituent of
blood, acting as an acid-base buerwhich binds drugs and electrolytes in the
blood. Most plasma globulins are also produced in the liver.ese globulins
perform several functions such as the transport of cholesterol, triglycerides,
steroid hormones etc. Furthermore, most components necessary for coagu-
lation are synthesised in the liver, as well as many of the proteins active in
brinolysis and proteins playing a role in the complement system (impor-
tant for the immune response).e liver also releases amino acids destined
to be used by other tissues [311, 409]. Next to protein production, the liver
also breaks down proteins to amino acids, which are reused to synthesise
new proteins or to produce energy [409].
1.2.9 Vitamin metabolism
e liver is responsible for the storage of vitamins such as vitamin A, D and
B12. Large quantities of vitamin A are stored in the hepatic stellate cells,
complemented by vitamin D and B12 [309, 311].
1.2.10 Iron metabolism
Except for the iron in haemoglobin molecules, the liver is the biggest stor-
age location for iron as ferritin.e liver functions as an iron buer. When
excess iron is available in the body uid, the liver will convert iron into fer-
ritin destined for storage. When the level of circulating iron decreases to low
levels, iron is released from the ferritin stored in the liver [309, 311].
1.2.11 Biotransformation
e liver plays a crucial role in the metabolism of drugs to protect the body
against harmful chemicals (xenobiotics) by converting drugs and alcohol
into inactive products that can be secreted by the kidneys. Most water-
soluble xenobiotics are eliminated via the kidneys, while the non-water-
soluble xenobiotics are rst metabolised by the liver to less lipophilic sub-
stances, which are easier to eliminate by the kidneys.is involves two sub-
sequent phases: rst the oxidation, reduction, hydrolysis and hydration re-
actions, and secondly, the conjugation with hydrophilic ligands, making the
molecules more water-soluble. Aerwards, the kidney or bile ow can elim-
inate the resulting conjugated metabolite [309, 311, 409].
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1.2.12 Liver regeneration
e liver possesses the unique property of regeneration to re-establish the
appropriate ratio between liver size and body size.is means that the liver
is capable of growing back to a sucient liver size aer a partial hepatec-
tomy (resection of up to 70% of the liver tissue; see also chapter 8).e liver
is capable of healing rapidly and replacing damaged tissue in a time window
of only a few weeks/months. Regeneration happens by proliferation of he-
patocytes such that the critical mass, necessary for a normal liver function,
is achieved [151, 239, 265, 309, 329–331, 409, 415, 464].
Aer liver injury, the hepatocytes secrete vascular endothelial growth
factors. ese factors bind to receptors of the sinusoidal endothelial cells.
Hence, the sinusoidal endothelial cells proliferate and release other growth
factors, among which interleukin 6 and hepatic growth factor. e latter
promotes the proliferation of hepatocytes by induction of DNA synthesis in
the hepatocytes [253, 409].
Interestingly, the growth of the liver remnant happens by enlargement
of the remaining part, rather than a morphogenetic restoration of the liver
shape. is phenomenon is called compensatory hyperplasia, because the
remaining part enlarges due to hepatocyte proliferation, while the resected
part does not grow back.e liver actually has two dierent types of growth
mechanisms: liver regeneration and postnatal liver growth. In the case of
liver regeneration, the enlargement of lobules is responsible for the growth
following partial hepatectomy, resulting in liver lobules having a more com-
plex and irregular shape. In contrast, postnatal liver growth is not only due
to the enlargement of lobules, but also to the multiplication of lobules and
the enlargement of hepatocytes [375].
Liver regeneration has consequences for liver transplantation. When a
transplanted liver is too small for the host, the liver will grow to the optimal
mass for this person.e inverse is also true: when a transplant liver is too
big for the host, the liver will decrease in size [336, 409].
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Liver pathology
Liver pathologies range frommild infections to life-threatening liver failure.
In general, symptoms of liver diseases seem to be negligible in the initial
stage. When symptoms become more severe and start attracting attention,
the condition is usually quite serious. An early and eective detection of
liver disease is thus very important. A well-known example of a symptom is
jaundice.e yellow colour of the eyes and skin indicates that bilirubin is no
longer suciently ltered from the blood. Liver pathologies are oen clas-
sied in two categories. e rst category contains the hepatocellular dis-
eases, characterised by inammation and necrosis leading to liver damage.
e cholestatic diseases make up the second category and are characterised
by inhibition or obstruction of bile ow. A number of hepatic vascular dis-
orders may be associated with hepatocellular or cholestatic diseases, which
is especially relevant for the research concerning liver perfusion in this dis-
sertation. In this chapter, we will discuss the major liver pathologies and
hepatic vascular disorders, liver failure and the treatment options [214, 287].
2.1 Hepatocellular pathologies
2.1.1 Steatosis
Steatosis or fatty liver (Fig. 2.1b) is associated with a disturbance in the fat
metabolism and leads to the accumulation of fat inside the liver. Steatosis
occurs when the triglyceride synthesis is higher than the export or lipolysis
(breakdown of lipids) capacity of the liver [409].
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(a)           (b)         (c)
Figure 2.1: Illustration of the macroscopic dierences between (a) a normal liver, (b) a ste-
atotic liver and (c) a cirrhotic liver.
ere are two types of fatty liver disease: macrovesicular and microve-
sicular steatosis (Fig. 2.2). Also, a mixture of macro- and microvesicular
steatosis is possible.
e most frequent causes of macrovesicular steatosis are a fatty diet or
obesity, chronic alcohol abuse, diabetes mellitus, drug abuse or hyperlip-
idemia.e cell architecture of hepatocytes is disturbed by large fat vacuoles,
displacing the cell nucleus to the periphery of the cell (Fig. 2.2a).e accu-
mulation of fat in the cytoplasm of hepatocytes results in an increasing cell
volume, reducing the sinusoidal space up to 50% of its normal size, as well as
the volume of the space of Disse. ese microvascular changes result in an
increased intrahepatic resistance due to narrow and irregular sinusoids and
blood cell adhesion to sinusoidal walls.is may lead to sinusoidal obstruc-
tions. Consequently, the access of blood solutes to the ballooned hepatocytes
is restricted, possibly leading to chronic hypoxia. Macrovesicular steatosis
is oen benign, but makes the liver severely susceptible to ischaemic injury
and may even lead to liver failure. Macrovesicular steatosis is potentially
reversible by taking away the cause, e.g. by stopping alcohol consumption
[190, 217, 444].
Microvesicular steatosis is mostly caused by toxins or drugs, impairing
mitochondrial beta-oxidation (one of the processes in the fat metabolism)
and inducing inammatory changes. Multiple small vacuoles are dispersed
in the cytoplasm (Fig. 2.2b), but do not displace the nucleus or change the
sinusoidal diameter, as is the case for macrovesicular steatosis. Nonethe-
less, severe microvesicular steatosis can lead to fulminant liver insuciency,
multiorgan failure, coma or even death. As such, microvesicular steatosis is
more severe than macrovesicular steatosis [190, 217].
When the cause of steatosis is not taken away, fat accumulation can
evolve to inammation of the liver (hepatitis), as is the case in non-alcoholic
steatohepatitis (NASH). NASH may result in liver brosis, and leads to cir-
rhosis in 20% of the cases (see section 2.1.4) [409, 444]. e severity of
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(a)                           (b)
Magnication: 400 x Magnication: 400 xMagnication: 200 x Magnication: 200 x
Figure 2.2: Oil red staining of steatotic cells: (a) macrovesicular steatosis showing large va-
cuoles, (b) microvesicular steatosis showing numerous small vacuoles. Adapted from [408].
steatosis is classied in three degrees: mild, moderate and severe steatosis
corresponding to maximally 30%, 30-60% and more than 60% of the hepa-
tocytes containing fatty inclusions, respectively [444].
e incidence of steatosis is continuously increasing, mainly due to the
increasing number of cases of non-alcoholic fatty liver disease among the
general population. Fatty liver disease is the most common liver disease in
the Western civilisation with a non-alcoholic fatty liver disease prevalence
of 17-33% in the United States [132, 408, 444].
2.1.2 Hepatitis
Hepatitis or inammation of the liver is most oen caused by a viral in-
fection (virus of hepatitis A, B, C, D, E and G). Drugs, alcohol, medication
etc. may also induce hepatitis (e.g. by a toxic overdose of paracetamol or
ibuprofen). In addition, autoimmune hepatitis may be encountered when
the immune system attacks the own liver.
Hepatitis A accounts for approximately 32% of the hepatitis cases and is a
benign formwith only an acute phase and no chronic stage. It is transmitted
through the oral-faecal route by contaminated water, food etc.
Hepatitis B is responsible for more than 40% of the hepatitis infections
in theUnited States and is transmitted by blood transfusions, sexual contact,
contaminated needles, in utero from mother to unborn child etc. Patients
with hepatitis B have 5% chance to develop a chronic infection. Vaccines for
hepatitis A and B are available.
Hepatitis Cmay lead to chronic liver disease, which can be life-threaten-
ing. Hepatitis C patients have a 20% chance to develop cirrhosis and a 25%
chance to develop hepatocellular carcinoma (HCC).
Hepatitis E is transmitted similar to hepatitis A and is known to cause
waterborne epidemics in developing countries [103, 309, 311, 391].
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2.1.3 Fibrosis
Chronic liver disease is mostly associated with liver brosis. Hepatic brosis
is the process of excessive accumulation of extracellular matrix in the liver
(Fig. 2.3).e deposition of a certain amount of extracellular matrix (bro-
genesis) is necessary for wound healing, but an excessive deposition can be
pathological. Hepatic brosis is a dynamic and regulated process, in which
an increase in the synthesis and a decrease in the degradation of extracellular
matrix results in excess extracellularmatrix in the liver, disposed in the form
of vascularised septa in the space ofDisse (perisinusoidal brosis).e latter
results in a loss of fenestrations of the sinusoidal endothelial cells, a loss of
hepatocyte microvilli and the formation of basement membranes lining the
endothelial cells. e combination of fenestration losses with the presence
of capillary basal membranes is called sinusoidal capillarisation [246, 486].
Fibrosis has a substantial impact on the mechanical behaviour of the liver,
because the liver tissue becomes stier due to excess extracellular matrix.
Since there is a cross-talk between the mechanical properties and the vas-
cular perfusion of the liver, brosis may result in higher hepatic vascular
resistances which alter the hepatic haemodynamics.
As a result of brosis, the liver function is impaired as the ability to ex-
change substances between blood and hepatocytes is reduced. Hepatic stel-
late cells play a key role in this process.ey are activated by liver injury to
become myobroblasts and represent the main source of accumulated ex-
tracellular matrix in case of chronic liver injury. Liver brosis may lead to
cirrhosis and increases the risk for HCC [285, 470].
Liver brosis is classied in ve stages according to its location. As such,
the METAVIR scale denes the F0, F1, F2, F3 and F4 stage as no brosis,
portal brosis, periportal brosis, bridging brosis (reaching from a portal
area to another portal area) and cirrhosis, respectively [22, 154, 388].
2.1.4 Cirrhosis
Liver cirrhosis (Fig. 2.1c) is the (later) end-stage of any chronic and long last-
ing liver disease, characterisedmorphologically by a combination of brosis
and regenerative parenchymal nodules, and functionally by a progressive
loss of liver function, nally ending in liver failure. Liver cirrhosis is the
most frequent reason for liver transplantation and is amongst the most im-
portant causes of death in theWestern world. It is the twelh most frequent
cause of death in the United States and has a 5-year mortality rate higher
than 50% [24, 311, 467].
Frequent causes of cirrhosis are the chronic or repetitive injuries due to
alcohol abuse, long term infections of hepatitis B or C, fatty liver disease,
diseases related to the biliary tree, inherited liver pathologies, drug abuse or
intoxication etc. [24, 311].
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Figure 2.3: Illustration of the deposition of extracellular matrix in liver brosis: (a) normal
liver; (b) injured liver with activated stellate cells. Adapted from [306].
Cirrhosis is the result of repetitive and sustained inammatory liver in-
juries (cell death by necrosis) and healing responses (nodular regrowth of
hepatocytes). It causes an excessive production of extracellular matrix and
disorganised proliferation of hepatocytes. Liver cirrhosis is not limited to a
local part of the liver, but is a diuse process aecting the whole liver (Fig.
2.1c).e current denition of cirrhosis is based onmorphological grounds,
as described by Anthony et al. [22]: "Liver cirrhosis is a diuse process charac-
terised by brosis and the conversion of normal architecture into structurally
abnormal (regenerative) nodules". Liver brosis (see section 2.1.3) is the early
stage of cirrhotic liver disease, while the formation of regenerative nodules
is the more advanced stage. Regenerative nodules are lumps of liver tissue,
surrounded by brous bands (Fig. 2.4).
Figure 2.4: Histological image of advanced cirrhotic liver disease showing regenerative nod-
ules surrounded by brous tissue. Source: [13].
29
2. Liver pathology
According to themorphological characteristics, cirrhosis is usually clas-
sied in threemain groups: micronodular cirrhosis, macronodular cirrhosis
and amixture of both. Micronodular cirrhosis is characterised by thin regu-
lar bands of connective tissue and small regenerative nodules with a diame-
ter of 3 mm or less, containing no portal tracts or hepatic venules. Typically,
the nodules have a uniform size and lack a lobular organisation, while ter-
minal hepatic venules and portal triads are distorted. Micronodular livers
may have an enlarged size (e.g. due to steatosis). Cirrhosis oen begins with
micronodular entities and may progress towards macronodular cirrhosis,
but there are exceptions to this course of events. Macronodular cirrhosis is
associated with regenerative nodules, having a diameter of more than 3 mm
and possibly containing portal tracts and/or terminal hepatic venules. Mac-
ronodules vary considerably in diameter (3-50 mm) and are surrounded by
broad brous bands of varying thickness.e concentration of portal triads
in the brous scars suggests a collapse of the normal hepatic architecture.
Macronodular livers may be reduced in size when they are severely scarred.
In many cases, mixed cirrhosis is observed, which is a mixture of approxi-
mately equal portions of micro- and macronodules [22, 192].
Due to the morphological alterations in which newly formedmasses re-
place normal liver tissue, cirrhosis has a devastating eect on the hepatic
(micro)architecture resulting in a step-by-step loss of normal lobular struc-
ture and an altered mechanical behaviour due to the higher stiness of dis-
torted liver tissue. As such, scattered focal necrosis may occur and hepatic
arterial (HA), portal venous (PV) and hepatic venous (HV) vessels may be
tangled with each other. Abnormal branching patterns (e.g. parallel portal
vessels of the sameorder), sharp bends, tortuosity and branching angles have
been observed in blood vessels such as PV vessels in cirrhotic livers. An in-
creased intrahepatic vascular resistance and the capillarisation of sinusoids
result in a deteriorated hepatic perfusion and a loss of hepatic metabolic
functions. Fibrous bridging may occur between portal tracts or between a
portal tract and a central vein. Furthermore, new vessels may arise to cre-
ate new blood supply and venous draining routes in regenerative nodules.
Consequently, nodules give evidence of a complex and conspicuous vascu-
lature [181]. Lymphatic vessels may be enlarged [497] and lymph ow in-
creased, whichmay result in ascites when the remaining ltrated uid passes
into the peritoneal cavity [169]. Cirrhosis may also lead to the compression
of biliary tracts impairing normal drainage, which may result in jaundice.
In addition, patients may be confronted with other severe complications or
symptoms such as portal hypertension, the formation of shunt vessels by-
passing the hepatocytes (shunts between portal venules and hepatic venules)
and arterioportal shunts (capillary shunting between arterioles or capillaries
and portal venules) [47, 192, 212], the formation and bleeding of oesophageal
30
2.1. Hepatocellular pathologies
varices, ascites, hepatic encephalopathy, the hepatopulmonal or hepatorenal
syndrome, liver cancer and even death. A number of these complications is
more elaborately discussed in section 2.3 [55].
Since cirrhosis is characterised by a continuous disease spectrum of de-
teriorating liver function, cirrhosis is not a static disease, but rather a dy-
namic and potentially bidirectional process [154]. Hence, cirrhosis is clin-
ically oen classied in two stages: compensated and decompensated cir-
rhosis. In the rst stage, compensated cirrhosis will induce liver damage,
but the liver has the ability to compensate for the damage and functions
normally. Compensated cirrhosis may thus be non-symptomatic and can
be further divided in dierent substages, being with or without portal hy-
pertension, with or without oesophageal varices. However, when extensive
damage occurs, the liver is no longer able to function normally and decom-
pensation takes place. Decompensated cirrhosis is associated with clinically
evident complications which can be classied in three categories: portal hy-
pertension (section 2.3), liver failure (section 2.4) and hepatocellular car-
cinoma (section 2.1.5) [154].
e severity and prognosis of cirrhosis can be estimated by using dif-
ferent scoring systems, of which a few examples are briey discussed. e
Child-Pugh score is used to classify patients based on their circulating levels
of bilirubin and albumin, prothrombin time (international normalised ratio;
INR), the presence and severity of ascites and encephalopathy. is score
was originally intended to assess the risk of patients undergoing surgery
(e.g. placement of a portosystemic shunt). e model for end-stage liver
disease score (MELD; more elaborately discussed in section 3.1) is based
on the risk of dying while the patient is waiting for a liver transplantation.
Furthermore, there is the recently developed cirrhosis relative wellness in-
dex, which is based on desirability functions of 10 mostly uncorrelated pa-
rameters: prothrombin time, portosystemic encephalopathy mental status
score, the quantities of aspartate aminotransferase (AST), creatinine, plate-
lets, white blood cells, albumin, total bilirubin, sodium and haemoglobin
[157].
2.1.5 Liver cancer
Primary liver cancer or hepatocellular carcinoma (HCC) is initiated within
the liver. Most HCC patients have liver cirrhosis before evolving towards
HCC. HCC is the thirdmost common cause of cancer-related deaths world-
wide and the h most frequent cancer [287]. Hepatitis B and C infections
are the most important risk factors for HCC. Hepatic resection is not an op-
tion for the majority of patients with primary liver malignancies.is may
be due to a severe hepatic dysfunction, the tumour size, the tumour loca-
tion, multifocality and distant metastases. In the case of an unresectable
liver cancer, patient survival is estimated at 2-10 months [89, 302].
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Secondary liver cancer or metastasis means that the cancer originates
from another organ and was spread to the liver.
Liver cancer is dicult to diagnose in an early stage, because the symp-
toms may be vague (weight loss, less appetite, fatigue, debility, jaundice,
fever etc.). Oen, liver cancer is diagnosed during surveillance radiological
examination in the case of known cirrhosis.
2.1.6 Alcoholic liver disease
Alcoholic liver disease may originate when heavily drinking alcohol for a
certain period of time. Aer consumption, alcohol is absorbed at the level
of the gastrointestinal tract. Subsequently, the liver receives about 90% of
the alcohol to be detoxied.e oxidativemetabolism of ethanol in the liver
may result in the formation of acetaldehyde (toxic molecule contributing to
liver damage), highly reactive oxygen species (ROS; may lead to inamma-
tion, necrosis and apoptosis) etc. Alcohol overconsumption may thus result
in an alcohol overload and liver damage [124].
Oen, patients with alcoholic liver disease rst develop steatosis and
then progressively evolve towards hepatitis and cirrhosis. e occurrence
and progress of alcoholic liver disease depends on the drinking behaviour
of the patient (the amount of alcohol consumed, the duration of alcohol con-
sumption, binge drinking versus steady drinking etc.). Also, the type of al-
coholic beverages may be important, since certain types of alcohol may be
more toxic to the liver than others. More specically, some studies state that
wine drinkers are at lower risk of developing alcoholic cirrhosis compared
to spirit or beer drinkers [171, 307]. Below, a short overview of the dierent
(stages of) alcoholic liver disorders is given.
• Alcoholic fatty liver
Approximately 20% of the alcoholics develop steatosis, oen associ-
ated with an enlarged liver (hepatomegaly). is condition may be
reversible when alcohol consumption is stopped. However, alcoholic
fatty liver can lead to death if alcohol consumption is not reduced or
stopped. Furthermore, the liver may show inammatory changes as
an early sign of more severe liver disease.
• Alcoholic hepatitis
Usually, alcoholic hepatitis is diagnosed when a liver biopsy shows in-
ammatory changes, liver degeneration, brosis or other abnormal
liver cell changes. Symptoms may include a swollen liver, nausea,
vomiting, abdominal pain, fever, jaundice, liver failure, bleeding etc.
In severe cases of alcoholic hepatitis, the mortality rate is 50%. When
these patients continue to drink heavily, they have a 40% chance of
developing cirrhosis [316].
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• Alcoholic cirrhosis
Alcoholic cirrhosis is responsible for serious illness and many deaths.
Approximately 10-15% of the individuals with alcoholism develop al-
coholic cirrhosis. Possible symptoms are liver enlargement, capillary
dilations leading to palm redness, nger muscle shortening due to
toxic eects and brous changes etc.
Alcohol abuse may also be a risk factor in the context of other forms of
liver disease. For instance, heavy drinking in combination with a hepatitis
B or C infection substantially increases the risk of developing liver cirrhosis
and people having alcohol-related cirrhosis have a much higher chance of
developing liver cancer [124, 307].
2.1.7 Inherited liver diseases
Some liver diseases are inheritable, but do not show any symptoms until
adulthood. An example is haemochromatosis, in which the ironmetabolism
is disturbed and the liver stores more iron from food than needed for the
body. When haemochromatosis is not diagnosed, it can be lethal. Another
inheritable liver pathology is the disease of Wilson. Here, too much copper
is stored within the liver. When the excess copper enters the blood stream,
this can lead to psychological symptoms or physical disorders (going from
trembling, having diculty to speak etc. to liver failure).
2.2 Cholestatic pathologies
2.2.1 Cholestasis
Cholestasis stands for a stagnation of bile ow in the liver. e causes may
be intrahepatic (parenchymal diseases, pathology of intrahepatic bile ducts)
and/or extrahepatic (problems with the extrahepatic bile duct conduits e.g.
gall stones). Gall stones are caused by too much cholesterol or too little bile
salts, resulting in cholesterol crystallisation.e stones obstruct the bile ow
andmay cause severe painwhen the gallbladder contracts. Furthermore, the
blockage of bile drainage may lead to an accumulation of bile pigments in
blood and subsequently to jaundice [85, 103, 311, 434].
2.2.2 Primary sclerosing cholangitis
is pathology is associated with a chronic inammation of the bile canals
leading to destruction of the intrahepatic and/or extrahepatic bile ducts. Bile
is no longer suciently drained from the liver (bile stasis) resulting in liver
damage. Primary sclerosing cholangitis leads to hepatic brosis which can
evolve towards cirrhosis, end-stage liver disease with liver failure and the
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need for transplantation. Oen, primary sclerosing cholangitis is preceded
by inammatory bowel disease. It takes a median time period of 12-18 years
for a patient to go from the diagnosis of primary sclerosing cholangitis to
end-stage liver disease [435].
2.2.3 Primary biliary cirrhosis
is chronic autoimmune liver pathology leads to slow, progressive dam-
aging of the bile ducts. e slow progression of primary biliary cirrhosis
may extend over several years with varying rates and disease severity among
individual patients. Similar to primary sclerosing cholangitis, bile acids re-
main in the liver due to poor bile drainage and lead to damage of liver cells,
brosis, cirrhosis and eventually liver failure. Primary biliary cirrhosis is
histopathologically characterised by immune-mediated destruction of the
intrahepatic bile ducts and portal inammation [241, 288].
2.2.4 Cholangiocarcinoma
e bile ducts can also be aicted by cancer. For example, cholangiocar-
cinoma is oen the consequence of primary sclerosing cholangitis. It is
characterised by malignant tumourous tissue in the intrahepatic bile ducts
and has a poor prognosis with a mean survival time of less than two years
[309, 435].
2.3 Hepatic vascular disorders
Most liver pathologies are associatedwith a number of complications, among
which vascular disorders. Dierent vascular disorders oen interact with
each other (e.g. portal hypertension (see also chapter 8) and the formation
or bleeding of collaterals). Below, an overview is given of the most frequent
hepatic vascular disorders [385].
2.3.1 Portal hypertension
Portal hypertension is dened as an increased blood pressure in the PV. Any
condition hampering the ow to the portal vein will lead to portal hyper-
tension. e most important factors leading to portal hypertension are an
increased vascular resistance of the liver and/or an increased blood ow in
the splanchnic circulation. For instance in case of cirrhosis, which is the
most common cause of portal hypertension, the intrahepatic resistance is
increased, followed by an increase of the splanchnic blood ow in a more
advanced cirrhotic stage.
e increased intrahepatic vascular resistance to blood ow is the re-
sult of a combination of structural and functional causes. Structural factors
account for 70% of the resistance and include brosis, distortion of blood
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vessels by regenerative nodules, capillarisation of sinusoids etc. Functional
factors account for 30% of the resistance and are modiable. Here, the he-
patic stellate cells play a major role. Studies revealed that stellate cells are
able to contract and relax in response to endothelium-derived vasoactive
molecules. is response is enhanced during liver injury (stellate cell ac-
tivation) and may lead to narrowing of the sinusoids. Nonetheless, the re-
sponse of stellate cells can be modulated by the administration of vasoactive
substances (e.g. nitric oxide). In the case of cirrhosis, a net increase of the
hepatic resistance is due to the imbalance between vasoconstrictor and va-
sodilator agents.
Next to an increased vascular resistance, a higher splanchnic blood ow
is the result of splanchnic arteriolar vasodilatation. is vasodilatation is
caused by increased levels of circulating vasodilators and a reduced sensi-
tivity to vasoconstrictors. When the intrahepatic vascular resistance is ele-
vated, the increased blood ow maintains and further aggravates portal hy-
pertension. Chronic vasodilatation increases the PV blood ow andmay in-
duce the formation of portosystemic varices. Splanchnic vasodilatation and
an increased portal ow may result in a hyperdynamic circulation, which
is a combination of a low arterial pressure, a low overall vascular resistance
due to systemic vasodilatation, an increased heart rate, an increased plasma
volume and an increased cardiac output.
e major complications of portal hypertension (related to cirrhosis)
include the development of varices (collateral circulation), ascites, spleno-
megaly, hepatic encephalopathy and renal dysfunction. A severely elevated
PV pressure increases the risk of variceal bleeding (see also section 2.3.2)
[186, 267, 269, 405, 427, 467, 483].
Portal hypertension can be classied into three types, corresponding to
the location of increased vascular resistance: prehepatic, intrahepatic (si-
nusoidal) or posthepatic. Fig. 2.5 schematically shows the potential causes
of portal hypertension.
2.3.1.1 Prehepatic causes of portal hypertension
An impaired PV inow may be caused, for instance, by a thrombosis or
compression by a tumour in the PV or splenic vein. e consequences of
blockage of the extrahepatic PV go from being well tolerated to catastrophic
complications with death as a consequence. Impaired PV inow or PV oc-
clusion is oen accompanied by abdominal pain, ascites, portal hyperten-
sion and principally oesophageal varices, prone to rupture [55, 83].
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2.3.1.2 Intrahepatic causes of portal hypertension
Impairment of blood ow through the microvascular hepatic bed results in
a major loss of physiological function. Cirrhosis is the most common cause
of sinusoidal blood ow obstruction. is impairment is caused by capil-
larisation of the sinusoids, activated stellate cells constricting the sinusoidal
lumen, brosis etc. Another disorder is the veno-occlusive disease, which
may impair the hepatic ow and is characterised by the obstruction of mi-
crovascular HV vessels. is disease occurs primarily in patients receiving
bone marrow transplantation and in cancer patients receiving chemother-
apy [55, 83].
2.3.1.3 Posthepatic causes of portal hypertension
Typically, the obstruction of only one major HV is clinically silent, but an
obstruction of two or more HV results in the Budd-Chiari syndrome, char-
acterised by liver enlargement, ascites andpain. It is caused by the bloodow
not being able to shunt around the blocked portion of the HV, inducing an
increased intrahepatic blood pressure.e obstructionmay be caused by an
HV thrombosis as well as an obstruction of the inferior vena cava. When
HV obstruction develops acutely, the liver is red-purple and swollen. Acute
HV thrombosis has a high mortality when le untreated [55, 83].
2.3.2 Development of collateral circulation
When the pressure gradient between the PVandHVreaches a certain thresh-
old (for instance in the case of portal hypertension), one oen observes the
development of a network of collaterals which decompresses the portal sys-
tem. Doing so, blood is diverted into alternative routes from the PV tree
to the systemic veins and bypasses the liver. e portosystemic collateral
circulation is created by opening, dilation and hypertrophy of pre-existing
vascular channels as well as by neoangiogenesis. By bypassing the liver, col-
laterals carry portal blood containing toxic substances (e.g. drugs) to the
systemic circulation, which can result in severe complications such as en-
cephalopathy, bleeding and sepsis. Despite the fact that collaterals lead to a
decreased portosystemic resistance, the portal pressure usually remains el-
evated due to the persistent high portal inow [382, 483].
Examples of the development of the collateral circulation are oesopha-
geal and gastric varices.ese vessels are fragile andprone to rupture. Hence,
they can cause severe oesophageal and gastric variceal bleeding [55, 83, 222].
In cirrhosis, there is also a signicant collateral ow into smaller veins that
connect branches of the portal with the hepatic veins (portocaval shunts)
[382].
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2.3.3 Arteriovenous and portovenous shunts
Portovenous and arteriovenous shunt vessels may bypass the sinusoids and
hepatocytes.ese typically occur in case of cirrhosis. When a parenchymal
region becomes extinct, the corresponding liver tissue collapses, resulting
in a portal tract lying close to and adjacent to a terminal HV.is is an op-
portunity for the portal tract vessels to directly drain in the HV vessel and,
hence, leads to the creation of shunt vessels [83].
2.4 Liver failure
In the case of liver failure, liver cells are so severely damaged that the liver
is no longer able to function suciently. As a consequence, substances like
bilirubin and ammonia start to accumulate in the body.is leads to symp-
toms such as jaundice, hepatic encephalopathy etc. A second consequence
of liver failure is the absence of the synthesis functionality, resulting in hy-
poalbuminemia, coagulopathy etc. Liver failure can be life-threatening. Ba-
sically, there are four types of liver failure.
• Acute liver failure corresponds to an acute absence or drop in liver
function in a time span of a few days or weeks. A whole range of
clinical problems abruptly appears. Acute liver failure is rare, and -
unfortunately - most of the times fatal.
• Chronic liver failure is more frequent than acute failure. Here, the
liver is progressively damaged during a period of years. Hepatitis B or
alcohol abuse are possible causes.
• Acute-on-chronic liver failure occurs when a patient with chronic
liver failure develops a superimposed complication including acute
liver failure.
• Primary liver dysfunction of a donor liver is sometimes observed in
the context of liver transplantation. In this case, the donor organ is
not working properly.
2.5 Treatment options for liver disease
In this section, dierent treatment options for liver failure are addressed:
medical treatments, liver transplantation, (bio)-articial livers and potential
future treatments.
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2.5.1 Medical treatments
Medical treatments focus on (early) detection of complications and the use
of general supportive measures. is includes monitoring blood parame-
ters (e.g. the glucose level), measuring the intracranial pressure etc. Classic
medical treatments include the administration of drugs (e.g. to slow down
or reverse the progression of brosis, to dissolve gall stones, antibiotics to
treat patients with severe bacterial infections), surgical procedures (e.g. to
remove the gallbladder or tumourous tissue) etc. Nevertheless, classic treat-
ments are not sucient to help patients with end-stage liver failure, whose
only option to survive may be transplantation [24, 134, 161, 311].
2.5.2 Liver transplantation
Liver transplantation is oen the only solution for patients suering from
incurable liver disease. More detailed information on this technique will be
given in chapter 3.
2.5.3 e (bio-)articial liver
e (bio-)articial liver systems are - to some extent - comparable to acute
kidney dialysis systems.ey are intended to act as a bridge towards trans-
plantation to gain time to nd a suitable donor organ for patients, or to allow
the liver to recover spontaneously. e best treatment for irreversible liver
failure is liver transplantation, but unfortunately, the demand for donor liv-
ers is higher than the supply and some people die while being on the waiting
list. ese patients could be helped with an alternative or temporary solu-
tion, such as the articial or bio-articial liver.ese systems could also help
patients for whom liver transplantation is not an option due to contraindi-
cations, or for recipients in whom the liver gra does not function properly,
but recovery may be expected [290, 359, 360, 381].
2.5.3.1 e articial liver
Articial liver systems only contain mechanical components and provide
detoxication of blood through ltration and/or adsorption. ey are not
able to perform other liver functions such as the synthesis of substances.
Filters with semipermeable membranes are used to separate the blood or
plasma ow from the dialysis solution. Water-soluble particles are displaced
from the blood compartment to the dialysis solution through diusion or
convection. Additionally, adsorption columns are used and contain acti-
vated charcoal or resin as adsorbent. In this way, the columns make sure
that protein-bound toxins (especially albumin-bound toxins) are drained
by adsorption or ion exchange. A few examples of articial livers are the
MARS system (Molecular Adsorbents Recirculating System, Gambro, Lund,
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Sweden [9, 27, 107, 461]; Fig. 2.6a), the FPSA or Prometheus system (Frac-
tionated Plasma Separation and Adsorption, Fresenius, BadHomburg, Ger-
many [8, 263]) and the SPAD system (Single Pass Albumin Dialysis) [161,
290, 309, 359, 360, 363, 381].
(b) HepatAssist
(a) MARS
Low ow dialysis      Albumin circuit      Blood circuit
Blood
pump
MARS
dialyser
Albumin
pump
Bicarbonate
dialysis Adsorption columns
Hepatocytes
Plasma
Plasma-
pheresis
device
Pump
Charcoal
 column
Oxygenator
Bioreactor
  Plasma
reservoir
Figure 2.6: Schematisation of (a) the MARS system (Molecular Adsorbents Recirculating
System; articial liver) and (b) the HepatAssist system (bio-articial liver). Adapted from
[57].
2.5.3.2 e bio-articial liver
Whereas articial liver systems only provide detoxication, bio-articial liver
systems have the ability to also perform metabolic functions (protein syn-
thesis, gluconeogenesis etc.).ese systems contain one ormore bioreactors
lled with hepatocytes. Plasma ows through these bioreactors and is able
to interact metabolically with the hepatocytes in the bioreactor.ese hepa-
tocytes can have dierent origins.e ELAD system (Extracorporeal Liver
Assist Device [333]) works with immortalised C3A human hepatocytes, de-
rived from a human hepatoblastoma cell line. In contrast, the HepatAssist
system uses porcine hepatocytes (Fig. 2.6b). Porcine as well as human hepa-
tocytes are being used in the MELS (Modular Extracorporeal Liver Support
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[416]) and AMC BAL (Academic Medical Centre Bio-Articial Liver [364])
systems [325, 381]. Previously, our group developed numerical models to
simulate the ow and mass transport in the AMC BAL [309]. During the
last decade, however, researchers shied their focus more to the articial
liver instead of the bio-articial liver for several reasons, such as safety con-
cerns about the use of porcine cells (risk of zoonosis) and the use of human
cell lines derived from liver tumour cells [363].
Using (bio-)articial systems, improvements have been achieved such as
a decrease of jaundice, more stable haemodynamics, reduction of portal hy-
pertension, lowering of the intracranial pressure and improvements of he-
patic encephalopathy. However, these benecial eects are oen of short
duration, while the long term survival time, which is a crucial parameter,
did not change signicantly. Hence, more elaborate and long term research
is necessary to improve and optimise these systems [363].
2.5.4 Future perspective on liver disease therapy
Currently, experimental technologies such as adult hepatocyte transplan-
tation, foetal hepatocyte transplantation and bone marrow stem cell trans-
plantation are being explored as possible future therapies for liver failure.
Several clinical studies on these therapies attempted to enhance liver regen-
eration. ey showed clinical improvements, but the mechanisms leading
to these improvements are still unknown [403]. Since no overall survival
benet was observed without transplantation, these therapies should still be
considered as experimental treatments and more research is necessary [44].
However, when up and running, these technologies have the potential of
establishing an unlimited supply of hepatocytes.is would facilitate hepa-
tocyte transplantation [20, 367, 529].
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Liver transplantation
e history of liver transplantation, which is the main research context of
this manuscript, started in 1955, the year in which Welch [504] used the
term ‘liver transplantation’ for the rst time in the scientic literature. He
reported on a canine liver transplantation experiment. During the follow-
ing years, versatile transplantation procedures were tested and optimised
on dogs. Eventually, in 1963, Starzl performed the rst series of human liver
transplantations [446, 447, 450]. Unfortunately, the rst donor liver recip-
ients died within the rst 3 weeks aer transplantation. A few years later,
liver transplantation had become more successful. In 1967, the rst human
liver transplantation with a survival time of more than one year was accom-
plished [447, 448]. At that time, the estimated chance to survive one year
aer liver transplantation was about 30%. Survival chances luckily augmen-
ted substantially during the eightieswith the introduction of cyclosporin [58,
449], an immunosuppressive drug to prevent rejection. From that moment
on, chances to survive at least one year aer liver transplantation increased
up to 80% [248, 282, 447, 449, 481]. At present, survival chances are even
85% according to international registry data or higher (for instance higher
than 90% in the University Hospitals Gasthuisberg, Leuven, Belgium [383]).
e major reasons for these increased survival chances are optimised sur-
gical procedures, better preservation techniques, better immunosuppressive
agents, better patient selection, better prophylaxis and infection treatments,
and an improved care during the peri- and postoperative period [454].
Irreversible acute or chronic liver failure is ideally treated by liver trans-
plantation.e primary indications for liver transplantation in Europe, ac-
cording to the European Liver Transplant Registry, are given in Fig. 3.1 for
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the period 1988-2010 [6]. e total number of liver transplantations in this
period was 86764. Liver cirrhosis was responsible for more than half (58%)
of these liver transplantations.
Cirrhosis:
     58%
Cancer:
   14%
  Cholestatic
diseases: 10%
Acute hepatic
   failure: 8%
  Metabolic
diseases: 6%
Others: 4%
- Budd-Chiari
- Parasitic diseases
- Benign liver diseases
   or polycystic diseases
- Other liver diseases
Figure 3.1: Primary indications for liver transplantation from January 1988 until December
2010 according to the data of the European Liver Transplant Registry [6].
3.1 The donor pool
Although liver transplantation is now a successful therapy for end-stage liver
disease, there is a large shortage of donor livers.e evolution of the short-
age of donor livers is illustrated in Fig. 3.2. Since the number of patients on
the waiting list substantially outnumbers the availability of donor livers (in
2012 by approximately 33% based on Fig. 3.2), patients are dying while wait-
ing for transplantation. As such, 660 patients with liver failure died in 2012
in the Eurotransplant region while waiting for an organ (see also section
3.2.1.1) [127].e number of patients on the waiting list has been increasing
enormously during the past 20 years. In fact, the number of patients waiting
for a liver in 2012 is approximately the ten-fold of that in 1991, while the num-
ber of transplantations rose to approximately its three-fold.e elongation
of the waiting list is due to dierent factors, such as the increasing number
of patients with liver cirrhosis (for instance following steatosis or hepatitis C
infections), new indications for transplantation etc. A lot of research eorts
are invested in tackling the donor shortage problem by searching for new
resources to enlarge the donor pool, for instance by the usage of extended
criteria donor livers. As a result, the donor pool for liver transplantation
represents dierent types of donors, based on their origin. Basically, there
are deceased donors and living donors. Hereby, deceased donors are clas-
sied in three types: donation aer brain death donors (DBD), donation
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aer circulatory death donors (DCD) and extended criteria donors (ECD)
[68, 248, 345, 355, 481].
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Figure 3.2: Evolution of the number of patients on the waiting list for liver transplantation
within the Eurotransplant region (red), the number of deceased donor liver transplantations
(blue) and the number of living donor liver transplantations (green) between 1991 and 2012
according to the data of Eurotransplant [127].
3.1.1 Donation aer brain death
emajor portion of the transplanted donor livers originates from donation
aer brain death donors (DBD). In the case of DBD donors, cerebral death
is diagnosed because of severe brain damage and irreversible cessation of all
brain functions. e blood circulation in all organs (except for the brain)
is still intact, implying that the liver receives blood and oxygen until the
onset of the organ procurement procedure.ough DBD donor organs are
generally of good quality, they do not generate a sucient donor pool to help
all patients on the waiting list [454].
3.1.2 Donation aer circulatory death
Donation aer circulatory death (DCD) donors, previously referred to as
non-heart-beating donors, are declared dead based on cardiorespiratory cri-
teria and are characterised by the irreversible cessation of circulation. is
implies that, at themoment of procurement, the organs are exposed to a cer-
tain period of warm ischaemia. Because of the stagnating blood circulation,
several processes of organ damage are initiated, e.g. blood coagulation and
anoxia under normothermic conditions. Since this hampers the chances of a
successful transplantation and aects early gra function as well as survival,
it is of utmost importance to shorten the period of warm ischaemia as much
as possible [50, 292, 327, 389, 454].
45
3. Liver transplantation
Livers originating from DCD donors represent a potential resource to
substantially enlarge the donor pool. Although the quality of DCD is known
to be inferior to that of DBD donors (mainly due to an increased risk of
ischaemic type biliary strictures), they are increasingly being used to de-
crease the shortage of transplantable organs. At the moment, DCD donors
account for 10-20% of the donor pool in several countries [74, 345]. How-
ever, these organs are very susceptible to additional hypothermic preserva-
tion induced damage, which implies that it is very important to optimise
preservation methods (such as machine perfusion; see also section 3.3 and
chapter 6 and 7) for donor livers in order to improve the quality of these or-
gans [54, 74]. DCD donors are divided in four categories [74, 259, 340, 345].
• Category 1: Dead on arrival at the hospital
ese patients are declared dead upon arrival at the hospital. In this
uncontrolled type of donor, the exact moment of cardiac arrest as well
as the moment of onset of warm ischaemia is unknown.
• Category 2: Unsuccessful resuscitation aer cardiac arrest
In this case, the patient fails to respond to cardiopulmonary resusci-
tation aer witnessed cardiac arrest.
• Category 3: Cardiac arrest aer withdrawal of life-sustaining ther-
apy
In these patients, life-sustaining support (e.g. a ventilator) is with-
drawn at a planned moment. is category mostly includes patients
with irreversible brain injury who do not meet the criteria of cerebral
death. Aer removing life sustaining therapy, irreversible circulatory
arrest is awaited and a ‘no touch’ waiting period is respected before
starting the organ procurement procedure.
• Category 4: Cardiac arrest in a brain-dead donor
is category includes brain-dead patients undergoing a sudden car-
diac arrest.
In general, controlled DCD donors (category 3 and 4) provide organs
which are suering less from ischaemia than uncontrolled ones (category 1
and 2).e organs from controlled DCD donors result in a better posttrans-
plant outcome.
With careful selection of donors and recipients (e.g. patients who can
tolerate some degree of partial liver function), DCD liver gras can be safely
used to expand the donor pool, but until now no objective viability criteria
have been dened [463]. Finally, euthanasia may potentially result in a new
source of donor organs in countries where this is legal [345].
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3.1.3 Extended criteria donors
e usage of extended criteria donors (or so calledmarginal donors) is clearly
increasing, although their organs were previously believed to be untrans-
plantable. Extended criteria donor organs are of less good quality compared
toDBDdonor organs.ey are associatedwith a higher risk of physiological
dysfunction and potential transmission of diseases. Furthermore, extended
criteria organs are more succeptible to ischaemia-reperfusion injury, poten-
tially resulting in an initially non-functioning gra, early gra dysfunction
or severe damage of the biliary tract. Extended criteria include advanced age
(older than 70 years), increased ischaemic time, prolonged stay in the in-
tensive care unit, prolonged hypotensive episodes, macrovesicular steatosis,
previous malignancy, hepatitis C infection etc. In fact, deceased aer cir-
culatory death (DCD) donors are also extended criteria donors, but they
are discussed separately in section 3.2.2 [50, 135, 165, 282, 326, 341, 345, 355].
Below, we shortly discuss a few extended criteria.
• Advanced age
Since the life expectancy is generally increasing, the age of potential
donors also increases. ere is no universal age limit that is con-
sidered as a contraindication for donation. However, there are indi-
cations that the use of donors older than 70 years is associated with
less favourable outcomes compared to younger donors. As such, ad-
vanced age is e.g. associated with an impaired drug metabolism and a
higher susceptibility to toxins, which may be due to a reduced sinus-
oidal ow through aged livers. e loss of hepatic clearance capacity
in the elderly is probably caused by a combination of leukocyte ac-
cumulations in the sinusoids, pseudocapillarisation of the sinusoids
(thickening of the basement membrane and defenestration, deposi-
tion of collagen etc.) and dysfunction of liver sinusoidal endothelial
cells [221, 496, 501]. In selected cases, equally good results have been
reported aer the transplantation of older livers compared to younger
organs.erefore, age should never be considered a contraindication
for donation and transplantation. On the other hand, additional risk
factors (such as steatosis or a prolonged ischaemic time) should be
avoided [266, 345].
• Steatosis
Since the prevalence of steatosis (see also section 2.1.1) caused by obe-
sity or alcohol intake is increasing, especially in developed countries,
it is likely thatmore andmore steatotic liver gras will be encountered
in clinics.oughmany steatotic donor livers are discarded for trans-
plantation, it has been reported that steatotic livers can be transplanted
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with good results. Of course, it is recommended to only use graswith
a low or mild steatosis and without any extra extended criterion [183].
• Hepatitis C infection
Due to the shortage of donor livers, gras with hepatitis C infections
can be safely used to transplant hepatitis C positive patients.is pro-
cedure has been shown to be safe and leads to long-term survival of
the recipient, comparable to using hepatitis C negative gras. How-
ever, it is important to only use hepatitis C positive gras without
brosis, severe inammation or cirrhosis [183].
ough the results seem to be promising, many transplant centres are
still relatively reluctant to use extended criteria donor organs for transplan-
tation because of the risk of lower organ viability and the higher chance of
(initial) liver gra dysfunction. Attention should be paid to optimise preser-
vation techniques for these organs.e latter is one of the research objectives
of this thesis (see chapter 6 and 7).
3.1.4 Living donors
In the case of living donor liver transplantation, a healthy volunteer donates
a part of his liver to a patient with liver failure (see also section 3.2.3.2).
3.2 Transplantation procedure
3.2.1 Organ allocation
3.2.1.1 e role of Eurotransplant
e Eurotransplant International Foundation is a non-prot organisation
that coordinates the allocation and distribution of donor organs for the Eu-
rotransplant countries, being Belgium, Austria, Germany, Luxembourg,e
Netherlands, Slovenia and Kroatia. Transplantation centres in these coun-
tries have access to the Eurotransplant computer database, in which they can
enter patient data to put patients on the international waiting list.
When a donor comes available, Eurotransplant rst collects all relevant
information about the donor and his/her specic organs. Subsequently, the
Eurotransplant allocation computer algorithm determines the best donor-
recipient matches for each organ taking into account valid medical and eth-
ical criteria that are supported by the transplant community.e matching
procedure is based upon a combination of several factors, such as the ex-
pected outcome and the national organ balance, since a reasonable balance
is pursued in the exchange of organs between countries. More specically,
the general characteristics used to nd a suitable recipient for an organ are
the clinical urgency, the waiting time, virology, the ABO blood group rules,
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the country balance, the centre and recipient prole, the presence or ab-
sence of sepsis, meningitis, malignant tumours, drug abuse etc. Since the
cold ischaemic period must be limited to only a few hours (for some or-
gans in particular such as the heart), transportation logistics are also taken
into account to bring the donor organ from the country of origin to the po-
tential recipient. In addition, there are some criteria specically used when
allocating donor livers: the weight (and height) of the donor as well as the
MELD-score of potential recipients (see section 3.2.1.2).
When the physician treating the potential recipient accepts the donor or-
gan, the patient is contacted and admitted to the hospital. Simultaneously,
Eurotransplant establishes contacts between the donor hospital and recip-
ient transplant centre, and arranges the transportation of the donor organ.
When there is no suitable recipient found within the Eurotransplant region,
other transplantation centres are contacted through other organ allocation
organisations. Since the cold ischaemic period between organ procurement
and implantation is limited (e.g. to approximately 12 hours for livers and 24
hours for kidneys), the whole process must run very smoothly [7].e de-
velopment of better preservation techniques allowing longer preservation
times would be welcome to facilitate this process (see also section 3.3 and
chapter 7).
3.2.1.2 Model for end-stage liver disease
e model for end-stage liver disease (MELD) score is helpful as one of the
allocation criteria for liver transplantation. As shown in eq. 3.1, the MELD-
score incorporates three dierent and objective lab parameters of the pa-
tient: serum creatinine (mg/dl), serum bilirubin (mg/dl) and the interna-
tional normalised ratio (INR; reecting blood coagulation) [236, 304].
MELD = 9.6 ln(creatinine) + 3.8 ln(bilirubine) + 11.2 ln(INR)+6.4 ⋅ (aetiology: 0 if cholestatic or alcoholic, 1 otherwise) (3.1)
eMELD score varies between 6 and 40. It reects the condition of the
patient, since it is a measure of the severity of the patient’s illness and his/her
probability of mortality within three months. A MELD score of 40 shows
a patient with severe illness and an urgent need for transplantation, while a
score of 6 shows a less diseased patient. In the case of organ allocation, donor
livers are rst allocated to patients with amore severe condition. In 2002, the
United Network for Organ Sharing (UNOS) decided that the MELD score
was a goodmeasure to use in donor liver allocation. In 2003, Eurotransplant
also started using the MELD score [7].
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3.2.1.3 Contraindications for liver transplantation
Not all patients with end-stage liver disease are suitable for liver transplan-
tation. e goal of these contraindications is to use the scarce amount of
donor livers to gain a maximum of successes and advantages for the recip-
ients. Contraindications are divided into absolute and relative counterar-
guments. Absolute contraindications include liver cancer with metastases,
advanced cardiopulmonary pathologies, active alcohol abuse, as well as pa-
tients who are unable to accept the procedure or who are unable to under-
stand and cooperate with the medical care aer transplantation. Relative
contraindications endanger a successful transplantation when balancing the
disadvantages and advantages. Examples of relative counterarguments are
chronic kidney diseases, old age, severe cardiovascular problems etc. Poten-
tial candidates for transplantation are thus rst evaluated by a multidiscipli-
nary liver transplantation team. If the result of the evaluation is positive, the
patient is added to the waiting list [370].
3.2.2 Orthotopic liver transplantation
e most frequently used liver transplantation technique is orthotopic liver
transplantation. Below, the donor procedure and the recipient procedure are
discussed.
3.2.2.1 Donor procedure
According to the dead donor rule, procurement procedures can only start
aer the declaration of death. First, an incision is made in the donor body to
provide exposure for multiorgan procurement. A thorough abdominal ex-
ploration can be performed to exclude any contraindications such as malig-
nancy etc. In the next step, cannulas are placed in the aorta (and the inferior
mesenteric vein) to ush the abdominal organswith a cold preservation uid
(4-6°C). As such, the blood of the donor is removed from the organ and the
organs are rapidly cooled down.e peritoneal and pericardial cavities are
lled with slushed ice to speed up the cooling process. e procurement
of thoracic organs can start when ushing is initiated. en, the abdom-
inal organs are procured starting with a hepatectomy by mobilising the liver
and by dissecting and transecting its blood vessels. Subsequently, the pan-
creas is removed en bloc with the duodenum and spleen, followed by the
kidneys. ereaer, the donor body is closed with respect. Aer procure-
ment, the donor organs are packed for transport to the recipient transplant
centre. Organ retrieval techniques may vary between dierent transplant
centres. As such, possible variations are: single (aorta) versus dual cannula-
tion (aorta and the inferior mesenteric vein or the portal vein), dissection in
cold versus warm conditions, single versus en bloc organ removal, the usage
of dierent preservation solutions etc. [50, 175, 454, 510].
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During this normothermic process, organ ischaemia is absent in DBD
donors, since the administration of cold preservation solution occurs shortly
aer circulatory arrest. In contrast, DCD donors (especially uncontrolled
DCD donors) suer more from normothermic ischaemia due to the pro-
longed period between cardiac arrest and cooling [345].
3.2.2.2 Recipient procedure
Once the donor liver has arrived at the recipient’s transplantation centre, the
organ is carefully inspected. When the liver is judged transplantable, bench-
ing of the liver gra is performed, meaning that unneeded tissue is removed
and the hilar structures as well as the infra- and suprahepatic vena cava are
dissected. Simultaneously, the recipient is prepared for transplantation.e
recipient procedure counts three steps: the pre-anhepatic, the anhepatic and
the post-anhepatic phase.
• Pre-anhepatic phase
During this phase, an abdominal subcostal incision is made and the
recipient liver is mobilised to prepare for its removal. e bile duct
andmajor blood vessels (hepatic artery (HA), portal vein (PV), supra-
hepatic vena cava (or vena cava superior; VCS) and infrahepatic vena
cava (or vena cava inferior; VCI) will be isolated.
• Anhepatic phase
Vascular clamps are placed on the bloods vessels and the liver is re-
moved. is hepatectomy is a dangerous intervention with risks of
coagulopathy and major bleeding related to the portal hypertension.
e occlusion of the PV and VCI results in a decreased venous re-
turn to the heart. Sometimes, a veno-venous bypass is used to prevent
a drop in venous return. Doing so, blood from the lower body and
bowel is bypassed towards the upper body, resulting in a better hae-
modynamic stability. Aer a successful hepatectomy, the donor liver
can be implanted.e donor liver is placed in the recipient’s body in
an orthotopic position. First, the VCS is anastomosed followed by the
VCI and the PV (Fig. 3.3).
• Post-anhepatic phase
Subsequently, the clamps of the PV and VCI are removed, allowing
for reperfusion of the donor liver by restoring blood ow through the
liver. Before or aer reperfusion, the HA is also anastomosed (Fig.
3.3). Oen, hypotension, arrhythmia or coagulopathymay occur dur-
ing reperfusion. Next, the bile duct system is reconstructed.
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Figure 3.3: Implantation of a donor liver in a recipient. Adapted from [493].
Variations of the liver transplantation technique have been reported. For
example, the piggy-back technique preserves the recipient’s VCI implying
no need to completely cross clamp the VCI, in contrast to the technique
described above [515].
Aer transplantation, post-operative care is important to stabilise the
major organs systems, to evaluate the gra function and immunosuppres-
sion, to monitor and possibly treat complications [214].
3.2.3 Alternative transplantation techniques
Due to the donor shortage despite the increasing use of extended criteria
donors to enlarge the donor pool, new and innovative liver transplantation
techniques have been developed.e alternative transplantation techniques
have a positive, but modest inuence on the number of liver transplanta-
tions.
3.2.3.1 Split liver transplantation
In the 1980s, split liver transplantation (SLT) was performed for the rst
time to increase the number of liver transplantations. During SLT, the donor
liver is split into two liver gras (Fig. 3.4). In this way, the two partial liver
gras are transplanted in two recipients. e regeneration capacity of the
liver enables each part to regrow to a normal liver size in both recipients
[68, 155, 205, 398, 521].
In most SLT procedures, one adult liver is split among one adult and
one child. Doing so, the liver is split in a smaller portion for the child (the
le lateral superior and inferior segment; see Fig. 1.3 and 3.4) and a larger
portion for the adult (the extended right lobe). To obtain two liver gras of
a sucient size aimed at transplanting two adults, division of the liver has to
be done dierently, i.e. by transection of the livermidplane to divide the liver
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in its anatomical right (60% of the liver tissue) and le liver lobe (40% of the
liver tissue). However, it is practically impossible at this moment to predict
the functionality of the splitted liver gras, resulting in a risk of developing
the small-for-size syndrome (SFSS). In chapter 8, we developed a model to
gain more insight into this problem.ough SLT is an attractive alternative
to enlarge the donor pool, careful donor and recipient selection is necessary.
As such, SLT is oen restricted to ‘ideal donors’, being young and stable with
a short period of hospitalisation [214].
 Portion 
for adult
 Portion 
for child
(a)              (b)
 Right
  lobe
   Left
  lobe
Figure 3.4: Split liver transplantation. (a) Liver split in a small portion for a child (le lateral
superior and inferior segment) and a large portion for an adult (extended right lobe); (b)
liver split in its anatomical le and right lobe, both destined to transplant an adult. Adapted
from [214].
3.2.3.2 Living donor liver transplantation
At the end of the 1990s, living donor liver transplantation (LDLT) became
feasible. LDLT involves a healthy personwho iswilling to donate a part of his
liver to be implanted in a patient with liver failure (Fig. 3.5). Similar to SLT,
the LDLT technique leans on the regeneration capacity of the liver. During
approximately three months aer the procedure, the regeneration capacity
enables the liver parts in the donor and recipient to regrow to a sucient
liver size tomaintain liver function of the body.e LDLT procedure is only
performed when both the donor and recipient are stable.e main problem
is the substantial mortality risk for the donor of a right lobe. Since a partial
hepatectomy of the living donor is a major surgical procedure and to ensure
that there are no risk factors that would contraindicate donation, potential
donors are preoperatively carefully screened for their medical condition to
rule out major diseases and to check biochemical markers of liver function
etc. Some centres also perform a liver biopsy to check for steatosis or other
liver diseases. Additionally, their psychosocial condition is checked. e
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donor should bemade aware of the risks and possible complications, and has
to be able to come to a personal decision without being coerced by anyone
else. Before performing LDLT, surgical planning is being donewith specially
developed soware packages using CT images of the liver to study the liver
anatomy and volume of both donor and recipient. is is done to estimate
the best splitting location so that both the donor and recipient would hope-
fully possess sucient viable liver tissue to sustain life aer transplantation.
As such, a current guideline says that the donor should retain at least 40%
of the original liver and that the gra to body weight ratio should be higher
than 0.8% [59, 129, 130, 155, 410].
(a) Donor             (b) Recipient
Vena cava
inferior
Portal vein
Hepatic artery
Right hepatic vein
Section of donor liver
to be transplanted
Donor section 
transplanted
to recipient
Vena cava
inferior
Aorta
Loop of small
intestine
Figure 3.5: Adult living donor liver transplantation: the right lobe of the donor (a) is being
resected to be transplanted in the recipient (b). Adapted from [14].
In the beginning, LDLT as well as SLT were mainly applied in the pae-
diatric context, since it was dicult to nd donor organs with good size
matches for smaller children. As the number of patients on the waiting list
kept growing, however, these techniques were extended to the adult setting.
In the case of a paediatric recipient, a gra containing the le lateral superior
and inferior segments (representing approximately 25% of the liver tissue) is
most frequently used. For larger children, the total le lobe may be used.
For adult recipients, the most frequently used gra is the right liver lobe,
although a le lobe as well as a combination of two le liver lobes (called
‘dual donor LDLT’ involving two donors) also have been reported as suc-
cessful measures. Removal of the right lobe is more drastic than removal of
the le lobe [374, 507]. In contrast to paediatric LDLT, adult LDLT is still
more likely to lead to complications and a substantial risk of death for the
healthy volunteering donor (approximately 0.5-1%). Since the greatest con-
cern in LDLT is the risk of death for the donor, adult LDLT has not gained
general acceptance yet [159, 214, 345].
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Amajor complication associated with LDLT (and SLT) is SFSS. SFSS can
occur in both the donor and recipient and is usually the consequence of a
gra size mismatch. A living donor develops SFSS when an excessive liver
resection leads to progressive liver dysfunction and failure. SFSS is basically
caused by an insucient amount of hepatocytes, resulting in an unbalance
between an accelerated liver regeneration and an increased demand of liver
function. SFSS is characterised by overperfusion of the portal system, typ-
ically accompanied by portal hypertension, and may cause other complica-
tions, such as delayed or no synthetic function, prolonged cholestasis, biliary
problems (e.g. poor biliary drainage due to bile duct stricture, bile leak from
cut surface), coagulopathy etc. It is thus of vital importance to do a careful
donor and recipient selection and to preserve a sucient volume of remnant
liver in the donor [64, 151, 189, 214, 218, 374, 392, 415, 430, 431, 462, 474, 513].
To gain more insight into this delicate balance, we developed an electrical
analog model to simulate the impact of a partial hepatectomy on the liver
haemodynamics (see chapter 8).
LDLT can take place between family members, as well as between non-
related people.e results of this technique are favourable for paediatric liv-
ing donation. As such, a parent may donate part of his liver to save his/her
child’s life [243]. LDLT has the big advantage of bypassing the waiting time
for a deceased donor liver. In this way, liver transplantation can be done
before the condition of the patient with liver failure further deteriorates.
Typically, LDLT happens more frequently in areas of the world where de-
ceased donation is (almost) not performed, such as Asia and the Middle
East [355, 366, 436].
Alternative techniques have been reported to procure living donor gras
using less invasive methods such as laparoscopic and hand assisted tech-
niques, but these methods are still under exploration in dedicated and expe-
rienced centres (e.g. the transplantation centre ofGhentUniversityHospital,
Ghent, Belgium) [70, 218].
3.2.3.3 Domino transplantation
is rare form of liver transplantation involves a patient with a metabolic
disease undergoing liver transplantation, while at the same time donating
his own liver to another patient. In this way, the second patient receives a
donor liver which is carrier of ametabolic disorder, most likely to be familial
amyloidotic polyneuropathy. e only curative treatment for this disorder
is liver transplantation. Familial amyloidotic polyneuropathy is an inherited
mutation disorder, which takes about 15 years or more to develop symptoms
in genetically aected individuals and usually never manifests during the
lifetime of most carriers. Since it is thought that a similarly long incuba-
tion period is needed to develop symptoms in a domino transplant recipi-
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ent, these disorders are an interesting source of donor organs especially for
stable older recipients [123].
3.2.3.4 Xenotransplantation
e persistent donor shortage has led to an increased interest in xenotrans-
plantation. Xenotransplantation is a procedure during which an organ from
one species is implanted in another species. In that way, animals would be a
potential resource of organs to transplant into humans.e pig seems to be
the best candidate due to the similarity in size and the unlimited supply. At
themoment, further research ismandatory, since xenotransplantation is not
feasible yet due to safety reasons. Problems include rejection due to the im-
mune response, risks of zoonosis (potentially resulting in the transmission
of infectious agents from the gra to the recipient), and thrombocytopenia
with spontaneous haemorrhage immediately aer gra reperfusion. Fur-
thermore, a number of ethical and regulatory issues should be dealt with. It
is believed that aer solving the current issues (e.g. by genetic modication)
in the next coming years, clinical trials may be feasible to test xenotrans-
plantation as a bridge to allogra transplantation [121, 248].
3.2.4 Complications associated with liver transplantation
e surgical procedure of liver transplantation is very complex and there
is a continuous risk of rejection of the donor liver by the recipient body.
Moreover, the lifelong consumption of immunosuppressive medication by
the recipients makes them more sensible for infections and malignity. Most
surgery-related complications aer liver transplantation occur within the
rstweeks. An increased postoperative chance for complications is observed
for partial-liver transplantations (e.g. SFSS in SLT and LDLT) as well as for
patients who are critically ill at the time of transplantation.e most com-
mon complications are haemorrhage, vascular complications (e.g. throm-
bosis, stenosis, variceal bleeding etc.), liver dysfunction, biliary leaks or ob-
structions, wound infection or haematoma, primary liver dysfunction, re-
currence of disease (e.g. HCC recurrence aer transplantation) etc. [17, 139,
184, 214, 347, 384, 439].
e biggest future challenges will be nding solutions for the reduced
motivation for donation and the high costs of maintaining potential donors
on life support, as well as to improve storage solutions and techniques (e.g.
by machine perfusion; see also chapters 6 and 7), to improve intraperitoneal
cooling etc. [54].
3.3 Donor liver preservation
e time span during which a donor liver can be safely preserved is limited.
is time limitation is stricter for extended criteria donor organs (such as
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DCD donors) than for DBD donors. When aiming at expanding the use of
extended criteria donor organs, better preparation and preservation meth-
odswill be necessary for these organs, prone to ischaemia-reperfusion injury
[481].
During liver transplantation, the preservation period starts at the mo-
ment of organ procurement and lasts until the moment of implantation in
the recipient. Hereby, the moment of removal of the liver from the donor
body (or the moment of death in case of DCD donors) initiates a cascade of
processes by which the organ starts to get damaged. From that moment on,
the liver is no longer perfused by blood until it is reperfused aer implanta-
tion in the recipient. To bridge the ischaemic period between removal and
implantation, the liver has to be preserved in such a way that the ischaemic
damage is minimised and the organ viabilitymaintained.ough static cold
storage is usually applied to preserve donor livers, the upcoming use of ex-
tended criteria donors resulted in a revival of machine perfusion [187]. In
addition, total donor perfusion is a technique to perfuse the donor organs
in situ during organ procurement.
3.3.1 Cold storage and its limitations
e current standard for the preservation of donor livers is cold storage (CS).
Aer an initial ush to remove blood [469] and hepatectomy, the liver is
packed in a special bag lled with preservation uid. From that moment
on, the preservation time is started. e bag is immersed in a box lled
with melting ice. To prevent direct contact between the organ and ice, a
second bag (lled with a salt solution) is placed around the rst bag and
a third bag is used for sterility reasons. Once the organ is packed, it can
be transported. During the preservation period, the water/ice temperature
has to be kept constant between 2 and 4°C. Cooling of the organ implies a
strongly reduced metabolic need (approximately 10% of the normal cellular
metabolic activity at 37°C). As a consequence, nutrients and oxygen are less
needed [283, 441, 479, 481].
oughCS is themostwidely used preservation technique for liver trans-
plantation, some CS-related problems are encountered. Livers of extended
criteria donors do not tolerate prolonged cold ischaemia and thus cannot
be optimally preserved by CS. During CS, there is no circulation through
the liver resulting in no oxygen or nutrient delivery as well as no waste re-
moval. A cascade of detrimental events (ATP depletion, cellular swelling
etc.) is initiated and may progressively damage the organ upon reperfu-
sion. When reperfusing the organ aer cold ischaemia, this may lead to the
production of radical oxygen species initially, inammation and cell death
[46, 168, 283, 326, 378, 440]. Moreover, CS oers no possibility to assess vi-
ability markers of the liver gra. As a consequence, alternative preservation
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techniques (e.g. machine perfusion) may be a solution to these limitations
[188, 297, 344, 442].
3.3.2 e revival of machine perfusion
In 1813, le Gallois was the rst to propose perfusion as a method to pre-
serve donor organs. However, it took a long time before Carell and Lind-
berg reported on the rst perfusion pump system in 1935, used to preserve
thyroid glands [61, 109, 346]. e system was able to maintain a pulsatile
uid circulation through living organs. Nevertheless, the interest in perfu-
sion decreased during the following decades in favour of CS. During the last
decades, however, the increasing shortage of donor organs has forced trans-
plantation centres to consider using (more) extended criteria donors, having
a reduced ischaemic tolerance. Simultaneously, this resulted in a revival of
machine perfusion (MP) to revitalise or resuscitate extended criteria organs
[56, 110, 111, 146, 223, 227, 279, 282, 296, 340, 341, 343, 346, 387, 475, 519].
e goal of MP preservation is to mimic - to some extent - the physiolo-
gical blood circulation in order to limit ischaemic liver damage [92]. MP
aims to optimise the quality and viability of donor organs in order to pre-
vent organ damage and complications aer transplantation. In addition,
MP may enable longer preservation times. MP is already elaborately tested
[338, 352] and clinically used for kidneys. Liver MP prototypes have been
developed and experiments and trials are ongoing, but liver MP systems are
not yet commercially available. is is due to a number of substantial dif-
ferences with kidneys, mainly caused by the complexity of the liver (such
as its dual aerent vasculature with ow competition ([342]; see also sec-
tion 3.3.3) and its complex microvasculature with endothelial cells suscepti-
ble to damage) [35, 110, 111, 175, 361, 378, 478, 479]. Nevertheless, liver MP
has shown potential to be a better preservation technique than CS.e ad-
vantage is that dynamic MP ensures active perfusion.ere is a continuous
supply of nutrients (metabolic substrates) supporting the metabolism, the
possibility of oxygen and therapeutic agent delivery and removal of meta-
bolic waste products and toxins. Moreover, MP better preserves the mi-
crovascular integrity and oers a unique timewindowbetween procurement
and transplantation to assess the viability of organs prior to transplantation
[25, 26, 35, 173, 340, 346, 378]. As a result, MP can improve the clinical out-
come and enable prolonged preservation times without increased preserva-
tion damage. Moreover, MP leads to economic benets due to lower gra
dysfunction, shorter hospital stays and better gra survival rates [341, 343].
Dierent MP systems have been developed. In essence, an MPmachine
contains an organ chamber and is typically equipped with one or two pumps
(an HA and/or PV pump) to pump perfusion uid from the reservoir into
the liver (Fig. 3.6). Fig. 3.6a shows a schematic example of a liver perfusion
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machine, while Fig. 3.6b and 3.7 show pictures of liver MP systems. Below,
some important characteristics of liver MP systems are addressed as well as
the extension of MP to extracorporeal donor body perfusion. Furthermore,
we describe the MP device that was used for the liver MP experiments pre-
sented in this dissertation (see section 3.3.3 and chapter 7).
3.3.2.1 Perfusion system
Several studies have investigated dierent perfusion modes, e.g. HA and/or
PV perfusion, pulsatile versus continuous perfusion [476] etc. Hereby, per-
fusion of both the HA and PV leads to the best results according to cer-
tain studies [488]. Roughly, there are two types of pump systems: pressure-
and ow-controlled pumps. Systems with ow-control (e.g. displacement
pumps with a piston) deliver a certain ow, independent of any occlusion
or increased vascular resistance in the circuit. is can lead to the genera-
tion of enormous pressures and shear stresses, whichmay aect and damage
the sinusoidal endothelial cells. In contrast, pressure-controlled pumps are
essential to prevent endothelial cell damage due to overperfusion. When
assuming that the law of Poiseuille is valid (eq. 3.2 with ∆p [Pa] the pres-
sure drop, R [Ns/m5] the vascular resistance, q [m3/s] the ow, µ [Pa⋅s] the
dynamic viscosity, l [m] the length and r [m] the radius), pressure-control
implies that the ow depends on the vascular resistance.
∆p = Rq = 8µl
pir4
q (3.2)
As such, the ow as well as the corresponding shear stress is restricted
by the pressure. Pressure-control is possible by using for instance pressure-
controlled rotation pumps. Normally, rotation pumps result in a continuous
ow, but by controlling and varying their rotational speed, a pulsatile ow
can be generated.e latter type of pumps is used in the LifePort Worksta-
tion (Organ Recovery Systems, Zaventem, Belgium; Fig. 3.7), theMP system
that we used to perform HMP experiments as described in section 3.3.3 and
chapter 7. e MP system is also provided with controllers to monitor the
pumps and adjust the settings when necessary.
3.3.2.2 Temperature
ere is an ongoing debate on the most optimal perfusion temperature. MP
systems are subdivided in hypothermic (HMP), subnormothermic (SNMP)
and normothermic perfusion (NMP) [187, 238, 371].
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• HypothermicMP(HMP) implies a preservation temperature between
4-6°C.is temperature ensures a lower metabolic activity resulting
in a lower need for nutrients as well as a lower production of waste
products. HMP thus combines the advantages of hypothermic pre-
servation with continuous perfusion [35, 36, 111–113, 173, 340, 458, 478,
479, 481]. e low HMP temperatures induce a vasoconstrictive re-
sponse of the blood vessels [481]. A decrease of the radius of the blood
vessels results in a substantial increase of the vascular resistance, as il-
lustrated by Poiseuille’s law (eq. 3.2) inwhich the resistance is inversely
proportional with the fourth power of the radius. However, aer ap-
proximately 30 minutes of MP, the eect of vasoconstriction is slowly
diminishing.
Dierent microscopic studies observedmorphological changes of en-
dothelial cells aer HMP [110, 227]. Endothelial cells seem to get par-
tially detached from their surrounding tissue and change froman elon-
gated shape to a round shape indicating swollen cells.ese changes
can lead to ow heterogeneity, an increased vascular resistance and
obstruction of the sinusoidal lumen and ow, which may result in
loss of the barrier between vascular and interstitial spaces. As such,
the vasculature may be torn and oedema may develop.is course of
events may induce irreversible damage to the donor organ. Maintain-
ing the integrity of endothelial cells is thus one of the biggest chal-
lenges for HMP of donor livers [35]. erefore, HMP should avoid
rapidly varying shear stresses. Since preservation happens at low tem-
peratures, uid viscosity values will be higher compared to conditions
of normal physiological temperatures, corresponding with a higher
vascular resistance (eq. 3.2). As such, lower perfusion ows should be
used to prevent damage of fragile endothelial cells.
HMP has been shown to reduce molecular markers of preservation
injury and to improve gra viability and function compared to CS
[187, 187, 226]. Guarrera et al. [174] demonstrated in a rst clinical
HMP trial with human livers that HMP is safe and feasible. HMP
preserved livers showed shorter postoperative recovery, less biliary
complications and hepatic injury compared to simple CS [25]. HMP
was performed during patient preparation and recipient hepatectomy,
thus only during a part of the preservation time aer a certain period
of cold ischaemia. Dutkowski et al. [111] also suggested that a short
period (e.g. one hour) of oxygenated HMP prior to transplantation
is able to improve cold ischaemic induced energetic disturbances and
injuries. Human liverHMPexperiments ofMonbaliu et al. [343] show-
ed well-preserved parenchyma and an intact endothelial cell lining
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aer 24 hours of HMP. Furthermore, oxygenation in HMP has been
shown to be important to protect frommitochondrial and nuclear in-
jury [419]. ough HMP gives evidence of good results in normal
livers, its use for the preservation of extended criteria gras may lead
to increased Kuper cell activation and endothelial cell destruction
[141, 188]. An inherent limitation of HMP is the fact that the cellular
activity may remain quiescent. As such, a more correct assessment of
viability may be possible in more physiological conditions as seen in
(sub)normothermic perfusion [343].
• SubnormothermicMP (SNMP)may be a promising intermediate ap-
proach in between HMP and NMP by perfusing at 20-28°C close to
room temperature [341]. As such, Olschewski et al. [371] and Vairetti
et al. [477] showed that SNMP results in a better preservation of the
hepatic functional capacity and a reduction in damage of steatotic liv-
ers compared to HMP. Gringeri et al. [170] reported the resuscitation
of DCD livers using SNMP. However, one has to be careful to avoid a
progressive oxygen debt by using a solution with an adequate oxygen-
carrying capacity [188]. In the end, SNMP is able to avoid the disad-
vantages of hypothermia, while circumventing the logistic diculties
of normothermic perfusion [371].
• NormothermicMP (NMP) is being performed at a normal body tem-
perature (37°C) [49, 144, 228, 341, 395, 495]. Since these preservation
conditions mimic normal physiological conditions, one of the advan-
tages of NMP is the ability to perform a more advanced assessment
of the organ viability by measuring key functional parameters corre-
lating with function aer transplant, such as bile ow, urea produc-
tion, oxygen uptake etc. [519]. In theory, NMP preservation avoids
ischaemia-reperfusion injuries and could even last for several days
[110, 494]. NMP has been shown to be superior over CS, and to have
the ability to resuscitate DCD gras aer warm ischaemia [219, 420].
A potential disadvantage is that NMP is a complex undertaking with
a high risk of organ damage when not performed correctly or in case
of any technical failure [326, 420, 494]. Drawbacks are the complex
logistics of NMP and the risk of infection. One of the major chal-
lenges in NMP is to use a carrier providing sucient oxygen without
inducing any vascular damage. Oen, (diluted) autologous blood is
used with adequate additives of nutrients required to regulate homeo-
stasis of the high liver metabolism, heparin etc. [110, 146, 188, 341].
Hessheimer et al. [188] stated that NMP appears to be the best option
in liver transplantation to improve the viability of extended criteria
organs. Other studies on the perfusion of extended criteria livers also
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indicated that higher temperatures (approaching 37°C) improved the
gra preservation when adequate oxygen supply was provided [188].
3.3.2.3 Perfusion solution
Perfusion solutions aim at protecting the donor liver by maintaining a nor-
mal intravascular osmotic and oncotic pressure, by regulating the pH and
limiting reperfusion damage. In the rstMP experiments, bloodwas used to
perfuse the liver. However, due to several problems (such as blood coagula-
tion and limited availability), the switch wasmade to acellular perfusion u-
ids such as KPS (Kidney Preservation Solution), Celsior, UW (University of
Wisconsin solution), HTK (Histidine-Tryptophan-Ketoglutarate), Vasosol,
Polysol etc. Modications of these uids are possible by using additives
to administer nutrient or medication. For instance, anti-apoptotic drugs
are added to reduce ischaemia/reperfusion damage and nitrogenoxide (NO)
precursors are added to protect mitochondria against warm ischaemia. Fur-
thermore, the perfusion uid can be oxygenated [21, 48, 175, 187, 283, 296,
297, 326, 335, 519].
Acellular preservation solutions are dierent from blood and also act
dierently concerning their ow behaviour. Blood is a non-Newtonian uid
and - to some extent - behaves like a shear thinning uid, showing lower
viscosity values for higher shear rates and vice versa. In addition, the hem-
atocrit (the percentage of red blood cells in blood) inuences the viscosity.
Several models have been proposed to describe the viscosity behaviour of
blood as a function of shear rate (e.g. theQuemadamodel including hemato-
crit eects and the Cassonmodel including yield stress) [339]. Furthermore,
blood gives rise to the Fahraeus-Lindqvist eect (diameter-dependent vis-
cosity decrease due to red blood cell aggregation in the centre of small blood
vessels) [128, 185]. In contrast to blood, acellular perfusion solutions don’t
show these eects [28, 480].
3.3.2.4 e role of oxygen
e liver consumes oxygen during preservation. Also in the case of HMP
with a lower metabolic activity, the liver is assumed to consume a certain
amount of oxygen for oxidative energy production (aerobic metabolism)
[110, 487]. is implies that optimal preservation should include the ad-
ministration of oxygen to reduce the risk of cell damage due to hypoxia.
However, oxygenation is a double-edged sword and can also result in the
production of reactive oxygen species (ROS), damaging cellular structures
such as membranes. To prevent ROS formation, ROS scavengers may be
added to the perfusion uid [343, 457, 481].
An alternative technique to administer oxygen is persuation of gas
through the vessels, more specically by a retrograde venous insuation
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of humidied pure oxygen. In several experiments, this technique showed
improvements of liver gra viability and is now evaluated clinically [187, 274,
296, 335, 456].
In the end, several studies have shown the benecial eect of oxygena-
tion resulting in less overall damage and improved liver function [110, 187,
429, 487].
3.3.2.5 Monitoring
Carefulmonitoring of perfusion characteristics (such as pressures, ows and
vascular resistances) may enable estimating the viability of the organ aer
preservation. In kidney HMP, the intrarenal resistance is used as a measure
of kidney quality, but should not be used to discard organs for transplanta-
tion [232]. An elevated resistance may indicate microvascular disturbances
such as cell swelling and oedema, which may result in a decreased viability
[115, 173]. Using pressure sensors close to the HA and PV of the liver, the
perfusion pressure can be monitored and controlled. In this way, twisted
or loosening cannulas can be detected. Flows may be estimated by using
the pump rotation speed or by using ow probes. Calculating the vascular
resistances may allow estimating the liver viability. Furthermore, a temper-
ature sensor is advised to detect and correct for temperature variations. In
addition, biochemical analysis of the perfusate (e.g. enzymatic markers such
as aspartate transaminase, lactic dehydrogenase etc.) may be interesting to
provide information to the clinicians about the viability [26, 343].
3.3.2.6 e quest for optimal MP parameters
e balance between goodperfusion parameters and the occurrence of dam-
age at the endothelial level is crucial. However, the optimal manner to per-
form MP is still a matter of debate [188]. Many dierent MP protocols have
been proposed: single versus dual perfusion, dierent pressure or ow set-
tings, pulsatile versus non-pulsatile perfusion, oxygenation or not, the per-
fusion temperature etc. [342, 488]. For example, a study of ’t Hart et al.
[457] postulates that - to minimise cellular damage - the perfusion pres-
sure should be set at 25% of the in vivo pressures in physiological conditions.
However, these settings still result in some cellular damage. Another impor-
tant factor is the usability of the system. As such, a practical MP machine
should be easy to transport, not expensive and user friendly [341]. More re-
search is thus necessary to rene perfusion systems and parameters so that
a balance is found between stable and complete MP and endothelial injury
[25, 26, 92, 371, 458, 481].e latter is also the research objective of chapter
6.
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3.3.2.7 Extracorporeal MP of the donor body
Similar to the extracorporeal perfusion support during cardiac surgery, ex-
tracorporeal MP of the donor body enables the recirculation of blood or
perfusion uid through the donor organs during procurement. is ap-
proach may allow changing the period of warm ischaemia aer cardiac ar-
rest (especially relevant in the case of DCD donors) to a preconditioning
period. In this way, the potential donor and his/her organs may be eval-
uated [140, 156]. Similar to MP, dierent types of extracorporeal support
systems have been developed, using dierent temperatures (hypothermic
versus normothermic) [235, 300]. Usage of these systemsmay allow expand-
ing the donor pool by improved gra function and performing controlled
and unhurried organ procurements [50, 188, 300, 407].
Roller pumps
  Organ
cassette
Control panels for 
perfusion settings
Figure 3.7: e LifePort Workstation (Organ Recovery Systems, Zaventem, Belgium).is
liver machine perfusion (MP) prototype was used to perform porcine and human liver hy-
pothermic machine perfusion (HMP) experiments.
3.3.2.8 e LifePort Workstation (Organ Recovery Systems, Zaventem,
Belgium)
e LifePort Workstation (Organ Recovery Systems, Zaventem, Belgium)
was used for all experiments discussed in section 3.3.3 and chapter 7 (Fig.
3.7). Two roller pumps are included to pump perfusion solution from the
reservoir (organ cassette) to the HA and PV (Fig. 3.6a and 3.7).e LifePort
Workstation prototype generates pressure-controlled MP, meaning that the
perfusion ow through the organ is secondary to the pressure, which is set
by the operator (pressure range of 5-99 mmHg). Optionally, a ow limita-
tion can be added by specifying the maximum allowed ow for each pump
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(with an absolute maximum ow of approximately 700 ml/min). Perfusion
regimes are either continuous or pulsatile with pulsatile perfusion being im-
plemented as the generation of sinusoidal pressure curves. e perfusion
circuit of each pump also includes a dampener (accordion-like reservoir
lled with water and air; Fig. 7.3) to reduce unwanted pressure uctuations
generated by the pumps. Porcine as well as human livers are perfused with 2
litres of KPS-1, which is a perfusion solution that is oen used for renalHMP
(see also section 3.3.2.3) [201]. During HMP, livers are placed in a dome-
shaped organ cassette and are partially immersed in the KPS-1 solution (Fig.
3.6a and 3.7).e organ cassette is placed in a tub, lledwith icewater to cool
the organ and perfusion solution (see Fig. 7.3). A tubing circuit guides the
preservation solution from the organ cassette to the pumps, which generate
ow to the cannulated inow vessels (HA and PV). Aer leaving the liver
through its hepatic venous (HV) system, the perfusion uid drains into the
organ cassette, aer which it is recirculated (Fig. 3.6a). Optionally, an oxy-
genator and a heater/cooler system can be added to the circuit in order to
oxygenate and heat/cool the perfusion solution before entering the donor
organ (Fig. 3.6a). Furthermore, the device is designed to regularly ush the
tubing for a short period of time (wash cycle of 10 seconds aer every 10
minutes of perfusion).
3.3.3 Porcine HMP experiments to study ow competition
As ow competition between the HA and PV may lead to unbalanced liver
MP and thus hampers perfusion homogeneity, a set of porcine HMP experi-
ments was conducted to enlighten this phenomenon.is section discusses
the key points of “Flow competition between hepatic arterial and portal ve-
nous ow during hypothermic machine perfusion preservation of porcine liv-
ers”, as published in the International Journal of Articial Organs, 35(2):119-
131,2012. For more detailed information on this study, please consult the full
paper [342].
3.3.3.1 Background and aim
Several papers focused on the hepatic ow characteristics during HMP fea-
sibility studies with someHMP experiments showing a progressive decrease
and/or a complete cessation of the PVowwhilst theHAowwas increasing
[102, 340, 487]. is phenomenon, dened as ow competition, was occa-
sionally observed during HMP of porcine as well as human livers discarded
for clinical transplantation, which illustrates that the observation was not
species-specic. As ow competition disturbs the HA-PV ow distribution,
it may interfere with a homogeneous perfusion. erefore, the aim of this
study was to evaluate whether ow competition could be reproduced in an
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animalmodel. We hypothesised that the PVowmay be hampered as a con-
sequence of an elevated sinusoidal pressure, reducing the pressure dierence
between the PV and the sinusoids. To test this hypothesis, an increased in-
trasinusoidal pressure was evoked by either increasing the HA pressure or
obstructing the hepatic outow. In addition, the reversibility of ow com-
petition was investigated.
3.3.3.2 Materials and methods
is study was approved by the local animal care committee of the Univer-
sity Hospitals Leuven (Belgium) and was carried out in accordance with the
Belgian federal guidelines. Five porcine livers (average weight 600 g, from
30-35 kg pigs) were procured. Aer cannulating the HA, PV and infrahe-
patic vena cava inferior (VCI) and clamping the suprahepatic VCI, the liv-
ers were perfused with 2 liters of non-oxygenated 4-6°C KPS-1®. e Life-
Port Workstation (see section 3.3.2.8) allowed for pressure-controlled, ow-
unlimited continuous perfusion through the HA and pressure-controlled,
ow-limited continuous perfusion through the PV. PV ow was limited to
0.5 ml/g/min, because it was previously observed that PV pressure-control
alone gave rise to very high ow rates, which may induce a high shear stress
duringHMP, possibly damaging the sinusoidal endothelial lining. Pressures
(PHA, PPV and PHV ) and ows (QHA andQPV ) were measured continuously
with a sampling frequency of 1 Hz (for more details on the data acquisition:
see [342]). HMP was initiated by applying the following conditions: PPV≤7
mmHg andQPV≤300ml/min for the PV inlet, and PHA=25 mmHgwith un-
limited QHA for the HA inlet. A stable perfusion regime was awaited before
starting the experimental measurements. Two experimental settings were
designed to increase the sinusoidal pressure in order to evoke ow compe-
tition in the porcine livers. First, PHA was incrementally increased (steps
of 10 mmHg) until a signicant decrease in QPV was observed. When ow
competition was observed, the reversibility was investigated by a step-wise
decrease of the PHA. Secondly, an outow obstruction was evoked by clamp-
ing the VCI cannula to increase the PHV , whilst complete cessation of the
hepatic outow was avoided.
3.3.3.3 Results and discussion
Increasing the PHA evoked gradual ow competition with QPV cessations at
the highest PHA (Fig. 3.8). Flow competition could be reversed by lowering
PHA (and/or increasing PPV ). During severe outow obstruction, a repet-
itive pattern of alternating increases/decreases between the QHA and QPV
was observed (Fig. 3.9). is interaction repeated itself and was eventually
observed to be self-limiting. Comparison of the ow competition phenom-
ena evoked by PHA alterations and VCI obstructions reveals a clear dier-
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ence. Where PHA increases led to competition in one direction (QHA in-
creasedwhileQPV decreased), VCI obstructions aected bothQHA andQPV
in an alternating and repetitive way.
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Figure 3.8: Hypothermic machine perfusion (HMP) measurements of a porcine liver when
evoking ow competition by increasing the hepatic arterial pressure (PHA). Panel a depicts
PHA and panel b depicts the portal venous pressure (PPV ), while panel c depicts the hepatic
arterial ow (QHA) and the portal venous ow (QPV ). PHA was incrementally increased every
10 minutes starting from 25 mmHg, resulting in an incremental QHA increase. A PHA of 50
mmHg (time stamp 1; t=37 min) evoked a series of decreasing but initially self-restoring
QPV . ese ow oscillations occur as the precursors of a ow instability. Eventually, QPV
was hampered indicating the initiation of the ow competition (time stamp 2; t=75 min). To
reverse the ow competition, PHA was lowered (time stamp 3; t=95 min). Portal ow was
gradually restored by also increasing the PPV (time stamp 4; t=103 min). Further decreasing
the PHA (time stamp 5; t=135 min), resulted in a decreased QHA, allowing the full restoration
of QPV .
Under normal in vivo conditions, intrinsic autoregulation mechanisms
regulate the ow through the hepatic vascular bed. As such, the hepatic
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Figure 3.9: Hypothermic machine perfusion (HMP) measurements of a porcine liver when
evoking ow competition by a vena cava inferior (VCI) outow obstruction. Panel a and b
display the hepatic arterial (HA) and portal venous (PV) pressure and ow measurements,
respectively. When initiating a severe outow obstruction, an alternating increase/decrease
between the HA ow (QHA) and PV ow (QPV ) was evoked (time stamp 1-4), also detectable
in the HA pressure (PHA) and PV pressure (PPV ) measurements.
arterial buer response (HABR; section 1.2.1) implies that QPV may directly
inuence QHA in vivo. In contrast, the response observed during ex vivo
HMP experiments in our study showed that the QHAmay directly inuence
the QPV (Fig. 3.8). Similar observations of ow competition - albeit in a
dierent perfusion model using cirrhotic rat livers - were made by Zipprich
et al. [531]. However, most studies concerning liver perfusion did not report
any occurrence of ow competition between the HA and PV.
When theoretically interpreting the hepatic circulation as a passive sys-
tem, the observation of ow competition evoked by an increased PHA would
analogously lead to ow competition evoked by an increased PPV leading to
a decreased QHA. However, we did not manage to evoke ow competition
by increasing PPV , as this cannot be reached within the physiological PPV
ranges. Since the PHA is higher compared to the PPV , a PPV increasewill sub-
stantially aect the pressure dierence between the PV and sinusoids, while
it will only mildly aect the HA pressure dierence.ese observations are
theoretically illustrated by the electrical liver model of chapter 6 (Fig. 6.7a),
where even large PPV variations only result in minor QHA changes. How-
ever, when increasing the PHA similar to theHMP experiments (Fig. 3.8), the
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mathematical liver model clearly illustrates the appearance of ow compe-
tition.ese results support our hypothesis that when changing the arterial
ow, portal ow changes through an altered sinusoidal perfusion.
Due to the absence of equipment to directlymeasure sinusoidal pressure
and ow in an intact organ, our data do not allow analysing themechanisms
of the observed ow competition more profoundly. However, the observa-
tions made in this study showed that ow competition could be consistently
reproduced, justifying the nature of our hypothesis. Consequently, these ob-
servationsmight have important implications on the design and ow control
for clinical ex vivoMP devices.
3.3.3.4 Conclusion
In this study, ow competition between theHA and PVwas observed during
liverHMP. Flow competition could be evoked by increasing PHA or obstruct-
ing the outow, suggesting that this phenomenon is related to alterations of
pressure dierences between the HA, PV, sinusoids andHV. In the end, ow
competition should be taken into account when designing appropriate dual
perfusion protocols for hepatic HMP control.
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Modelling the liver
An overview of the liver anatomy and physiology was given in chapter 1,
while chapter 2 addressed liver pathologies aecting hepatic functionality.
In chapter 3, liver transplantation was discussed together with the current
challenges concerning optimal preservation methods for donor livers, sur-
gical planning etc. Experimental as well as numerical modelsmay be helpful
to gain more insight into these liver-related topics and challenges.
e goal of this PhD thesis was to develop computer models of the he-
patic vasculature and perfusion to better understand the inner liver haemo-
dynamics. Before addressing this work in the following chapters, an over-
view is given of the state-of-the-art in hepatic modelling. Models are clas-
sied as models of the liver vascular architecture, liver perfusion and other
hepatic models on liver mechanics and liver function.
4.1 Modelling the liver vascular architecture
An intact hepatic vascular architecture is one of the cornerstones of a well-
functioning liver. An altered blood circulation (e.g. due to disease or surgical
complications) may result in organ damage and even liver failure. Lehmann
et al. [282] underlined the importance of the hepatic architecture: “Ana-
tomic insights provide the fundamental basis for hepatic surgery”. One could
even extend this statement to the broader eld of liver-relatedmedical appli-
cations (including quantitative diagnosis, outcome assessment, monitoring
disease progression etc.). Below, we discuss the available hepatic architec-
tural models on the macro- and microvascular level.
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4.1.1 Hepatic macrovascular architecture
e architecture of the largest vessels of animal and human livers has been
investigated using dierent techniques. One of those techniques is vascu-
lar corrosion casting, which results in physical replicas of vascular systems
[62, 63, 77, 203]. Practically, casting resin is injected in situ or in an isolated
organ aer cannulation of the blood vessel(s) and/or bile duct of interest. It is
typically a polymeric mixture of several substances, such as the Batson’s cor-
rosion kit (Polysciences, Florida, USA) which was used in this dissertation
(see chapters 5, 6, 8 and 9). Aer hardening of the injected resin, the speci-
men is immersed in a bath of potassium hydroxide or chloride acid solution
to macerate the tissue during a period up to several days. Aer rinsing, a
polymeric replica of the vessel system is obtained. For example, in 1906,Mall
[305] used corrosion specimens of dog livers to study the branching pattern
and geometrical characteristics of the hepatic vasculature. Zanchet et al.
[526] and Court et al. [80] studied the hepatic segmental architecture of por-
cine liver casts (Fig. 4.1), while Shirai et al. [432] focused on the vasculature
and bile ducts of bovine liver casts. Van Steenkiste et al. [484] made vascu-
lar corrosion casts of the venous system of mice and rats to compare normal
animals with portal hypertensive and cirrhotic animals. Human liver casts
were used by Gupta et al. [176, 177] to study the hepatic segmental structure
and the architecture of the HV tree. Fasel et al. [133] combined vascular cor-
rosion casting of human livers with subsequent CT (computer tomography)
scanning to investigate the intrahepatic PV architecture, while Hahn et al.
[178] similarly analysed the PV and HV trees.
(a)             (b)
Figure 4.1: Vascular corrosion cast of the hepatic arterial (HA; red), portal venous (PV;
green) and hepatic venous (HV; blue) tree of a porcine liver: (a) anterior and (b) posterior
view. Adapted from [80].
e recent progress in high resolution (small animal) imaging modali-
ties enabled researchers to more precisely describe the liver. As such, Fiebig
et al. [18] used in vivomicro-CT scanning in combination with injections of
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contrast agents to study the macroscopic anatomy of the murine liver and
hepatic vessels. Micro-CT scanning typically results in higher resolutions
and more detailed images compared to conventional CT scanners. Some
studies combine Microl (Flow Tech., Inc., Carver, MA, USA) injections
with micro-CT scanning. Microl is a radiopaque liquid silicone polymer
containing lead and is being used to inject vascular systems. Aer polymer-
isation, the tissue is xated (e.g. in formalin) and immersed in several glycer-
ine solutions followed by immersion in bioplastic. Wan et al. [500], Masyuk
et al. [315] and Op Den Buijs et al. [52] combined Microl injections with
micro-CT scanning to study the architecture of the rat liver. More specif-
ically, Wan et al. [500] studied the HA tree, while Op Den Buijs et al. [52]
studied one lobe of the rat PV tree. Masyuk et al. [315] and Kline et al. [256]
used three types of rat liver casts of which the HA, PV or biliary tree was
injected.
Several methods have been developed and adopted to analyse and quan-
tify the geometrical features of vascular systems. As such, the concept of
blood vessel generations has widely been used to analyse the topology of
the placental vasculature, the bronchial tree etc. [167, 206, 207, 524, 525]. In
this approach, generation 1 is the main trunk of the vascular tree (Fig. 4.2a).
Subsequently, when a mother vessel of generation x splits in two (or more)
similar daughter vessels, the daughter vessels belong to generation x+1. Mall
[305] used this approach to study the vascular trees of the dog liver, while
Op Den Buijs et al. [52] and Kline et al. [256] used generations to quantify
the geometrical characteristics of a rat liver lobe.
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(a)              (b)
Figure 4.2: Illustration of the principle of (a) blood vessel generations and (b) the Strahler
ordering system
Another classication system for vascular trees is the Strahler ordering
system [453]. In contrast to vessel generations, the Strahler ordering system
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starts by assigning order 1 to the terminal vessels (Fig. 4.2b). Subsequently,
if all daughter vessels have the same order number o, the mother vessel is
assigned to order o+1. If the daughter vessels have dierent order numbers,
the mother vessel is assigned to the highest order number of the daughter
vessels.e Strahler ordering system has been used to study the topology of
e.g. renal vascular trees [365], the pulmonary arterial tree [230, 365, 453], the
coronary arterial tree [337] and the largest vessels of the PV and HV hepatic
trees [178].
In addition to vessel generation and ordering models, other morpho-
metric studies [18, 244, 245, 337] and fractal models have been used to de-
scribe vascular branching patterns. In the latter approach, vascular trees are
interpreted as self-similar structures for which each generation of the tree is
obtained from the generation preceding it [149, 179, 502, 522–525] (Fig. 4.3a).
For instance, Op Den Buijs et al. [52] and Hahn et al. [178] applied this ap-
proach to analyse the PV vessels of a rat liver lobe and the human PV and
HV trees, respectively. Also, 3D models of hepatic vascular trees (see Fig.
4.3b for an example) have been generated by creating binary trees based on
constrained constructive optimisation methods [37, 179, 234, 261, 262, 328].
For instance, digital hepatic trees were generated as phantoms for dynamic
image formationmodels to study the performance of contrast-enhanced CT
[37, 261] or dynamic contrast-enhancedMRI (magnetic resonance imaging)
[328] e.g. to better detect and understand the complexity of hepatic tumour-
ous tissue.
(a)                              (b)
Figure 4.3: Examples of (a) self-similar fractal tree structures (adapted from [179]) and
(b) a portal venous (PV) tree generated by a constrained constructive optimisation method
(adapted from [234]).
In the clinical context, patient-specic models of the liver architecture
may be very helpful to plan surgical interventions and transplantations. Aer
a CT or MRI angiography, the patient-specic imaging data is processed to
create 3D reconstructions as input for surgical planning models [23, 60, 362,
396, 414, 425, 514, 516]. As such, several geometrical and structural analysis
methods based on vascular territories have been proposed to facilitate living
donor liver transplantation (LDLT) and oncologic partial hepatectomy pro-
cedures (see Fig. 4.4 for an example) [45, 354, 356, 418, 423, 424]. In this way,
74
4.1. Modelling the liver vascular architecture
computer-assisted decision-making models enable planning the optimal re-
section surface based on the best solution for blood supply and drainage (e.g.
for both donor and recipient in the case of LDLT) and preventing intraop-
erative heavy bleeding etc. Furthermore, the concept of resection maps (or
risk maps) has been suggested as an intraoperative navigation tool in liver
surgery [182, 270].
Tumour
Vascular
structures
Resection plane
Figure 4.4: Surgical planning for a tumour resection. Adapted from [182].
4.1.2 Hepatic microvascular architecture
e hepatic microstructural architecture is still not fully understood.ere
is an ongoing debate on the best suited model to describe the structural or
functional liver unit (see section 1.1.2.4). Nevertheless, several techniques
have been applied to investigate and model the hepatic microvascular ar-
chitecture. For example, Teutsch et al. [465, 466] obtained 3D reconstruc-
tions of the hepatic microvasculature by registering photographs of serial
sections. Also, a combination of vascular corrosion casting and scanning
electron microscopy (SEM) has been used to study the hepatic microvas-
cular architecture in detail for normal conditions ([162]; Fig. 4.5) as well as
liver pathologies (e.g. capillary shunting in cirrhosis [192]). Vollmar et al.
[496] gave an excellent overview of available techniques to study the hepatic
microcirculation (e.g. in vivo uorescencemicroscopy, orthogonal polarised
spectral imaging etc.).
In conclusion, the hepatic vascular architecture has been the topic of
many studies, but some questions are still unanswered. Most macrovascular
studies focused on a part of the hepatic vascular system, but never simul-
taneously studied the HA, PV andHV tree of the same liver. Furthermore, a
vascular analysis of the complete spectrum of blood vessels going from the
macrocirculation to the microcirculation of a liver was not performed yet.
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erefore, one of the aims of this PhD thesis was to study all hepatic vascu-
lar trees simultaneously and at dierent spatial scales for one and the same
liver (see chapters 5 and 9).
CV
Figure 4.5: SEM image of the centre of a liver lobule.e sinusoids clearly drain in the central
vein (CV). Source: [162].
4.2 Modelling liver perfusion
In this section, we will focus both on experimental studies and numerical
models of the hepatic macro- and microvascular perfusion.
4.2.1 Experimental animal (and human) models
Several studies used animal experiments to assess hepatic haemodynamic
parameters in normal physiological circumstances [34, 42, 180, 293–295, 358,
401]. As such, Bohlen et al. [42] measured hepatic pressures in rats, dog
puppies and rabbits. Pressures were in the same order of magnitude for all
three species with hepatic venous pressures of 5.1 ± 1.0, 6.4 ± 1.1 and 5.4 ±
1.0 mmHg in rats, puppies and rabbits, respectively. Bohlen et al. [42] and
Maass-Moreno et al. [293] used rabbits to show that - in normal conditions
- the major resistance to hepatic blood ow must lie upstream to the major
hepatic veins. Subsequently, Maass-Moreno et al. [295] measured microvas-
cular pressures in vascular networks close to the liver surface of rabbits by
using a servo-null micropipette pressure-measuring system. eir results
showed a gradual pressure decrease from the portal venules to the hepatic
venules with average pressures of 5.7 ± 0.8, 5.4 ± 0.7 and 4.7 ± 0.6 mmHg for
the portal venules, sinusoids and initial hepatic venules, respectively. Richter
et al. [401] performed in vivo HA and PV ow measurements in rats using
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ultrasonic ow probes.eir results conrmed the hepatic arterial buer re-
sponse (HABR; see section 1.2.1) and suggest that there are arteriolo-portal
venular shunts, which regulate the ratios of HA and PV ow.
Next to invasive measurement techniques, Halavaara et al. [180] imaged
rabbits by functional CT scanning aer a bolus injection of an iodinated
experimental intravascular contrast agent. is enabled measuring hepatic
ows. ey estimated the total hepatic ow to be 241.1 ± 33.6 ml/min per
100 g of liver tissue. Chen et al. [69] demonstrated the ability of perfusion
CT with contrast agents to assess hepatic microvascular changes in patients
with cirrhosis. Lueck et al. [291] used contrast-enhanced ultrasound by in-
jecting microbubbles to assess liver perfusion. MRI techniques are also be-
ing used to study the liver perfusion, such as perfusion MRI with contrast
agents (e.g. to analyse hepatic blood ow parameters). Yzet et al. [520] tested
two non-invasive techniques to assess liver haemodynamics. e perform-
ance of human free breathing phase contrast MRI was compared with that
of Doppler ultrasound (US) by measuring blood velocities and ow rates in
the HA and PV. Phase contrast MRI provided reliable non-invasive meas-
urements of hepatic ow parameters with a lower variability and higher re-
producibility compared to Doppler US.
Oen, animal models are used to test and optimise novel and alterna-
tive transplantation techniques or surgical procedures [105, 211, 231, 530]. As
such, a number of rodent and porcine models have been developed to study
the haemodynamic eects of partial hepatectomy [19, 86–88, 106, 131, 140,
209, 210, 280, 313, 348, 349, 386, 485, 511]. For instance, Fan et al. [131, 485] and
Dahmen et al. [86, 209] performed rat liver resections up to 90% and 97%
removal of liver tissue, respectively. Consecutive resections demonstrated
a clear increase of the portal pressure and the portal ow per gram of liver
tissue. Partial hepatectomy rat models illustrate the importance to prevent
the small-for-size syndrome (SFSS; see section 3.2.3.2) by preserving a suf-
cient amount of functional liver mass and avoiding outow obstructions
[87, 210]. Outow obstructions may arise when the middle hepatic vein is
not incorporated in the liver gra (e.g. in LDLT) [88, 386]. Dirsch et al. [106]
showed that this can lead to centrilobular necrosis in the early postoperative
phase or even to SFSS. However, they also demonstrated that the liver may
recover due to dilation of sinusoids forming vascularised canals.
Large animal experiments were done by Fondevila et al. [140], who used
a porcine LDLT model to perform partial (70%) liver transplantations and
to study SFSS, while Mortensen et al. [349] used pigs to look into the regen-
erative response in the liver remnant. Studies on human patient data also
demonstrated that SFSS is characterised by an excessive portal venous in-
ow and pressure and is considered as one of the most important causes of
liver gra dysfunction in LDLT [65, 431, 513, 528].
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To reduce SFSS risks, partial hepatectomy rat models have been used to
test the eect of portosystemic shunts (Fig. 4.6; shunt between a PV and a
HV vessel [314]), showing an improved early survival rate [145]. Addition-
ally, Glanemann et al. [163] and Eipel et al. [114] performed splenectomy
procedures in rats, resulting in a reduced risk for postoperative hyperper-
fusion. Troisi et al. [472] used portocaval shunts to decompress the portal
system in patients and also illustrated that gra inow modulation reduces
the risk of SFSS complications.
Hepatic vein Liver
Shunt
Spleen
Portal vein
Figure 4.6: Illustration of a portosystemic shunt connecting a portal venous (PV) and a
hepatic venous (HV) vessel. Adapted from [4].
Machine perfusion (MP) is a potentially better preservation technique
for donor livers than cold storage (CS).Numerous experimental studies have
been performed to compare MP protocols with CS, as well as to test several
MP parameters, such as the perfusion pressures or ows, temperature, pre-
servation solutions etc. For more detailed information on this topic, the
reader is referred to section 3.3.2 [25, 26, 92, 138, 188, 289, 341, 342, 371, 457,
458, 481, 488].
Experimental animalmodels have also been used to elucidate the patho-
genesis, architectural changes and haemodynamic impact of liver patholo-
gies. As such, Spannbauer et al. [444] and Rosenstengel et al. [408] de-
veloped ratmodels of steatosis by administering either a fatty diet or ethanol.
Peterson et al. [379]modelled brosis in pigs by adding yellowphosphorus to
their feed. Welsch et al. [505] developed a porcine model of cystic brosis by
genetic modications. Chen et al. [67] ligated the common bile ducts of pig-
lets to model the impact of bile duct obstruction, as is the case in cholangitis
or other cholestatic diseases (see section 2.2). Maksan et al. [302] used a
rat model of hepatocellular carcinoma (HCC) to investigate the hepatic and
tumourous microcirculation with intravital uorescence microscopy. Addi-
tionally, several experimental studies attempted to develop animal models
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of liver cirrhosis [24, 246, 268, 486, 527, 531]. For instance, Laleman et al.
[268] showed that thioacetamide intoxication of rats during 18 weeks results
in a reproducible model of cirrhosis including portal hypertension and en-
dothelial dysfunction. Other models, however, did not succeed in develop-
ing full blown cirrhosis [24, 527].
4.2.2 Mathematical models
4.2.2.1 Hepatic macroperfusion models
Macrocirculatory perfusion models range from compartmental models to
3D computational uid dynamics studies accounting for the largest hepatic
vessels.
4.2.2.1.1 Compartmentalmodelling. Compartmentalmodelsmayhelp cla-
rifying the major characteristics of the hepatic vascular system [71, 136, 240,
413]. Traditionally, open two-compartment models were used (with a he-
patic vascular and interstitial compartment; Fig. 4.7a) to measure liver per-
fusion with contrast-enhanced functional CT scanning, but they did not
provide unique solutions for blood and interstitial volume fractions.ere-
fore, an open-four compartment model was proposed by splitting the he-
patic vascular space in three compartments: the impermeable supplying ves-
sels (HA andPV tree), the permeablemicrocirculation and the impermeable
draining vessels (Fig. 4.7b) [240]. Dierential equations, derived from the
conservation ofmass, allowed solving this four-compartmentmodel and led
to more accurate results (HA and PV ows, blood and interstitial volume
fractions etc.) than those obtained from the two-compartment model.
(a)              (b)
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Figure 4.7: Compartmentmodels used byKapanen et al. [240]: (a) two-compartmentmodel
and (b) four-compartment model.
4.2.2.1.2 Electrical analog modelling. Reduced order models such as elec-
trical analog models provide a concise way to analyse complicated vascular
networks.ey are oen used to improve our understanding of the circula-
tory system [428, 459]. As such, several studies used electrical analogmodels
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to simulate the total body haemodynamics (e.g. the human cardiovascular
system [16, 29], the arterial system [264, 281], the perinatal cardiovascular
system [357] etc.), while others focused on a specic organ or a specic vas-
cular bed (e.g. the cerebral blood ow [445], the respiratory ow in lungs
[220], lymph ow [108, 452] etc.). e idea behind electrical analog mod-
elling is the analogy between the uid ow through (blood) vessels and the
electrical current through an electrical circuit. Here, we will focus on elec-
trical models of liver perfusion.
A number of lumped parameter models have been applied to model
the hepatic haemodynamics. Lumped parameters are basically quantities
in which the bulk properties of a large number of vessels are condensed to
only a few parameters. As such, Rypins et al. [411] investigated the haemo-
dynamic impact of portocaval shunts used in the context of portal hyper-
tension using a Wheatstone bridge circuit (Fig. 4.8). In this model, the HA
resistance determines the pressure drop from the mean aortic pressure to
the sinusoidal pressure, while the splanchnic arterial resistance represents
the vascular system that supplies blood to the PV.e PV vessels are repre-
sented by the presinusoidal resistance forming the bridge. At the sinusoidal
pressure point, the HA and PV ows meet and blood is drained through
the HV tree (postsinusoidal resistance) towards the VCI. In addition, two
ow paths are available between the portal pressure and VCI. e collat-
eral bed resistance represents the presence of collaterals that shunt PV blood
ow directly to the VCI (see also section 2.3.2), while the portocaval gra is
modelled as a variable shunt resistance to investigate the impact of shunting
blood to decompress the portal system. When varying the latter resistance,
the bridge can be balanced so that no ow passes through the PV vessels. By
modulating the resistance, higher values result in a positive PV ow, while
lower values would lead to a reversed PV ow. Adding on the model of
Rypins et al. [411], H. Ho et al. [194] developed a 1D model to study the hae-
modynamic impact of portocaval shunts. Simulation results conrmed a
substantially reduced (or even reversed) PV ow when a portocaval shunt
was present.
Mynard [357] developed a computer model of perinatal cardiovascular
(dys)function. Within this model, a lumped parameter model of the liver
haemodynamics was embedded (Fig. 4.9).e vascular bed model contains
an HA inow compartment (Zart , Cart and Rart) including resistance arter-
ies (Rart) that cause the pressure to fall to pp/a, where theHA and PV inows
meet. Subsequently, blood ows through the lobules (Rlob) accounting for
the pressure drop to venous pressure (pven), followed by the HV draining
system.
In literature, dierent types of electrical analog models have been pro-
posed to model the blood ow through a blood vessel (e.g. L-elements, in-
verted L-elements, T-elements, pi-elements etc.) [90, 91, 148, 196, 197, 225,
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Figure 4.8: e Wheatstone bridge model of Rypins et al. [411] to investigate the eect of
portocaval shunting on liver perfusion.
Figure 4.9: Lumpedparametermodel of the hepatic haemodynamics byMynard [357]with Z
being impedance, R resistance, C capacitance, p pressure, q ow, port portal venous vessels,
art hepatic arterial vessels, ven hepatic venous vessels and p/a being combined properties
of portal venules and arterioles.
332, 372, 428, 445, 482]. In this dissertation, the pi-element model of de Pa-
ter [90, 91] is used (see chapters 6 and 7). De Pater [90, 91] developed an
electrical analogue of the circulatory system to get a better insight in the im-
portant and vital phenomena of the circulation. An electrical analog model
for blood vessels can be derived starting from the Navier-Stokes equations
and the continuity equation describing the uid ow.ese equations were
simplied to two dierential equations bymaking a number of assumptions:
laminar ow (no rotational motion), no gravitational forces, blood being an
incompressible Newtonian uid (constant density and viscosity), the blood
vessel being a horizontal axisymmetric and elastic tube. With these assump-
tions and by using a cylindrical coordinate system (r, θ , z) as illustrated in
Fig. 4.10, the Navier-Stokes equations (eq. 4.22 and 4.23 in section 4.2.2.1.3)
were simplied to eq. 4.1 and 4.2 describing the radial and longitudinal pres-
sure gradients with p the pressure, v the velocity, ρ the density and µ the
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dynamic viscosity.e continuity equation (conservation of mass) becomes
eq. 4.3.
r
z
θ
Figure 4.10: Cylindrical coordinate systemwith the z-axis aligned along the axis of the blood
vessel.
−∂p
∂r
= ρ (∂vr
∂t
+ vr ∂vr∂r + vz ∂vr∂z ) − µ (∂2vr∂r2 + 1r ∂vr∂r − vrr2 + ∂2vr∂z2 ) (4.1)−∂p
∂z
= ρ (∂vz
∂t
+ vr ∂vz∂r + vz ∂vz∂z ) − µ (∂2vz∂r2 + 1r ∂vz∂r + ∂2vz∂z2 ) (4.2)
∂vr
∂r
+ vr
r
+ ∂vz
∂z
= 0 (4.3)
In addition, de Pater [90, 91] assumed an incompressible, homegeneous
and isotropic vessel wall material, obeying Hooke’s law. e blood vessel is
assumed to have a constant length and the wall thickness is assumed to be
small compared to the radius. ese assumptions allow integrating eq. 4.1-
4.3 over the cross-section of the blood vessel, resulting in equations 4.4 and
4.5 describing the relation between pressure and ow (for more details on
this derivation: see [91]) with q the ow, Ewal l the Young’s elasticitymodulus
of thewall, hwal l thewall thickness and µwal l the viscosity of the visco-elastic
wall material.
−∂p
∂z
= 8µ
pir4
q + 4ρ
3pir2
∂q
∂t
(4.4)
−∂q
∂z
= 3pir3
2Ewal lh
∂p
∂t
+ µwal l
Ewal l
∂2q
∂z∂t
(4.5)
When restricting to harmonic signals, the ow can be rewritten using
the complex notation based on eq. 4.6-4.7 with q the ow as a function of
time, qm the ow magnitude, j the imaginary unit, t the time, ϕ the phase
angle, ω the angular frequency and Q the complex ow as a function of the
angular frequency.
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q = qme j(ωt+ϕ) = qme jϕe jωt = Qe jωt (4.6)
Q = qme jϕ = qm(cos(ϕ) + j sin(ϕ)) = a + b j (4.7)
Doing so, eq.4.4 can be rewritten as eq. 4.8, demonstrating that the pres-
sure gradient depends on the vascular impedance (Z, eq. 4.9) and the ow q.
e rst term of the vascular impedance Z represents the vascular resistance
in the longitudinal direction, while the second term represents the inertia of
the uid ow. Note the resemblance to the law of Poiseuille (eq. 3.2). Eq. 4.5
was derived from the continuity equation and shows the relation between
the ow gradient and the material properties of the vessel wall.
−∂p
∂z
= ZQ (4.8)
Z = 8µ
pir4
+ jω 4ρ
3pir2
(4.9)
Eq. 4.4 and 4.5 show a clear resemblance with the equations relating
the voltage and current of an electrical transmission line. Fig. 4.11a shows
a lumped parameter model of a segment (length z) of a transmission line
with a serial resistance Rs1, a series inductance L1, a parallel capacitance C1
and a parallel resistance Rp1 per unit of length.
pz
qz
L   ∆z1 R    ∆zs1
pz+∆z
qz+∆z
C  ∆z1
R     /∆zp1
L R s
C 
R p
C 
R p
(a)                   (b)
Figure 4.11: Electrical analogmodels: (a) electrical equivalent of a transmission line segment;
(b) pi element as an electrical anolog model of a blood vessel as dened by de Pater [90, 91].
Since voltage and current are analog to pressure and ow, the relations
between voltage and current for this transmission line model can be written
as:
pz − pz+∆z = L1∆z ∂q∂t + Rs1∆zq (4.10)
∂pz+∆z
∂t
= ∂(qz − qz+∆z)
∂t
Rp1
∆z
+ qz − qz+∆z
C1∆z
(4.11)
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For ∆z going to 0, these equations result in eq. 4.12 and 4.13.
−∂p
∂z
= Rs1q + L1 ∂q∂t (4.12)−∂q
∂z
= C1 ∂p∂t + C1Rp1 ∂2q∂z∂t (4.13)
Except for the coecients, the relation between voltage and current of
the latter two equations is the same as the relation between pressure and
ow in eq. 4.4 and 4.5. As such, there is a clear analogy between the elec-
trical model of a transmission line and the ow equations of a blood vessel.
Consequently, the corresponding coecients should be equal. However, to
model a blood vessel of a nite length l , de Pater [90, 91] adapted the elec-
trical model to a pi-lter (Fig. 4.11b). Hereby, the length was taken into ac-
count, resulting in the following coecients:
Rs = Rs1 l = 8µpir4 l (4.14)
L = L1 l = 4ρ3pir2 l (4.15)
C = C1 l2 = 3pir32Ewal lh l2 (4.16)
Rp = Rp1 2l = 2µwal lh3pir3 2l (4.17)
Since literature values of Ewal l , µwal l and h are very scarce and/or in-
accurate, de Pater [90, 91] chose to use the Moens-Korteweg equation (eq.
4.18) to calculate values of C using the pulse wave velocity cp (eq. 4.19).
c2p = Ewal lh2ρr (4.18)
C = l2
2c2pL
(4.19)
Since values of µwal l are only roughly known, de Pater [90, 91] dened
Rp by eq. 4.20. is was thought to be an acceptable assumption as the in-
uence of Rp seemed rather limited.
Rp = 2 ⋅ 10−6C (4.20)
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By now, an electrical analog model of a blood vessel is derived, of which
the electrical components (eq. 4.14, 4.15, 4.19, 4.20) can be calculated by us-
ing the dimensions of the blood vessel (radius and length), the physical prop-
erties of the uid (density and viscosity) and the pulse wave velocity.
Van der Plaats et al. [482] combined the modelling approach of de Pater
[90, 91] with the hepatic vascular architecture data of Mall [305] to develop
an electrical analog model of the hepatic perfusion in the dog liver. To do
so, the hepatic vasculature was schematised as two inlet vascular trees (HA
and PV) leading blood to the sinusoids, and one outow vascular tree (HV)
to drain blood into the VCI (Fig. 4.12).
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Figure 4.12: Schematic representation of the hepatic vascular trees and their generations.
Each of these trees was interpreted as a sequence of blood vessel gener-
ations, in which each generation represents a number of parallel blood ves-
sels. As a consequence, each generation could be represented by a pi-lter by
adjusting the electrical components for the number of parallel blood vessels
(n) (eq. 4.21 for Rs, analogous for the other components).
Rs = 8µlnpir4 (4.21)
Doing so, each vascular tree was represented by a series of pi-lters, re-
sulting in the electrical model of a total liver as shown in Fig. 4.13. Using this
model, van der Plaats et al. [482] simulated the perfusion of the dog liver. In
chapter 6, we use a similar modelling approach to simulate the perfusion
of the human liver based on detailed anatomical data acquired in chapter 5.
Recently, two papers have been published that build further on the human
liver model that we developed in chapter 6. As such, H. Ho et al. [195–197]
used a simplied version of our model to simulate the HABR eect [196].
Furthermore, they used a similar simplied model to investigate the eect
of transjugular intrahepatic portosystemic shunts (TIPS; see Fig. 4.6) [197]
and to model the eect of a right lobectomy [195].
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Figure 4.13: Electrical analog model of a liver. Source: [482].
4.2.2.1.3 3Dmodelling. In addition to the reduced ordermodels discussed
above, a number of 3D models of the blood ow through the largest hepatic
vessels have used computational uid dynamics (CFD) [251, 492].is nu-
merical modelling technique is based on the principles of conservation of
mass and momentum. When assuming an incompressible Newtonian uid
and neglecting gravitational forces, the mathematical formulation of these
principles results in the Navier-Stokes equations and the continuity equa-
tion (eq. 4.22 and 4.23) with ρ the uid density, v⃗ the ow velocity eld, t the
time, p the pressure and τ¯ the shear stress tensor [506].
ρ ∂v⃗
∂t
+ ρv⃗ ⋅ ∇v⃗ = −∇p +∇ ⋅ τ¯ (4.22)∇ ⋅ v⃗ = 0 (4.23)
In most cases, it is impossible to obtain an analytical solution for this
set of non-linear partial dierential equations. CFD overcomes this prob-
lem by discretising the uid domain. For instance, Fluent (used in chapters
9 and 10; Ansys, Pennsylvania, USA) applies the nite volume method to
divide the domain in a number of control volumes. As a result, a numerical
grid of cells, called a ‘mesh’, is obtained. In this context, Yuan et al. [518]
developed an interesting method to mesh tubular structures with a tree to-
pology using centrelines. e performance of their method was tested by
using MR images of a hepatic vascular tree. Next to discretisation in space,
the governing equations also have to be discretised in time in the case of
non-steady-state (transient) simulations. In this PhD dissertation, however,
only steady-state CFD simulations were performed.
Aer discretisation of the uid domain, uid properties (e.g. the viscos-
ity) have to be dened as well as the boundary conditions at the borders of
the uid domain. Subsequently, the governing equations are converted into
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algebraic equations for all control volumes. e solution of this system of
equations is approximated in an iterative way until the solution converges
up to an error lower than a predened threshold.
Several papers focused onmodelling the PV ow using CFD. Petkova et
al. [380]modelled the ow through the rst branches of an idealised PV tree
to investigate the inuence of PV thrombosis. PV thrombosis was modelled
as local vessel narrowing and was found to result in substantial increases of
the velocity magnitude and shear stress. C.-M. Ho et al. [193] focused on
the portal haemodynamic changes in the case of a right liver partial hepa-
tectomy for LDLT.ree CFD simulations were performed using a patient-
specic PV geometry: before, immediately aer and onemonth aer partial
hepatectomy (Fig. 4.14).eir results clearly showed altered haemodynam-
ics with elevated pressure immediately aer hepatectomy. Aer one month,
pressure values were again decreased to normal values and the remnant liver
was regenerated, but had a dierent structural pattern compared to the liver
before resection due to regenerative PV remodelling.
(a)                (b)
(c)
Figure 4.14: Results of the portal venous (PV) computational uid dynamics (CFD) simu-
lations of C.-M. Ho et al. [193]: pressure maps (a) before, (b) immediately aer and (c) one
month aer right lobe hepatectomy.
Similarly, H. Ho et al. [195] also simulated the impact of a lobe hepa-
tectomy in the case of LDLT, but they incorporated the splenic vein and the
superior mesenteric vein (which merge into the PV) into their simulation
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geometry (Fig. 4.15). As a result of the fact that the le PV receives the full
PV ow aer hepatectomy, the 3D simulations of the complex ow revealed
substantial increases in the owvelocity andwall shear stress aer partial he-
patectomy compared to the baseline haemodynamics before resection. Also,
strong helical ows seemed to develop aer hepatectomy at the level of the
merging point of the splenic vein and superior mesenteric vein. Next to
partial hepatectomy, H. Ho et al. [197] also studied the liver haemodynam-
ics induced by a TIPS procedure by using a patient-specic TIPS geometry
reconstructed fromCT images. Simulations showed helical ow distal to the
merging point of the splenic and mesenteric ow.
Left portal vein
Portal vein
Right portal
vein
Splenic vein
  Superior
mesenteric
      vein
(a)
(b)
 Before hepatectomy           After hepatectomy
Figure 4.15: Simulation results of the potal venous (PV) system by H. Ho et al. [195]: (a)
velocity magnitudes and (b) wall shear stresses before and aer partial hepatectomy.
George [158] used idealised geometries as well as patient-specic geo-
metries of the PV system (including the splenic and superior mesenteric
vein) to investigate the PV ow in normal conditions, as well as in patients
with cirrhosis and portal hypertension. ough a small sample size, cir-
rhotic patients showed a signicantly increased PV cross-sectional area (1.75
cm2 versus 0.97 cm2) and a decreased average blood velocity per liver volume
compared to normal patients (5.8⋅10−3 1/(cm2s) versus 10−2 1/(cm2s)).
In addition, Van Steenkiste et al. [484] used 3D geometries of the portal
system of rats to compare normal portal haemodynamics (sham operated
rats) with those of portal hypertensive (common bile duct ligation; CBDL)
and cirrothic (partial PV ligation; PPVL) rats (4.16). Sham operated rats
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clearly showed lower wall shear stresses compared to portal hypertensive
and cirrhotic rats, with the highest wall shear stress values located at the PV
ligation of the cirrothic rat model. Furthermore, their results illustrated the
decompressing eect of collaterals with lower wall shear stress values when
collaterals were incorporated in the simulation geometry.
Figure 4.16: Simulation results of the potal venous (PV) system byVan Steenkiste et al. [484]:
Time-averaged (over a cardiac cycle) wall shear stress distribution in the PV system of sham
operated, common bile duct ligated (CBDL) and partial PV ligated (PPVL) rats.
Next, a number of CFD simulations studied the blood ow through the
HA tree in order to assess the transport ofmicrospheres (Yttrium-90) for ra-
dioembolisation of tumours [30, 31, 250]. Ideally, all injected microspheres
should reach the periphery of the tumour via the blood vessels. Kennedy
et al. [250] and Basciano et al. [31] used a representative idealised HA geo-
metry based on literature values to study microsphere release and targeting
(Fig. 4.17). eir CFD simulations showed that many variables inuence
the microsphere trajectories (vessel geometry, particle characteristics, spa-
tial and temporal particle injection conditions etc.). Richards et al. [399] ex-
perimentally validated the simulation methodology, enabling targeting the
microspheres to ow into individual branches. In the end, patient-specic
computational analysis may help to optimise microsphere injection for liver
tumour treatment.
In contrast to the CFD models of the hepatic haemodynamics, Ooi et
al. [373] modelled the bile ow to investigate the inuence of the cystic duct
geometry and resistance to bile ow on the formation of gall stones. Ideal-
ised as well as actual patient-specic cystic duct geometries were modelled.
Cystic ducts contain a number of valves, called the ‘valves of Heister’, nar-
rowing the cross-section.e size and number of valves were found to be the
most signicant parameters aecting the resistance to bile ow. In the end,
this modelling approach may help to assess the risk of gall stone formation
in patients.
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Figure 4.17: Illustration of the computational uid dynamics (CFD) model of Basciano et al.
[31] showing that individual branches can be targeted by choosing the corresponding injec-
tion location.
Particle image velocimetry (PIV) is an experimental technique, which
may be applied to investigate and quantify perfusion in order to validate
CFD models. Hereby, small particles are added to a uid that is owing
through a transparent simulation geometry.e ow is illuminated so that
particles can be observed and images are captured by a camera for ow anal-
ysis. For example, Lara et al. [273] studied the haemodynamics of the HV
conuences using PIV to better understand abnormal HV ows due to car-
diovascular venous disease.
4.2.2.2 Hepatic microperfusion models
Until now, relatively little papers have taken up the challenge of modelling
the hepatic microperfusion. is is probably due to the uniqueness and
complexity of the hepatic microcirculation as well as the diculties asso-
ciated with the acquisition of anatomical and functional data at sucient
resolution.
Kretowski et al. [261] coupled their hepatic macrovascular model (see
section 4.1.1) with macro-functional units (MFU) to enable computing the
local contrast agent concentration, e.g. for a functional CT scan. Each unit is
a compartmentmodel representing the hepaticmicrocirculation and counts
three compartments: the sinusoids, the extracellular space and a hepatic
venule (Fig. 4.18). Dierential equations based on the conservation of mass
allow solving themodel to study the variations in concentrations in dierent
compartments. However, this model could be improved, e.g. by incorporat-
ing communication between the sinusoids and hepatic venules.
Other hepatic microperfusion models are based on porous media [43,
302, 433] in which the sinusoids are represented by pores that are imbedded
in a parenchymal matrix. Darcy’s law (eq. 4.24) is used to prescribe the uid
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Figure 4.18: Compartmental model of the hepatic microcirculation. Source: [261].
ow through such a porous medium with p [Pa] the sinusoidal blood pres-
sure, µ [Pa⋅s] the dynamic viscosity of blood, k [m2] the permeability and
v⃗porous [m/s] the Darcy velocity.
v⃗porous = − kµ∇p (4.24)
Bonglio et al. [43] developed a 2D model of the blood ow through
a liver lobule based on porous media. ey studied the ow patterns in a
hexagonal cross-section of a lobule (Fig. 4.19). Furthermore, they analysed
the eects of isotropic versus 2D anisotropic permeability conditions (ra-
dial versus circumferential) as well as the inuence of non-Newtonian uid
properties. Bothmodications were shown to only have a small eect on the
behaviour. In this way, the model gives insight in the pressure and velocity
distribution in liver lobules.
(a)                 (b)
Figure 4.19: Results of the lobulemodel of Bonglio et al. [43]: (a) non-dimensional pressure
and (b) velocity eld.
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Similarly, Siggers et al. [433] used a 2D symmetric triangular porousme-
dium model to represent one-sixth of a hexagonal cross-section of a lobule.
e model was solved analytically and PT inows and CV outows were
modelled as point sources and point sinks, respectively. Siggers et al. [433]
investigated the eect of VS by modelling them as line sources connecting
two PT inows. It was suggested that VS lead to a better spatial distribution
of nutrients.
Ricken et al. [402, 508] developed a 2D biphasic mechanical model of
liver lobules using porous media.e aim of this study was to describe the
vascular remodelling process in normal conditions aswell as aer an outow
obstruction, for instance due to a liver resection.emodelling domain was
an idealised geometry of a 2D longitudinal cross-section of liver lobules (Fig.
4.20). A transverse isotropic permeability was introduced in the direction
of the vein as well as a relationship between the pressure gradient and direc-
tion of sinusoidal blood ow. e results for normal conditions are clearly
dierent from those for an outow obstruction, which results in redirect-
ing the sinusoidal ow towards neighbouring hepatic venules that are not
obstructed (Fig. 4.20).
   Normal 
conditions
   Outow
obstruction
Obstructed vein
Pressure [Pa]            Norm of uid velocity [m/s]
Figure 4.20: Results of the biphasic hepatic micromodel of Ricken et al. [402]. e pres-
sure (le) and velocity (right) distributions are given for normal conditions as well as for an
outow obstruction.
Rani et al. [393] developed a 3D nite volume blood ow model of the
hepatic microcirculation in a segment of a lobular structure. e idealised
3D geometry included a high pressure terminal hepatic arteriole, a low pres-
sure portal venule and a hepatic venule (CV) as well as two fenestrated si-
nusoids (Fig. 4.21). Non-Newtonian blood properties were used to study the
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ow features. As expected, pressures decreased from the inow HA and PV
vessels towards the sinusoids and hepatic venule.
(a)               (b)
Figure 4.21: Hepatic microcirculation model of Rani et al. [393]: (a) simulation geometry
and (b) pressure distribution.
Since modelling the hepatic microcirculation started only a few years
ago, it is still in its infancy and more work has to be done to extend and
improve these models. For example, all the discussed hepatic micromodels
are based on idealised geometries, while it may be important to take into
account the real 3D structure of the sinusoids.erefore, chapter 9 discusses
a CFD model of the hepatic microcirculation based on micro-CT acquired
3D imaging data.
4.3 Other liver models
Although the focus of this dissertation is modelling the liver vascular ar-
chitecture and perfusion, we will shortly highlight other hepatic modelling
approaches (liver mechanics and liver function) for completeness.
4.3.1 Liver mechanics
As the liver is a very vascular organ, liver tissue can be interpreted as a
sponge-like porous structurewith blood vessels running through it. A simple
linear elastic or visco-elastic material model would thus be insucient to
model liver tissue.erefore, constitutivemodels need to consider the poro-
visco-elastic behaviour of liver tissue and dynamic testing is necessary to
unravel its behaviour.
Several experimental studies have focused on characterising the me-
chanical behaviour of liver tissue by performing tensile, compression and/or
shear deformation tests etc. [51, 72, 73, 150, 249, 319, 390]. For example, the
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results of Chui et al. [73] suggest that the mechanical behaviour of liver tis-
sue is anisotropic, while Kemper et al. [249] showed that human liver paren-
chyma behaves rate dependent with higher rates resulting in higher failure
stresses and lower failure strains.ese experiments provide novel data that
can be useful to develop material models of liver tissue.
By now, several numerical models of the mechanical behaviour of liver
tissue have been developed [72, 73, 150, 308, 390, 402, 404, 438, 508]. Raghu-
nathan et al. [390] used a poro-visco-elastic model to model liver tissue as
a biphasic uid-lled porous medium. ey simulated the mechanical re-
sponse of porcine livers, resulting in accurate simulations of the stress relax-
ation behaviour for dierent strain rates. Roan et al. [404] developed a visco-
hyperelas-tic constitutive model of bovine liver tissue.eir model was able
to accurately describe the strain-rate dependent response. Marchesseau et
al. [308] tried to combine both approaches in developing a porous visco-
hyperelastic model of liver tissue aimed at performing real-time surgery
simulations (Fig. 4.22). is study was conducted within the framework
of the Passport project, an EU-FP7 project that stands for ‘Patient-specic
simulation and preoperative realistic training for liver surgery’ (for more in-
formation: [12]). One of the project goals was to model the mechanical be-
haviour of liver tissue and its response to mechanical manipulations during
surgery.
Elastography can be a useful tool to validate liver mechanics models and
can be used in the clinical setting to assess in vivomechanical properties of
liver tissue (such as the stiness as a measure of the stage of brosis) [310,
350]. Elastography techniques (ultrasound [32, 66, 101, 334, 353, 489, 490]
and MRI [75, 215, 310, 421] based) seem to become a safe and reliable non-
invasive alternative to liver biopsies [310].
(a)               (b)
Figure 4.22: Constitutive models of liver tissue by Marchesseau et al. [308]: (a) constitutive
model combining viscosity, hyperelasticity and porosity; (b) simulated deformation of a liver
with black being the initial position, blue the deformation of a hyperelastic liver, and pink
the deformation of a visco-hyperelastic liver.
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4.3.2 Liver function
As shown in section 1.2, the liver plays a key role in maintaining the body
homeostasis due to its multitude of hepatic functions. Dierent mathemat-
ical models of the hepatic metabolism have been developed to elucidate the
ammonia metabolism [368], toxicological eects [120, 224, 247, 426, 499],
liver regeneration [147, 198–200] etc. [160, 190, 229, 287, 376, 503].
Since the liver removes harmful chemicals from the body, it is important
to study the long-term risk of environmental pollutants. Wambaugh et al.
[499] and Shah et al. [426] used a graphicalmodel with a discrete topology of
the sinusoidal network to simulate the portal to centrilobular mass transfer
of chemicals in hepatic lobules (Fig. 4.23).ese virtual tissues were created
within the context of the Virtual Liver Project (for more information: [1])
funded by the USA to simulate the impact of environmental chemical pollu-
tants on the onset of chronic liver diseases with the focus on liver cancer. To
this end, models are being developed to estimate the risk of liver injury and
to reduce the dependence on animal testing by estimating dose-dependent
toxicities [224, 247].
Portal 
 tract
Central
   vein Sinusoids
Hepato-
  cytes
Figure 4.23: Lobule models by Wambaugh et al. [499] used to simulate mass transport of
chemicals: ve dierent morphologies were examined.
Additionally, attempts have been undertaken to develop models which
are able to support diagnosingwhether a patient has a liver disease and to de-
termine the corresponding type of disease (e.g. a hybrid intelligent diagnos-
tic model based on biomedical liver tests and a health/lifestyle survey [287],
models to detect liver steatosis using electrical bioimpedance spectroscopy
[190, 376], models to estimate the health status in patients with cirrhosis by
using the ‘Cirrhosis Relative Wellness Index’ [157] etc.).
Liver regeneration (section 1.2.12) is a unique functionality of the liver
that is exploited in the context of partial hepatectomy, e.g. for LDLT pro-
cedures. As the processes of regeneration are not well understood, some
models have been developed to elucidate this phenomenon [147, 198–200].
Furchtgott et al. [147] developed a model of the network of interactions be-
tween cytokines and growth factors, active in the hyperplasia process of re-
generation. Hoehme et al. [198–200] established a mathematical model of
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liver regeneration aer CCl4 intoxication. e model showed pericentral
cell death aer CCl4 intoxication, followed by the proliferation of hepato-
cytes to restore themacro-architecture (Fig. 4.24).eirmodels suggest that
the orientation of hepatocytes may play an important role in the regenera-
tion process. e work of Hoehme et al. [198–200] ts within the Virtual
Liver Network (VLN; [15]), an ongoing German project on modelling hu-
man liver function [204].
Figure 4.24: Model of liver regeneration aer CCl4 intoxication. CCl4 intoxication rst
results in centrilobular damage (day 1) followed by liver regeneration during the following
days. Source: [198].
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Analysing the human liver vascular
architecture by combining vascular
corrosion casting andmicro-CT
scanning
e liver has a unique vascular architecture, which is not fully understood.
Nevertheless, detailed data on the vasculature are necessary to model liver
perfusion.erefore, this chapter proposes a multiscale approach to further
unravel the hepatic angioarchitecture at the level of the macro-, meso- and
microcirculation.
is chapter is based on: “Analyzing the human liver vascular architecture
by combining vascular corrosion casting and micro-CT scanning: a feasibility
study”, submitted for publication [95].
5.1 Introduction
e liver is a fascinating but complex multifunctional organ, characterised
by its intricate vascular architecture. Compared to other organs, the liver’s
vasculature is unique due to the dual blood inow. Traditionally, the hepatic
artery (HA) is regarded to supply the liverwith oxygenated blood.e portal
vein (PV) collects partially deoxygenated blood from the intestinal tract in-
cluding spleen and pancreas. HA and PV blood mixes in the sinusoids, the
hepatic microcirculation, oen portrayed as a lattice of small vessels in be-
tween rows of hepatocytes, determining the smallest functional unit or liver
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lobule. Blood subsequently leaves these liver lobules through central veins
and eventually drains into the vena cava inferior (VCI) via the hepatic ve-
nous system (HV) [409]. All vascular trees as well as the microcirculation
have their ownmorphological and functional characteristics. Together, they
determine the hepatic haemodynamic behaviour, such as the hepatic arte-
rial buer response (HABR; [114]) or less physiologic phenomena such as
ow competition between the HA and PV [342] (see chapter 1 for more in-
formation).
e clinical relevance to understand the exact hepatic vascular anatomy
is illustrated by the disturbed vascular architecture in case of liver pathology,
such as cirrhosis with brosis (overproduction of extracellular matrix), re-
generative nodules, increased vascular resistance, neoangiogenesis and vas-
cular remodelling leading to portal hypertension and intrahepatic shunt ves-
sels [22, 69, 467] (see section 2.1). Moreover, the hepatic vasculature is sub-
ject to intraspecies anatomical dierences, relevant in the context of trans-
plantation (see section 1.1.3). Patient-specic analysis of the hepatic vascular
topology through CT andMRI angiographymay facilitate surgical planning
and improve its outcome [356, 423, 514] (see section 4.1.1). Furthermore, to-
pology information and geometrical characteristicsmay be fed to numerical
models to simulate hepatic haemodynamics, useful to model surgical pro-
cedures or the performance of new preservation techniques for transplant
livers (e.g. machine perfusion) etc. [43, 93, 98, 100, 393, 402].
Morphological analysis of vascular trees in dierent organs and spe-
cies is not new (e.g. rodent pulmonary trees [166], mouse placental arteries
[397], human coronary arteries [137], mouse kidneys [498]). However, to our
knowledge, only a few papers were published on the liver’s vasculature (see
also chapter 4). Op Den Buijs et al. [52] classied the PV tree of the rat liver,
but not the HA orHV tree. Selle et al. [423] focused on analysing themacro-
circulation for surgical planning based on vascular territories. Wepreviously
performed studies on modelling liver perfusion based on the macrovessel
architecture of the human [93] and rat liver [100, 142]. A larger number of
studies has been published on liver microcirculation using microscopy, his-
tological techniques etc. [118, 119, 169, 317, 318, 321, 324, 394, 465, 466], or
by performing 3D reconstructions by registering 2D serial cryosections as
done by Teutsch et al. [465] (see section 4.1.2).
Until now, the human liver vascular architecture has not been analysed
yet in a systematic way on single liver samples. erefore, the aim of this
study was to analyse the human liver vascular architecture using a com-
bination of vascular corrosion casting, micro-CT scanning and image pro-
cessing. Hereby, a novel multiscale approach was applied to consecutively
analyse the macro- and mesocirculation.
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5.2 Materials and methods
In this study, a human liver was used aer being discarded for transplan-
tation due to failed reallocation. e protocol was conform to the ethical
guidelines of the 1975 Declaration of Helsinki, and was approved by the Eth-
ical Committee of theUniversityHospitals Leuven, Belgium, and by the Bel-
gian Liver and Intestine Committee as foreseen by the initial protocol.
5.2.1 Vascular corrosion casting
Aer hepatectomy, the liver (weight ± 1.9 kg) was connected to a machine
perfusion preservation device (LifePort Workstation, Organ Recovery Sys-
tems, Zaventem, Belgium; see also section 3.3.2.8) during a 24h period, and
was continuously perfused at 4-6°C with pressure-control through the HA
(25mmHg; unlimited ow) andPV (7mmHg; ow limitation of 300ml/min).
is allowed preserving the vasculature and parenchyma and keeping the
blood vessels open whilst preparing the necessary logistics. Subsequently,
the liver was prepared for the vascular corrosion casting procedure by can-
nulation of the HA, PV as well as the VCI. Casting resin was prepared by
mixing Batson’s #17monomer solution, catalyst and promoter (Polysciences,
Florida, USA)withmonomericmethylmetacrylate (Merck, Darmstadt, Ger-
many) and colour dyes (red and blue for the HA and PV, respectively). In
addition, barium sulfate (50 mg/ml; Micropaque, Delpharm, France) was
added to the HA injection to amplify the contrast between arterial and ve-
nous vessels on CT images, facilitating distinguishing dierent contributing
vessels.eHAandPVwere simultaneously andmanually injected until the
resin emerged suciently from the VCI. Aerwards, inlet and outlet vessels
were clamped to avoid resin leakage during polymerisation of the injected
mixture. Next, the liver was macerated in a potassium hydroxide bath.
5.2.2 Micro-CT imaging
5.2.2.1 Macrocirculation
e resulting human liver cast (Fig. 5.1a) was imaged in globo to acquire
data of the rst blood vessel generations, being a similar number of gener-
ations as obtained with traditional angiography techniques (macrocircula-
tion; Fig. 5.1a). is was done using a state-of-the-art in-house developed
high resolution micro-CT scanner (Fig. 5.2). Two thousand images were re-
corded during a 360° rotation of the cast. e image dataset (resolution of
102 µm) was reconstructed with Octopus soware (Ghent University, Gent,
Belgium) and converted to the DICOM format. More detailed information
on the scanning procedure is available in section 6.2.1.2.
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(a) Macrocirculation                  (b) Mesocirculation   
Location of dissection of
mesocirculation sample
PV treeHV treeHA tree
by two hepatic arterial vessels
micro-CT resolution: 102 µm         micro-CT resolution: 71 µm 
Inows: portal venous vessel ankedOutow
Figure 5.1: Human liver vascular corrosion cast: (a) total liver with indication of the dissec-
tion location of the mesocirculation sample; (b) mesocirculation sample.
5.2.2.2 Mesocirculation
A smaller sample (wedge-shaped; approximately 88 mm x 68mm x 80mm)
was dissected from the inferior part of the right lobe (Fig. 5.1a-b) to inves-
tigate the morphology of vessel generations distal to the macrocirculation.
is sample was imaged at a resolution of 71 µm.
Liver
cast
Flat panel
detector
X-ray
tube
Figure 5.2: Micro-CT scanner. In contrast to traditional computer tomography (CT) scan-
ners in clinics, the X-ray tube (closed-type with directional target; Hamamatsu Photonics
KK, Shimokanzo, Japan) and at panel detector (amorphous-Si; Varian Medical Systems,
Inc., PaloAlto, California) of this setup are static, while the liver cast rotates to capture images
during a 360°rotation.
5.2.3 Image processing and vascular architecture analysis
5.2.3.1 Macrocirculation
e resulting micro-CT dataset was processed using Mimics (Materialise,
Leuven, Belgium). e vascular trees were segmented based on the grey
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values of the images. Separating arterial from venous vessels was straightfor-
ward due to the arterial contrast agent. It was, however, challenging to seg-
ment the PV and HV trees (having similar grey values), which were manu-
ally separated at locations where they touched each other. erefore, each
vascular tree was followed starting at the rst generation vessel going down
to smaller vessels. When a touching vessel was detected, it was separated by
removing the pixel(s) of the connection. Aer segmentation, a 3D recon-
struction of each tree was calculated. Aer image processing, the vascular
tree centrelines were calculated. Using the concept of blood vessel gener-
ations, the centrelines were used to determine the branching topology and
geometrical features of all vascular trees.is was done by classifying vessels
based on their branching pattern, being either n-furcations (parent vessels
splitting in n similar daughter vessels (dichotomous bifurcations when n=2)
or monopodial vessels (small side branches coming of parent vessels at an
angle close to 90°) [167]. Hereby, the inlet vessel of each vascular tree is as-
signed to generation 1. Daughter vessels typically have higher generation
numbers than their parent vessel. For instance, if a generation n vessel splits
into two daughter vessels with a similar smaller diameter, the daughter ves-
sels are assigned to generation n+1. In addition, each vessel was also assigned
its radius (r; best t radius) and length (l; centreline length). Aer data ac-
quisition, exponential trend lines were tted to the data (mean radius, mean
length, number of vessels) as a function of the generation number (eq. 5.1
with y the geometrical feature, x the generation number; a and b the coe-
cients to be tted).
y = a e−bx (5.1)
5.2.3.2 Mesocirculation
Again, segmentations and 3D reconstructions were performed. As this sam-
ple contains vessel generations distal to the macrocirculation, while the res-
olution is insucient to capture the microvessels, it is labeled ‘mesocircula-
tion’. Vascular tree analysis of this sample was similar to that of the mac-
rocirculation. However, for labour-intensity reasons, we did not analyse
the total sample but selected four representative subsamples. To register
the mesocirculatory dataset with the macrocirculatory dataset, the ingoing
HA, PV and HV vessel of each mesocirculation subsample were identied
by their corresponding vessel in the macrocirculatory dataset. Doing so, it
was straightforward to assign generation numbers and geometrical feature
measurements (radii and lengths) to themesovessels. However, since we did
not quantify the total livermesovasculature, the number of vessels versus the
generation number (nmeso,estimated(x); x is the generation number) had to
be estimated.is was done by multiplying the measured number of vessels
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for each mesocirculation generation (nmeso(x)) by a factor. is factor is
determined by dividing the number of macrocirculation vessels of the f th
generation (nmacro( f ); f is the number of the rst mesocirculation genera-
tion included in all four subsamples) by the number of measured vessels of
generation f in the mesocirculation (nmeso( f )) (eq. 5.2).
nmeso,estimated(x) = nmacro( f )nmeso( f ) nmeso(x) (5.2)
5.3 Results
e casting procedure resulted in a replica of the human hepatic vascular
system (Fig. 5.1a). HA vessels were red, while PV and HV were blue, due
to the relatively high PV ow (75% of the outow) compared to HA ow,
resulting in dominantly blue HV ow.
5.3.1 Macrocirculation
Fig. 5.3 shows 3D reconstructions of the total liver micro-CT scan.e HA,
PV and HV vascular beds were clearly distinguishable. Next to n-furcations
(such as bifurcations and trifurcations), the trees count a high number of
monopodial vessels, sprouting from parent vessels at angles close to 90°
(Fig. 5.3b-d). Aer the rst generations, HA vessels run parallel to PV ves-
sels. In a few cases, one PV vessel is even anked by two HA vessels. More-
over, HA vessels have predominantly circular cross-sections compared to
elliptical cross-sections of PV and HV vessels. Each tree was classied ac-
cording to its branching topology, resulting in 6, 6 and 5 generations for the
HA, PV and HV tree, respectively. Mean HA radii drop from 3.45 mm to
5.92⋅10-1 mm, PV radii from 7.34 mm to 1.08 mm and HV radii from 13.2
mm (VCI) to 1.13 mm (Fig. 5.4a-c). As anticipated, portal and hepatic ve-
nous vessels (PV and HV) have larger diameters compared to HA vessels.
Exponential trend lines, tted to radii measurements, have high determina-
tion coecients (R2 ≥ 0.97). Mean lengths don’t show a clear-cut decreas-
ing trend in the rst generations (especially for PV vessels), but decrease in
higher generations (Fig. 5.4d-f). is is partially due to the rst generation
vessel of each tree being cut to resect the liver, implying an underestimated
length.erefore, the rst generation length is not accounted for when cal-
culating length trend lines.e PV length trend line has the lowest R2 value
(0.77). Length standard deviations are higher than those for radii. Numbers
of vessels per generation clearly increase exponentially towards higher gen-
eration numbers: from 1 to 271, 1 to 216, and 1 to 76 vessels for the HA, PV,
and HV tree, respectively (Fig. 5.5).
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(a)                (b)
(c)                (d)
Figure 5.3: 3D reconstructions of the macrocirculation: (a) superposition of three vascular
trees with indication of the dissection location of the mesocirculation sample; (b) hepatic
arterial (HA), (c) portal venous (PV) and (d) hepatic venous (HV) trees. Arrows indicate
examples of monopodial branches.
5.3.2 Mesocirculation
Segmentations of themesocirculation subsample (Fig. 5.1b) weremore chal-
lenging than themacrocirculation, becausemore vessels were touching each
other (Fig. 5.6). Fig. 5.1b and 5.6a show that the PV inow runs parallel to
two HA vessels. Similar to the macrocirculation, this sample shows ellip-
tical PV and HV vessels compared to circular HA vessels. Analysing four
subsamples (brighter subsamples in Fig. 5.6b-d) resulted in the visualisation
of higher generation vessels, going up to generation 13, 13 and 10 for the HA,
PV and HV trees, respectively (Table 5.1, Figs. 5.4-5.5). Mean radii decrease
to 8.00⋅10-2, 1.23⋅10-1 and 1.60⋅10-1mm for the HA, PV and HV trees, respec-
tively (Fig. 5.4a-c). Radii trend lines were tted to the pooled macro- and
mesocirculation measurements (R2 ≥ 0.98). Mean lengths also decrease for
all trees (R2 ≥0.94).e numbers of vessels per generation again increase ex-
ponentially, almost exactly following extrapolations of the macrocirculation
trend lines. All trend lines tted to the combination of macro- and meso-
circulation measurements show equal or higher goodness of t than those
tted to only the macrocirculation, except for the HA radii (Figs. 5.4-5.5).
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Figure 5.4: Results of the vascular tree analysis of themacro- andmesocirculation: radius (a-
c) and length (d-f) with their standard deviations as a function of the generation number for
the hepatic arterial (HA), portal venous (PV) and hepatic venous (HV) trees, respectively.
Macro- and mesocirculation measurements are indicated by black and white markers, re-
spectively. Exponential trend lines are depicted by full lines when tted to macrocirculation
data, and dashed lines when tted tomacro- andmesocirculation data. Equations and coe-
cients of determination (R2) of the exponential functions are given.e rst HV generation
(vena cava inferior; VCI) was not taken into account when tting the radius trend line, since
the VCI has a much larger diameter and is not really part of the hepatic vasculature. Length
trend lines did not incorporate the rst generation, since these vessels were cut to resect the
liver, resulting in an underestimated length.
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Figure 5.5: Results of the number of vessels per generation number of the macro- and meso-
circulation for the hepatic arterial (HA), portal venous (PV) and hepatic venous (HV) trees,
respectively. Macro- and mesocirculation measurements are indicated by black and grey
markers, respectively. Estimated numbers of vessels for the mesocirculation (Table 5.1) are
indicated by white dots. Exponential trend lines are depicted as full lines when tted to the
macrocirculation data, and dashed lines when tted to the macro- and estimated mesocir-
culation data. Equations and coecients of determination (R2) of the exponential functions
are given.
5.4 Discussion
For the rst time, the (human) hepatic vasculature of one and the same liver
is visualised and 3D reconstructed at dierent length scales (from the largest
vessels down to themesocirculation; see chapter 9 for themicrocirculation).
erefore, this pilot study used a combination of state-of-the-art vascular
corrosion casting and micro-CT scanning techniques with a novel image
processing and analysis technique.
However, one has to be careful when generalising these ndings based
on a single liver. More livers should thus be similarly analysed to get a gen-
eral overview of the human hepatic vascular architecture. As such, this pilot
study should be interpreted as the vascular analysis of a specic liver. is
human liver was oered to our lab aer failed rescue allocation and there
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Table 5.1: Overview of the HA, PV and HV measurements of the macro- and mesoscale.
Results are reported as the generation numberwith itsmean radius,mean length andnumber
of vessels. (Estimated numbers of vessels of mesocirculation generations are calculated using
eq. 5.2.)
Generation Mean Radius Mean Length Number Estimated
number radius standard length standard of number
[mm] deviation [mm] deviation vessels of
[mm] [mm] vessels
HA 1 3.45 0 10.0 0 1
HA 2 2.91 6.33⋅10−1 73.9 29.2 2
HA HA 3 1.78 5.28⋅10−1 40.4 17.5 7
Macroscale HA 4 1.13 3.71⋅10−1 30.6 19.9 36
HA 5 8.25⋅10−1 2.00⋅10−1 25.3 18.5 120
HA 6 5.92⋅10−1 9.61⋅10−2 15.7 10.5 271
HA 5 8.62⋅10−1 3.54⋅10−3 54.4 25.4 2
HA 6 5.21⋅10−1 1.54⋅10−1 12.2 8.29 6
HA 7 3.45⋅10−1 3.90⋅10−2 7.22 4.04 12 542
HA HA 8 2.77⋅10−1 4.70⋅10−2 3.51 2.62 34 1536
Mesoscale HA 9 2.41⋅10−1 4.19⋅10−2 3.09 2.08 76 3433
HA 10 2.08⋅10−1 2.73⋅10−2 2.36 1.38 198 8943
HA 11 1.60⋅10−1 2.62⋅10−2 1.48 1.05 342 15447
HA 12 1.19⋅10−1 2.47⋅10−2 1.00 5.45⋅10−1 225 10163
HA 13 8.00⋅10−2 2.46⋅10−2 7.41⋅10−1 2.40⋅10−1 9 407
PV 1 7.34 0 34.7 0 1
PV 2 6.30 1.36 34.9 32.5 2
PV PV 3 4.00 1.52 33.2 23.6 7
Macroscale PV 4 2.09 5.17⋅10−1 32.3 7.55 27
PV 5 1.49 3.09⋅10−1 26.5 14.8 80
PV 6 1.08 1.60⋅10−1 15.9 8.18 216
PV 5 1.41 0 19.9 0 1
PV 6 8.86⋅10−1 2.25⋅10−1 14.8 7.94 5
PV 7 7.18⋅10−1 1.72⋅10−1 8.14 4.33 10 432
PV PV 8 4.82⋅10−1 1.12⋅10−1 5.24 2.80 31 1339
Mesoscale PV 9 3.09⋅10−1 6.16⋅10−2 3.16 1.80 86 3715
PV 10 2.31⋅10−1 3.92⋅10−2 2.68 1.39 244 10541
PV 11 1.75⋅10−1 2.61⋅10−2 1.48 8.75⋅10−1 555 23976
PV 12 1.38⋅10−1 2.39⋅10−2 1.03 4.91⋅10−1 73 3514
PV 13 1.23⋅10−1 2.71⋅10−2 9.50⋅10−1 3.79⋅10−1 6 259
HV 1 13.2 0 68.4 0 1
HV HV 2 5.02 1.20 74.4 25.2 3
Macroscale HV 3 2.43 5.79⋅10−1 33.0 20.1 18
HV 4 1.70 4.45⋅10−1 27.6 16.7 33
HV 5 1.13 1.94⋅10−1 18.8 9.60 76
HV 5 1.27 4.42⋅10−1 32.5 12.7 4
HV 6 7.41⋅10−1 9.27⋅10−2 8.56 5.30 9 171
HV HV 7 4.56⋅10−1 9.66⋅10−2 6.59 3.23 26 494
Mesoscale HV 8 2.46⋅10−1 7.65⋅10−2 4.09 1.97 111 2109
HV 9 1.71⋅10−1 5.59⋅10−2 2.61 1.47 74 1406
HV 10 1.60⋅10−1 6.10⋅10−2 2.17 1.06 20 380
108
5.4. Discussion
(a)        (b)
(c)        (d)
Portal venous 
vessel anked 
by two arterial
vessels
Figure 5.6: 3D reconstructions of the mesocirculation: (a) superposition of three vascular
trees; (b) hepatic arterial (HA), (c) portal venous (PV) and (d) hepatic venous (HV) trees.
e brighter parts of (b)-(d) show the four subsamples used to acquire geometrical data.
was no obvious macroscopic abnormality.e casting procedure was done
by manual injection, having the advantage of sensing how the organ reacts
while injecting. Also, it has been described that casting may lead to slight
shrinkage of the resin, which would imply slightly smaller diameters [260].
However, our diameter measurements were comparable with literature data
on the largest hepatic vessels [317, 496, 501]. Moreover, the casting proce-
dure was performed according to standardised procedures by a team having
many years of expertise [63, 93, 100].
Ideally, the complete cast should be scanned at once at a suciently high
resolution to allow visualising all vessels down to the sinusoids. However, it
was technically impossible to scan a total liver at a resolution of a few mi-
crometers due to computational and soware limitations to process datasets
with an extremely large le size. Consequently, a multiscale approach was
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used to consecutively study the macro- and mesocirculation (see chapter 9
for themicrocirculation), allowing the quantication of 13 (HA and PV) and
10 (HV) blood vessel generations as well as the sinusoids. However, there is
still a gap of a number of generations between the 10/13th generation and
the sinusoids. Nonetheless, the total number of generations can be approx-
imated by extrapolating the resulting exponential trend lines of the radius
(Fig. 5.4) down to the level of radius values of the terminal vessels, resulting
in an estimation of 19-20, 17-18 and 13-14 generations for theHA, PV andHV
trees, respectively. Hereby, sinusoids are interpreted as being the connection
between the terminal/last generation of the inow trees (HA and PV) and
outow tree (HV).
Our data reveal a complex hepatic vascular topology covering themacro-
down to themicrocirculation, showing that hepatic trees donot solely branch
according to a dichotomous bifurcating pattern, which is oen assumed
in vascular tree models. N-furcations as well as monopodial vessels were
clearly visualised in the macro- and mesocirculation. Geometrical charac-
teristics (Figs. 5.4-5.5) show exponential behaviour as a function of gener-
ation numbers. HA and PV trees show similar behaviour and exponential
trends, resulting in equal numbers of generations for the macro- and meso-
circulation. However, PV radii are larger than HA radii, and starting from
generation 4, numbers of HA vessels are higher than those of PV vessels
(Table 5.1), probably due to some PV vessels being anked by two parallel
HA vessels. e HV tree has the largest radii and typically counts less gen-
erations than the HA and PV tree.
e novel and detailed morphological data gathered in this study are
useful to complement scientic insights into liver morphology and phys-
iology. e new multiscale approach is also applicable in the context of
liver pathophysiology, e.g. to investigate pathology-related vascular alter-
ations in case of brosis and cirrhosis [69, 486], hepatocellular carcinoma
[302], portal hypertension [140, 513] etc. Furthermore, this approach may
generate input data for the development of numerical models of liver perfu-
sion.ese models can be applied to simulate the haemodynamic impact of
(ab)normal situations such as isolated organ perfusion and surgical proce-
dures, e.g. partial hepatectomy.
5.5 Conclusion
Combining vascular corrosion casting with state-of-the-art high resolution
micro-CT scanning provides novel and unique data on the human hepatic
vasculature from the macrocirculation and mesocirculation (see chapter 9
for the microcirculation). A new multiscale approach allows visualising the
complex liver vasculature at dierent levels in 3D and performing a detailed
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analysis of the topology and geometrical features. ese data are useful to
create numerical models of the hepatic blood circulation. is approach
could also be applied to other organs, such as kidneys.
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From vascular corrosion cast to
electrical analogmodel for the
study of human liver
haemodynamics and perfusion
is chapter is based on “From vascular corrosion cast to electrical analog
model for the study of human liver hemodynamics and perfusion”, as pub-
lished in IEEE Transactions on Biomedical Engineering, 58(1):25-35, 2011
[93]. In this chapter, the macrocirculation data obtained in chapter 5 are
used.
6.1 Introduction
Liver transplantation is an eective therapy for patients with end-stage liver
disease, but is being confronted with an increasing shortage of donor liv-
ers. In 2008, the Eurotransplant International Foundation (responsible for
the mediation and allocation of organ donation in Austria, Belgium, Croa-
tia, Germany, Luxemburg, the Netherlands and Slovenia) reported 2442 pa-
tients on the waiting list for liver transplantation, of whom 463 patients died
[125]. A possible solution is to extend the donor pool to marginal or expan-
ded criteria donors, including non-heart-beating donors [481]. Transplant-
ing these suboptimal donor organs, however, requires better preservation
methods than static cold storage (CS), where donor organs are not perfused,
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but simply preserved on ice. Due to the limitations of CS, the organs lose vi-
ability, suer from irreversible injury (e.g. cellular oedema, acute inamma-
tion and reperfusion damage) and can only be preserved during a restricted
period [326]. As a result, hypothermic machine perfusion (HMP) is experi-
encing a revival as an alternative organ preservation method. In HMP, the
physiological perfusion within the body is imitated by continuous perfu-
sion of the organ with a hypothermic (4 - 6°C) perfusion uid. HMP thus
combines the advantages of hypothermia, which substantially decreases the
metabolic activity, and perfusion, which can supply nutrients, pharmaceu-
ticals and oxygen to the organ, and remove waste products [340]. Although
HMP is already commercially available and clinically widely applied for kid-
neys [338], this is not the case for livers.e liver has amore complex vascu-
lar architecture with two blood inlets, requiring a more complicated perfu-
sion and the need for two supplying pumps (either pressure- or ow-driven).
However, prototypes of perfusion machines for donor livers exist, but they
still encounter several problems. Shear stresses, produced by the perfusion
uid ow, may damage the endothelial cells lining the sinusoids. Morpholo-
gical changes of sinusoidal endothelial cells have been reported aer HMP,
as well as ow heterogeneity, elevated vascular resistances and possibly si-
nusoidal ow obstruction [227]. Furthermore, there is still no consensus on
the optimal perfusion settings and on the composition of the most appro-
priate perfusion uid for liver HMP. In addition, ow competition has been
observed between the hepatic artery (HA) and the portal vein (PV) dur-
ingHMP experiments, counteracting a well-balanced perfusion (see section
3.3.3) [191, 342]. Consequently, the challenge is to dene optimal parameter
settings for HMP to maintain sucient perfusion without damaging liver
tissue [488]. Within this context, it would be of specic interest to gainmore
insight into the liver vascular architecture and the distribution of pressure
and ow throughout the organ during HMP.
e aim of the present study is to develop an electrical analog model
of the blood ow through the human liver following a methodology previ-
ously applied to the dog liver. Since (electrical) models of the total human
liver do not yet exist, we based our model on an electrical analogue of a
dog liver [482] and adapted it to a human liver. Because detailed anatomical
data of the human liver vasculature are required as input for the electrical
model and since literature only provides few data of the main human liver
branches, we rst gathered detailed data of the human liver, using a novel
data acquisition technique (including vascular corrosion casting, micro-CT
imaging and image processing).
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6.2 Materials andMethods
6.2.1 Anatomical data
e study was conducted on two human livers discarded for transplanta-
tion aer failed reallocation. is was approved by the Ethical Committee
of the University Hospitals Leuven (Belgium) and by the Belgian Liver and
Intestine Committee as foreseen by the initial protocol. e procedure to
obtain anatomical data consisted of four steps: vascular corrosion casting,
micro-CT scanning, image processing and data acquisition.
6.2.1.1 HMP and vascular corrosion casting procedure
Aer the initial vascular ush and hepatectomy, the livers underwent HMP
and were perfused for 24 hours with KPS-1 perfusion uid (Organ Recov-
ery Systems, Zaventem, Belgium) at 4-6°C in order to preserve the macro-
circulation as well as the microcirculation. A liver HMP prototype (Life-
Port Workstation; Organ Recovery Systems, Zaventem, Belgium) allowed
pressure-controlled (25 mmHg), ow-unlimited continuous perfusion for
the HA and pressure-controlled (7 mmHg), ow-limited (300ml/min) con-
tinuous perfusion through the PV. For the vascular corrosion casting proce-
dure of the HA, PV and hepatic veins (HV), the livers were positioned with
their diaphragmatic surface down into a bowl-shaped container, allowing
the organ to preserve its normal anatomical shape as much as possible. Sub-
sequently, each liverwas simultaneously injected via theHAand the PVwith
a casting resin prepared just before the injection bymixingBatson’s#17mon-
omer solution (100 parts), Batson’s catalyst (15 parts) and Batson’s promoter
(1 part) (Polysciences, Florida, USA) with monomeric methyl metacrylate
(20 parts) (Merck, Darmstadt, Germany). In addition to using two dier-
ent colouring dyes to distinguish the arterial and venous trees (red for HA,
blue for PV), a suspension of 25% barium sulfate (Micropaque, Delpharm,
France) was mixed with the resin for the HA tree. e goal of adding this
contrast agent was to allow a discrimination of the arterial blood vessels
from the venous system on X-ray images. e PV and the HA were manu-
ally injected with a total volume of ± 200 ml and ± 100 ml casting solution,
respectively.is volume proved to be sucient, as the resin was emerging
from the HV in sucient quantities at the end of the injection. Next, all ves-
sels were clamped and the injected uid was allowed to polymerise for ± 2
hours. Manipulation of the liver was kept to a strict minimum during this
period. Subsequently, the livers were macerated in a 25% potassium hydrox-
ide solution for approximately two days.e remaining casts of the vascular
trees were rinsed in tap water overnight, ushed with three liters of distilled
water and dried under a vented hood.
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6.2.1.2 Micro-CT imaging
e 3D geometry of the liver casts was acquired with an in-house developed
high-resolution micro-CT scanner. In contrast to conventional CT scan-
ners, this scanner has a dierent conguration: the sample rotates, while
the X-ray tube and at panel detector are static. As normally small samples
with mm-dimensions are scanned, scanner setup adjustments were neces-
sary to be able to scan liver casts with larger dimensions.e setup consisted
of a closed-type X-ray tube with directional target (Hamamatsu Photonics
KK Shimokanzo, Japan) and an amorphous-Si at panel detector (Varian
Medical Systems Inc., Palo Alto, California). e detector (0.127 µm pixel
size) was tiled with a mechanical translation stage in order to obtain a de-
tector eld of 2800 x 1000 pixels (36 x 12 cm). Two thousand projection
images were recorded while the cast was rotated over 360°. e tube op-
erated at 90 keV and 250 µA, and the reconstruction was performed with
Octopus-soware (Ghent University, Gent, Belgium), resulting in a 2800 x
2800 x 1000 voxel dataset with a voxel pitch or resolution of 101.8 µm for
cast 1 and 111.8 µm for cast 2. Because of computer performance restrictions,
3D datasets were binned. e datasets of cast 1 and 2 underwent binning 4
and 2, respectively, meaning that new datasets were obtained by calculating
the mean grey values of all volumes built up of 4 x 4 x 4 and 2 x 2 x 2 voxels,
respectively.e new image datasets with smaller le size were subsequently
converted to DICOM format for image processing.
6.2.1.3 Image processing
Images were processed using Mimics soware (Materialise, Leuven, Bel-
gium). First, the datasets were segmented in three vascular trees based on
their grey values. Segmentations of arterial (HA) and venous (PV and HV)
vascular beds were relatively straightforward because of the arterially ad-
ded barium sulfate. In contrast, PV and HV trees were not clearly distin-
guishable due to their similar range of grey values in the digital images. PV
andHVsegmentationswere therefore completed bymanually separating the
segmentation masks on locations where PV and HV vessels touched each
other. Secondly, 3D reconstructions of the vascular trees were calculated
and visualised.
6.2.1.4 Data acquisition
Data acquisition was performed using the centreline algorithm in Mimics,
which allowed calculating the centrelines of all vessel segments dened by
the soware. Aerwards, vessel segments were manually grouped to blood
vessels. Vessel classication and data acquisition was performed based on
the vascular tree centrelines. First, an inventory of the vascular trees was
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obtained using the concept of blood vessel generations. In literature, clas-
sication of vascular trees is usually based on branching patterns concern-
ing dichotomous (bifurcations) and monopodial (side branches) branching
(see also section 4.1.1) [167]. In contrast, human livers do not only contain
these patterns, but also more sophisticated patterns such as trifurcations. To
determine to which generation a vessel belonged, we started by dening the
mother vessel of each vascular tree (HA, PV andHV) as generation 1. When
the mother vessel branched into two or more equal daughter vessels, these
were dened as generation 2. In this way, all vessels (except the monopodial
vessels) were classied. Since neglecting themonopodial vessels would have
a signicant inuence on the number of vessels and the results of the elec-
trical model, it was necessary to take them into account. Monopodial side
branches weremostly classied as belonging to the generation following that
of the mother vessel from which they originate (e.g. a side branch of a gen-
eration 3 vessel was usually classied as a generation 4 vessel). However,
when its diameter was signicantly smaller than that of the other branched-
o dichotomous daughter vessels, the monopodial vessel was classied as
a further generation branch corresponding to its diameter by comparison
with the mean diameters of the following generations.
All vessels were given a name ‘x.y’, in which x stands for the generation
number and y represents a unique vessel number inside the generation. Ad-
ditionally, vessel diameters and lengths were measured. Since vessel diame-
ters are usually not perfectly circular, diametermeasurements were based on
‘best t diameter’ measurements, using an algorithm which minimises the
average distance between the vessel circumference and the circle dened by
the tted diameter. Vessel lengths were measured by determining lengths of
the vessel centrelines. Applying this approach, a quantitative analysis was
performed to collect the anatomical vascular data of human livers.
6.2.2 Electrical analog model
6.2.2.1 Principle
emodel is based on an electrical analogue of hepatic blood ow through a
dog liver, obtained in a previous study by van der Plaats et al. (see also section
4.2.2.1.2) [482]. Like any electrical analogmodel, it is based on the analogy of
the simpliedNavier-Stokes equations describing ow through a cylindrical
tube (representing a blood vessel), and the electrical equations describing
current and voltage through an electrical circuit, in this case a pi-lter (see
dotted line in Fig. 6.1) [90, 91].e lter contains four dierent components
dened in eq. 6.1 to 6.4 as derived in section 4.2.2.1.2: serial resistance Rs,
serial inductance L, parallel conductance C and parallel resistance Rp.
Rs = 8µlpir4 [Nsm5 ] (6.1)
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Figure 6.1: Electrical model of the liver. HA and PV inlet vascular trees are represented by
hepatic arterial (HA) and portal venous (PV) voltage sources, each followed by a series of
pi-lters. ese two vascular trees are connected at the level of the sinusoidal generation
(dotted line). Subsequently, a third series of pi-lters referring to the hepatic venous (HV)
vascular tree ends in a vascular outow resistance at the vena cava inferior (VCI).
L = 1.33ρl
pir2
[Ns2
m5
] (6.2)
C = l2
2cp2L
[m5
N
] (6.3)
Rp = 2 ⋅ 10−6C [Nsm5 ] (6.4)
Variables are the dynamic viscosity (µ = 3.5 ⋅10−3 Pa⋅s) and density (ρ =
1050 kg/m3) of the perfusion uid (in this case of blood), the radius (r [m])
and length (r [m]) of the blood vessels and the pulse wave velocity (cp [m/s])
as a measure of vessel stiness. Rs represents the vascular resistance of the
blood vessel, C the elasticity, Rp the visco-elasticity and L the inertia of the
blood. Equations 6.1 to 6.4 refer to the components of a pi-lter representing
one blood vessel. Considering a blood vessel generation as a group of n
parallel connected identical vessels, this corresponds to n parallel connected
pi-lters. Subsequently, this can be simplied to one pi-lter by taking into
account the number of parallel vessels (n).e component values of the pi-
lter are then found by dividing Rs, Rp and L by n and multiplying C by
n. In this way, one generation of vessels is represented by one pi-lter, the
building block of the electrical analogue.
As the liver has three main vascular trees each comprising several gen-
erations, an electrical analogue of the liver with three pi-lter branches was
obtained (Fig. 6.1): two inlet branches representing the HA and PV tree, and
one outlet branch representing the HV tree. e last generation of the HA
and PV tree refers to the inlet arterioles and venules respectively, forming
the portal triads at the corners of the lobules. ese triads deliver blood
to the sinusoids, modelled as the last HV generation where the HA and PV
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blood ismixed (see dotted line in Fig. 6.1). Consequently, the second lastHV
generation stands for the central veins draining the blood coming from the
sinusoids to the vena cava inferior (VCI).e output values of the model
are the pressure and ow through all blood vessel generations. Based on
these results, wall shear stresses (τsin [Pa]) at the level of the sinusoids, which
are very prone to shear-related damage, can also be estimated using eq. 6.5,
assuming Poiseuille ow and an equal ow in each of the sinusoids. QHV
[m3/s] represents the mean HV ow, nsin refers to the number of vessels in
the sinusoidal generation and rsin [m] is the mean sinusoidal radius.
τsin = 4µQHVnsinpirsin3 [Pa] (6.5)
6.2.2.2 From anatomical data to pi-lter parameters
Anatomical data (and hence input data for eq. 6.1-6.4) could be directly de-
termined for the rst 5 to 6 generations. For these generations, themeasured
data were used in the nal model. However, it was not possible to obtain
data for the smaller generations (generations 5 or 6 down to the sinusoids)
from the scanned casts, so estimates had to be made. Since plots of diame-
ter, lengths and numbers of vessels versus generation numbers showed ex-
ponential trend lines, extrapolations of these lines were used to estimate the
lacking number of generations and their parameter values. To determine the
number of generations, the trend line of the radius versus generation num-
ber was extrapolated up to the generation in which a radius value, being in
accordance with literature values for diameters of liver sinusoids (7-15 µm)
[309], was reached.
Results obtained with data based on simple extrapolations up to the
last generation showed some dierences in terms of model-predicted pres-
sure and ow distributions in comparison with physiological values. For
example, the sinusoidal pressure was higher than the PV pressure, which
would result in backow at the PV side. To solve this, the trend lines with the
highest degree of uncertainty (the length and number of vessels per genera-
tion) were tuned in order to increase the physiological accuracy using, how-
ever, the original data where available (i.e. for the rst 5 to 6 generations).
By reverse engineering, starting from literature values of pressures and ows
at the inlets (100 mmHg and 350 ml/min for the HA; 10 mmHg and 1100
ml/min for the PV) [309], sinusoids (5 mmHg and 1450 ml/min) [169] and
outlet (3 mmHg and 1450 ml/min) [309] of the human liver, the presumed
total vascular resistances Rs in each tree, necessary for truthfully simulating
blood ow through the liver, were calculated. ree length and two num-
ber of vessels trend lines were optimised (by adjusting the coecient and/or
power of the exponential trend line) to approximately meet these resistance
criteria. As such, trend lines for radii were not adjusted (Table 6.1).
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Table 6.1: Equations of original and adjusted exponential trend lines. Only the length and
two out of three number of vessels trend lines were adapted, original radius trend lines were
maintained. Parameter x represents the generation number.
HA PV HV
Radius[mm] Original 5.4e−0.37x 13e−0.42x 19e−0.6x
Length[mm] Original 136e
−0.36x if (x > 1) 46e−0.14x 113e−0.36x
Adjusted 680e−0.36x 265e−0.36x 161e−0.5x
Number Original 0.24e1.2x 0.27e1.1x 0.39e1.1x
of vessels Adjusted 0.27ex / 0.39e1.6x
To determine suitable values of the pulse wave velocity cp, necessary to
calculate theC-parameters (representing the elasticity), theMoens-Korteweg
equation was used (eq. 6.6, in which h [m] refers to the vessel wall thickness
and Ewall [Pa] to its Young’s elasticity modulus).
cp = ¿ÁÁÀhr Ewal l2ρ [ms ] (6.6)
Since data for the Young’s moduli and wall thickness of the hepatic ves-
sels in humans were not collected in this study, cp was estimated by nding
its value for a typical large vessel and a typical small vessel: for a large vessel
(h/r ≈ 0.1; Ewal l ≈ 400 kPa) cp ≈ 4 m/s and for a small vessel (h/r ≈ 0.5;
Ewal l ≈ 2000 kPa) cp ≈ 22 m/s.ese two values were used to estimate cp in
the rst generation of the HV tree (the VCI, being the largest hepatic vessel)
and in the sinusoids, respectively. For the intermediate generations of this
tree, cp was estimated by linear interpolation between these two values, de-
pending on the generation number. For the HA and PV tree, an analogous
interpolation was applied for the intermediate generations by using for the
rst generation cp ≈ 5 m/s at the PV (second largest hepatic vessel) and cp ≈
12 m/s at the HA (signicantly smaller than both the PV and HV).
To test the cp sensitivity of the model, several scenarios of cp variations
were applied: multiplying or dividing all cp values by 2, and using constant
mean, minimum and maximum cp values throughout the vascular trees.
ese variations only slightly inuenced the amplitude and phase of the AC
solution, suggesting that our linear cp interpolations are acceptable.
6.2.2.3 Boundary conditions to model natural liver blood ow
For simulating natural liver blood ow, two voltage sources were used as
input (analogous to theHA and PV perfusion pressure).e sinusoidal PHA
source was assumed to have a mean value of 100 mmHg, an amplitude of 20
mmHg and a frequency f of 1.2 Hz (heart rate of 70 bpm; eq. 6.7).
PHA = 100 + 20 cos(2pi f t) [mmHg] (6.7)
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e PPV source was given a constant value of 10 mmHg. At the VCI
where the HV converge, the electrical circuit was closed by an outow resis-
tance R, which was estimated as R = PHV/QHV = 3 mmHg / (1450 ml/min)
= 165⋅105 Ns/m5. R represents the vascular resistance of the remaining blood
vessels in the body, and PHV refers to the pressure at the end of the HV.
ough QHV is possibly inuenced by right atrial pressure changes, this ef-
fect was not accounted for in our simulations. Since the outlet resistance R
has only a minor inuence on the nal solution and the main interest of this
study is HMP with free outow, this assumption appears justied.
6.2.2.4 Solution method
e electrical superposition method was applied to solve the model. is
means that the circuit was split into three partial networks: two direct cur-
rent (DC) networks with only the PV source and the DC component of the
HA source activated, respectively, and a third alternating current (AC) net-
work with only the AC component of the HA source activated. e total
solution of themodel was the sumof the three partial network solutions.e
methodology incorporated working in the frequency domain using com-
plex numbers to facilitate calculations. In this way, it was possible to solve
the model in steady state conditions of continuous or sinusoidal regimes (as
well as more complex regimes in which the source signal is decomposed in
its harmonics (Fourier analysis) to solve the AC part).e code was imple-
mented in Matlab and was veried by using the same parameter values as
applied by van der Plaats et al. [482], which were taken from data for dog
livers [305]. Obtained results were identical.
6.2.2.5 Model application: HMP simulations
e model was used to simulate both natural human liver blood ow and
HMP. As there is free HV outow in HMP, PHV = 0 and hence R = 0.
Furthermore, the uid viscosity µ had to be adapted to that of a perfusion
uid instead of blood. We used KPS-1 perfusion uid with a viscosity of 4.5
mPa⋅s at the operating temperature (4-6°C). In contrast to periodic natural
blood ow, liver HMP was assumed to be steady by applying continuous in-
let pressures. To test the inuence of the inlet pressures on the sinusoidal
shear stress, a rst HMP simulation was executed using the physiological
inlet pressures. Secondly, we simulated the HMP settings applied to the or-
gans prior to vascular corrosion casting (see methods section 6.2.1.1) using
PHA = 25 mmHg and PPV = 2.5 mmHg. Additionally, a parameter study was
conducted to determine viscosity and ow competition eects during HMP.
Since other perfusion uids than KPS-1 can be used, viscosity values were
varied between 2 and 12 mPa⋅s, the typical range of perfusion uid viscos-
ities [384, 480]. Previous HMP experiments revealed that ow competition
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occurred between the HA and PV when changing mean values of the inlet
pressures [191, 342]. To study this competition phenomenon which disturbs
homogeneous perfusion, the mean PV inlet pressure was varied between
dierent runs from 1 to 7 mmHg.
6.3 Results
6.3.1 Anatomical data
Vascular corrosion casts of two human livers are shown in Fig. 6.2.e rst
liver was completely lled with the casting solution. In contrast, the second
liver was only partially cast: the HV tree and half of the HA tree were miss-
ing, probably due to an obstruction in one or a few major vessels. Results
of vascular measurements are therefore mainly based on the rst liver cast.
Red blood vessels representHA vessels and blue refers to PV andHVvessels.
ese latter two were more dicult to distinguish, as HV ow is a mixture
of approximately 75 % PV ow (blue) and 25 % HA ow (red), resulting in
an HV ow with a dominating blue colour.
Image processing of cast 1 resulted in the geometries depicted in Fig. 6.3.
Panel (a) shows the three vascular trees, panels (b) through (d) each depict
one single tree. Internal branching patterns of all vascular trees could be
visualised in this way.
Geometrical data could be determined for the rst generations of every
tree, i.e. up to six generations for theHAandPV tree of cast 1 (Fig. 6.4; Tables
6.2-6.4), and ve for the HV tree. For cast 1, measured HA radii dropped
from 3.5 mm to 0.59 mm (generation 6), PV radii from 7.3 mm to 1.1 mm
(a) (b)
Figure 6.2: Liver casts: cast 1 (a) and cast 2 (b). Red blood vessels represent the arterial tree
(HA), whereas blue vessels refer to venous vessels (portal venous (PV) and hepatic venous
(HV) vascular trees).
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(a) (b)
(d)(c)
Figure 6.3: Segmentation and 3D reconstruction of the three vascular trees (a), and the he-
patic arterial (HA) (b), portal venous (PV) (c) and hepatic venous (HV) (d) tree with 6, 6
and 5 generations visualised, respectively. Panel A depicts all blood vessels which have been
measured to obtain the anatomical model.
(generation 6) and HV radii from 13 mm to 1.1 mm (generation 5). For a
given generation, HV and PV radii were larger than HA radii. Numbers
of vessels per generation rose from 1 to 271 (generation 6) for the HA tree,
from 1 to 216 (generation 6) for the PV and from 1 to 76 (generation 5) for
the HV tree.e variation of mean radii and numbers of vessels in function
of generation numbers tended to be exponential. For each of the vascular
beds,mean lengths droppedwith rising generation numbers (not taking into
account the rst HA, PV and HV generation). Trends in lengths were less
distinct: no exponential trend line could be determined for the PV lengths.
Fig. 6.4 also shows a comparison of HA and PV radii of cast 1 and 2. e
casts seem to have radii in the same range.
6.3.2 Electrical model
Using the anatomical measurements supplemented with estimations (Table
6.1) based on the trend line extrapolations, a total of 18 HA, 16 PV and 14HV
generations were obtained. A complete list of the data necessary to calculate
the default model is given in Tables 6.2-6.4.
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6.3.2.1 Pressure and ow: model of natural liver blood ow
Results of mean pressures and ows throughout the liver are given in Fig.
6.5a and d, respectively. Pressure smoothly decreased along the subsequent
generations, resulting in pressures of approximately 5 mmHg at the level of
the liver sinusoids. In the HV tree, pressures were further reduced until they
reached 3mmHg at the VCI outlet (where theHV converge). Mean ow dis-
played values of approximately 400 ml/min, 1100 ml/min and 1500 ml/min
for the HA, PV and HV vascular tree, respectively. Next to the mean values,
the pulsatile pressure and ow proles versus time were also obtained (Fig.
6.6).e amplitude of pressure and ow proles clearly decreased with in-
creasing generation number through the HA tree from 20 mmHg and 236
ml/min respectively to 0.15mmHg and 86ml/min (Figs. 6.6a and b). In con-
trast, the PV tree displayed no pressure pulse at the inlet but a small pulse
with an amplitude of 0.15 mmHg was developed towards the sinusoids (Fig.
6.6c). e outow from the sinusoids to the HV and VCI again demon-
strated a small drop in pressure amplitude from 0.15 mmHg to 0.10 mmHg
(Fig. 6.6e). Pulsatile components of the PV and HV ow barely showed a
change through the generations (Figs. 6.6d and f).
6.3.2.2 Pressure and ow: HMP simulations
Resulting pressure proles throughout the liver in HMP conditions with
physiological and low pressures are depicted in Figs. 6.5b and c, respectively,
andwere qualitatively very similar to natural blood ow (Fig. 6.5a).e only
pressure dierence between natural blood ow andHMPwith physiological
conditions were the slightly lower HV tree pressures caused by the zero out-
ow resistance inHMP conditions. HMPwith low pressures, however, leads
to overall lower pressures. Considering the ows (Fig. 6.5d), HMP with
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Figure 6.4: Comparison of hepatic arterial (HA) radii (a) and portal venous (PV) radii (b)
between liver cast 1 and 2 in function of generation numbers. Both graphs show similar HA
and PV radii for the two liver casts.e trend lines and accompanying equations tted on the
radii of liver cast 1 are also depicted and illustrate the exponential proles. As the HA tree of
liver cast 2 was only half cast, the radius of the rst HA generation could not be determined.
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Table 6.2: Anatomical data of the hepatic arterial (HA) tree.
Generation Number Radius Length
of vessels [mm] [mm]
HA 1 1.0 3.5 10
HA 2 2.0 2.9 74
Measured HA 3 7.0 1.8 40
generations HA 4 36 1.1 31
HA 5 1.2 ⋅ 102 8.3 ⋅ 10−1 25
HA 6 2.7 ⋅ 102 5.9 ⋅ 10−1 16
HA 7 2.9 ⋅ 102 4.0 ⋅ 10−1 56
HA 8 8.0 ⋅ 102 2.7 ⋅ 10−1 39
HA 9 2.2 ⋅ 103 1.9 ⋅ 10−1 27
HA 10 5.9 ⋅ 103 1.3 ⋅ 10−1 19
HA 11 1.6 ⋅ 104 9.0 ⋅ 10−2 13
Extrapolated HA 12 4.4 ⋅ 104 6.2 ⋅ 10−2 9.4
generations HA 13 1.2 ⋅ 105 4.2 ⋅ 10−2 6.5
HA 14 3.2 ⋅ 105 2.9 ⋅ 10−2 4.6
HA 15 8.8 ⋅ 105 2.0 ⋅ 10−2 3.2
HA 16 2.4 ⋅ 106 1.4 ⋅ 10−2 2.2
HA 17 6.5 ⋅ 106 9.6 ⋅ 10−3 1.6
HA 18 1.8 ⋅ 107 6.6 ⋅ 10−3 1.1
physiological pressures resulted in a lowerHA, a higher PV and a higherHV
ow compared to natural blood ow, while HMP with low pressures over-
all resulted in much lower ows. ese ows corresponded to estimated
sinusoidal shear stress values of 1.04 Pa and 0.26 Pa in case of HMP with
physiological and low pressures, respectively, compared to 0.77 Pa in case of
natural blood ow.
Data obtained with variations of the PV inlet pressure are depicted in
Fig. 6.7a-c. Increasing the PV pressure resulted in a manifest increase of the
PV ow and a slightly decreasingHAow, depicting a trade-o betweenHA
and PV ows (Figs. 6.7a and b). HV ows, equaling the sum of the HA and
PV ows, also increased (Fig. 6.7c). Rising PV pressures corresponded with
higher sinusoidal pressures and wall shear stresses (Fig. 6.7d).ese results
were calculated using a uid viscosity of 3.5 mPa⋅s, but the same results were
obtained for all viscosity values as the higher viscosity was counteracted by
a decrease in ow.
6.4 Discussion
In this study, an electrical model of the human liver blood circulation was
built based on detailed anatomical data of the human liver vasculature. To
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Table 6.3: Anatomical data of the portal venous (PV) tree.
Generation Number Radius Length
of vessels [mm] [mm]
PV 1 1.0 7.3 35
PV 2 2.0 6.3 35
Measured PV 3 7.0 4.0 33
generations PV 4 27 2.1 32
PV 5 80 1.5 27
PV 6 2.2 ⋅ 102 1.1 16
PV 7 7.0 ⋅ 102 6.8 ⋅ 10−1 22
PV 8 2.1 ⋅ 103 4.5 ⋅ 10−1 15
PV 9 6.6 ⋅ 103 3.0 ⋅ 10−1 11
PV 10 2.0 ⋅ 104 2.0 ⋅ 10−1 7.5
Extrapolated PV 11 6.2 ⋅ 104 1.3 ⋅ 10−1 5.2
generations PV 12 1.9 ⋅ 105 8.5 ⋅ 10−2 3.7
PV 13 5.9 ⋅ 105 5.6 ⋅ 10−2 2.6
PV 14 1.8 ⋅ 106 3.7 ⋅ 10−2 1.8
PV 15 5.5 ⋅ 106 2.4 ⋅ 10−2 1.3
PV 16 1.7 ⋅ 107 1.6 ⋅ 10−2 8.8 ⋅ 10−1
Table 6.4: Anatomical data of the hepatic venous (HV) tree.
Generation Number Radius Length
of vessels [mm] [mm]
HV 1 1.0 13 68
HV 2 3.0 5.0 74
Measured HV 3 18 2.4 33
generations HV 4 33 1.7 28
HV 5 76 1.1 19
HV 6 5.4 ⋅ 103 5.2 ⋅ 10−1 8.1
HV 7 2.6 ⋅ 104 2.9 ⋅ 10−1 4.9
HV 8 1.3 ⋅ 105 1.6 ⋅ 10−1 3.0
HV 9 6.3 ⋅ 105 8.6 ⋅ 10−2 1.8
Extrapolated HV 10 3.1 ⋅ 106 4.8 ⋅ 10−2 1.1
generations HV 11 1.5 ⋅ 107 2.6 ⋅ 10−2 6.6 ⋅ 10−1
HV 12 7.4 ⋅ 107 1.4 ⋅ 10−2 4.0 ⋅ 10−1
HV 13 3.7 ⋅ 108 7.9 ⋅ 10−3 2.4 ⋅ 10−1
HV 14 1.8 ⋅ 109 4.3 ⋅ 10−3 1.5 ⋅ 10−1
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Figure 6.5: Mean pressure proles before and aer each blood vessel generation of the he-
patic arterial (HA), portal venous (PV) and hepatic venous (HV) trees of liver cast 1 obtained
from the electrical model for natural human liver blood ow (a), hypothermic machine per-
fusion (HMP) with physiological pressures (PHA = 100 mmHg and PPV = 10 mmHg) (b)
andHMPwith low pressures (PHA = 25mmHg and PPV = 2.5mmHg) (c). In the subsequent
HA and PV generations, pressures decreased with the highest pressure drop before the si-
nusoids. Pressure proles are qualitatively very similar, but absolute values are signicant
lower for HMPwith low inlet pressures. Mean HA, PV and HV ows are depicted in (d) and
clearly demonstrate that the HV ow is equal to the sum of the HA and PV ow. HMP with
physiological pressures results in ow competition illustrated by a lower HA and a higher PV
ow compared to natural blood ow. HMP with low pressures results in much lower ow in
contrast to the other conditions.
the best of our knowledge, these human vascular data are unique.emodel
was used to generate pressure and ow distributions throughout the liver as
a function of vessel generation, and was subsequently used to assess the hae-
modynamic impact of HMP perfusion. It was shown that the model could
be tuned to simulate natural human hepatic blood ow, and that the results
were in accordance with physiological literature values [169, 309]. Next, the
model was applied to simulate liver HMP, resulting in more insight into the
internal haemodynamic impact of HMP on human livers.
By extracting anatomical data from the digital 3D reconstructions of the
vascular corrosion casts, it was possible to measure and classify the rst 5 to
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Figure 6.6: Time-dependent ow parameters calculated by the electrical liver model for nat-
ural human liver blood ow: sinusoidal pressures (a, c, e) and ows (b, d, f) of each blood
vessel generation of the hepatic arterial (HA), portal venous (PV) and hepatic venous (HV)
trees.eHApressure andow amplitudes clearly decreasewith increasing generation num-
bers. Pressures in the PV tree were almost steady, except for a small pressure pulse develop-
ing towards the sinusoids. e HV tree demonstrated a small drop in pressure amplitude,
whereas PV andHVows showed almost no change inmean aswell as pulsatile components.
6 generations of human liver vascular trees (see also the macrocirculation
in chapter 5). Due to incomplete lling of one of the casts, complete data
could only be obtained from one cast. Nevertheless, when comparing the
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Figure 6.7: Results of the hypothermic machine perfusion (HMP) simulations investigated
at several portal venous (PV) inlet pressures and uid viscosities. Increasing the mean PV
inlet pressure from 1 to 7 mmHg resulted in an increasing PV ow and a decreasing he-
patic arterial (HA) ow, depicting the ow competition between HA and PV ows (a and b).
Hepatic venous (HV) ows also increased (c). Increasing the viscosity (µ) lowered all liver
ows. Variations of the PV inlet pressure also inuenced the haemodynamic behaviour at
the sinusoids (d). Rising PV pressures resulted for all viscosity values in higher sinusoidal
pressures and wall shear stresses. To compare with natural liver ow in the body, a hori-
zontal line is drawn at 0.77 Pa, referring to the sinusoidal shear stress level in natural blood
ow (constant PV pressure of PPV = 10 mmHg).
data from both liver casts wherever possible (PV and half of the HA tree), a
reasonable resemblance was observed (Fig. 6.4). However, as the electrical
model was based on data from a single liver cast, it is safe to consider these
data as the basis of amodel for that specic liver, rather than a genericmodel
of human liver vasculature. Ideally, the complete cast should be scanned at
a sucient resolution to allow visualisation of the liver vasculature from the
level of the large vessels down to the sinusoids, requiring a resolution of a few
micrometers. It is, however, practically impossible to scan objects of the size
of the human liver at this resolution due to computational limits (scanning
an entire liver at 5 µmresolutionwould result inmore than 7000Gb of data).
In addition, currently available soware is unable to handle datasets of that
magnitude. As such, data beyond the sixth generation used for the electrical
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analogue were estimated based on extrapolations. For the complete cast, the
evolution of vessel radii and lengths with the generation numbers is fairly
well described by exponential trend lines. ese trend lines allow estima-
tions of parameters concerning the further generations, of which data could
not be measured, to complete the electrical model. As a result, we obtained
18 HA, 16 PV and 14 HV generations. Knowing that ducts of the biliary tree
run parallel with those of the HA and PV tree, our estimations are very sim-
ilar to a previous study, which stated that there are 18 vessel generations in
the biliary tree [272].e direct extrapolations of the trend lines tted on our
geometrical measurements resulted in unphysiological pressures and ows,
probably due to small measurement errors and thus slightly deviating expo-
nential trend lines (or because the actual relation is not a true exponential).
e problem was solved by adjusting the trend lines for the lengths and the
number of vessels of the HA and HV tree. We feel this to be justied as the
mean length and the number of vessels of the last measurable generation are
probably underestimated because of the resolution and segmentation limits
that are occurring at that level.is can be illustrated by the original extra-
polation of the HV number of vessels trend line resulting in 2⋅106 sinusoids,
while a larger value of ±1.9 ⋅ 109 sinusoids is stated in literature [482]. Aer
the modication, the nal model results in 1.8 ⋅ 109 sinusoids. Trend lines
for length showed lower R2 values than the other trend lines, indicating a
higher inaccuracy for these relations. We stress that we preserved the ori-
ginal tted radii trend lines, so that the most determining and best meas-
urable parameter to calculate the electrical components was not adjusted.
To complete the model, simplications were made regarding the structure
of the liver microcirculation. We assumed that HA and PV vessels branch
until they reach the eighteenth and sixteenth generation, respectively. Sub-
sequently, blood is mixed at the sinusoids and drained via collecting HV.
ereby, sinusoids are modelled as a number of parallel vessels. Although
liver microvasculature in reality is more complex due to a specic organisa-
tion of arterioles, venules and sinusoids in functional units, it is probably less
important to incorporate this in our lumped parameter model, which repre-
sents a simplication of real liver blood ow. However, these assumptions
possibly have an inuence on the calculated wall shear stress at the level of
the sinusoids. e hepatic microvascular structures would thus be of more
concern in detailedmicrovascular owmodels. Future research will include
scans on higher resolutions to verify whether our estimated data based on
adjusted extrapolations are in accordance with measurements on these scan
datasets. Additionally, we also aim to develop a numerical model of the hu-
man liver microow based on these detailed scan data (see chapter 9). Pre-
viously, Rani et al. [393] built a numerical model of the microcirculation in
a single hepatic lobule, but this model was based on a simplied representa-
tion of a portal triad leading to two sinusoids draining into a central vein.
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In addition to the considerations mentioned above, other issues should
be taken into account when interpreting the data. First, the organs are recu-
perated from human donors discarded for transplantation. is, however,
was based on strict medical criteria: liver 1 was discarded because of ste-
atosis, and liver 2 because of a lung tumour in the donor body. Although dis-
carded, the organs did not show signicant dierences in comparison with
the anatomical vasculature of healthy subjects. A more complicated ques-
tion arises from the procedure that was followed starting at the moment of
harvesting the liver until the casting procedure was done, and more speci-
cally howHMP and the casting proceduremight have aected themeasured
vascular diameters. e livers were placed on HMP, which has the advan-
tage that the microvasculature is kept open and intact, but the disadvantage
is that high shear stresses may originate, caused by the hypothermic more
viscous perfusion uids that dier from natural blood, damaging the sinus-
oidal endothelial cells. Still, our simulation data seem to suggest that, with
the appliedHMP settings including low pressures (Fig. 6.5c), sinusoidal wall
shear stress was probably not higher during HMP (± 0.26 Pa) than during
normal perfusion in the body (± 0.77 Pa). However, when HMP would be
executed using physiological pressures (Fig. 6.5b), the shear stress would be
larger (± 1.04 Pa), probably resulting in organ damage. is is exactly why
lower pressures are applied in HMP conditions. Following HMP, the casting
procedurewas done bymanual injection, which does not provide an optimal
control of the applied pressures. For instance, pressures may be elevated
due to an obstruction, which could be the case for the incomplete casting
of liver 2, with a risk of disrupting the internal vasculature. It has also been
described that casting leads to slight vasoconstriction and shrinkage of the
hardening Batson’s, which implicates slightly smaller vessel diameters than
in vivo [203, 260]. Nevertheless, the casting procedure was executed follow-
ing standardised procedures and by a teamwithmany years of expertise and
knowledge in this eld. As such, we are condent that the obtained casts re-
present the best possible achievable results using this technique.
Vascular pressure and ow parameters at the level of each liver gener-
ation could be calculated by the electrical model and were in accordance
with physiological values for liver blood ow [169, 311]. Qualitatively, pres-
sure proles for all investigated conditions (Fig. 6.5a, b, and c) showed de-
creasing values starting at the HA and PV inlets with the highest pressure
drop taking place proximal to the sinusoids between generations 7-18, and
not over the sinusoids themselves. Distal to the sinusoids, only very slight
pressure drops appeared through the HV tree until reaching the VCI. As ex-
pected, HV ow was equal to the sum of the HA and PV ow (Fig. 6.5d),
and mean ow obviously remained constant over the generations of a spe-
cic vascular tree. A similar electrical model has previously been applied
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to dog livers [482], but, to the authors’ knowledge, this is the rst time that
an extended electrical model has been applied to blood ow in the total hu-
man liver. e dog liver model of van der Plaats et al. [482] was based on
partially measured and estimated anatomical data collected by Mall [305].
Quantitatively, results of the dog and human liver model are dierent. For
example, the dog liver described by Mall [305], only counts 8 HA, 7 PV and
8 HV generations [482]. Next, absolute ow values in the dog (e.g. QHV =
540 ml/min) are clearly lower than adult human values (e.g. QHV = 1500
ml/min). In contrast, pressure and ow proles qualitatively correspond to
each other. Both canine and human models give evidence of a similar de-
velopment of pressure drops from HA and PV trees through the sinusoidal
level down to the HV.
As well as to simulate blood ow in the natural liver, the model can also
be used to simulate HMP. Assuming that the internal structure of the organ
does not change, simulating HMP implies using a dierent set of boundary
conditions and changing the uid viscosity from blood to a perfusion uid.
In the context of the unknown optimal perfusion settings for liver HMP,
this model may be useful to determine these settings without e.g. using an-
imal experiments.e model enables calculation of the inuence of various
parameters on relevant outcomes such as the sinusoidal wall shear stress
(Fig. 6.7). Varying the viscosity of the perfusion liquid from 2 to 12 mPa⋅s
lowered the liver ows (as a consequence of the induction of higher vascular
resistances), but did not inuence the calculated pressure and shear stress at
the level of the sinusoids. is is due to the pressure-driven HMP simula-
tions, in which ows are adapted to obtain a certain imposed pressure [479].
It is expected that inuences of uid viscosity would be more pronounced
when applying a ow-drivenmodel, referring to the use of ow-drivenHMP
pumps, in which a specic ow is forced to enter the liver regardless of the
pressure this implies. Such a ow-driven model would be obtained by sub-
stituting the voltage sources by current sources.is, however, suggests that
pressure-driven HMP is the best mode of operation to avoid organ damage.
Ex vivo, ow competition has been observed and monitored between HA
and PV vascular trees during porcine liver HMP in a previous study [191].
We were able to mimic this phenomenon by comparing HA and PV ows
of HMP under physiological pressures with natural blood ow (Fig. 6.5d).
Additionally, ow competition could be provoked by changing the PV inlet
pressures (Fig. 6.7). Elevating this pressure increased the ow through the
corresponding PV vascular tree, but decreased the ow through the HA in-
let tree slightly. Increasing the HA pressure, would inversely imply higher
HA and lower PV ows, as well as a higher HV ow, sinusoidal pressure and
wall shear stress. is ow competition is an important parameter inu-
encing perfusion stability and homogeneity inside donor livers (see section
3.3.3).
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Despite the fact that the model generates physiological data, it should
be kept in mind that a lumped parameter model remains a drastic simpli-
cation of the complex anatomical reality. However, we feel that its use is
justied for our current purpose, where we are mainly interested in relative
dierences (natural liver versus HMP) in overall haemodynamic parame-
ters. Anyhow, future model renements are advisable. First, more livers
should be cast and investigated in order to provide a more generic dataset of
the human liver. On the other hand, human livers are scarce and their availa-
bility depends on themoment that organs of a potential donor are discarded
and permission is given to apply these organs for research purposes. Also,
given the labour-intensity of the complete casting and data-acquisition pro-
cedure, it is expected that the nal dataset on which a more generic model is
to be based will still be fairly limited. Additionally, more exact data should
be obtained on the higher order generations down to the sinusoids. ese
data can be obtained via dissections of small cast fragments and scanning
them at higher resolutions (as was done for the meso- and microcircula-
tion in chapters 5 and 9). Microvascular data could then be measured, and
compared with the estimations of extrapolated data. Nevertheless, an im-
portant aspect will be the connectivity of the datasets and how to map this
high-resolution scans of small samples onto the low-resolution scan of the
complete liver. Next to renements, future research should also address val-
idation of the models. Ex vivoHMP experiments using isolated livers, com-
bined with real time pressure and ow measurements (from which the im-
pedance of the organ can be derived), would oer a good basis to test the
corresponding results obtained via the electrical analogue (see chapter 7).
A feasibility experiment using a porcine liver on HMP demonstrated good
qualitative resemblance with our simulations when comparing input impe-
dances of the experimentwith those obtained using the electricalmodel (un-
published results). Moreover, the simulated results of the electrical model
are in good qualitative agreement with the pressure measurements done in
rabbit livers by Maass-Moreno et al. [295]. In addition, computational uid
dynamics (CFD) models could be applied for the rst generations as well as
to derive a microvascular model, in which ow parameters are calculated
and visualised based on the original 3D geometries.eir results could sub-
sequently be compared with results of the electrical model. is would in
particular allow to assess to what extent the simple estimates of wall shear
stress correspond to the actual values.
6.5 Conclusion
e combination of casting and high-resolution micro-CT scanning with
image processing provides unique data on the human hepatic circulation.
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is allows digital visualisation of the complex liver vasculature and the col-
lection of high-resolution data for quantitative morphological analysis.e
established electrical analog model of the human liver can predict ow pa-
rameters throughout the liver vasculature in accordance with physiological
data. e model can be applied not only to natural blood ow, but also to
HMP, simulations of certain pathologies and living donor liver transplanta-
tion, in which only a part of a living donor liver is removed to implant in a
patient. In the case of HMP with low pressures, the model predicts lower si-
nusoidal shear stresses than in the case of natural blood ow, and hence no
shear-related damage. However, there may be other factors that inuence
the impact on organ damage, e.g. transient eects when starting HMP or
non-biomechanical parameters, such as biochemical inuences evoked by
using synthetic perfusion uids instead of blood. Future research should fo-
cus on renements of the model as well as on validation of the electrical
model with ex vivo HMP experiments and numerical CFD models. Al-
though further research and renements are necessary, the rst results seem
to be promising.
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Validation and tuning of an
electrical analogmodel of hepatic
perfusion based on human liver
HMP experiments
is chapter is based on: “Validation and calibration of an electrical analog
model of hepatic perfusion based on human liver hypothermic machine perfu-
sion experiments”, submitted for publication [94].
7.1 Introduction
In previous work (chapter 6), we developed an electrical analog model to
gain more insight into the human hepatic perfusion, in particular during
machine perfusion (MP).e electrical components of the model were cal-
culated by using the geometrical vascular features as acquired in chapter 5
and the equations derived by de Pater [91] and van der Plaats [482]. Due
to a number of unknown parameters (e.g. cp values), however, some as-
sumptions had to be made to fully dene the model (section 6.2.2.2). At
this point, it is unclear to which extent these assumptions are acceptable
due to a lack of data to validate the model. Furthermore, the model was de-
rived on data from a single liver. To tackle these limitations, additional data
on human liver perfusion are required to test the model-predicted results
against experimental measurements. erefore, the aim of this study was
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to (i) capture anatomical and functional data of human livers during hypo-
thermic MP (HMP) experiments, (ii) to develop and test a procedure to t
the electrical model parameters to a specic liver, and (iii) to validate and
possibly netune the electrical model by comparing model predictions to
experimental data. To achieve (ii) and (iii), we rst tted compactWindkes-
sel (WK) models, containing only a few parameters, to the measurements,
aer which these lumped properties were ‘smeared out’ in a liver-specic
extended electrical model.
7.2 Materials and methods
is study was conducted on two human livers, labelled HL2 and HL3 (dif-
ferent from the liver used in chapters 5 and 6 labelled HL1; see also Table
7.1), discarded for transplantation aer failed reallocation, as approved by
the Ethical Committee of the University Hospitals Leuven, Belgium, and by
the Belgian Liver and Intestine Committee as foreseen by the initial pro-
tocol. e procedure to obtain experimental perfusion data and tune the
electrical model consisted of several steps, as illustrated in the owchart of
Fig. 7.1. First, the livers were used for HMP experiments, aer which their
vasculature was cast and imaged. Data analysis of theHMP experiments and
geometrical vascular features enabled generating compact WK models and
further tuning an extended liver-specic electrical analog model.
Table 7.1: Characteristics of the human livers (HL). Dimensions were obtained during image
processing (see also Fig. 7.6a).e weight of HL2 and HL3 was estimated as 2.5% of the body
weight (see section 1.1.1.1). Additionally, it is illustrated which livers underwent hypothermic
machine perfusion (HMP) experiments, casting and segmentation. (*) Since the bodyweight
was unavailable for HL1, its weight was approximated as the volume of its image-based 3D
envelope multiplied by the density of water.
Human liver HL1 HL2 HL3
Width [cm] 26 23 19
Height [cm] 20 19 14
Depth [cm] 6 8 5
Weight [kg] 1.9 * 2.1 1.2
HMP experiment (unavailable) x x
Casting x x x
Segmentation x x (unavailable)
7.2.1 HMP experiments
e goal of these experiments was to acquire simultaneous pressure and ow
measurements at the inlet and outlet blood vessels of human livers during
HMP (Fig. 7.2).
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Human liver discarded 
   for transplantation
HMP experiment
Input impedances
    
Vascular corrosion casting 
Geometrical analysis 
    of vascular trees 
Signal processing
  Fitting Windkessel 
              models
Initial electrical model
 Tune electrical model
     to measurements
         Data analysis of 
HMP experimental data
        Geometrical data 
acquisition and analysis
Micro-CT scanning
Figure 7.1: Methodological approach to obtain and to tune an extended liver-specic elec-
trical model based on hypothermic machine perfusion (HMP) experiments and geometrical
vascular analysis.
7.2.1.1 Liver benching
Aer an initial ush, the isolated livers were prepared for HMP by cannula-
tion of theHA and PVwith atraumatic straight-in cannulas (Fig. 7.2 and 7.3),
while a larger cannula was positioned in the suprahepatic vena cava inferior
(VCI). Two balloon catheters were retrogradely inserted into the hepatic ve-
nous (HV) system (Fig. 7.3).e infrahepatic VCI was closed by a watertight
suture. Subsequently, the liver was placed in the organ cassette of the Life-
PortWorkstation (Organ Recovery Systems, Zaventem, Belgium), being the
HMP device that was used in this study (see section 3.3.2.8 for more detailed
information on this prototype).
7.2.1.2 Experimental setup
While cannulating the gra, the HMP device and data acquisition (DAQ)
equipment were prepared. e tub and organ cassette of the HMP device
were lled with ice water and 2 litres of KPS-1 perfusion solution, respec-
tively. An oxygenator (Minimax Plus Oxygenator; Medtronic, Minnesota,
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Figure 7.2: Schematic overview of the experimental hypothermicmachine perfusion (HMP)
setup. Two roller pumps provide the inow into the hepatic artery (HA) and portal vein
(PV) via the tubing and cannulas. Aer leaving the liver, the perfusion uid is recirculated.
roughout HMP experiments, pressures and ows are measured at the HA and PV inows
and the hepatic venous (HV) outow.
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  liver 2
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Figure 7.3: Experimental hypothermic machine perfusion (HMP) setup of human liver 2
(HL2) with indications of the measurement equipment and the hepatic in- and outows.
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USA) was included in the perfusion circuit to provide oxygenation of the
perfusate (PO2 of 150-300 mmHg) before entering the roller pumps (Fig.
7.2). Silicon tubes were used to connect the roller pumps to the HA and
PV inlet cannulas (Fig. 7.3). A short tube was attached to the VCI cannula
to guide the free uid outow into the organ cassette in order to be recircu-
lated.ree pressure transducers (BD, New Jersey, USA) were connected to
the tubing via three-way valves to perform pressure measurements as close
as possible to the HA and PV inlet and the VCI outlet (Fig. 7.2 and 7.3). In
addition, two pressure transducers were connected to the balloon catheters
(inserted in the HV vessels; Fig. 7.3).e latter was done to estimate sinus-
oidal pressures, as the pressure dierence between the sinusoids andHV sys-
tem is known to be small. Before starting any measurements, the pressure
transducers were zeroed to the ambient air pressure. Flow measurements
were performed by using Transonic ow meters (T206 and HT109; Tran-
sonic Systems Inc., New York, USA) together with their corresponding ow
probes. Tubing ow probes with a diameter of 5 mm, 5 mm and 9.5 mm
were attached to the tubing of the HA, PV and VCI, respectively, as close
as possible to the pressure transducers to minimise potential pressure-ow
signal delays (Fig. 7.3). Both pressure transducers and owmeters were con-
nected to an SC-2345 DAQ system (National Instruments Corporation (NI),
Texas, USA) to simultaneously record all signals at a frequency of 200Hz. A
DAQ Card 6062E (NI) enabled reading all signals into a laptop using Lab-
view soware (NI).roughout the HMP experiment, the temperature of
the perfusate was measured by a thermometer (Ebro, Ingolstadt, Germany).
7.2.1.3 HMP measurement protocol
Perfusion settings of the HMP device were varied to investigate the liver’s
response. For every perfusion condition, stable perfusion was awaited (un-
less specied dierently) and measurements were recorded for at least ve
minutes. Pressure-controlled pulsatile perfusion without a ow limit was
used for the HA, while pressure-controlled continuous perfusion with an
optional ow limit was used for the PV.e initial perfusion settings were a
maximumHAperfusion pressure (PHA,set) of 25mmHg and amaximumPV
pressure (PPV ,set) of 5 mmHg (lowest achievable pump pressure; see section
3.3.2.8) with an additional PV ow limit of ± 300 ml/min. Subsequently,
these settings were repeated while varying certain perfusion parameters,
such as increasing the PHA,set (to 35, 45, 55, 65, 85 and 99 mmHg), turning
o the PV ow limit and increasing the PPV ,set (to 7 and 9mmHg). Further-
more, transient behaviour measurements were done to study the eect of
starting and stopping perfusion, squeezing the HA, PV or VCI tubing, and
perfusing only the HA or PV side.
139
7. Validation and calibration of an electrical analog model of
hepatic perfusion based on human liverHMP experiments
7.2.2 Data analysis
Aer the HMP experiments, pressure and ow signals were processed to
calculate the corresponding input impedances and tune compact Windkes-
sel models to capture the hepatic perfusion behaviour. Data analysis was
performed using Matlab (MathWorks, Massachusetts, USA).
7.2.2.1 Signal processing
Before analysing the acquired data, measured pressures and ow signals
were calibrated and ltered. Flow measurements were calibrated by com-
paring the raw ow signals (voltage [V]) to volumetric ow values [m3/s],
acquired by physically collecting the perfusate volume per unit of time. For
each ow signal (HA, PV and VCI), a linear t was performed to all meas-
urement points and allowed converting the raw signals [V] to calibrated ow
signals [m3/s]. Pressure signals were corrected for pressure losses between
the blood vessel in-/outlet (HA, PV or VCI) and its pressure transducer ac-
cording to Poiseuille’s law (eq. 3.2) with a perfusate viscosity according to eq.
7.1 with T [°C] the perfusate temperature (based on previous viscosity meas-
urements of KPS-1; data not shown). Aer calibration, pressure and ow
signals were ltered to remove unwanted high frequency noise by a low pass
third order Butterworth lter with a cut-o frequency of 15 Hz.
µKPS−1 = −1.19 ⋅ 10−4T + 5.51 ⋅ 10−3 (7.1)
7.2.2.2 Input impedances
Aer signal processing, HA and PV hydraulic input impedances were cal-
culated to capture the hepatic perfusion behaviour. Hydraulic impedances
are the hydraulic equivalent of electrical impedances and reect the relation
between pressure and ow as a function of frequency. Basically, the impe-
dance of a system is, for every frequency (f [Hz]), represented by a complex
number (Z [mmHg⋅min/ml] with a the real part and b the imaginary part)
characterised by its modulus ∣Z∣ [mmHg⋅min/ml] and phase angle ϕ [°] (eq.
7.2-7.4 with j the imaginary unit).
Z = a + b j = ∣Z∣e jϕ (7.2)∣Z∣ = √a2 + b2 (7.3)
ϕ = atan (b
a
) (7.4)
In order to calculate HA and PV input impedances, pressure and ow
signals were converted from the time domain to the frequency domain by
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means of the discrete Fourier transformation (DFT; eq. 7.5 with x an N
points discrete time signal, X the DFT of x, l and k the indices of the time
and frequency vector, respectively).is transformation represents a math-
ematical technique to rewrite (noisy) time signals as a sum of single fre-
quency sinusoidal waves, which facilitates studying signal properties. e
fast Fourier transform algorithm was used, and pressure and ow DFT cal-
culations were based on a moving window method, implying that the re-
sulting DFT was the average DFT of a series of time windows (30 s) with a
50% time overlap. Subsequently, HA and PV hydraulic impedances Z were
calculated by dividing their pressure DFT (PDFT) by their ow DFT (QDFT)
(eq. 7.6).
X(k) = N−1∑
l=0 x(l)e− j2pi l kN with k = 0, 1, ...,N − 1 (7.5)
Z = PDFT
QDFT
(7.6)
In the next step, the magnitude-squared coherences between pressure
and ow signals were calculated for both theHA and PV (eq. 7.7 withCxy the
coherence, Gxy the cross-spectral density between signals x and y, Gxx and
Gyy the autospectral densities of x and y, respectively). is allows quan-
tifying how well pressure and ow signals correspond to each other at each
frequency, and to estimate the reliability of the corresponding Z spectra. Co-
herence values range between 0 (signals are not related) and 1 (signals are
perfectly related). As noise is inherent to experimental measurements, noise
may negatively aect the coherence values.
Cxy = ∣Gxy ∣2GxxGyy (7.7)
7.2.2.3 Windkessel model tting
Since it is not straightforward to directly tune an extended electrical model
to MP-acquired data (due to a limited amount and non-homogeneous dis-
tribution of coherent points), the idea was to rst determine the global pa-
rameters describing the hepatic perfusion behaviour by usingmore compact
lumped parameter models (Windkessel models; WK). Subsequently, these
WKmodels were used to ‘smear out’ the global properties over the extended
electrical model. WK models are oen used to model the haemodynamic
properties of vascular systems (e.g. the arterial system) in a simplied way
[39, 208, 264, 332, 372, 422, 428, 451, 471, 473, 491]. Ideally, the conguration
141
7. Validation and calibration of an electrical analog model of
hepatic perfusion based on human liverHMP experiments
of the reduced model would equal the conguration of the previously de-
veloped extended electrical livermodel in analogywith the ndings of de Pa-
ter [91] and van der Plaats [482] (sections 4.2.2.1.2 and 6.2.2).erefore, a pi-
elementWKmodel (WKpi)was studied (Fig. 7.4; including a distal resistance
Rd , an inductor L, a capacitor C and Rp representing the visco-elasticitity of
the blood vessel walls). In addition, the performance of two other frequently
used four-element WK models was studied with Rc (the characteristic im-
pedance) and L either in series (WK4s) or in parallel (WK4p). Although
three-element WK models (WK4s without L component) also have been
used frequently in the past, we found that they are insucient to describe
the dynamic behaviour of the liver and are therefore not included in this
study.
C      Rd
Rc
LC      Rd
Rc L
Rd
L
C
Rp
C
Rp
         R   and L in series (WK4s)c       R   and L in parallel (WK4p)
(a) π-element Windkessel
                     (WKπ) c
(b) 4-element Windkessel with (c) 4-element Windkessel with
Z’
Figure 7.4: Overview of the Windkessel (WK) models that were tuned to the input impe-
dances: a pi-element model (a) and two four-element WK models with Rc and L either in
series (b) or in parallel (c).
WKmodels were tted for both theHA and PV byminimising themod-
ulus dierence between the WK impedances (ZWK ; eq. 7.8-7.11 with Z′ as
indicated in Fig. 7.4a) and the experimentally acquired impedances (Z).
ZWK4pi = 1 + Z′ + j2pi f RpCZ′ + j2pi f RpCZ′ (7.8)
with Z′ = j2pi f L + 1 + Rd + j2pi f RpC
Rd + j2pi f RpCRd (7.9)
ZWK4s =Rc + j2pi f L + Rd1 + j2piRdC (7.10)
ZWK4p = j2pi f RcLRc + j2pi f L + Rd1 + j2pi f RdC (7.11)
e tuning approach did not incorporate minimising the dierence be-
tween phase angles, as this seemed to result in good tting to the phase
angles but not themoduli, or vice versa. Also, phase anglesmay be unreliable
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to t to as they are potentially aected by time delays resulting from pres-
sure and corresponding ow measurements which could not be measured
at the exact same location due to practical restrictions. Furthermore, only
coherent impedance points (coherence ≥ 0.9) were taken into account and
a weighting factor (w) was introduced to correct for the non-homogeneous
distribution of coherent points along the frequency spectrum (see for ex-
ample Fig. 7.11): the larger the frequency dierence of a coherent point to
its neighbouring coherent points, the higher its weight (eq. 7.12 with f [Hz]
the frequency and k the index of the frequency vector of coherent points).
(e non-homogeneous distribution of highly coherent points was also the
reason why simply using coherence values as weighting factors was not suf-
cient.)
wk = ( fk − fk−1) + ( fk+1 − fk) = fk+1 − fk−1 (7.12)
e weighting factor of the 0 Hz impedance was set to a very high value
tomake sure that the 0Hz impedancemodulus (vascular resistance) was t-
ted correctly.e resulting cost function (eq. 7.13) was minimised by means
of unconstrained nonlinear optimisation using the fminsearch function in
Matlab.
costWK =∑w ⋅ (∣ZWK ∣ − ∣Z∣)2 (7.13)
7.2.3 Fitting of the extended liver-specic electrical analog model
is section explains how a liver-specic electrical analog model can be de-
veloped and tuned to HMP experimental data.
7.2.3.1 Geometrical data acquisition
Similar to the methods described in sections 5.2 and 6.2 for HL1, vascular
corrosion casting and micro-CT imaging of the global human liver gras
(HL2 and HL3) were performed (Fig. 7.5). Since the imaging results of HL3
were dicult to analyse due to a number of insuciently cast regions (prob-
ably due to air bubbles), only data from HL2 was further processed.
emicro-CT scan ofHL2 (resolution of 179 µm) enabled segmentation,
3D reconstructions (Fig. 7.6) and measurements of the vascular geometrical
features (radii, length and numbers of vessels) up to the 4th HA, PV and
HV generation (Fig. 7.7 and 7.8). Data estimations for higher generations
were based on the exponential trend lines resulting from the mesocircula-
tion measurements of HL1 (see chapter 5; Fig. 5.4 and 5.5). For all vascular
trees, the a coecient of each HL1 exponential trend line (eq. 5.1) was recal-
culated to match to the r, l or n value of the 4th generation of HL2. Doing
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(a)          (b)
Figure 7.5: Vascular corrosion casts of human livers HL2 (a) and HL3 (b).
so, data were extrapolated up to generation 10, 10 and 8 for the HA, PV and
HV tree, respectively (Fig. 7.7 and 7.8). Subsequently, new exponential trend
lines were tted to the combination of HL2measured data (up to generation
4) and estimated mesodata. Analogous to the methods of chapter 6 (section
6.2.2.2), these trend lines were used to extrapolate the geometrical features
up to the terminal HA, PV and HV level, and an additional HV generation
was added to represent the sinusoids.
(a)                (b)
(c)        
width = 23 cm
height = 19 cm
        (d)
Figure 7.6: 3D reconstructions of themacrocirculation of human liver 2 (HL2): (a) superpo-
sition of the three vascular trees with indications of the height and width; (b) hepatic arterial
(HA), (c) portal venous (PV) and (d) hepatic venous (HV) trees.
7.2.3.2 Initial extended electrical model of HL2
In addition to the geometrical features, cp values (pulse wave velocity) had
to be determined to dene the electrical components of the initial extended
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Figure 7.7: Results of the vascular tree analysis of human livers HL1 and HL2: radius (a-c)
and length (d-f) with their standard deviations as a function of the generation number for
the hepatic arterial (HA), portal venous (PV) and hepatic venous (HV) trees, respectively.
Macro- and mesocirculation measurements are indicated by black markers for HL1. Mac-
rocirculation measurements and mesocirculation estimations of HL2 are indicated by grey
andwhitemarkers, respectively. Exponential trend lines are depicted by full and dashed lines
when tted tomacro- andmesocirculation data of HL1 andHL2, respectively. Equations and
coecients of determination (R2) of the exponential functions are given.e rst HV gener-
ation (vena cava inferior; VCI) was not taken into account when tting the radius trend line,
since the VCI has a much larger diameter and is not really part of the hepatic vasculature.
Length trend lines did not incorporate the rst generation, since these vessels were cut to
resect the liver, resulting in an underestimated length.
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Figure 7.8: Results of the number of vessels per generation number of the macro- andmeso-
circulation for the hepatic arterial (HA), portal venous (PV) and hepatic venous (HV) trees
of HL1 and HL2. Macro- and mesocirculation measurements are indicated by black mark-
ers for HL1. Macrocirculation measurements and mesocirculation estimations of HL2 are
indicated by grey and white markers, respectively. Exponential trend lines are depicted by
full and dashed lines when tted to macro- and mesocirculation data of HL1 and HL2, re-
spectively. Equations and coecients of determination (R2) of the exponential functions are
given. Points between brackets indicate unreliable numbers of vessels, which were not used
for the extrapolations.
electrical model. Similar to the methods described in section 6.2, cp values
were determined by interpolation between a maximum and minimum cp
value depending on the radius.
Next, Rs values (representing vascular resistance) were tuned such that
the mean pressures and ows of the model match those measured during
the experiments. Similar to section 6.2, the desired total vascular resistances
were calculated for each vascular tree from themeasurements. Subsequently,
the exponential b coecients of the length trend lines were tuned to corres-
pond to literature values of terminal lengths, while the b coecients of the
number of vessels trend lines were adapted to yield the desired total vascular
resistances. With this approach, only the trend lines with the highest degree
of uncertainty are tuned (radii were not tuned), while the original data gen-
erated by measurements and meso-estimations were used where available.
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Hereupon, all electrical components of the initial electrical liver model were
calculated using eq. 6.1-6.4. HA and PV input impedances of the electrical
model were calculated based on the electrical circuit of Fig. 6.1 by summing
the impedances of all components (in series or parallel) up to the HA and
PV inlet, respectively.
7.2.3.3 Finetuning the extended electrical model of HL2
Aer tuning the Rs values, additional tuning of the other electrical com-
ponents (L, C and Rp) was required to match the input impedances of the
extended electrical model (ZEM) to those of the WK models (ZWK ; already
tuned to represent the global properties of the liver-specic perfusion beha-
viour as described in section 7.2.2.3). Using unconstrainednonlinear optimi-
sation (fminsearch function in Matlab), the optimal factors ( fLHA , fCHA and
fRp ,HA) were determined to multiply with the L, C and Rp values of the HA
blood vessel generations in order to t ∣ZEM ,HA∣ to ∣ZWK ,HA∣. Subsequently,
the optimal PV factors ( fLPV , fCPV and fRp ,PV ) were similarly determined.
e corresponding cost function that was minimised for both the HA and
PV when tuning the extended liver-specic electrical model, is shown in eq.
7.14.
costEM =∑ (∣ZEM ∣ − ∣ZWK ∣)2 (7.14)
7.2.4 Sensitivity analysis
Finally, a parameter study was conducted on the tuned electrical model in
order to investigate the sensitivity of the model to changes of its electrical
components (all Rs, L, C and Rp components were divided and multiplied
by 2).
Due to practical restrictions, pressure transducers and their correspond-
ing ow probes could not be mounted at the exact same locations. As this
may lead to time delays between pressure and ow signals, we investigated
the eect of inducing time delays of -20 ms to 20 ms.
7.3 Results
Results are mainly focused on HL2 due to the image processing restrictions
of HL3. e frequency domain of the reported impedances is restricted to
0-10 Hz as higher frequencies are physiologically of less importance.
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Figure 7.9: Hepatic arterial (HA) and portal venous (PV) pressure and ow measurements
of the hypothermicmachine perfusion (HMP) experiment on human liverHL2 for perfusion
settings with a PV pressure (PPV ,se t) of 5 mmHg, a PV ow limit of 300 ml/min and an HA
pressure (PHA,se t) of 25, 45, 65 mmHg, respectively. Panels a, c, e, g and b, d, f, h present
measurements during 300 s and during a shorter time window of 150-200 s as indicated by
the boxes in panels a, c, e, g (except for the PPV with a 2 s window to illustrate its inherent
8 Hz component). PV pressure (PPV ) and ow (QPV ) signals gave evidence of unstable ow
uctuations starting at time stamp 1 (± 20 s) and 2 (± 70 s) for measurements with a PHA,se t
of 45 and 65 mmHg, respectively (panels c and g).
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7.3.1 HMP experiments
7.3.1.1 Pressure and ow time signals
Pressure and ow signals are rst visualised as a function of time (Fig. 7.9
for HL2). Time-averaged pressure, ow and vascular resistances (Z(0 Hz))
of HL2 and HL3 are shown in Table 7.2 for a subset of measurements. Pul-
satile PHA and QHA signals showed repetitive uctuations (± 1 Hz; Fig. 7.9
b and f). Due to MP protocol limitations, PPV and QPV were more con-
tinuous, but the roller pump did induce some pulsatility with a sinusoidal
component of ± 8 Hz (Fig. 7.9 d). An increasing PHA,set resulted in an in-
creasing QHA, while the time-averaged PPV also seemed to increase (espe-
cially for a PHA,set of 65 mmHg) in order to maintain QPV approximately
constant (Fig. 7.9 and Table 7.2). PPV and QPV signals gave evidence of un-
stable ow uctuations starting at time stamp 1 (± 20 s) and 2 (± 70 s) for
measurements with a PHA,set of 45 and 65 mmHg, respectively (Fig. 7.9).
is instability may indicate the onset of ow competition (section 3.3.3).
Interestingly, measured PHA values did only sporadically reach PHA,set (Fig.
7.9; especially for a PHA,set of 25 and 45 mmHg), probably due to the HMP
feedback system using PHA measurements near the pump outlet, while we
measured PHA at the HA vessel inlet, imposing an additional pressure drop
between both measurement points. Z(0 Hz) was found consistently higher
in theHA compared to the PV. ZHA(0 Hz) clearly decreased with increasing
PHA values, while ZPV(0 Hz) tended to increase (especially for a PHA,set of
65 mmHg). HL3 showed consistently higher ZHA(0 Hz) values (more than
2.5-fold) than HL2, while its ZPV(0 Hz) values tended to be lower.
Table 7.2: Time-averaged pressure, ow and vascular resistance values of the hypothermic
machine perfusion (HMP) experiments on human livers HL2 andHL3 for perfusion settings
with a PV pressure (PPV ,se t) of 5 mmHg, a PV ow limit of 300 ml/min and an HA pressure
(PHA,se t) of 25, 45 and 65 mmHg, respectively.
PHA,set [mmHg] 25 45 65
Human liver HL2 HL3 HL2 HL3 HL2 HL3
PHA [mmHg] 19.7 19.5 33.0 38.2 60.5 54.1
PPV [mmHg] 4.69 3.07 4.54 3.38 5.35 4.36
QHA [ml/min] 27.8 8.86 105 48.3 303 100
QPV [ml/min] 236 249 233 257 228 270
ZHA(0Hz) [mmHg ⋅min/ml] 7.07⋅10−1 2.20 3.14⋅10−1 7.91⋅10−1 2.00⋅10−1 5.40⋅10−1
ZPV(0Hz) [mmHg ⋅min/ml] 1.99⋅10−2 1.24⋅10−2 1.95⋅10−2 1.32⋅10−2 2.35⋅10−2 1.61⋅10−2
7.3.1.2 Input impedances
e resulting HA and PV input impedances for a PHA,set of 25, 45 and 65
mmHg are plotted in Fig. 7.10. While ∣ZHA∣ values at 0 Hz decreased with an
increasing PHA,set , ∣ZHA∣ seemed to align with each other at the higher end
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of the studied frequency spectrum (± 7-10 Hz). For all three measurements,∣ZPV ∣ showed increasing values at low frequencies (± 0-5 Hz) and approx-
imately constant values for higher frequencies (± 5-10 Hz). e HA phase
angle (ϕHA) was mainly negative at low frequencies (± 0-4 Hz) and became
positive for higher frequencies (± 4-10 Hz). ϕPV followed a similar trend as
ϕHA.
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Figure 7.10: Hepatic arterial (HA) and portal venous (PV) input impedances of human liver
HL2 for perfusion settings with a PV pressure (PPV ,se t) of 5 mmHg, a PV ow limit of 300
ml/min and an HA pressure (PHA,se t) of 25, 45, 65 mmHg, respectively: HA and PV moduli
(a, c) and phase angles (b, d).
Subsequently, coherence values were calculated as a measure of the re-
liability of the impedance spectra. HA and PV impedances for a PHA,set of
45 mmHg were replotted according to their coherence values (Fig. 7.11). HA
coherence values were highest at the lower (0-1 Hz) and higher (6-10 Hz)
end of the frequency spectrum, supplemented by a few intermediate points
with relatively high coherences (near 2 and 3 Hz). is subset of coherent
points shows that ∣ZHA∣ values seem to decline from 0-3 Hz, followed by a
gradual and slow increase up to 10 Hz. PV impedances only showed coher-
ent points between 0-2 Hz and near 8 Hz, implying little frequency content
in the PV signals.
7.3.1.3 Windkessel models
HA and PV WK models were tted to the coherent impedance points (Fig.
7.12), resulting in the parameter values reported in Table 7.3. For ZHA, the
WKpi andWK4s outperformed theWK4pmodel, while theWKpi andWK4p
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Figure 7.11: Hepatic arterial (HA) and portal venous (PV) input impedances of human liver
HL2 colour-coded according to the coherence values for perfusion settings with a PV pres-
sure (PPV ,se t) of 5 mmHg, a PV ow limit of 300 ml/min and an HA pressure (PHA,se t) of 45
mmHg: HA and PV moduli (a, c) and phase angles (b, d).
models performed best for ZPV . WKmodels were tted based on the impe-
dance moduli, and we found some discrepancies between tted and meas-
ured phase angles. is might be due to time delays between the pressure
and ow (see further in section 7.3.3). Furthermore, caution is warranted
when analysing the PVWKmodels, as these were tted to only a small num-
ber of coherent points. When comparing the WKpi components of the HA
for measurements with an increasing PHA,set , Rd , L and C values seemed
to drop, while Rp values were rising. As WKpi models performed relatively
well for both HA and PV, and as they are similar to the pi-elements used for
the electrical liver model (chapter 6), WKpi model parameters were further
used to tune the extended electrical liver model (section 7.3.2.2).
7.3.2 Tuning of the extended liver-specic electrical model
Results for tuning the electrical liver model to HMP acquired data are fo-
cused on the measurement with a PHA,set of 45 mmHg (unless specied dif-
ferently), since the results are similar for other measurements.
7.3.2.1 Initial extended liver-specic electrical model of HL2
Mean pressures and ows predicted by the initial extended electrical liver
model throughout the blood vessel generations are shown in Fig. 7.13. Sim-
ilar to the results in section 6.3.2, pressures decreased along subsequent gen-
erations resulting in a pressure of ± 0.51 mmHg at the sinusoids. Mean ows
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Figure 7.12: Hepatic arterial (HA) and portal venous (PV) input impedances of theWindkes-
sel models tuned to the coherent impedance points of human liverHL2 for perfusion settings
with a PV pressure (PPV ,se t) of 5 mmHg, a PV ow limit of 300 ml/min and an HA pressure
(PHA,se t) of 45 mmHg: HA and PV moduli (a, c) and phase angles (b, d).
Table 7.3: Electrical components of the Windkessel models (WKpi, WK4s andWK4p) tted
to the hepatic arterial (HA) and portal venous (PV) impedances of human liver HL2 for
perfusion settings with a PV pressure (PPV ,se t) of 5 mmHg, a PV ow limit of 300 ml/min
and an HA pressure (PHA,se t) of 25, 45 and 65 mmHg (only 45 mmHg for the PV). Next to
parameter values, the root mean square error (RMSE) is given for each WK t.
PHA,set WKmodel Rd[mmHg⋅minml ] Rc[mmHg⋅minml ] L[mmHg⋅min2ml ] C[ mlmmHg ] Rp[mmHg⋅minml ] RMSE[mmHg⋅minml ]
WKpi 7.11⋅10−1 / 1.46⋅10−4 4.47⋅10−1 1.25⋅10−1 3.19⋅10−2
HA 25 WK4p 7.11⋅10−1 1.24⋅10−1 1.88⋅10−4 9.18⋅10−2 / 3.36⋅10−2
WK4s 6.69⋅10−1 4.17⋅10−2 3.93⋅10−5 1.04⋅10−1 / 3.21⋅10−2
WKpi 3.14⋅10−1 / 6.05⋅10−5 3.31⋅10−2 1.53⋅10−1 1.61⋅10−2
HA 45 WK4p 3.14⋅10−1 2.37⋅10−1 4.50⋅10−5 3.79⋅10−2 / 2.27⋅10−2
WK4s 2.58⋅10−1 5.63⋅10−2 3.14⋅10−5 8.67⋅10−2 / 1.48⋅10−2
WKpi 2.00⋅10−1 / 5.55⋅10−5 8.38⋅10−3 1.68⋅10−1 1.82⋅10−2
HA 65 WK4p 2.00⋅10−1 1.64⋅10−1 6.68⋅10−5 1.26⋅10−2 / 1.91⋅10−2
WK4s 1.45⋅10−1 5.46⋅10−2 3.71⋅10−5 2.65⋅10−2 / 1.65⋅10−2
WKpi 1.95⋅10−2 / 6.84⋅10−4 1.38⋅10−2 2.00⋅10−1 1.68⋅10−1
PV 45 WK4p 1.95⋅10−2 2.39⋅10−1 3.38⋅10−3 3.99⋅10−2 / 1.51⋅10−1
WK4s 1.54⋅10−2 4.16⋅10−3 7.71⋅10−5 5.34⋅10−3 / 2.26⋅10−1
were 105 ml/min, 233 ml/min and 338 ml/min for the HA, PV and HV vas-
cular tree, respectively. Pulsatile pressure and ow curves as a function of
time (Fig. 7.15 and 7.16) were calculated by applying boundary conditions
as measured during the HMP experiment (see Table 7.2): a sinusoidal PHA
waveform with a mean value of 33 mmHg, a frequency of 1 Hz and an am-
plitude of 3 mmHg at the HA source and a continuous PV pressure source
of 4.54 mmHg. Pressure amplitudes clearly decreased with increasing HA
generation numbers, while the PV pressure was constant at the inlet, but
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displayed a small pulse at its terminal generation.e HV outow pressures
again showed decreasing amplitudes along subsequent generations. Flow
proles throughout the vascular trees displayed only a very small change of
amplitudes. HA and PV impedances of the initial electrical model substan-
tially diered from those of the tuned WKpi models (Fig. 7.14). Impedance
values did agree at 0 Hz, but not at higher frequencies, implying that addi-
tional parameter tuning was necessary.
7.3.2.2 Tuning of the extended liver-specic electrical model of HL2
e resulting HA and PV factors to be multiplied with the L, C and Rp com-
ponents of the HA and PV tree, respectively, in order to tune the extended
electrical model, are shown in Table 7.4 for perfusion settings with PHA,set
values of 25, 45 and 65mmHg. Rp components of the HA and PV tree as well
as L components of the PV tree had to be multiplied by a remarkably high
factor in the order of 104 and 80-300, respectively. Increasing PHA,set values
were associated with decreasing fC , while fRp increased when the PHA,set
was set to 65 mmHg. No clear trend was observed for fL. e impedance
moduli of the tuned electrical model were in good agreement with theWKpi
tted impedances (Fig. 7.14). On the contrary, the HA and PV phase angles
of the tuned model underestimated the phase angles of the coherent points.
Pulsatile pressure curves of the tuned electrical model were very similar
to those of the initial model, but showed small amplitude dierences and
time shis (Fig. 7.15; e.g. pressure amplitudes at the sinusoids were 1.43⋅10−2
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Figure 7.13: Time-averaged results of the initial and tuned electrical liver model of human
liver HL2: (a) pressure proles before and aer each blood vessel generation of the hepatic
arterial (HA), portal venous (PV) and hepatic venous (HV) trees; (b) time-averaged ows
through the HA, PV and HV tree. Time-averaged values are equal for both the initial and
tuned electricalmodel, as the initial model was already tuned to time-averaged pressures and
ows.
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Figure 7.14: Hepatic arterial (HA) and portal venous (PV) input impedance of the initial
and tuned electrical liver model of human liver HL2: HA and PV moduli (a, c) and phase
angles (b, d). Coherent impedance points are also shown.
mmHg and 1.40⋅10−2 mmHg for the initial and tuned model, respectively).
In contrast, ow proles of the tuned model displayed substantially larger
QHA amplitudes (especially for the rst HA generations), while QPV ampli-
tudes were smaller and showed time shis (Fig. 7.16). QHV were similar to
those of the initial model with only very small amplitude dierences (e.g.
ow amplitudes at the sinusoids were 8.86 ml/min and 8.68 ml/min for the
initial and tuned model, respectively).
Table 7.4: Results of tuning the electrical liver model for human liver HL2: fL , fC , fRp factors
and root mean square error (RMSE) values for both the hepatic artery (HA) and portal
vein (PV) tuned to the WKpi models corresponding to perfusion setting with a PV pres-
sure (PPV ,se t) of 5 mmHg, a PV ow limit of 300 ml/min and an HA pressure (PHA,se t) of 25,
45 and 65 mmHg, respectively.
PHA,set fLHA fCHA fRp,HA RMSEHA fLPV fCPV fRp,PV RMSEPV[mmHg] [mmHg ⋅min/ml] [mmHg ⋅min/ml]
25 4.03 26.0 9.40 ⋅103 9.2 ⋅10−3 273 2.51 1.36 ⋅104 4.3 ⋅10−2
45 3.51 17.4 9.29 ⋅103 2.3 ⋅10−3 292 1.82 1.33 ⋅104 3.6 ⋅10−2
65 3.65 4.15 1.23 ⋅104 2.2 ⋅10−3 80.8 1.40 2.82 ⋅104 3.8 ⋅10−3
7.3.3 Sensitivity analysis
A sensitivity study of the electrical components (illustrated for ZHA in Fig.
7.17) showed that increasing Rs values lead to higher ∣ZHA∣ values at 0 Hz
and generally lower ∣ϕHA∣. Variations in Lmainly inuenced the higher end
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Figure 7.15: Time-dependent pressures calculated by the initial and tuned electrical liver
model of human liverHL2: sinusoidal pressures of each blood vessel generation of the hepatic
arterial (HA), portal venous (PV) and hepatic venous (HV) trees for the initial (a, c, e) and
tuned (b, d, f) electrical liver model.
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Figure 7.16: Time-dependent ows calculated by the initial and tuned electrical liver model
of human liver HL2: sinusoidal ows of each blood vessel generation of the hepatic arterial
(HA), portal venous (PV) and hepatic venous (HV) trees for the initial (a, c, e) and tuned (b,
d, f) electrical liver model.
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of the frequency spectrum with higher ∣ZHA∣ and ∣ϕHA∣ for higher L values.
When increasing the value of the C components, ∣ZHA∣ and ∣ϕHA∣ spectra
seemed to be shied to the le, resulting in lower ∣ZHA∣ at low frequencies
and higher ∣ϕHA∣ for the major part of the frequency spectrum. Rising Rp
values gave evidence of mainly lower ∣ZHA∣ and smaller dierences between
the minimum and maximum ∣ϕHA∣.
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Figure 7.17: Results of the sensitivity analysis of the tuned electrical model: hepatic arterial
(HA) impedance moduli (a, c, e, g) and phase angles (b, d, f, h) when varying Rs , L, C and
Rp components, respectively.
Fig. 7.18 illustrates that a time delay between pressure and ow signals
mainly inuenced the phase angles, while impedancemoduli did not change,
except for a slight increase at high frequencies. Hence, time delays may ex-
plain the phase discrepancy between the tuned extended electrical model
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and the coherent points. For example, a time delay of approximately −10 ms
would make the ∣ϕHA∣ of the extended model and coherent points collide
with each other.
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Figure 7.18: Impedance results when inducing a time delay between pressure and ow sig-
nals: hepatic arterial (HA) and portal venous (PV) impedancemoduli (a, c) and phase angles
(b, d) of the originally tuned model and coherent points with a time delay.
7.4 Discussion
7.4.1 Interpretation of the results
In this study, we developed a methodology to validate and tune an extended
electrical analog model of hepatic perfusion based on anatomical and func-
tional data of one and the same human liver gra. First, compact WKmod-
els were tted to experimentally acquired input impedances in order to re-
present the global HA and PV perfusion behaviour. Subsequently, the WK
impedances were ‘smeared out’ over an extended electrical analog model,
resulting in a liver-specic model.
WKpimodels (and impedance data) demonstrated that increasing PHA,set
values clearly altered the perfusion properties with a lower resistance to ow
(decreasing Rd), lower inertial forces of the blood ow (decreasing L), a
lower elasticity of the blood vessels (decreasing C) and a more outspoken
visco-elastic behaviour of the vessel walls (increasing Rp).
When comparing the results of the initial extended electricalmodel with
those of the tuned extended model, substantial dierences are observed in
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both the impedance spectra (Fig. 7.14) and damping of ow curves through-
out the livers (Fig. 7.15 and 7.16). As such, the tunedmodel resulted in higher
QHA and lowerQPV amplitudes, showing that tuning clearly inuences ows
- as well as the corresponding wall shear stress uctuations - whichmay play
a role in potential hepatic endothelial damage. However, the eect at the
level of the sinusoids was rather limited (mean wall shear stress of 1.35⋅10−1
Pa with an amplitude of 3.57⋅10−3 Pa and 3.51⋅10−3 Pa for the initial and the
tuned extended model, respectively). Sudhamshu et al. [455] reported Dop-
pler velocity measurements of the HA in 30 healthy patients, resulting in an
estimated mean QHA of 398 ml/min and a maximum QHA of 816 ml/min (±
105% higher than its mean QHA). When changing the boundary conditions
of the initial and tuned electrical analog model (based on a PHA,set of 45
mmHg) to physiological in vivo values (a PHA,set with a mean value of 100
mmHg and an amplitude of 20 mmHg, a PPV ,set of 10 mmHg), the tuned
extended model corresponds better to the measurements by Sudhamshu et
al. as it predicts higher QHA amplitudes (280 ml/min; ± 89% of its mean
QHA value of 314 ml/min) compared to the initial extended model (70.4
ml/min; ± 22% of its mean QHA value of 314 ml/min). However, absolute
values between the measurements of Sudhamshu et al. and the tuned model
still diered, whichmight have to dowith the dierences between individual
livers and perfusion settings (in vivomeasurements versus models based on
ex vivo isolated organHMP). Table 7.4 demonstrates that L, C and especially
Rp values were underestimated by the initial extended model. Fig. 7.17 illus-
trates that changing these components substantially aects the impedance
moduli and phase angles. Furthermore, changes in electrical components
can be related to changes in the radius, length, number of vessels and pulse
wave velocity values of the blood vessel generations (eq. 6.1-6.4). For ex-
ample, changing the cp values directly inuences the C values, as can be il-
lustrated for the HA by dividing all HA cp values by 4 (e.g. from 17.7 m/s and
22.0 m/s to 4.41 m/s and 5.50 m/s for the rst and terminal HA generation,
respectively), which results in the C values being multiplied by a factor of
approximately fCHA to obtain the tuned extended model (Table 7.4; eq. 6.3).
Hence, these lower cp values indicate that the initial model overestimated
the stiness.
Since large fRp values were needed to tune the extended electrical model
for both HA and PV, a closer look into the Rp component is advisable.e
initial extended model was based on the work of de Pater [91] and van der
Plaats [482], which resulted in an electrical analog model for blood vessels
and the dog liver, respectively (section 4.2.2.1.2). Visco-elasticity of the vessel
wall was introduced by de Pater by using the Kelvin-Voigt model (eq. 7.15
with σ the stress, Ewal l the Young’s elasticitymodulus of thewall, ε the strain,
µwal l the viscosity of the visco-elastic wall material and t time).
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σ = Ewal l ε + µwal l ∂ε∂t (7.15)
Aer deriving the dierential equations for the electrical analog model
from the Navier-Stokes equations, de Pater captured the visco-elastic beha-
viour of the vessel wall in eq. 7.16 with Rp and C dened as in eq. 7.17 and
7.18, p the pressure, q the ow, r the radius, hwal l the wall thickness (see
also section 4.2.2.1.2). Hereupon, de Pater stated that the inuence of Rp is
unimportant, certainly for low frequencies, and that Rp can be considered
constant and can be calculated from eq. 7.19.
−∂q
∂z
= 3pir3
2Ewal lh
∂p
∂t
+ µwal l
Ewal l
∂2q
∂z∂t
= C1 ∂p∂t + C1Rp1 ∂2q∂z∂t (7.16)
Rp = Rp1 2l = 2µwal lh3pir3 2l (7.17)
C = C1 l2 = 3pir32Ewal lh l2 (7.18)
Rp1C1 = RpC = 2 ⋅ 10−6s (7.19)
Van der Plaats et al. [482] used the electrical analog blood vessel model
of de Pater to develop an electrical analogmodel of the liver, hereby extrapo-
lating the visco-elastic behaviour of a vessel to the whole liver. However, we
speculate that the visco-elastic behaviour of the liver vasculature might not
only depend on the wall material of the blood vessels, but also on the ma-
terial properties of the surrounding liver tissue. Contradicting the assump-
tion that Rp can be considered constant, our sensitivity study gave evidence
of substantial moduli and phase dierences when changing Rp values, even
for low frequencies (Fig. 7.17 g and h). Moreover, the results for HL2 (Table
7.4) seem to indicate that eq. 7.19, used in the initial model, leads to Rp values
that are approximately a factor 104 too small. To test this more elaborately,
we compared the ndings of de Pater with the WKpi models of HL2 and
HL3, as well as a WKpi model tted to in vivo ∣ZHA∣ values of a single pa-
tient, whose liver is called HL4 hereaer, obtained by Basciano et al. [30]
(Table 7.5 and Fig. 7.19a). As we veried that no reliable frequency content
higher than 5 Hz was present in the pressure and ow curves of HL4 due
to ltering [30], the frequency spectrum, used to t the WKpi model, was
limited to 0-5 Hz. To the authors’ knowledge, additional literature values on
hepatic input impedances are non-existent. Despite the quite drastic dier-
ences in conditions, overall patterns agree well with our data (Fig. 7.19a).e
RpC values of all three human livers (Table 7.5) show substantial dierences
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with the value predicted by de Pater and presumed by van der Plaats for the
liver (RpC = 2 ⋅ 10−6 s = 3.33 ⋅ 10−8 min; [91]). Additionally, Fig. 7.19b illus-
trates the large discrepancy between the Rp versus 1/C relation as proposed
by de Pater (and used by van der Plaats) and the actual human liver results
acquired in this study. We speculate that this discordance may be due to the
eects of surrounding liver tissue.
Table 7.5:WKpimodels tted to the hepatic artetial (HA) impedancemodulus (∣ZHA∣) values
of human liversHL2,HL3 andHL4. HL2 andHL3Windkessel (WK)modelswere tted to the
hypothermic machine perfusion (HMP) acquired ∣ZHA∣ values for perfusion settings with a
PVpressure (PPV ,se t) of 5mmHg, a PVow limit of 300ml/min and anHApressure (PHA,se t)
of 45 mmHg. e WKpi model of HL4 was tted to the patient-specic values obtained by
Basciano et al. [30]. As we veried that no reliable high frequency content was present in
the pressure and ow curves of HL4, the frequency spectrum, used to t the WKpi model,
was limited to 0-5 Hz.e tted parameters as well as the root mean square error (RSME)
and RpC values are given. (*)e L value of HL4 is unreliable as L mainly aects the high
frequency response and no reliable high frequency data were available for tting.
Human liver Rd[mmHg⋅minml ] L[mmHg⋅min2ml ] C[ mlmmHg ] Rp[mmHg⋅minml ] RMSE[mmHg⋅minml ] Rp ⋅C[min]
HL2 3.14⋅10−1 6.05⋅10−5 3.31⋅10−2 1.53⋅10−1 1.61⋅10−2 5.06⋅10−3
HL3 7.92⋅10−1 4.09⋅10−5 2.93⋅10−3 4.20⋅10−1 5.48⋅10−2 1.23⋅10−3
HL4 5.75⋅10−1 2.16⋅10−10 * 3.78⋅10−3 6.36⋅10−1 1.04⋅10−2 2.40⋅10−3
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Figure 7.19: Comparison of the results of human livers HL2, HL3 and HL4: (a) hepatic
artetial (HA) impedance modulus (∣ZHA∣) values of the (coherent) data points and WKpi
models with HL4 data taken from [30]; (b) comparison of the relation between Rp and C as
assumed by de Pater [91] and as calculated from our WKpi data for ZHA.
HA and PV input impedances may not only be powerful tools to tune
hepatic perfusion models, but also to assess the liver response to perfusion,
161
7. Validation and calibration of an electrical analog model of
hepatic perfusion based on human liverHMP experiments
which may be related to gra properties and viability. Contrary to vascular
resistances (time-averaged pressure divided by time-averaged ow), impe-
dancesmay include information on the elasticity of blood vessels, the inertia
of the blood ow, and the visco-elastic behaviour of the walls and possibly
also the surrounding liver tissue.
e human liver gras used in this study were discarded for transplan-
tation because of tumourous tissue in the kidneys (HL2) and because no
suitable recipient was found (HL3).e livers showed no signs of abnormal-
ities and, hence, were perfectly suitable for our study.e experimental pro-
cedure, starting from the hepatectomy and ending aer vascular corrosion
casting, was completed within 24 h for both livers. HMP results indicated
that HL3 overall had a higher HA vascular resistance than HL2 (Table 7.2;
possibly due to the smaller size of HL3), while its PV resistance was lower.
Comparison of the HL1 and HL2 measured geometrical data up to the
4th generation (Fig. 7.7 and Fig. 7.8) demonstrates that HA, PV and HV radii
were very similar for both livers, while lengths were less related. e num-
bers of vessels per generation also showed similar trends with the largest
deviations for the HA tree.
7.4.2 Limitations
Aswe focusedmainly onHL2 due to image processing limitations withHL3,
care should be taken when generalising the results. Ideally, this study should
be repeated on more livers in order to clearly demonstrate perfusion beha-
viour similarities and dierences between livers. e procedure to obtain
experimental data and build models (especially the image processing and
data acquisition), however, is labour-intensive. Moreover, human liver gras
are scarce and their availability depends on the moment that a donor organ
is discarded aer failed reallocation.
e acquired PV impedances only showed a relatively small amount of
highly coherent points (Fig. 7.11). Consequently, caution is recommended
when interpreting the PV results. Changing the perfusion settings by indu-
cing perturbations (such as transient phenomena, e.g. starting or stopping
the pumps) or adjusting the HMP control circuit may enable generating PV
data with more frequency content. HV outlet impedances were not studied,
as these were not relevant due to the free outow conditions.
Ideally, pressure and ow measurements at the sinusoids should be in-
cluded to fully dene the hepatic perfusion behaviour. We attempted to
measure sinusoidal pressures using balloon catheters which were inserted in
the HV system, but measurements were inaccurate and could not be used.
7.4.3 Future perspective
An obvious extension is to conrm our ndings in a higher number of hu-
man liver gras in order to generate a larger dataset. Furthermore, the pre-
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sented experiments and models may also be applied to pathological organs
to gain more insight into the vascular alterations aecting haemodynamics
(e.g. in cirrhosis). Since data of only the rst 4 generations of blood vessels
were used to generate the electrical model, this could also be done using
conventional CT-scanners in clinics. is may enable generating patient-
specic liver models, which might be helpful in the context of surgical plan-
ning.
7.5 Conclusion
HMP experiments were used to capture the perfusion behaviour of human
liver gras, a.o. by calculating the liver-specic HA and PV hydraulic in-
put impedances. Impedances were used to tune extended liver-specic elec-
trical analog models of the hepatic perfusion. Future research may focus
on broadening the applications of this approach from modelling HMP and
natural blood ow to investigating hepatic pathologies and surgical proce-
dures. Furthermore, the acquired impedances may be useful as boundary
conditions for numerical models of e.g. the descending aorta, the splanch-
nic circulation or the portal circulation.
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Modelling the impact of partial
hepatectomy on the hepatic
haemodynamics using a rat model
is chapter is based on “Modeling the impact of partial hepatectomy on the
hepatic hemodynamics using a rat model”, as published in IEEE Transactions
on Biomedical Engineering, 59(12):3293-3303, 2012 [100].
8.1 Introduction
During the last decades, the number of patients on the waiting list for liver
transplantation increased enormously (e.g. from 229 (1991) to 2695 (2010) in
the Eurotransplant region [126]). As the number of available gras did not
grow accordingly, this results in a substantial shortage of donor livers. A lot
of research therefore aims to enlarge the donor pool, such as the use of sub-
optimal gras, donation aer circulatory death donor organs etc. [345]. In
addition to total donor organs, the usage of split liver transplantation [205] is
being investigated as well as living donor liver transplantation (LDLT) [152].
In the LDLT procedure, a healthy donor undergoes a partial hepatec-
tomy, resulting in a part of his liver being transplanted into a patient with
severe liver failure. During a post-transplant period of a few months, both
donor and recipient usually regain a normal liver mass due to liver regener-
ation. However, LDLT-induced complications (such as cholestasis, ascites,
gastrointestinal bleeding, renal impairment etc.) may occur in the donor as
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well as the recipient [65]. If the remaining liver mass is too small compared
to the total bodymass, LDLT can lead to the small-for-size syndrome (SFSS;
see also section 3.2.3.2) and tremendously hamper survival chances of both
donor and recipient [140, 151, 153, 163, 218, 462, 513]. A typical complica-
tion of SFSS is portal hypertension, caused by a higher vascular resistance
of the hepatectomised liver in comparison with the total liver before resec-
tion. Moreover, the portal venous (PV) inow per gram of liver tissue is
higher in the remnant liver than in the total liver before resection [431].is
is typically associated with higher intravascular shear stress [86, 114], which
is necessary to trigger liver regeneration aer hepatectomy [415, 513]. Nev-
ertheless, excessive hyperperfusion and shear stress eects may irreversibly
damage endothelial cells of the microvascular sinusoids and lead to gra
dysfunction [65, 140]. In addition to LDLT, other procedures involving par-
tial hepatectomy (e.g. split liver transplantation, liver resection due to hepa-
tocellular carcinoma etc.) may also lead to similar complications.
Previous studies concerning the haemodynamic impact of liver hepatec-
tomy mainly focused on an experimental approach, oen using lab animals
such as rodents (rats) or pigs [86, 106, 114, 131, 140, 145, 242, 280, 284, 298,
313, 314, 348]. Some other studies focused on virtual planning and mod-
elling of LDLT procedures [423, 514]. Yamanaka et al. [514] developed so-
ware to virtually predict gra volumes and corresponding drainage volumes
based on CT images. Similarly, Selle et al. [423] presented methods to plan
surgical interventions based on vascular territories determined by a geo-
metrical and structural analysis of the vascular trees. Although some other
studies provide insights into how to possibly overcome hepatectomy-related
complications using e.g. portocaval shunts, splenectomy etc. [114, 314, 472,
512], there is no consensus on how to prevent or treat the complications in
the best way, and how to predict the optimal resection volumes and locations
in the liver [151].
e aim of this studywas to gainmore insight into the inuence of a par-
tial hepatectomy on the liver haemodynamics. Detailed anatomical data of
rat livers were obtained using a vascular corrosion casting technique. Aer-
wards, these data were applied to build an electrical analogue to model the
blood circulation before and aer partial hepatectomy (total liver versus re-
sected liver) using dierent sets of boundary conditions. Hereby, we aim to
model the moment immediately aer hepatectomy, a haemodynamic snap-
shot which might set the trigger for an evolution towards either liver regen-
eration (recovery) or liver failure (due to SFSS complications).
166
8.2. Materials and Methods
8.2 Materials andMethods
8.2.1 Vascular corrosion casting of rat livers
Two female Wistar rats (albino, age of 10 weeks) with a body weight of 200-
225 g (Harlan Laboratories Inc., Indianapolis, US) were used. Both rats were
euthanised by an intraperitoneal injection of 1ml of a solution containing 0.2
ml Xylazine Hydrochloride (Xyl-M 2%; V.M.D., Arendonk, Belgium) and
0.8 ml Ketamine Hydrochloride (Anesketin 10%; Eurovet, Bladel, the Neth-
erlands). Subsequently, the abdomen was opened. e rst rat was cast via
a cannula inserted in the abdominal aorta with a resin (Batson’s #17; Poly-
sciences, Florida, USA) including a red colouring dye and a contrast agent
(barium sulfate; Micropaque, Delpharm, France). Simultaneously, the ileo-
colic vein was injected with a blue coloured resin without contrast agent. As
such, the rat liver was cast through resin entering the hepatic artery (HA)
and PV, respectively. Subsequently, the injected resins polymerised (approx-
imately two hours) and the tissue wasmacerated in a 25% potassiumhydrox-
ide solution during a few days (as more elaborately explained in [93]). Since
there were some problems (likely caused by the particle size of the contrast
agent) to gather data based on the HA vascular tree of this rat, a second rat
was cast exclusively through the arterial side without contrast agent.
Vascular corrosion casting resulted in replicas of theHA, PV and hepatic
venous (HV) vascular trees (Fig. 8.1). In both rats, the livers were dissected
from the cast specimens to allow more detailed imaging of the liver vascu-
lature by micro-CT scanning.
(a) (b)
Figure 8.1: (a) Rat liver cast used to study the hepatic arterial (HA) vascular tree; (b) rat liver
cast used to study the portal venous (PV) and hepatic venous (HV) vascular trees.
8.2.2 Micro-CT imaging and data acquisition
e liver casts were scanned using a high-resolution micro-CT scanner de-
veloped in-house [93] at a resolution of 46.6 µm (Fig. 8.1a) and 50.3 µm (Fig.
8.1b), respectively. e resulting digital datasets were processed using the
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soware package Mimics (Materialise, Leuven, Belgium). One rat liver cast
was used to segment the HA vascular tree (Fig. 8.1a), while the other liver
cast enabled studying the PV andHVvascular trees (Fig. 8.1b). As illustrated
in Fig. 8.2, the rat liver typically contains 4 major liver lobes (of which 3 are
subdivided in 2 sublobes), each corresponding to a certain percentage of the
liver weight.e median lobe accounts for 38% of the liver tissue and is di-
vided by a ssure in the right (RML) and le median lobe (LML).e supe-
rior (cranial) right lobe (SRL; 12%) and the inferior (caudal) right lobe (IRL;
10%) form the right lobe. In addition, there is the le lateral lobe (LLL; 30%)
and the caudate lobe which consists of the anterior (ventral) caudate lobe
(AC; 4%), posterior (dorsal) caudate lobe (PC; 4%) and a small paracaval
portion called the caudate process (2%, not shown in Fig. 8.2) [312]. Seg-
mentations of the HA, PV, HV vascular trees allowed for the calculation of
3D reconstructions and the separation of the rat liver lobes based on the
vasculature (Fig. 8.3).
RML
SRL
LLL
LML
IRL
AC
PC
vena cava caudalis
portal vein
hepatic artery
Figure 8.2: Schematic overview of the rat liver with 4 major lobes of which 3 are subdivided
in 2 sublobes (with RML the right and LML the le median lobe, SRL and IRL the superior
(cranial) and inferior (caudal) right lobe, LLL the le lateral lobe, AC the anterior (ventral)
and PC the posterior (dorsal) caudate lobe) and its aerent (hepatic artery and portal vein)
and eerent (vena cave caudalis) blood vessels.
Aer image processing, Mimics was used to calculate the centrelines of
the vascular trees (HA, PV and HV) in all liver lobes separately (except for
the caudate process which is very small and has no major vessels). Based on
these centrelines, the branching topology of all trees (bifurcations, trifurca-
tions and monopodial branches [93, 167]) was analysed and blood vessels
were classied into generations. A similar study was performed by Op Den
Buijs et al. [52] to classify the rat PV tree. However, they only studied the
rat PV vascular tree, while data on the HA and HV trees were also required
for our study. Furthermore, classication was performed assuming a purely
bifurcating branching topology, while trifurcations and monopodial vessels
are also taken into account in our study.
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(a) (b) (c)
IRL
SRL
AC
PC
RML
LML
LLL
Figure 8.3: 3D reconstructions of the (a) hepatic arterial (HA), (b) portal venous (PV) and
(c) hepatic venous (HV) vascular tree. Dierent colours were used to separate the lobes as
explained in the legend with RML the right and LML the le median lobe, SRL and IRL the
superior (cranial) and inferior (caudal) right lobe, LLL the le lateral lobe, AC the anterior
(ventral) and PC the posterior (dorsal) caudate lobe.
Since rat liver lobes clearly dier in size (Fig. 8.2 and 8.3) and are imaged
with a nite spatial resolution, the number of blood vessel generationsmeas-
ured was not equal for all lobes. In the two rat liver casts, the minimum and
maximum generation number reached within one lobe was 5, 7, 6 and 6,
10, 7 for the HA, PV and HV tree, respectively. Subsequently, the radii and
lengths of all vessels were measured [93]. Geometrical classication allowed
for the calculation of the mean radius and length per blood vessel genera-
tion of the HA, PV and HV vascular tree, as well as the number of vessels
per generation as listed in Table 8.1 (with HA 1, PV 1, HV 1 being the he-
patic artery, portal vein and vena cava caudalis, respectively, n the number
of vessels per generation, r [mm] the mean radius, l [mm] the mean length,
and σ(r) and σ(l) the corresponding standard deviations). Moreover, data
allowed analysing geometrical features on a lobe-specic basis (as illustrated
for the PV and HV radii in Fig. 8.4).
Due to the nite spatial imaging resolution, a limited number of vessel
generations could be measured. However, data of all generations were nec-
essary to build the electrical model, and hence, extrapolations of the meas-
ured data were used to estimate the geometrical properties of lacking gener-
ations. Since measured data as a function of generation numbers (Fig. 8.4)
clearly showed an exponential-like behaviour (similar to the human data in
[93]), an exponential tting algorithm was implemented in Matlab (Math-
works, Massachusetts, USA).is allowed acquiring lobe-specic exponen-
tial trend lines of the geometrical data, as dened in eq. 8.1 with y the geo-
metrical measure (being r, l or n) and j the generation number.
y = aeb⋅ j (8.1)
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Table 8.1: Summary of measurements averaged over the total liver.
Generation n r [mm] σ(r) [mm] l [mm] σ(l) [mm]
HA 1 1 0.27 0 12 0
HA 2 5 0.11 1.3 ⋅ 10−2 6.3 4.2
HA 3 13 0.11 2.0 ⋅ 10−2 6.6 3.2
HA 4 32 9.6 ⋅ 10−2 1.6 ⋅ 10−2 4.2 2.3
HA 5 30 7.7 ⋅ 10−2 1.5 ⋅ 10−2 2.9 1.9
HA 6 8 6.5 ⋅ 10−2 5.4 ⋅ 10−3 1.8 0.73
PV 1 1 2.2 0 24 0
PV 2 4 0.71 0.13 3.9 3.4
PV 3 9 0.47 6.9 ⋅ 10−2 6.6 5.3
PV 4 23 0.36 7.2 ⋅ 10−2 4.7 2.2
PV 5 49 0.25 7.2 ⋅ 10−2 3.7 2.6
PV 6 114 0.17 6.2 ⋅ 10−2 2.1 1.4
PV 7 159 0.11 2.9 ⋅ 10−2 1.2 0.72
PV 8 136 7.8 ⋅ 10−2 2.1 ⋅ 10−2 1.0 0.58
PV 9 101 7.0 ⋅ 10−2 7.5 ⋅ 10−3 0.82 0.52
PV 10 204 4.8 ⋅ 10−2 7.4 ⋅ 10−3 0.66 0.31
HV 1 1 5.3 0 43 0
HV 2 6 0.87 0.24 14 5.3
HV 3 16 0.43 0.17 5.3 4.8
HV 4 53 0.27 0.13 2.6 1.6
HV 5 122 0.16 6.9 ⋅ 10−2 1.8 1.1
HV 6 191 0.12 2.8 ⋅ 10−2 1.3 0.64
HV 7 110 8.5 ⋅ 10−2 1.6 ⋅ 10−2 0.95 0.42
Since rat liver lobes substantially dier in dimensions (Fig. 8.1, 8.2 and
8.3), a lobe-specic tting algorithm was applied. Accordingly, a cost func-
tion was minimised to nd the optimal a and b values to determine the
exponential functions. We use the same value of b for all lobes of the liver,
because it was assumed that the exponential power of all lobes is similar and
that they mathematically only dier in the initial starting value determined
by the a value. e cost function c (eq. 8.2) was based on the least squares
(a) PV radii (b) HV radii
Figure 8.4: Lobe-specicmean radii and corresponding lobe-specic exponential trend lines
for the portal venous (PV) and the hepatic venous (HV) vascular tree.
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method. In (8.2), i is the lobe number, p the total number of (sub)lobes (be-
ing 7 in our study: RML, LML, LLL, SRL, IRL, AC and PC), j the generation
number, ni the number of generations in lobe i, ai the a value for lobe i, and
yi j the average of the geometrical measure for the jth generation of lobe i.
c = p∑
i=1
⎛⎝ n i∑j=1(ln(ai) + b ⋅ j − ln(yi j))2⎞⎠ (8.2)
To determine the number of blood vessel generations in every vascular tree
of all lobes, the exponential trend lines were extrapolated up to the genera-
tion number, for which a radius value corresponding to literature values of
terminal vessels, was reached (10 µm for HA arterioles [315], 15 µm for PV
venules [315], and 5 µm for the terminal HV generation modelled as being
the sinusoids [358]).
8.2.3 Total liver electrical analog models
e total liver model was based on the model of a human liver as described
in [93]. Since the rat liver (high variations in lobe size) substantially diers
from the human liver concerning the anatomy [312], the model was adapted
to be lobe-specic. Consequently, all blood vessel generations of every lobe-
specic vascular tree (HA, PV and HV) were modelled using a vascular re-
sistance Rs (eq. 8.3 with µ [3.5 ⋅ 10−3Pa ⋅ s] the dynamic blood viscosity, l [m]
the mean length of the generation, n the number of vessels, and r [m] the
mean radius).e vascular resistanceswere calculated using eq. 8.3 based on
the measured data and extrapolations of the geometrical data as described
in section 8.2.2.
Rs = 8µlnpir4 [Nsm5 ] (8.3)
is resulted in the network of Fig. 8.5a depicting the electrical model
of one liver lobe. e serial HA and PV generations, each represented by a
resistance, cluster aer their terminal generations and run into the HV tree
starting with the sinusoids. e sinusoids further drain the blood into the
HV tree, which clusters until it reaches the lobe HV outow. e total rat
liver model is separated in HA, PV and HV blocks as schematically illus-
trated in Fig. 8.5b, based on the topology of the vessels supplying each liver
lobe.
e analysis of themodel was implemented inMatlab based on the elec-
trical network theory. is allowed analysing the haemodynamics at every
lobe-specic generation by calculating pressure drops and ows throughout
the total liver.
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(a) Electrical model of one liver lobe
(b) Electrical model of total rat liver
Figure 8.5: (a) Schematic representation of the electrical model of a liver lobe. e lobe
model consists of vascular resistances each representing one generation of the hepatic arterial
(HA), portal venous (PV) or hepatic venous (HV) vascular tree of the lobe. e blood in
the last generation of the HA and PV tree (Rs ,HAn i and Rs ,PVm i , respectively) ows into the
sinusoids depicted by the terminal HV generation (Rs ,HV p i ), until it reaches the lobe outow
vessel (Rs ,HV 1). (b)e block diagram shows a schematic representation of the pressure-
controlled total rat liver model. e model is divided in HA, PV and HV blocks based on
the branching topology of the blood vessels supplying each liver lobe.
8.2.4 Boundary conditions for the total liver model
Two sets of boundary conditions were used to develop two models of the
blood ow through the total liver: a pressure- and a ow-controlled model.
A subset of the boundary conditions was dened by using results of in vivo
rat hepatectomy experiments by Fan et al. according to the surgical proce-
dure as described in [131, 485]. During these experiments, the PV pressure
(PPV ) and total PV ow (QPV ,total ) as well as the HA ow (QHA,total ) were
measured before and aer 70%, 80% and 90% hepatectomy (Table 8.2).e
other boundary conditions (HA pressure PHA and outlet resistance R) were
dened using literature values as described below.
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Table 8.2: Haemodynamic measurements of Fan et al. during in vivo rat experiments [131]
at baseline and immediately aer 70%, 80%, 90% hepatectomy.
PPV [mmHg] QPV,total [ml/min] QHA,total [ml/min]
Before hepatectomy 0% 5.85 7.35 3.17
Immediately 70% 8.18 8.52 0.96
aer 80% 9.88 6.13 0.62
hepatectomy 90% 10.92 5.78 0.50
8.2.4.1 Pressure-driven model
Fig. 8.5b represents the pressure-driven total livermodel, as pressure sources
were used at the HA and PV inlets. e applied pressures were PHA = 103
mmHg at the HA [3, 145, 412] and PPV = 5.9 mmHg at the PV inlet (Table
8.2). Moreover, an output resistance R is used at the liver outow (vena cava
caudalis; Fig. 8.2 and 8.5) to represent the vascular resistance of the blood
circulation distal from the liver (eq. 8.4 with PHV = 0.90 mmHg the outlet
pressure [84] andQHV ,total = 11 ml/min the total outow, estimated as being
the sum of QHA,total and QPV ,total before resection (Table 8.2)).
R = PHV
QHV ,total
= 6.1 ⋅ 108 Ns
m5
(8.4)
8.2.4.2 Flow-driven model
In addition to the pressure-driven model, an adjusted model was developed
to obtain ow-control at the PV side. is was done by changing the PV
pressure source into a PV ow source QPV ,total of 7.4 ml/min (Table 8.2),
while preserving the other boundary conditions as dened above.
8.2.5 Tuning of the total liver model
Both the pressure- and ow-driven model were initially solved and, sub-
sequently, tuned to be in accordance with the pressure and ow measure-
ments performed by Fan et al. [131] for a healthy total rat liver (Table 8.2).
Since results of the initialmodel showed some dierences betweenmod-
el-predicted haemodynamics and those measured by Fan et al. [131] before
hepatectomy, the exponential trend lines with the highest degree of uncer-
tainty (mainly due to the nite spatial scanning resolution) were adjusted
as in chapter 6 [93] in order to improve the physiological accuracy of the
model.is resulted in the a and b values of Table 8.3. First, the HA radius
power was adjusted from b = −1.1 ⋅ 10−1 to b = −3.3 ⋅ 10−1, and lobe-specic
HA a values were also optimised. In addition, powers of the PV and HV
number of vessels and the HV lengths exponential trend lines were adjusted
from b = 7.4 ⋅ 10−1 to b = 8.6 ⋅ 10−1, from b = 7.3 ⋅ 10−1 to b = 1.2, and from
b = −5.9 ⋅ 10−1 to b = −5.1 ⋅ 10−1, respectively. In the end, the tuned model
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counted 11-12, 11-12 and 10-12 generations for the lobe-specic HA, PV and
HV vascular trees, respectively. As such, a slightly dierent number of gen-
erations per lobe was possible, since data extrapolations were lobe-specic.
Table 8.3: Lobe-specic a and b values of the exponential trend lines aer model tuning.
Bold values were optimised.
Parameter b aSRL aIRL aAC aPC aLML aRML aLLL
rHA −0.33 0.36 0.26 0.36 0.36 0.36 0.36 0.36
lHA −0.33 23 29 29 18 23 13 26
nHA 0.91 8.2 ⋅ 10−2 7.1 ⋅ 10−2 5.8 ⋅ 10−2 0.12 0.15 0.21 0.13
rPV −0.34 1.4 0.90 1.4 1.4 1.4 1.4 1.4
lPV −0.31 14 14 12 12 16 12 22
nPV 0.86 0.16 0.17 6.8 ⋅ 10−2 7.9 ⋅ 10−2 0.11 0.12 0.20
rHV −0.49 1.9 1.3 2.6 2.5 2.1 2.8 3.2
lHV −0.51 23 15 34 33 31 28 39
nHV 1.2 0.11 0.19 4.2 ⋅ 10−2 3.8 ⋅ 10−2 3.6 ⋅ 10−2 0.12 9.1 ⋅ 10−2
8.2.6 Resected liver electrical analog models
In literature, dierent techniques are described to perform in vivo partial
rat liver hepatectomy. For instance, Vanheule et al. [485] and Fan et al. [131]
resected the LML, RML, LLL, IRL, AC and PC to do a 90% resection, while
in contrast, Dahmen et al. [86] removed the LML, RML, LLL, SRL and IRL
(Fig. 8.2). In this study, the resection method of Fan et al. [131] was applied
virtually to the 3D reconstructions of the vascular trees. Consequently, a
resection of 70% corresponds with the removal of the LML, RML and LLL
(Fig. 8.2). A 80% resection corresponds with the additional removal of the
IRL, and in the case of a 90% resection, the AC and PC lobes are also re-
moved. Additionally, the 90% hepatectomy method of Dahmen et al. [86]
was also simulated to compare with the results of Fan et al. [131].
Boundary conditions were adapted (as dened below) and the vascular
resistances Rs of resected liver lobes were set to innity. e latter resulted
in a zero ux through the resected lobes.
8.2.6.1 Pressure-driven models
For the pressure-driven LDLTmodel, only the PPV was changed to be equal
to the PPV measurements immediately aer hepatectomy by Fan et al. [131],
being 8.2mmHg, 9.9mmHg and 11mmHg for the 70%, 80% and 90% partial
hepatectomy simulations, respectively (Table 8.2).
8.2.6.2 Flow-driven models
e boundary conditions for the ow-driven resected livermodelwere equal
to those of the ow-driven total liver model. In this way, the QPV ,total of the
resected liver was set equal to theQPV ,total measured before resection, being
7.4 ml/min.
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8.3 Results
8.3.1 Total liver model
Results of the total liver model are equal for the pressure- and the ow-
controlled model (Fig. 8.6), since they are both tuned to correspond to the
experimental measurements before hepatectomy performed by Fan et al.
[131] (Table 8.2).
Pressure proles (Fig. 8.6a) show similar trends for the dierent rat liver
lobes.e pressure drop is hereby largest in theHA tree before the sinusoids
(from 103 mmHg to a mean value of 3.2 mmHg). In parallel, the pressure
drops from 5.9 mmHg to a mean value of 3.2 mmHg in the PV tree. e
pressure aer the last HA and PV generation of every individual lobe is thus
equal. At this location, the blood enters the sinusoids which cluster until
they reach the HV and the vena cava caudalis at a pressure of 0.90 mmHg.
When looking closer to the sinusoidal pressure in the lobes (Fig. 8.6a), there
is a pressure range of 2.0 mmHg (LLL) to 4.8 mmHg (LML) at the entrance
of the sinusoids and 1.8 mmHg (LLL) to 3.9 mmHg (LML) at the outlet of
the sinusoids.
(a) Pressures (b) Flows
Figure 8.6: Results of the total rat liver model: (a) lobe-specic pressure proles as a func-
tion of the hepatic arterial (HA), portal venous (PV) and hepatic venous (HV) generation
numbers; (b) lobe-specic HA, PV and HV ows (QHA, l obe , QPV , l obe , QHV , l obe).
ere is a QHA,total into the liver of 3.2 ml/min and a QPV ,total of 7.4
ml/min.is results in aQHV ,total of 11ml/min, which is the sumofQHA,total
and QPV ,total . In contrast to the overall pressure proles, there is a clear dif-
ference in the lobe-specic ows (Qlobe ; Fig. 8.6b). is seems to be logi-
cal, since smaller liver lobes have a higher vascular resistance, resulting in a
smaller inow when experiencing similar pressure drops. Qlobe varies be-
tween 6.0 ⋅ 10−2 ml/min (IRL) and 1.3 ml/min (RML) for the HA tree, be-
tween0.41ml/min (LML) and 1.8ml/min (LLL) for the PV tree, and between
0.58 ml/min (IRL) and 3.0 ml/min (RML) for the HV tree.
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8.3.2 Resected liver models
Virtual resections lead to 3D reconstructions of the vascular trees aer a
70%, 80% or 90% hepatectomy, as demonstrated in Fig. 8.7 for the PV tree.
Results of the resected liver electrical models are depicted in Fig. 8.8 for the
pressure-controlled models and Fig. 8.9 for the ow-controlled models.
(d)(a) (b) (c)
IRL
SRL
AC
PC
Figure 8.7: Illustration of the virtual resections with the portal venous (PV) vascular tree
for a (a) 70%, (b) 80% and (c) 90% hepatectomy as performed by Fan et al. [131], and a (d)
90% hepatectomy as performed by Dahmen et al. [86] (with SRL and IRL the superior (cra-
nial) and inferior (caudal) right lobe, AC the anterior (ventral) and PC the posterior (dorsal)
caudate lobe).
8.3.2.1 Pressure-controlled models
e pressure-drivenmodel results in increased pressures throughout the PV
vascular tree (Fig. 8.8a-c) compared to the total liver model (Fig. 8.6a). As
such, the PVpressure drops from8.2mmHg, 9.9mmHg, 11mmHg at the PV
inlet to a mean value of 4.1 mmHg, 5.4 mmHg, 6.3 mmHg at the entrance of
the sinusoids for a 70%, 80% and 90% resection, respectively. Consequently,
the lobe-specic pressure at the entrance of the sinusoids increases to a range
of 2.4-5.3 mmHg, 4.7-6.2 mmHg and 6.3 mmHg for a 70%, 80% and 90%
hepatectomy, respectively, compared to the lower range before surgery (see
8.3.1).
On the other hand, QHV ,total was smaller aer hepatectomy than be-
fore, and is almost equal for the 70% and 80% resection (6.6 ml/min and 6.9
ml/min, respectively), but clearly smaller for the 90% resection (3.6ml/min).
is trend was also noticed for QPV ,total : 5.6 ml/min, 6.0 ml/min and 3.3
ml/min for a 70%, 80% and 90% partial hepatectomy, respectively. QHA,total
decreased in successive resections (1.0ml/min, 0.93ml/min and0.28ml/min
for a 70%, 80% and 90% resection, respectively). When looking atQlobe (Fig.
8.8d-f), it becomes clear that QPV ,lobe and QHV ,lobe in all remaining lobes
are increasing when performing resections of more liver mass. As such,
QPV ,lobe was 0.80-2.3 ml/min, 1.4-2.9 ml/min and 3.3 ml/min aer a 70%,
80% and 90% partial hepatectomy, respectively, while QHV ,lobe ranged be-
tween 0.86-2.6ml/min, 1.8-3.1 ml/min and 3.6ml/min. In contrast,QHA,lobe
was almost equal before and aer hepatectomy (with only a very small de-
crease).
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8.3.2.2 Flow-controlled models
e ow-controlled model results in a more distinct rise of the PV pressure
(Fig. 8.9a-c) in comparisonwith the pressure-controlledmodel. PVpressure
ranges from 11mmHg, 12mmHg, 23.8mmHg at the PV inlet to amean pres-
sure of 5.2 mmHg, 6.7 mmHg, 14 mmHg at the entrance of the sinusoids for
a 70%, 80% and 90% resection, respectively. Sinusoidal pressure elevations
are more pronounced with 3.0-6.6 mmHg, 5.6-7.4 mmHg, and 14mmHg for
a 70%, 80% and 90% resection, respectively.
Concerning the ows (Fig. 8.9e-g), QHA,total seemed to decrease again
in case of resections of more liver mass to 0.98 ml/min, 0.92 ml/min and
0.26ml/min for a 70%, 80% and 90% resection, respectively. QPV ,total , how-
ever, is determined by the PVboundary conditions (7.4ml/min for all cases).
QHV ,total was 8.3 ml/min, 8.3 ml/min and 7.6 ml/min aer 70%, 80% and
90%hepatectomy, respectively. QHA,lobe rangeswere 6.0⋅10−2−0.49ml/min,
0.16 − 0.48 ml/min and 0.26 ml/min for a 70%, 80% and 90% hepatectomy,
respectively. In contrast, QPV ,lobe was clearly increasing to 1.0− 3.0 ml/min,
1.8 − 3.5 ml/min and 7.4 ml/min for a 70%, 80% and 90% hepatectomy, re-
spectively. QHV ,lobe was also increasing: 1.1 − 3.3 ml/min, 2.2 − 3.8 ml/min,
7.6 ml/min for a 70%, 80% and 90% hepatectomy, respectively.
In addition, the ow-controlled model was used to simulate the haemo-
dynamic eects of a 90% resection as performed by Dahmen et al. [86]. Fig.
8.9d and h depict the results of the remaining AC and PC lobe. In compar-
ison with the results of the 90% resection method of Fan et al. [131] (Fig. 8.9
and 8.10), this approach results in slightly lower PPV (21 mmHg) and sinus-
oidal pressures (9.5mmHg and 12mmHg), but an almost threefoldQHA,total
(0.61 ml/min). QPV ,total andQHV ,total were 7.4 ml/min and 8.0 ml/min, re-
spectively. QHA,lobe ,QPV ,lobe andQHV ,lobe were 0.15−0.46ml/min, 3.6−3.8
ml/min and 3.9 − 4.0 ml/min, respectively.
  Baseline
(total liver)
               90% 
          resection
              (Fan)
               90% 
          resection
         (Dahmen)
(a) Portal venous pressure (b) Sinusoidal pressure (c) Total hepatic arterial inow
  Baseline
(total liver)
               90% 
          resection
              (Fan)
               90% 
          resection
         (Dahmen)
  Baseline
(total liver)
               90% 
          resection
              (Fan)
               90% 
          resection
         (Dahmen)
Figure 8.10: Comparison of simulation results for baseline conditions and 90% resection as
performed by Fan et al. [131] and Dahmen et al. [86]: (a) portal venous pressure (PPV ) and
(b) mean sinusoidal pressure, (c) hepatic arterial ow (QHA,total ).
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8.4 Discussion
8.4.1 Interpretation of the results
In this study, detailed anatomical data of the rat liver vasculature were ob-
tained by a combination of vascular corrosion casting and high resolution
micro-CT scanning. Geometrical data (up to 10 generations) showed ex-
ponential relations with the generation number, and accordingly, enabled
extrapolating the measurements. Subsequently, the blood ow through the
rat liver was simulated and tuned using a lobe-specic pressure- as well as
ow-controlled electrical analog model. Virtual resections of 70%, 80% and
90% liver mass were performed and modelled to compare normal liver hae-
modynamics with those of resected livers.
When comparing results of the pressure- and ow-driven models (Fig.
8.8 and 8.9), it is clear that haemodynamic LDLT eects (hyperperfusion re-
sulting in portal hypertension and SFSS complications) aremore pronounced
in the ow-controlled model. Flow-driven resection models resulted in PPV
and sinusoidal pressures up to 24 mmHg and 14 mmHg, respectively, while
the pressure-drivenmodel resulted inmoremoderate LDLT eects (PPV and
sinusoidal pressures up to 11 mmHg and 6.3 mmHg, respectively). Further-
more, QPV ,lobe and QHV ,lobe only moderately increased in case of pressure-
control (Fig. 8.8), while a more severe rise, as described in literature [114,
145, 242, 280], was observed with ow-control (Fig. 8.9).
An advantage of ow-control is that the PV boundary condition (7.4
ml/min) is equal for every case (total liver versus resection). Practically, this
means that an equal QPV ,total is imposed into the liver before and aer he-
patectomy, as was also found in [145, 280].
In the end, the ow-driven model seems to correspond more closely
with the clinically observed hyperperfusion and SFSS eects (e.g. an in-
creased PV ow relative to the remnant liver weight), and is therefore pre-
ferred over the pressure-controlled model to predict the impact of LDLT on
the hepatic haemodynamics.
More extensive liver partial hepatectomy results in more severe LDLT
eects as can be seen in Fig. 8.8 and 8.9. When focussing on the ow-
controlled models (Fig. 8.9), a 70%, 80%, 90% hepatectomy increases the
baseline PPV by 4.7 mmHg, 6.2 mmHg, 18 mmHg and the sinusoidal pres-
sure by 2.0 mmHg, 3.5 mmHg, 10 mmHg, respectively. In addition to ele-
vated pressures, 70%, 80% and 90% hepatectomy increases QHV ,lobe , e.g. for
the SRL lobe by 1.6 ml/min, 2.1 ml/min, 5.9 ml/min, respectively. As such,
a 70% and 80% hepatectomy results in an approximately two-fold increase
of the PPV as well as the QPV ,SRL and QHV ,SRL in comparison with the total
liver. A 90% resection results in more severe elevations of these parameters
approximately by a factor 4.is is in good agreement with Eipel et al. [114]
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who observed an approximately fourfold increase of the PV ow relative to
liver weight in the case of a 90% resection during in vivo rat experiments.
Since sinusoids are very prone to higher ows and the thereby induced
higher shear stresses, one of the key issues in LDLT complications is dam-
age at the endothelial lining of the sinusoids by hyperperfusion [86, 114,
415]. Yagi et al. [513] performed a human follow up study on 32 adult re-
cipients who underwent LDLT, and reported that PV pressures higher than
20 mmHg (as is the case in the 90% resection model) were associated with
poor survival. In the context of these ndings and based on our results, we
hypothesise that a 90% hepatectomy induces very severe hyperperfusion ef-
fects, damaging the microcirculation. In contrast, 70% and 80% resection
might also induce SFSS eects, but are less explicit. is also corresponds
to the ndings of Fan et al. [131], who stated that 90% resections were most
of the time lethal in case of their experiments, but resections of 70% and
80%were not. Other studies also report low survival rates when performing
90% hepatectomy: 31% [145] and 27% [114]. Interestingly, Dahmen et al. [86]
mentioned that 95% resection showed 50% survival and 97 % hepatectomy
was lethal, and hence, a 90% hepatectomy was not lethal in their approach.
Simulation of the 90% resection technique of Dahmen et al. [86] resulted in
slightly lower PV and sinusoidal pressures than for Fan et al. [131] (Fig. 8.9
and 8.10): sinusoidal pressures of 9.5 mmHg (AC) and 12 mmHg (PC) in-
stead of 14 mmHg (SRL). Moreover, the simulated QHA,total (0.61 ml/min)
was approximately the threefold of the simulatedQHA,total (0.26ml/min) us-
ing the method of Fan et al. [131], resulting in more oxygen-enriched blood
owing into the liver. Consequently, the dierence in survival outcome be-
tween the results of Fan et al. [131] and Dahmen et al. [86] could be as a
result of the choice of lobes resected by Dahmen et al., rather than the sur-
gical techniques employed.
8.4.2 Comparison of results with literature
In literature, several studies have been published concerning rat liver hepa-
tectomy experiments [86, 106, 114, 131, 145, 242, 280, 284, 298, 313, 314, 348].
Pressure and ow measurements at baseline, 67-70% and 90% hepatectomy
conditions of the most relevant studies are summarised in Table 8.4. Flows,
reported in other units than ml/min, were converted to ml/min by assum-
ing a rat body weight of 200 g and a total rat liver weight of 10 g at baseline
conditions (liver weight is approximately equal to 5% of the rat body weight
[312]). For a 67%, 70% and 90% resection, rat liver weight was assumed to
be 3.3 g, 3 g and 1 g, respectively. Note the wide range of data: at baseline for
instance, QPV ,total ranges from 4.7 ml/min [145] to 16 ml/min [114]. Hence,
the studies showno clear consensus concerning haemodynamic parameters.
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8.4. Discussion
It is however important to keep inmind that dierences in the experimental
setups (rat breed, age, gender, weight, hepatectomy techniques such as step-
wise resections versus one resection per animal, etc.) probably have a non-
negligible impact on the reported measurements.
Results aer partial hepatectomy agree on a signicant increase of the
PVandHVowper g livermass, but a slight decrease ofHAows (Table 8.4)
as is also the case in our LDLT model for the lobe-specic ows. Concern-
ing QPV ,total , some studies state a decreasing QPV ,total when performing
resections, while Fukuchi et al. [145] and Lee et al. [280] report an approx-
imately equal QPV ,total before and aer hepatectomy (as is also assumed in
our LDLT model). In contrast, there is consensus on the fact that QHA,total
and QHV ,total (slightly) decrease when resecting liver tissue.
Concerning pressures, Fukuchi et al. [145] showed approximately con-
stant PHA before and aer LDLT (as was also stated in [114] and assumed
in the model), while Dahmen et al. [86] observed signicant PHA pressure
drops when performing stepwise resections. PHV seem to be in the same
order of magnitude between studies. However, PPV range from 8.2 mmHg
to 12.9 mmHg and from 10.9 mmHg to 12.5 mmHg for a 70% and a 90%
hepatectomy, respectively.
e ow-controlled model shows relatively good accordance with the
reported values for a 70% and 90% hepatectomy, except for an overestima-
tion of the PPV (23.8 mmHg) for a 90% hepatectomy. is may be due to
the sinusoidal dilatation eect evoked by hyperperfusion [86, 145] result-
ing in an increased permeability of the sinusoidal endothelium [348]. As
such, Dahmen et al. [86] reported a signicant increase in sinusoidal di-
ameter when performing stepwise hepatectomy, most explicitly aer 90%
hepatectomy. As a result, 23.8 mmHg may be an overestimated PPV for a
90% resection, since the sinusoidal dilatation eect is not incorporated into
the model. However, the model hereby clearly illustrates the severe hae-
modynamic impact of 90% hepatectomy with harmful hyperperfusion ef-
fects leading to critical small-for-size complications. Consequently, we can
interpret the ow-controlled model as the ‘worst case scenario’ simulation
when performing a partial hepatectomy. In addition, it illustrates that a 90%
partial hepatectomy rather than a 70% or 80% hepatectomy should be con-
sidered as a proper (experimental) model for SFSS in rats.
8.4.3 Limitations
ough the liver vasculature was studied in detail, there were some limita-
tions. Since the HA tree typically had the smallest vessel radii, this led to
some diculties to segment and quantify HA vessels with the initial dual-
cast rat liver. is was probably caused by the particle size of the contrast
agent, getting trapped in the smaller HA generations. Eventually, the dual
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cast was used to study the PV and HV tree. In addition, a new HA cast
was obtained by injecting a second rat liver only through the arterial side
without contrast agent, and the HA tree could be segmented. However, HA
were small compared to the nite resolution and radius measurements of
subsequent HA generations were close to each other.is resulted in an ex-
trapolation to 19HAgenerations, which is a high number compared to the 12
PV generations, especially knowing that theHA and PV trees approximately
run parallel and count a similar number of generations. Subsequently, the
HA exponential trend lines were corrected to correspond with 12 HA gen-
erations. In addition, the last measured PV and HV generations were also
at the resolution limits. To overcome these problems (as also described in
[93]), nPV , nHV and lHV exponential equations were tuned (section 8.3.1;
Table 8.3).
As this study was based on data coming from only one HA, PV and HV
vascular tree, it is important to keep in mind that the ndings in this study
are indicative. For instance, anatomical variations are possible within the
same rat breed, which implies that this may have an inuence on the results
as is also illustrated in the literature overview of section 8.4.2. Using more
rat livers may thus result in more accurate predictions using the models.
In this study, an electrical analog model is used solely based on vascular
resistances.ough this is a simplication of the original model (which in-
cludes elasticity and inertia eects [93]), it was justied in this case because
our main interest was to analyse the DCmodel to obtain mean pressure and
ow proles throughout the liver generations. Since signal amplitudes (AC
component) caused by the heart frequency are almost absent at the micro-
circulatory level due to dampening througout the HA tree, DC components
of pressure and ow proles were sucient to quantify hyperperfusion ef-
fects at the level of the microvasculature which are prone to elevated ow
and shear stress [93].
e presented hepatectomy model does not include any adaptation and
is to be seen as providing a snapshot of the liver’s haemodynamic conditions
at the moment immediately aer partial hepatectomy.is moment is likely
to trigger a cascade of both acute and chronic adaptive events determining
the evolution of the liver towards either regeneration or failure, which are
not included in themodel. As such, a potential extension of themodelmight
be to incorporate liver adaptation and remodelling as a function of time.
8.4.4 Future perspective
ese models may be tuned for the human liver by repeating the presented
modelling approach in the human setting. As such,modelsmay be helpful in
predicting patient outcomes in the case of a partial hepatectomy. Moreover,
themodels could also be applied in other contexts, for which liver resections
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are required: split liver transplantation, liver resections due to hepatocellular
carcinoma etc.
8.5 Conclusion
In conclusion, our model indicates that a 90% hepatectomy leads to an ap-
proximately fourfold rise of QPV ,lobe and QHV ,lobe , which may damage the
microvasculature. e model may be applicable in the human context and
help to optimise surgical planning for partial hepatectomy procedures.
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Perfusion characteristics of the
human hepatic microcirculation
based on 3D reconstructions and
CFD analysis
is chapter is based on “Perfusion characteristics of the human hepatic mi-
crocirculation based on three-dimensional reconstructions and computational
uid dynamic analysis”, as published in Journal of Biomechanical Engineer-
ing, 134(1), 2012 [98].
9.1 Introduction
e blood ow through the liver is known to be unique and complex, espe-
cially at the level of themicrocirculation due to the fact that the liver receives
blood from the hepatic artery (HA) and the portal vein (PV) (see chapter 1)
[303, 317, 318, 321, 324, 409]. e HA and PV vascular trees branch until
they reach the microcirculation at the level of the so-called hepatic func-
tional units, typically considered as hexagonal lobules [311, 465, 466]. In this
conceptual model, each lobule receives blood from its periphery through
the hepatic arterioles and portal venules located in each of the portal triads
(Fig. 9.1). At the level of the lobules, HA and PV blood is mixed in the sinus-
oids (hepatic-specic capillaries) where themetabolic activity and exchange
of nutrients, oxygen etc. with the hepatocytes takes place. Subsequently,
the blood is drained radially towards the central veins. ese veins cluster
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until they reach the outow hepatic veins (HV) and the vena cava inferior
[311, 409].
Portal venule
Hepatic arteriole
Central vein
Sinusoids
Hepatic
Venous
outow
Hepatic
Arterial
inow
Portal 
Venous 
inow
Liver 
microcirculation
Figure 9.1: e human liver macrocirculation (le) and microcirculation (right). e liver
receives blood from the hepatic artery (HA) andportal vein (PV).eHAandPVbranch un-
til they reach the level of the microcirculation at the typical hexagonal lobules (right panel).
Every lobule receives blood from its periphery through the hepatic arterioles and portal
venules. ese are located in the portal triads at each corner of the lobule. Consequently,
HA and PV blood is mixed in the sinusoids and drained radially towards the central vein.
On their turn, the central veins cluster towards the outow hepatic veins (HV) and vena cava
inferior.
Despite the fact that this conceptual model of liver functional units is
widely used, liver perfusion is still relatively poorly understood. is has
implications for several liver-related research areas. In liver transplantation
research, the optimal conditions to preserve and perfuse donor livers, when
livers are subjected to (hypothermic) machine perfusion, are still poorly
dened [110, 146, 227, 340–342, 389, 458]. Moreover, the haemodynamic in-
uence of complications such as portal hypertension and the small-for-size
syndrome induced by living donor liver transplantation is being investiga-
ted [140, 151, 462]. In addition, similar questions arise in the case of liver
pathologies (cirrhosis, steatosis etc.) inuencing the liver perfusion, abla-
tion treatments for hepatocellular tumours, diagnosis etc. [444, 527].
Numerical models may be an important tool to study liver perfusion
on dierent scales (macrocirculation versus microcirculation), and lead to
a better understanding of the organ’s haemodynamics. Existing liver circu-
lation models, however, mainly focus on the liver macrovasculature, repre-
senting the branching of the HA, PV and HV vessels [93, 250, 328, 482, 516].
In contrast, only a few studies have been performed on the liver microcir-
culation, i.e. the sinusoids between the portal tracts and the central veins
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within the lobules (Fig. 9.1). ese studies were usually based on idealised
geometries and the conceptual hexagonal liver lobulemodel. Rani et al. [393]
studied the hepatic microcirculation using nite volume blood ow simula-
tions in an idealised 3D segment of a hepatic lobule including a terminalHA,
PV, HV and fenestrated sinusoidal space. Ricken et al. [402] developed an
idealised 2D model of the blood ow through a longitudinal transection of
liver lobules using a transverse isotropic permeability in the direction of the
central vein. Furthermore, a 2D porous model of the blood ow through
a hexagonal lobule transection was developed by Bonglio et al. [43], as-
suming an isotropic permeability and porosity for their rst model, and an
anisotropic permeability (radial versus circumferential) but isotropic poros-
ity for a second model. Wambaugh et al. [499] and Shah et al. [426] used a
graphical model with a discrete topology of the sinusoidal network to simu-
late the portal to centrilobular mass transfer of chemicals in a virtual tissue
representing a hepatic lobule.
e sinusoidal microvasculature is thus oen modelled as a porous me-
dium with an isotropic permeability and/or porosity, an assumption which,
to our knowledge, has never been validated. In addition, (human) liver mi-
crovascular ow has so far only been studied based on idealised geometries.
e aim of the present study is to numerically model the blood ow in the
human hepatic sinusoidal microcirculation based on micro-CT images of
real 3D sinusoidal geometries of a human liver, using computational uid
dynamic methods. Moreover, we investigated whether modelling the he-
patic sinusoidal microvasculature as a homogeneous isotropic material is a
valid approach by calculating the sinusoidal porosity as well as the permea-
bility tensor of the tissue.
9.2 Materials and methods
is study was executed using a human liver discarded for transplantation
aer failed rescue allocation by Eurotransplant (Leiden,e Netherlands).
As part of research related to machine perfusion preservation of the liver,
this study was approved by the Ethical Committee of the University Hospi-
tals Leuven (Belgium) and by the Belgian Liver and Intestine Committee. To
obtain the numericalmicrocirculationmodel and the corresponding results,
several steps were taken as described below: (1) vascular corrosion casting
and micro-CT imaging to acquire the sinusoidal geometry; (2) image pro-
cessing to calculate the 3Dmorphology; (3) the generation of the meshes for
the computational uid dynamics calculations; (4) dening the boundary
conditions for the simulations and post-processing of the data; (5) calcula-
tion of the permeability tensor.
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9.2.1 Vascular corrosion casting and micro-CT imaging
e human liver used for this study was recuperated from a human donor
discarded for transplantation based on strict medical criteria (in this case
because of steatosis). Although discarded, the liver showed no evidence of
relevant anatomical or vascular dierences compared to healthy livers. Aer
resection of the liver from the donor body, the liver was preserved using
hypothermic machine perfusion (HMP) as described in [93] and chapter
6. Even though the advantage of HMP is that the microvasculature is kept
open and intact, the combination of HMP and casting might have had an
eect on themicrocirculation. Nevertheless, the dimensions of the sinusoids
were in good agreement with the sinusoidal dimensions found in literature
[169, 324, 409].
e goal of the vascular corrosion casting procedure was to obtain a
replica of the vascular trees of a human liver. A human liver with a nor-
mal macroscopic appearance was simultaneously injected with a polymer
through the HA and the PV.e injection uid contained Batson’s #17 mon-
omer solution (100 parts), Batson’s catalyst (15 parts), Batson’s promoter (1
part) (Polysciences, Florida, USA) andmonomericmethyl methacrylate (20
parts) (Merck, Darmstadt, Germany).e liver was injected until sucient
quantities of resin were emerging from the HV. Subsequently, all vessels
were clamped and the injected uid polymerised during a period of approx-
imately 2 hours. Aerwards, the liver tissue wasmacerated in potassium hy-
droxide (25%KOH) to generate the polymerised vascular replica. More elab-
orate details about the vascular corrosion casting procedure can be found in
[93].
A small volume sample (approximately 2.0 mm x 1.5 mm x 1.7 mm), was
dissected from the superior part of the right lobe to study the smallest vessels
of the liver. To assure that the sinusoids were suciently lled during cast-
ing, this sample was imaged by scanning electron microscopy (SEM; JEOL
JSM 5600 LV, Jeol, Zaventem, Belgium).is resulted in the SEM image of
the geometry shown in Fig. 9.2a. e intertwined and interconnected liver
sinusoids are clearly visible, giving evidence of a liver cast of which the mi-
crocirculation was clearly lled with the injected polymer. e sample was
subsequently imagedwith an in-house developed high-resolutionmicro-CT
scanner to obtain the 3D geometry with a resolution of 2.6 µm (see [93] and
chapter 6 for more information).
9.2.2 Image processing
e digital micro-CT datasets were processed using the soware package
Mimics (Materialise, Leuven, Belgium). e dataset was segmented based
on its grey values to extract the features of the liver lobules and sinusoids,
and a 3D reconstruction was calculated, leading to the visualisation of three
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(a) (b)
r
θ z
150 µm
 Inow guidance
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Figure 9.2: (a) Scanning electron microscopic image of the sample that was dissected out of
the human liver cast. e intertwined and interconnected liver sinusoids are clearly visible
in this cast sample representing three liver lobules. (b) 3D reconstruction of the simulation
geometry of the case in which a pressure dierence is established in the r direction. e
origin (0,0,0) is located at the centre of the sample. e inow and outow guidances are
clearly visible, as well as an illustration of the surfacemesh density.emeshes existed of ap-
proximately 1 million triangular surface elements and 9million tetrahedral volume elements
capturing the sinusoidal geometrical features.
liver lobules (see Fig. 9.2a) or three primary modules according to Teutsch
[465]. Consequently, this dataset was used to investigate the hepatic vascular
microstructure and its dimensions by measuring lobule and sinusoid diam-
eters. Because of the total dataset size and computer performance restric-
tions as well as computational costs, a sample was virtually dissected (Fig.
9.2b and 9.3) by calculating the intersection between a cube with predened
dimensions (0.15 x 0.15 x 0.15 mm3) and a lobule by using Magics (Materi-
alise, Leuven, Belgium). As such, the uid domain for the computational
uid dynamics model was created. However, it was not straightforward to
identify the individual classical liver lobules in the dataset (hexagonal prism-
like structures; Fig. 9.1 and 9.3), since it was dicult to localise the portal
triads (consisting of the terminal branches of the HA and PV as well as the
intrahepatic bile ductules) at the boundaries of the lobules in a human liver
(lobules are clearer delineated by connective tissue in other species such as
rat and porcine livers). e nal segmentation was based on the identi-
cation of the vascular septa in between lobules which appeared brighter on
the micro-CT images.is was due to contrast agent particles added to the
HA casting injectate. ese particles were probably captured before enter-
ing the sinusoids because of their particle size and, hence, delineated the
lobule boundaries. As illustrated in Fig. 9.3, the dissected cube was oriented
such that the origin (0,0,0) was at the centre of the sample and its z axis
was approximately parallel to the direction of the central vein (i.e. longitu-
dinally according to the liver lobule schematic with a hexagonal prism-like
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geometry). In addition, its transections perpendicular to the z axis were
located in the area which we considered to be in between the central vein
and the HA and PV at the portal triads. is resulted in the r and θ axis
being oriented along the radial and circumferential directions, respectively,
according to the hexagonal transection of the lobule (Fig. 9.3).
Central vein
Portal venule
Hepatic arteriole
r
θ
z
θ
Central vein
Portal venule
Hepatic arteriole
Figure 9.3: Dissection of the sample used for the numerical simulations: transectional (le)
and longitudinal side (right) views of a hexagonal lobule with indications of the location of
the dissected sample. A cube with dimensions (0.15 x 0.15 x 0.15 mm3) was dissected of a
liver lobule.e dissected cube was oriented in such a way that its z axis was approximately
parallel to the direction of the central vein (longitudinal according to the liver lobule). In
addition, the r and θ axis were approximately oriented along the radial and circumferential
directions, respectively, according to the hexagonal transection of the lobule.
9.2.3 Mesh generation
As we wish to assess the complete permeability tensor of the sample (see
also 9.2.5), three computational uid dynamics cases (and meshes) were de-
veloped corresponding to a simulation of ow in the r, θ and z directions,
respectively. For each of the setups, a dedicated simulation geometry needed
to be created. An inow and outow box was added (height being 10% of
the sample height) as a ow guidance proximal to the inlet and distal to the
outlet, respectively (Fig. 9.2b).is was done to avoid convergence problems
caused by toomany inlets and outlets, as well as to avoid forcing a predened
ow through the inlet sinusoids [299].
e obtained surface geometries were processed using 3-Matic (Materi-
alise, Leuven, Belgium) to provide good quality surface meshes of the uid
domain. First, noise shells were removed (e.g. a part of a bisected sinus-
oid which is not attached to the rest of the sinusoidal uid domain). Sub-
sequently, the meshes were improved by removing double or intersecting
triangles and lling small holes which may originate from mesh manipula-
tions. Next, the geometries were remeshed with a maximum triangle edge
length of 1.2 µm to capture the morphological features of the geometries
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studied, followed by a quality preserving reduction of triangles. To this pur-
pose, some channels with a very small diameter had to be rened because
they would otherwise collapse during the remeshing procedure. In a last
step, the surface meshes were further manually improved to result in a sur-
face mesh of which all triangles had a skewness less than 0.6.e resulting
surface meshes were then exported to TGrid (Ansys, Pennsylvania, USA) to
generate volume meshes. e volume meshes consisted of tetrahedral cells
with a maximal skewness less than 0.95.e resulting meshes existed of ap-
proximately 1 million triangular surface elements and 9 million tetrahedral
volume elements clearly capturing the sinusoidal geometrical features (Fig.
9.2b).
9.2.4 Computational uid dynamics simulations & post-processing
e steady and laminar computational uid dynamics models were solved
using Fluent (Ansys, Pennsylvania, USA).e inlet boundary condition con-
sisted of a at velocity prole at the top plane of the inow guidance (plane
dened by a r, θ, z coordinate equal to 90 µm for the r, θ, z ow simulation,
respectively; see Fig. 9.2). Since there are, to the authors’ knowledge, no lit-
erature data available on the ow velocities in three orthogonal directions
for the human hepatic microcirculation, the applied velocity was estimated
by scaling down the total liver blood ow to the ow through the sample
studied (eq. 9.1).is was done by using literature values of the average hu-
man liver blood ow Ql iver (1450 ml/min), the average liver massml iver (1.4
kg) [311], density ρ (1000 kg/m3 equal to water) and the dimensions of the
sample studied (volume Vsample = 0.153 mm3; area of inow plane Asample =
0.152 mm2). Using eq. 9.2, this resulted in a velocity inlet v of 2.59⋅10−6 m/s.
Qsample = Ql iver ρ ⋅ Vsampleml iver (9.1)
v = Qsample
Asample
(9.2)
As outlet boundary condition, a pressure outlet of 0 Pa was used at the
bottom (plane dened by a r, θ, z coordinate equal to -90 µm for the r, θ,
z ow simulation, respectively; Fig. 9.2b).e lateral boundaries existing of
transected sinusoidswere set to symmetry boundary conditions implying no
ux perpendicular to these planes.e sinusoidal lumen was modelled as a
closed wall (no slip). Blood was modelled as an incompressible Newtonian
uid with a density of 1050 kg/m3 and a dynamic viscosity µ of 3.5⋅10−3 Pa⋅s
[482]. Tecplot (Tecplot Inc., Washington, USA) was used to process, calcu-
late and visualise the haemodynamic parameters of interest such as pressure
dierence, ow velocity, wall shear stress, ow trajectories, etc.
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9.2.5 Calculation of the permeability tensor
Subsequently, the permeability tensorK (eq. 9.3; [286])was assessed to quan-
tify the permeable behaviour of the sinusoidal perfusion in dierent direc-
tions for the dissected sample (Fig. 9.3).e permeability tensor denes the
permeability of the tissue in the r, θ or z direction caused by the pressure
dierence in the r, θ or z direction. For instance, krθ species the permea-
bility along the r direction due to the pressure dierence in the θ direction
[286].
K = ⎡⎢⎢⎢⎢⎢⎣
krr krθ krz
kθr kθθ kθz
kzr kzθ kzz
⎤⎥⎥⎥⎥⎥⎦ (9.3)
e permeability tensor is calculated based on Darcy’s law, which de-
scribes the uid ow through a porous medium (eq. 9.4 with P the pressure
[Pa], µ the dynamic viscosity [Pa⋅s], k the permeability [m2] and v the velo-
city [m/s]).
v⃗ = − k
µ
∇P (9.4)
Darcy’s law can be rewritten for every pressure dierence direction sep-
arately inducing uid ow in the r, θ and z direction. is is illustrated in
eq. 9.5-9.7 for a pressure dierence in the r direction with L [m] the charac-
teristic length of the sample studied.
∆Pr
Lr
= − µ
krr
vr (9.5)
∆Pr
Lr
= − µ
kθr
vθ (9.6)
∆Pr
Lr
= − µ
kzr
vz (9.7)
e velocity magnitude in eq. 9.5-9.7 can be calculated as the corres-
ponding ow Q [m3/s] divided by the area A [m2].is is illustrated in eq.
9.8-9.10 in which Darcy’s law is rearranged to calculate the corresponding
permeability coecients for the pressure dierence in the r direction.
krr = −µ Lr∆Pr QrAr (9.8)
kθr = −µ Lr∆Pr QθAθ (9.9)
kzr = −µ Lr∆Pr QzAz (9.10)
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For each of the 3 computational uid dynamics cases (simulation of ow
in the r, θ and z direction), een cubic samples with a characteristic length
of 50 µmwere studied to determine the permeability tensor to allow for some
statistical sampling of the simulated specimen. e cubes were dened by
the coordinates as shown in Table 9.1. ey were positioned such that they
did not include the boundary regions, since the ow behaviour in those
regions is inuenced by the prescribed lateral boundary conditions (sym-
metry; no ux). For every cubic sample, all permeability coecients were
calculated based on eq. 9.8-9.10. e pressure dierences ∆P were calcu-
lated by subtracting the mean pressure of the inow plane of the studied
cubic sample from the mean pressure of the outow plane (eq. 9.11 for the r
direction).
∆Pr = Pr,in f low − Pr,out f low (9.11)
e characteristic lengths L (50 µm) and areas A (2.5⋅10−3 mm2) were
equal for all cubes since they had the same dimensions. e ow Q in eq.
9.8-9.10 was calculated as the average ow of the volumetric ows through
5 parallel planes equally distributed over the length of the cube and per-
pendicular to the permeability direction studied. is was implemented
in Fluent by writing journal les to obtain the necessary bounded planes.
Table 9.1: Coordinates of the cubes (characteristic length 50 µm) dissected from the simula-
tion geometry (characteristic length 0.15 mm; Fig. 9.2b).ese cubes were used to calculate
the permeability tensor.e boundaries of the cubes are given by specifying the upper and
lower limits of the r, θ and z coordinates, respectively. e origin (0, 0, 0) is located at the
centre of the sample dissected from the dataset (see also Fig. 9.3).
Cube rmin [µm] rmax [µm] θmin [µm] θmax [µm] zmin [µm] zmax [µm]
1 -25 25 -25 25 -25 25
2 -50 0 0 50 0 50
3 0 50 0 50 0 50
4 -50 0 -50 0 0 50
5 0 50 -50 0 0 50
6 -50 0 0 50 -50 0
7 0 50 0 50 -50 0
8 -50 0 -50 0 -50 0
9 0 50 -50 0 -50 0
10 -25 25 -25 25 0 50
11 -25 25 -25 25 -50 0
12 -25 25 -50 0 -25 25
13 -25 25 0 50 -25 25
14 0 50 -25 25 -25 25
15 -50 0 -25 25 -25 25
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Aer calculating the permeability tensor for every separate cube, the mean,
standard deviation and median values of all permeability coecients were
determined. e normality of the distribution of the permeability coe-
cients was veried by means of a Shapiro-Wilk test using SPSS (IBM, New
York, United States). Additionally, the principal axes (dened by the eigen-
vectors) as well as the permeability values in the principal directions were
calculated from the permeability tensor K (see Appendix A for the linear al-
gebraic equations).is allows quantifying the angles between the original
coordinate system axes and the principal axes of the permeability tensor.
Finally, the 3D sinusoidal porosity was also determined (using Magics so-
ware) for every cube (as dened by the coordinates in Table 9.1) by dividing
the volume occupied by the sinusoids by the volume of the cube studied (eq.
9.12).
ε = Vsinusoids
Vcube
(9.12)
9.3 Results
9.3.1 Image processing and geometrical analysis of the liver
microcirculation
Scanning electron microscopy of the microcirculation sample shows that
casting resin was observed in the sinusoids (Fig. 9.2).e sample represents
a complex network of interconnected and tortuous sinusoids (Fig. 9.4c-d).
Measurements of one hundred sinusoids resulted in amean diameter of 13.23± 2.36 µm.
9.3.2 Calculation of the permeability tensor
e computational uid dynamics simulation results are represented in Figs.
9.5-9.8. Fig. 9.5 illustrates the static pressure visualisation on the boundaries
of the 3 cases.e pressure dierences over the cube along the r and θ ow
directions are very similar (approximately ranging from 0 to 170 Pa and 0 to
180 Pa, respectively). In contrast, the pressure dierence for the simulation
of blood ow in the z-direction is clearly smaller (0-100 Pa), while applying
the same boundary conditions as in the r and θ ow simulations (velocity
inlet of 2.59⋅10−6 m/s at the top and zero pressure outlet at the bottom).
As visualised in Fig. 9.5, the pressure drops signicantly through certain
sinusoids and stays almost constant throughout others. is corresponds
to the typical presence of preferential pathways in the sinusoidal geometry
along trackswith relevant pressure drops. Fig. 9.6 depicts some of these pref-
erential streamlines coloured by their velocity magnitude. e preferential
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(a)          (b)
(c)          (d)
Figure 9.4: Livermicrocirculation. (a) Singlemicro-CT slice showing bright spots (probably
contrast agent particles); (b) indication of the most likely lobule borders; (c) 3D reconstruc-
tion of the microcirculation sample and (d) of a virtually dissected cubic subsample.
paths seem to be mainly concentrated in the middle region of the geometry,
and not at locations near to the transected sinusoids delineating the lateral
boundaries. is is obviously a consequence of the symmetry boundary
condition applied at the sides.e velocity magnitude approximately ranges
from 0 to 1.4⋅10−3 m/s, 0 to 2.6⋅10−3 m/s, 0 to 1.1⋅10−3 m/s for the case of a
pressure dierence in the r, θ , z directions, respectively.e mean velocity
in all of these cases is typically at the lower end of these ranges as can be
deducted from the streamlines in Fig. 9.6.
Since the boundary conditions are likely to inuence the solution, data
of a smaller central cube of 50 µm (cube 1 as dened in Table 9.1) are further
analysed tominimise the boundary induced eects.e velocity magnitude
in the smaller cube has a mean value of 1.0⋅10−4 m/s, 7.3⋅10−5 m/s, 7.7⋅10−5
m/s for the r, θ, z ow simulations, respectively.
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For the major part of the model boundaries, wall shear stress remains
below 1 Pa for each of the simulations (Fig. 9.7). At narrow channel loca-
tions, however, higher values are found. Histograms of the wall shear stress
distribution for the central cube (cube 1 in Table 9.1) are depicted in Fig. 9.8.
Overall, very low wall shear stresses cover the major part of the sinusoidal
lumen surface. e mean wall shear stress in the central cube for the r, θ
and z simulation was 0.42 Pa, 0.31 Pa, and 0.28 Pa, respectively.e corres-
ponding local maximum wall shear stress was 6.62 Pa, 4.19 Pa, and 3.80 Pa,
respectively.
9.3.3 Porosity and permeability tensor
e sinusoidal porosity was calculated for every cube as dened by the co-
ordinates in Table 9.1, and values are depicted in the last column of Table 9.2.
e resulting mean porosity was 14.3% ± 2.8%.e components of the per-
meability tensor for each of the 15 subsampled cubes are given in Table 9.2.
As the Shapiro-Wilk test indicated that the distribution of the resulting per-
meability coecients was not normal for 4 out of 9 coecients (signicance
level of 0.1; see Table 9.2), the overall permeability tensor for the sample is
best based on the median values (as shown in eq. 9.13 and 9.14) to avoid a
large inuence of outlier values.
K = ⎡⎢⎢⎢⎢⎢⎣
krr krθ krz
kθr kθθ kθz
kzr kzθ kzz
⎤⎥⎥⎥⎥⎥⎦ (9.13)
= ⎡⎢⎢⎢⎢⎢⎣
1.78 ⋅ 10−14 −1.29 ⋅ 10−15 −7.20 ⋅ 10−15
1.07 ⋅ 10−15 1.76 ⋅ 10−14 −1.06 ⋅ 10−15−5.45 ⋅ 10−15 2.73 ⋅ 10−15 3.43 ⋅ 10−14
⎤⎥⎥⎥⎥⎥⎦ (9.14)
Calculating the eigenvectors of the permeability tensor as illustrated in
Appendix A, resulted in the principal axes determined by the eigenvectors
(e⃗1,e⃗2,e⃗3) in matrix V (eq. 9.15) and the corresponding diagonal matrix Kd
with the permeability values along the principal axes (eq. 9.16 and 9.17).
V = [e⃗1 e⃗2 e⃗3] = ⎡⎢⎢⎢⎢⎢⎣
0.943 0.0924 −0.320−0.0827 0.996 0.0438
0.323 −0.0148 0.946
⎤⎥⎥⎥⎥⎥⎦ (9.15)
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Kd = ⎡⎢⎢⎢⎢⎢⎣
kd ,11 0 0
0 kd ,22 0
0 0 kd ,33
⎤⎥⎥⎥⎥⎥⎦ (9.16)
= ⎡⎢⎢⎢⎢⎢⎣
1.56 ⋅ 10−14 0 0
0 1.75 ⋅ 10−14 0
0 0 3.64 ⋅ 10−14
⎤⎥⎥⎥⎥⎥⎦ (9.17)
Using these results, the angles between the original coordinate system
axes and the principal axes were 19.5°, 5.4° and 18.9° for the r, θ and z axes,
respectively. e principal axes coordinate system would thus be obtained
by rotating the original orthogonal coordinate system approximately -19°
around the θ axis. In addition, the permeability coecients in the prin-
cipal directions (diagonal coecients of Kd) show that the permeability in
the central vein direction (kd ,33 = 3.64⋅10−14 m2) is higher than the corres-
ponding permeabilities in the radial and circumferential directions (kd ,11 =
1.56⋅10−14 m2 and kd ,22 = 1.75⋅10−14 m2, respectively) which are almost equal.
9.4 Discussion
In this paper, a numerical model of the human liver microcirculation has
been developed based on a 3D image-based geometry of the liver sinusoids,
and was used to study the uid mechanical characteristics of perfusion at
the sinusoidal level.e model presented in this study is, to the best of our
knowledge, unique in its kind and provides a further step towards a more
quantitative assessment of the perfusion properties of the liver microcircu-
lation.
In contrast to the larger hepatic vessels (see chapter 5), the microcir-
culation gives evidence of a completely dierent type of organisation com-
pared to vascular trees. Tortuous sinusoids form an interconnected and in-
tertwined network embedded in a matrix of liver cells. Consequently, the
exponential behaviour of the HA, PV and HV trees probably stops at the
level of the terminal microcirculation (where blood is drained from the ter-
minal hepatic arterioles and portal venules into the sinusoids). From our
data, macro- andmesovesselsmay be interpreted as ‘distributing’ vessels (see
chapter 5), ensuring that blood reaches all liver lobules, and the sinusoids
may be interpreted as ‘functional’ vessels, ensuring that blood solutes are
able to penetrate through sinusoidal fenestrations into the space of Disse
and reach the microvilli of hepatocytes for metabolic exchange. e mi-
crovascular sample clearly shows sinusoidal structures (Fig. 9.2; meaning
that the casting resin was able to ll the sinusoids) and is thought to include
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three liver lobules. Hereby, the vascular septa of lobules seem to be high-
lighted by contrast agent particles (bright dots in Fig. 9.4a).ese particles
are probably not able to penetrate into the sinusoids because of their size,
leaving them trapped at the vascular septa, (partially) delineating the lobule
borders (Fig. 9.4b). Accordingly, the sample represents three liver lobules
(Fig. 9.4a-b) and based on these contours, lobule diameters were in the or-
der of 700-800 µm. As illustrated, it is not obvious to distinguish between
neighbouring lobules.is might be due to the fact that the human liver mi-
crocirculation is characterised by less connective tissue delineating its lobule
borders in comparison with pig or rodent livers, oen used as animal liver
models. Furthermore, lobules can have more irregular shapes than the tra-
ditionally hexagonal prism-shaped lobules. Concerning this, literature gives
evidence of an ongoing discussion on the most appropriate functional unit
to represent the liver microcirculation (e.g. hexagonal lobule, primary lob-
ule, liver acinus etc.) [409].
e sample that formed the basis of the model was obtained from a cast
of the human liver, and oriented such that - bearing in mind the functional
liver lobule unit - the z-axis was approximately aligned parallel to the cen-
tral vein. Our data indicate that the pressure dierence in the z direction is
typically smaller than those in the r and θ directions. Since the pressure dif-
ference can be interpreted as a degree of resistance to ow (given the same
boundary conditions in all 3 cases), the resistance to ow is smallest in the z
direction.is corresponds with the resulting diagonal permeability tensor
Kd in which kd ,33 is clearly larger than kd ,11 and kd ,22 (which are approxi-
mately equal), implying highest permeability of the liver lobule parallel to
the direction of the central vein (kd ,33). Radial (kd ,11) and circumferential
(kd ,22) permeabilities, as seen in the plane of a hexagonal transection of a
lobule, are of a similar magnitude (Fig. 9.3). Since rotating the original co-
ordinate system -19° around the θ axes approximately equals the principal
axes determined by the eigenvectors, this suggests that the orientation and
corresponding coordinate systemas applied in this study, are reasonablywell
aligned along the principal directions of permeability.e immediate result
of these ndings is that the sinusoidal circulation is clearly anisotropic. Con-
sequently, the assumption of a homogeneous isotropic tissue seems insu-
cient to describe the porous behaviour of the sinusoidal microvasculature.
Given the fact that the study is based on one sample from one human
liver cast, results should be interpreted as indicative and one should be re-
luctant to generalise our ndings. More samplesmight allow a better estima-
tion of these characteristics and identify potential regional heterogeneities in
tissue properties of the liver under study, but imply a very labour-intensive
procedure to acquire good geometries and meshes. Consequently, only one
sample was studied, of which, however, subsamples were used to character-
ise the permeability of liver tissue. Care was taken to make sure that the
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sinusoidal heterogeneity was suciently covered when selecting the sample
to study. A cubewith dimensions of 0.15 x 0.15 x 0.15mm3 seemed to be su-
cient to capture the heterogeneity of tortuous and interconnected sinusoids.
In the process of developing the computational uid dynamics model
geometry, it was inevitable to make compromises and take decisions that
have an impact (whichwe tried tominimise) on the simulation results. Some
sinusoids, for instance, were cut when dissecting the cubic sample. As a con-
sequence, these transection planes of bisected sinusoids had to be dened
as a boundary condition. Symmetry conditions were applied resulting in no
ux through the boundary sections. However, in reality these sinusoids are
continuous and ux is possible. To minimise the inuence of these bound-
ary induced eects on the results, we limited the quantitative analyses to
cubes at a certain minimal distance (25 µm which is equal to 16.6% of the
characteristic length of 0.15 mm) from these boundaries (Table 9.1).
In this study, blood is modelled as an incompressible and Newtonian
uid with a constant density and dynamic viscosity. It is, however, known
that the haemodynamic behaviour of blood at the microcirculation level is
dierent from the behaviour at the macrocirculation level (non-Newtonian
uid, Fahraeus-Lindqvist eect [28]). However, the assumption of an in-
compressible and Newtonian uid is justied for this study, since the Fah-
raeus-Lindqvist eect at sinusoidal diameters (±10 µm) indicates viscosit-
ies near that of blood plasma, which is close to a Newtonian uid. When
assuming a Newtonian uid and geometrically similar structures, the per-
meability tensor is independent of the uid studied and is a purely geomet-
rically determined parameter.e reported shear stress levels, on the other
hand, might not fully reect the haemodynamic stress exerted by the blood
in vivo. Note, however, that they might be indicative of shear stress exerted
by blood-mimicking liquids upon machine perfusion of isolated organs for
transplantation.
Our model and results can be compared with some studies based on
idealised microcirculation models, in particular the 2D models of Ricken et
al. [402] and Bonglio et al. [43]. However, both 2Dmodels lack one dimen-
sion which has a non-negligible inuence on the resulting ow behaviour.
emodel of Ricken et al. [402] does take into account longitudinal sections
of idealised lobules with the central veins and hepatic arterioles, while mod-
elling the liver microcirculation using a biphasic approach. On the contrary,
the model of Bonglio et al. [43] focuses on the hexagonal transection of a
liver lobule to build a porous medium model of the liver microcirculation.
In this study, a porosity estimate (ε = 12%) based on brain tissue imaging,
was used to calculate the corresponding sinusoidal permeability.is value
is somewhat lower than the porosity acquired in our study (14.3% ± 2.8%).
e results of our study can lead to new, improved models using po-
rous media to simulate the behaviour of the liver microcirculation taking
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into account the anisotropy. Moreover, these models could also be applied
to liver perfusion settings other than the natural blood ow, such as the hae-
modynamic conditions experienced by the microcirculation in the case of
liver pathologies, treatments and transplantation procedures such as ma-
chine perfusion preservation, ischaemia reperfusion etc.
9.5 Conclusion
Vascular corrosion casting and micro-CT scanning allowed to generate mi-
crocirculation morphological data. ese data enable gaining more insight
into structural-related characteristics (porosity, permeability tensor), which
allow capturing and modelling the microcirculation behaviour (especially
relevant when studying microvascular alterations caused by e.g. cirrhosis).
A 3D numerical microcirculation model of a human liver was construc-
ted and the resulting data indicate that the human hepatic microcirculation
clearly displays anisotropic behaviour in terms of permeability, which was
quantied bymeans of a permeability tensor. In particular, a higher permea-
bility was demonstrated along the direction of the central vein, and about
two times lower but approximately equal permeabilities along the radial and
circumferential directions of the liver lobule. Since the permeability coe-
cients depend on the ow direction, liver microcirculation models should
take into account sinusoidal anisotropy.
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A 3D porousmedia liver lobule
model: the importance of vascular
septa and anisotropic permeability
for homogeneous perfusion
is chapter is based on “A 3D porous media liver lobule model: the impor-
tance of vascular septa and anisotropic permeability for homogeneous per-
fusion”, Computer Methods in Biomechanics and Biomedical Engineering,
2012 [99].
10.1 Introduction
e perfusion of the liver is complex and distinct from that of other organs,
mainly due to its dual blood supply from both the hepatic artery and the
portal vein [93, 311, 342, 409]. In particular, themicrocirculation on the scale
of the liver lobules and sinusoids displays complicated haemodynamics [118,
169, 311, 317, 318, 409, 466].
In the literature, microperfusion of the liver is oen schematically re-
presented in terms of classical lobules, each having the shape of a hexagonal
prism (Fig. 10.1) [311, 409]. Liver lobules are assumed to be congured in
a tessellating pattern, similar to the organisation of hexagonal wax cells in
the honeycombs of bees. Blood enters a lobule via the portal tracts (PTs),
located at the corners. Each PT contains a hepatic arteriole (supplying the
liver with oxygenated blood), a portal venule (providing nutrient-rich blood
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from the intestines), and a bile duct. e latter drains the bile produced in
the lobule in the opposite direction from the blood ow in the PTs. A frac-
tion of the blood from the PTs enters the vascular septa (VS), which are the
vascular surfaces between neighbouring lobules, bordered at opposite edges
by two PTs (Fig. 10.1). As such, the VS foresee the blood supply of the tissue
between PTs by a number ofmicrovessels branching o the PTs. Blood ows
from the PTs and VS into the interconnected network of tortuous sinusoids,
which are the hepatic-specic capillaries and are lined by a fenestrated en-
dothelial cell layer. Blood solutes can ow through the fenestrations into
the space of Disse, which is the space between the endothelial cells and the
hepatocytes. Here, the metabolic exchange (e.g. oxygen or nutrient uptake)
takes place with the neighbouring hepatocytes.e blood is further drained
from the sinusoids into the central vein (CV), and from there into the he-
patic veins and vena cava inferior [311, 409]. Due to the liver’s microvascular
organisation and its metabolic functions, liver lobules are characterised by
metabolic zonation [409, 532]. For example, the cell zone closest to the PTs
will receive blood that is rich in nutrients and oxygen, while the zone close
to the CV receives blood that is poorer in nutrients and oxygen. Although
the liver lobule is the most frequently used functional liver unit, a number
of other units has been proposed in the past, such as the hepatic acinus [394]
(dotted line in Fig. 10.1b) and the primary lobule [317, 318]. Nevertheless, the
actual real 3D structure of the liver microcirculation seems to be more com-
plicated, as was illustrated in one of our previous papers ([98]; chapter 9), on
the basis of a high resolution 3D micro-CT dataset of the human liver mi-
crocirculation, and liver lobules are not always perfect prisms. Additionally,
variations are frequently observed in the number of PTs per lobule (poly-
hedral lobules with four, ve or seven corners instead of six).
Hepatic arteriole
Central vein
Sinusoids
Portal
tract
Vascular septum
Bile duct
Portal venule
(a) (b)
Figure 10.1: Schematic representation of the hepatic microcirculation. (a) Liver lobule with
the shape of a hexagonal prism and its vascular network; (b) Spatial organisation of the liver
lobules. A liver acinus is indicated by the white dotted line.
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Until now, our knowledge of the liver microcirculation is mainly based
on schematic concepts, and its haemodynamic behaviour is still not fully
understood. Especially in the case of abnormal liver conditions, the livermi-
crocirculation plays a crucial role: when impaired or damaged (for instance
due to disease), this can result in a loss of liver function due to the tight
coupling between liver microperfusion and its metabolic function. Con-
sequently, it is necessary to gain more insight into liver microvascular hae-
modynamics to also have a deeper understanding of function. Previously,
numerical models have been used successfully to better understand the mi-
crocirculation.ese models (or modelling techniques) might be helpful to
understandmicrohaemodynamics in a healthy liver as well as in liver patho-
logy. Knowing that the microcirculation operates within relatively narrow
ranges of haemodynamic conditions,microcirculation alterationsmight lead
to biomechanical stressors (high shear stresses, high wall stresses). As such,
these numerical models are applicable to investigate transplant-related phe-
nomena (for which the preservation of the hepatic microcirculation is cru-
cial for the viability of the liver gra [340, 341]), pathology-relatedmicrovas-
cular alterations (e.g. in the case of brosis, cirrhosis [69, 486], hepatocellu-
lar carcinoma [302], steatosis [408], portal hypertension [140, 513]), as well
as surgery-induced eects (e.g. small-for-size liver syndrome [163, 218, 462]
aer partial hepatectomy). For example, cirrhosis is known to alter and de-
teriorate the liver’s microvessel structure leading to higher vascular resis-
tances, which could be modelled by changing structure-related parameters
such as the permeability. Next to these applications, reduced order versions
of these models may also be implemented in larger scale models (e.g. [93])
to capture the total liver haemodynamics, incorporating the macro- as well
as themeso- andmicrocirculation and the interaction of the liver with other
organs in whole system models.
However, only a few models on the topic of liver microhaemodynamics
have been published, which might be due to the complexity of the liver mi-
crocirculation and the diculties associated with the acquisition of the re-
quired anatomical and functional data at sucient resolution. A few studies
focused on modelling the lobule haemodynamics based on porous medium
approaches, in which the sinusoids are represented as pores imbedded in a
parenchymal matrix. One such, Ricken et al. [402] developed a 2D biphasic
model of the blood ow in a longitudinal cross-section of the liver lobules
using a permeability that is isotropic over the cross-section. Bonglio et al.
[43] studied the ow patterns in a 2D hexagonal cross-section in a porous
lobulemodel, assuming both isotropic permeability aswell as 2D anisotropic
permeability (radial versus circumferential). Both of thesemodels neglected
the existence of VS [43, 402], leading to predictions of poor perfusion of the
regions midway between neighbouring PTs in the paper of Bonglio et al.
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[43]. Given the need to perfuse every hepatocyte well, this is unlikely to
occur in vivo. Consequently, Siggers et al. [433] used a 2D symmetric trian-
gular porous medium model (representing one sixth of a hexagonal cross-
section of a lobule), which they solved analytically to investigate the eect
of VS.e PT inows, VS inows and central outows were approximated
as point sources, line sources and point sinks, respectively.
Although the porousmediummodels described above are useful to cap-
ture the overall haemodynamics, they are based on a number of key as-
sumptions. e ow is assumed to be planar (2D), while it is known that
the real liver microcirculation has a complex 3D structure [98]. In all but
one section of the paper by Bonglio et al. [43], the permeability is assumed
to be isotropic. Furthermore, VS were either neglected [43, 402] or mod-
elled as a line source, implying a constant inow into the sinusoids along the
length of the VS [433]. However, in reality, the inow from the VS is likely
to be smaller further away from the PTs (due to a lower pressure within the
VS there). Since these assumptions were not validated before, 3D models
may be helpful to clarify this. Rani et al. [393] previously developed a -
nite volume blood ow model in a 3D geometry incorporating a terminal
hepatic arteriole, portal venule and CV, as well as two fenestrated sinusoids
using non-Newtonian blood properties. ough the modelling approach
was sophisticated, an idealised 3D geometry was used to locally represent
the blood ow from the portal tract passing through two sinusoids into the
central vein. More complex tortuous and interconnected sinusoids as well
as the VS were not taken into account here, while these are relevant for the
haemodynamics at this level. In recent work, we developed a 3D numerical
model of the liver terminal circulation based on high resolution micro-CT
data [98]. We demonstrated that the three-dimensional permeability tensor
of a sinusoidal network displays signicant anisotropy, which is in contrast
with the isotropic permeability conditions assumed in the 2Dporousmodels
mentioned above [43, 402, 433]. Working in a cylindrical coordinate system
with the z-axis along the central vein of a lobule (Fig. 10.2), we found the
permeability tensor to be approximately diagonal with an axial component
roughly two times that of the radial and azimuthal components, which were
themselves approximately equal.
Combining the strengths of the previous models and extending them
could lead to a more accurate model and a better understanding of the he-
patic microhaemodynamics.erefore, the aim of this study was to develop
a 3D porous medium model of the perfusion of a liver lobule, accounting
for anisotropy in the permeability of the sinusoidal network and incorpo-
rating the VS as a separate volume zone within the model. In addition, we
performed a parameter sensitivity analysis of the newly proposed model.
214
10.2. Materials and methods
Central 
venous 
outow
Portal
 tract 
inow
Vascular
   septa
Vascular
   septa
(a) Lobule geometry (b) Pressure contours of lobule model M100A
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Figure 10.2: (a) Simulation geometry of a liver lobule; (b) pressure contours (in mmHg)
obtained in model M100A (see also Table 10.1).e z-axis of the cylindrical coordinate sys-
tem is located along the longitudinal axis of the lobule and its origin is at the centre of the
simulation geometry.
10.2 Materials and methods
10.2.1 Simulation geometry and mesh generation
A geometry, representing a liver lobule with VS, was studied using a cylin-
drical coordinate system (r,θ,z) with its z-axis along the CV and its origin
at the centre of the simulation geometry (Fig. 10.2a).
e lobule geometry (Fig. 10.2a) was assumed to be a hexagonal prism
with cross-section dened by a circumscribing cylinder of diameter 1 mm
[309, 409], resulting in a hexagonal edge length of 0.5 mm. Lobules are re-
ported to have lengths of up to several millimetres [309], and in this study
we used a length of 1 mm as a representative value. Reported measurements
of the diameter of the CV and portal venule (corresponding to the major PT
inow) vary substantially in the literature [295, 358, 409, 465, 466], and in
our model we chose representative values. As such, the CV was modelled as
a cylinder of diameter 60 µm parallel to the z-axis, and the PTs along the six
parallel edges as cylinders, each of diameter 40 µm. VS zones were dened
as the outermost 10 µm depth on the six faces of the prism that delineate the
borders with the neighbouring lobules (Fig. 10.2a).
e simulation geometry was meshed with Gambit (Ansys, Pennsylva-
nia, USA). A mesh sensitivity study was performed by creating four meshes
using the Cooper scheme with the linked surface meshes of the top and bot-
tom plane of the geometry as sources, and applying an interval size of 24, 12,
6 and 5 µm resulting in 4.6⋅104, 3.8⋅105, 3.1⋅106 and 5.1⋅106 hexahedral volume
elements, respectively.e mesh sensitivity analysis showed approximately
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constant results for models having 3.1⋅106 or more elements. Consequently,
the mesh with a 6 µm interval size corresponding to 3.1⋅106 elements was
used.
10.2.2 Cell zone conditions and uid properties
e volume of the lobule, representing the sinusoids, was characterised as a
porous medium, with uid ow given by Darcy’s law:
v⃗porous = − 1µK∇p (10.1)
where p [Pa] is the sinusoidal blood pressure, µ [Pa⋅s] the dynamic vis-
cosity of blood, K [m2] the second order permeability tensor and v⃗porous
[m/s] the Darcy velocity) [286]. e permeability tensor K (consisting of
permeability coecients k [m2]; eq. 10.2) is represented by a diagonal ma-
trix in the cylindrical coordinate system (r,θ,z):
K = ⎡⎢⎢⎢⎢⎢⎣
krr krθ krz
kθr kθθ kθz
kzr kzθ kzz
⎤⎥⎥⎥⎥⎥⎦ =
⎡⎢⎢⎢⎢⎢⎣
krr 0 0
0 kθθ 0
0 0 kzz
⎤⎥⎥⎥⎥⎥⎦ (10.2)
In this study, two dierent permeability tensors were used: an isotropic
and an anisotropic tensor. e anisotropic tensor was dened by the per-
meability coecients found in chapter 9 [98], giving kzz = 3.64⋅10−14 m2, krr
= 1.56⋅10−14 m2 and kθθ = 1.75⋅10−14 m2. Isotropic permeability conditions
were dened by assuming that the isotropic permeability equals the aniso-
tropic radial permeability coecient, krr = kθθ = kzz = 1.56 ⋅ 10−14 m2.is
choice was based on the observation that the radial permeability coecient
has the biggest impact on the resulting lobule outow (CV).
e porosity of the lobule, ε , equals the fraction of the volume occupied
by the blood (Vsinusoids) divided by the total volume Vtotal (eq. 10.3), and we
xed its value at 0.143, as found in chapter 9 [98]. It also equals the ratio of
themagnitude of theDarcy velocity (the volume-averaged ux per unit area;
v⃗porous [m/s]) to the magnitude of the cross-sectionally averaged physical
velocity in the sinusoids (v⃗physical [m/s]):
ε = Vsinusoids
Vtotal
= ∥v⃗porous∥∥v⃗physical∥ (10.3)
In the following, all reported velocities are Darcy velocities and we will
denote v⃗porous simply by v⃗. In order to estimate the typical physical veloci-
ties within the sinusoids, the Darcy velocity should thus be divided by the
porosity ε (eq. 10.3).
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For the model without VS, the VS zones were dened using the same
permeability coecients as for the lobule zone of the sinusoids. In the case
of models with VS, VS were treated as porous media with a higher circum-
ferential permeability due to the circumferential orientation of the vessels
within the VS. As such, we used in the VS the lobular value of kθθ multiplied
by a factor of either 10 or 100, but keeping the values of the radial and lon-
gitudinal coecients, krr and kzz , the same as their values in the sinusoids.
Note that, ideally, we would have altered the component of the permeability
tensor in the exact direction of theVS (rather than kθθ in the circumferential
direction, which is approximately in the same direction), but in this paper
we considered this slightly simpler case.
In total, six cases were simulated to investigate the inuence of includ-
ing VS and the usage of (an)isotropy. We denote thesemodels asM0I,M0A,
M10I, M10A, M100I, M100A, where ‘0’ refers to no VS, ‘10’ to VS with kθθ
10 times that in the lobule interior and ‘100’ to VS with kθθ 100 times that
in the lobule interior, and ‘I’ refers to isotropic permeability and ‘A’ to aniso-
tropic permeability (Table 10.1). Blood was assumed to be an incompressible
Newtonian uid with a dynamic viscosity of 3.5 mPa⋅s [482].
10.2.3 Boundary conditions and computational uid dynamics
For all models, the top and bottom hexagonal planes were characterised by
a translational periodic boundary condition (Fig. 10.2b), and we assumed 1
mmHg/mm to be the z-component of the pressure gradient. e pressure
was dened to drop from 6.18 mmHg to 5.18 mmHg along the PT inow
and from 5.23 mmHg to 4.23 mmHg along the CV outow (corresponding
to mean pressures of 5.68 mmHg at the PTs and 4.73 mmHg at the CV, as
found in [295]). At the planes of interface between the lobule and VS, con-
tinuity of pressure and ux was applied. Since we assumed a repeating hon-
eycomb pattern (Fig. 10.1b), we used symmetry boundary conditions at the
surfaces delineating the lobule borders.e steady computational uid dy-
namicmodelswere solved using Fluent (Ansys, Pennsylvania, USA). Tecplot
(Tecplot Inc.,Washington, USA) was used to process, calculate and visualise
the haemodynamic parameters of interest.
10.2.4 Parameter sensitivity study
Since some assumptions were made concerning the boundary conditions
and simulation geometry, with some degree of variability in values reported
in literature, we performed a parameter sensitivity analysis of the model.
e M100A model was used as the baseline model to perform parameter
variations of the pressure boundary conditions as well as geometry-related
parameters (see also Table 10.1).
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As such, the longitudinal pressure gradient was changed from the de-
fault value of 1 mmHg/mm to 0 mmHg/mm (M100A_1), 0.5 mmHg/mm
(M100A_2) and 2 mmHg/mm (M100A_3). e pressure drop between the
PTs and CV was changed by increasing the default PT pressure, dened to
drop from 6.18 mmHg to 5.18 mmHg along the PT inow, by 0.5 mmHg
(M100A_4) and 1 mmHg (M100A_5).
e thickness of the VS was changed to 5 µm (M100A_6) instead of 10
µm, and the PT (M100A_7) and CV diameters (M100A_8) were increased
by 50% of their original value. Additionally, the eect of the lobule circum-
ferential diameter was investigated by scaling down the lobule. Note that if
we would consider a scaled model in which we change all length scales (lob-
ule circumferential diameter, and the radii of the CV and PTs) in the same
way, the ux would remain unchanged, since the velocity scale is inversely
proportional to the length scale. Consequently, we considered a lobule cir-
cumferential diameter of 0.5 mm instead of 1 mm, but kept the radii of the
PTs and CV the same (M100A_9). A summary of all simulated cases and
the corresponding parameters is shown in Table 10.1.
10.3 Results
We rst compare the haemodynamics of the models with and without VS
(Section 10.3.1), followed by a comparison of the isotropic and anisotropic
permeability cases (Section 10.3.2). e results of the parameter sensitivity
analysis are reported in section 10.3.3.
10.3.1 Comparison of the models with and without vascular septa
Since the impact ofVS on the results for the isotropic and anisotropicmodels
are qualitatively similar (Figs. 10.3-10.7), we only describe here the results for
the anisotropic models in detail.
10.3.1.1 Flow in the hexagonal cross-sectional plane in the middle of the
lobule (z=0)
In model M0A, over the hexagonal cross-section z=0, the pressure drops
from 5.68 mmHg at the PTs to 5.40 mmHg at the points midway between
neighbouring PTs to 4.73mmHg at the CV (Fig. 10.3a, 10.4b).e projection
of the velocity into the cross-section, ∥v⃗rθ∥, has a relatively high magnitude
at the entry from the PTs (Fig. 10.3b). From there the blood ows to the CV,
either directly, or rst towards the regions midway between neighbouring
PTs and then towards the CV. Along each pathway, the cross-sectional velo-
city decreases away from the PTs, reaching a streamline-specic minimum
(with the lowest value being a zero velocity, which is attained at the stagna-
tion points at the outer lobule borders midway between neighbouring PTs;
Fig. 10.3c) before rising to its highest value at the CV outlet (Fig. 10.3d).
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Figure 10.3: Comparison of the pressures and velocities at particular locations in the lob-
ule for the models M0I, M0A, M10I, M10A, M100I and M100A: (a) pressure at the points
midway between neighbouring portal tracts (PTs); (b-d) magnitudes of the cross-sectional
projection of the velocity (∥v⃗rθ∥): (b) at PT inlets (mean value over the PT inlet), (c) at the
midpoints of the border lines of the sinusoidal volume connecting neighbouring PTs, and
(d) at the central venous (CV) outlet (mean value over the CV outlet); (e-f) magnitude of
the velocity projected into a longitudinal cross-section (∥v⃗rz∥): (e) at PT inlets (longitudinal
section through the PTs, θ = 0°, 180°), and (f) at the vascular septal (VS) inow into the
lobule (longitudinal section through the midpoints of the VS, θ = ± 90°).
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Figure 10.4: Pressures (top) and streamlines (bottom, coloured according to the magnitude
of the projection of the velocity into the plane (∥v⃗rθ∥) obtained on the middle cross-section
(z=0) of the lobule models: (a) M0I, (b) M0A, (c) M10I, (d) M10A, (e) M100I, (f) M100A.
As can be seen in Figs. 10.4d, f, the model demonstrates dierent hae-
modynamics whenVS are present.e pressure drop from the PTs to the VS
is smaller in M10A andM100A than in the case without VS (Fig. 10.3a), and
the pressure drop from the centre of the VS to the CV is larger.ere are two
ow pathways: those pathways on which uid enters the sinusoids directly
from the PTs; and those on which uid travels through the VS before enter-
ing the sinusoids. Within the VS, the ow is predominantly circumferential,
and the cross-sectional velocities at the PT-VS interface are high. At the CV
outow the velocities are approximately spatially uniform (Fig. 10.3d, Fig.
10.4 d, f). On leaving the PTs, the ow pathways that go directly from the
PTs into the sinusoids have lower velocities than those that rst enter the
VS and also than those leaving the PTs in model M0A (see Fig. 10.3b).e
streamlines in models M10A and M100A are predominantly radial, and the
regions midway between neighbouring PTs are better perfused, leading to a
more uniform distribution of blood throughout the tissue than inM0A (Fig.
10.4).is eect is more pronounced for higher circumferential permeabil-
ity in the VS, i.e. more inM100A than inM10A.Moreover, as shown in Table
10.2, the volumetric ow rate at the outow of the lobule (Qlobul e) is higher
when including VS (6.58⋅10−5 ml/min and 6.78⋅10−5 ml/min for M10A and
M100A, respectively) thanwhen neglectingVS (6.02⋅10−5ml/min forM0A).
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10.3.1.2 Flow in the longitudinal cross-section through opposite PTs (θ=0°,
180°)
Fig. 10.5b shows the pressure and streamlines inM0A in a longitudinal plane
of cross-section containing the axis of the lobule and two PTs.e ow fol-
lows a diagonally downward pathway, due to the combined eects of the
imposed z-component of the pressure gradient and of the radial pressure
gradient. e velocity is high at the inow (Fig. 10.3e), lower midway be-
tween the PTs and the CV, and then higher near the CV outow.
Similar ow patterns are found in M10A and M100A (Figs. 10.5d, f);
however, these models have lower velocities at the PT inow (Fig. 10.3e),
and higher velocities at the CV outow.
Without vascular septa With vascular septa (k     x 10)θθ With vascular septa (k     x 100)θθ
y x
z
+
Velocity
  [m/s]
Pressure
[mmHg]
Velocity
  [m/s]
(a) Isotropic (M0I) (b) Anisotropic (M0A) (c) Isotropic (M10I) (d) Anisotropic (M10A) (e) Isotropic (M100I) (f ) Anisotropic (M100A)
Figure 10.5: Pressures (top) and streamlines (bottom, coloured according to the magnitude
of the projection of the velocity into the plane (∥v⃗rz∥)) obtained on a longitudinal cross-
section passing through two portal tracts (θ = 0°, 180°) of the lobule models: (a) M0I, (b)
M0A, (c) M10I, (d) M10A, (e) M100I, (f) M100A.
10.3.1.3 Flow in the longitudinal cross-section through the centrelines of
opposite VS (θ=±90°)
Fig. 10.6b shows the pressure inM0A in a longitudinal plane of cross-section
containing the axis of the lobule and passing through the midpoints of two
VS.e pressure decreases from the outer boundary to theCVoutow. Flow
velocities in this plane are generally smaller than the velocities in the plane
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passing through the PTs, especially near the peripheral boundaries, where
there is a stagnation line with a zero velocity midway between two PTs along
the outer lobule borders. Comparing the models with and without VS, we
nd that the pressures in M10A andM100A are generally higher than those
inM0A, see Fig. 10.6b, d, f.e planar velocity magnitudes at the VS-lobule
interfaces are 1.40⋅10−6m/s and 1.43⋅10−6m/s forM10A andM100A, respec-
tively (see Fig. 10.3f). However, velocities at the CV outow are higher.
Without vascular septa With vascular septa (k     x 10)θθ With vascular septa (k     x 100)θθ
x y
z
Pressure
[mmHg]
Velocity
  [m/s]
No relevant
streamlines
No relevant
streamlines
(a) Isotropic (M0I) (b) Anisotropic (M0A) (c) Isotropic (M10I) (d) Anisotropic (M10A) (e) Isotropic (M100I) (f ) Anisotropic (M100A)
Figure 10.6: Pressures (top) and streamlines (bottom, coloured according to the magnitude
of the projection of the velocity into the plane) obtained on a longitudinal cross-section
passing through the centre of two opposite vascular septa (θ = ± 90°) of the lobule mod-
els: (a) M0I, (b) M0A, (c) M10I, (d) M10A, (e) M100I, (f) M100A.
In the end, the models without VS show lowmagnitudes of velocity and
thus poor perfusion of the zones lying between neighbouring PTs (Figs.
10.4a-b, 10.7a-b). In contrast, the models with VS predict a better perfu-
sion of these zones and a more uniform velocity distribution (Figs. 10.4c-f,
10.7a-b). Figs. 10.7c-d show, respectively, the in-plane and the total (3D)
magnitudes of the velocity as a function of the angle on a circle around the
CV (r = 0.3 mm), in order to investigate the homogeneity of the perfusion.
e ow is more homogeneous when VS are included, with the amplitude
of the velocity magnitude uctuations clearly being smaller when including
VS.
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Figure 10.7: Comparison of the velocities at various locations for models M0A, M100I and
M100A. (a-c) Magnitudes of the projection of the velocity in the cross-section (∥v⃗rθ∥): (a)
along a line connecting the central vein (CV) to the middle of a vascular septum (θ=90°)
(the range of r is 0.030 mm < r < 0.433 mm), (b) along a line connecting two portal tracts,
and (c) around the circle centred on the CV with radius 0.3 mm, plotted against the angle.
(d) Magnitudes of the 3D velocity vector around the same circle as shown in (c).
10.3.2 Comparison of isotropic versus anisotropic permeability
In this section we discuss isotropic versus anisotropic conditions, focussing
on models M100I and M100A.
In the hexagonal cross-section z=0, the pressure contours and directions
of the ow trajectories are similar in the isotropic and the anisotropic mod-
els (Fig. 10.4e-f).e in-plane magnitudes of the velocity as well as the total
ow rate through the lobule are almost equal (slightly higher in the aniso-
tropic cases): 6.77⋅10−5 ml/min in M100I and 6.79⋅10−6 ml/min in M100A
(Table 10.2). Figs. 10.5e-f and 10.6e-f show that the ow is similar for the
corresponding cases of isotropic and anisotropic permeability, although it is
closer to vertical in the anisotropic case. As such, anisotropic permeability
leads to a larger longitudinal z-component of the velocity, due to the larger
longitudinal permeability in the z-direction. Similar eects are observed in
the other models: M0I, M0A, M10I and M10A.
Fig. 10.7c shows that the planar velocity along a circle around the CV in
the hexagonal cross-section is approximately equal for both the anisotropic
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and isotropic cases, with isotropic conditions resulting in only a slightly
higher variation of the predicted velocity. However, the spatially averaged
magnitude of the total (3D) velocity is signicantly higher and also shows
a smaller spatial variance in the anisotropic case, owing to the higher z-
component of the velocity (Fig. 10.7d).
10.3.3 Parameter sensitivity study
Boundary conditions as well as geometrical features were varied to investi-
gate the sensitivity of the lobule uid dynamics to the choice of such param-
eters.
10.3.3.1 Impact of changes in imposed boundary conditions
Comparing Fig. 10.5f with Fig. 10.8 illustrates how changes of the pressure
gradient in the z-direction aect the solution. Increasing the longitudinal
pressure gradient leads, as expected, to a larger z-component of the velocity.
In contrast, the lobule and total liver outow and resistance do not change
in comparison with the baseline model M100A (Table 10.1 and 10.2). Ob-
viously, the radial and circumferential components of the velocity do not
depend on the longitudinal pressure gradient, whereas the z-component of
the velocity is directly proportional to ∂p/∂z. As the total ux through the
lobule only depends on the radial and circumferential velocity components,
it is also independent of ∂p/∂z.
Secondly, the PT-CV pressure drop was increased by increasing the PT
pressure by 0.5 mmHg and 1 mmHg (Fig. 10.9). is resulted in higher ve-
locities and lobule ows (1.03⋅10−4 ml/min and 1.39⋅10−4 ml/min for a 0.5
mmHg and 1 mmHg increase of the PT pressure, respectively), because the
ow is given by dividing the pressure dierence by the resistance (see also
Appendix B for details). e lobule resistance remained equal, since the
simulation geometry did not change (Table 10.1 and 10.2). Lobule and total
liver ow increases were linearly proportional to the increase of the PT-CV
pressure drop (Table 10.2). Note that this dependence of the results on the
PT-CV pressure dierence is predictable, owing to the linearity of the gov-
erning equations: the radial and circumferential components of the velocity
(and consequently also the ux through the lobule) are directly proportional
to the PT-CV pressure drop, while such dierence does not aect the z-
component of the velocity. Doubling the PT-CV pressure drop, for instance,
thus implies doubling the ux through the lobule.
10.3.3.2 Impact of geometry-related parameter variations
Reducing the VS thickness to 5 µm (instead of 10 µm) results in a decrease of
the fraction of the PT inow that drains into the VS (Fig. 10.10).is led to
an increase in the lobule resistance (1.46⋅104mmHg⋅min/ml) and a decrease
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Figure 10.8: Pressures and streamlines (coloured according to the magnitude of the projec-
tion of the velocity into the plane ∥v⃗rz∥) obtained on a longitudinal cross-section passing
through two portal tracts (top; θ=0°, 180 °) and on a longitudinal cross-section passing
through the centre of two opposite vascular septa (bottom; θ=± 90°) for variations of the
pressure gradient along the longitudinal z direction (0, 0.5 and 2 mmHg corresponding to
models M100A_1, M100A_2 and M100A_3, respectively) compared to the baseline model.
of the lobule ow (6.51⋅10−5 ml/min). As such, decreasing the VS thickness
by 50% resulted in a lobule and total liver outow decrease of 4.0% (Table
10.2).
Increasing the PT diameter from 40 to 60 µm results in a decrease of the
lobule resistance (1.35⋅104 mmHg⋅min/ml). Consequently, the lobule out-
ow increased (7.01⋅10−5 ml/min). Pressures and velocities changed accord-
ingly, as illustrated in Fig. 10.10 (lower PT inow velocity but a larger PT
inow front, higher CV outow velocity). A 50% increase of the PT diame-
ter thus resulted in a 3.4% increase of the lobule and total liver outow (Table
10.2). When increasing the CV diameter to 90 µm (instead of 60 µm; Fig.
10.10), the lobule outow increases (7.80⋅10−5ml/min) while the lobule resis-
tance decreases due to a larger CV outow front (1.22⋅104 mmHg⋅min/ ml).
As such, a 50% CV diameter increase results in a 15.1% increase of the lobule
and total liver outow (Table 10.2).
Furthermore, when reducing the lobule circumferential diameter to 0.5
mm(Fig. 10.10), the result is a signicant increase in the lobule ow (9.74⋅10−5
ml/min), implying a smaller lobule resistance to ow (9.75⋅103 mmHg⋅min/
ml). In addition, a smaller lobule results in a larger number of lobules in a
liver of a given size, and leads in this case to a total estimated liver ow of
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Figure 10.9: Pressures and streamlines (coloured according to the magnitude of the projec-
tion of the velocity into the plane ∥v⃗rθ∥) obtained on the middle cross-section (z=0) using
a 0.5 mmHg and 1 mmHg increase of the portal tract pressure (corresponding to models
M100A_4 and M100A_5, respectively) compared to the baseline model.
900 ml/min. Consequently, a 50% decrease of the lobule circumferential di-
ameter leads to a 43.7% increase of the lobule outow and a 474.8% increase
of the total liver outow (Table 10.2).
In summary, amongst the model parameters studied, the lobule circum-
ferential diameter is the most sensitive parameter when looking at the total
liver outow, followed by the pressure drop between the PTs and the CV.
10.4 Discussion
In this study, a 3D computational uid dynamics model of a liver lobule was
developed to study the hepatic microcirculation in order to investigate the
eect of vascular septa and anisotropic permeability properties. Addition-
ally, a parameter sensitivity analysis was performed to study the inuence
of the choice of geometrical and physical parameters on the lobule uid dy-
namics.
e models with VS clearly show better perfusion of the zones lying be-
tween neighbouring PTs compared to the models without VS, and the ow
patterns are more homogeneous when VS are included. e physiological
needs of the hepatocytes, and, in particular the requirement of a sucient
supply of oxygen and nutrients for every cell, make the models that include
VS seemmore physiologically plausible than those without.is is particu-
larly the case for the cells midway between neighbouring PTs whose supply
of oxygen is dramatically increased by the existence of VS.
Models with anisotropic permeability show amore spatially homogene-
ous magnitude of the velocity eld compared to those having isotropy (Fig.
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VS thickness of 5 µm (instead of 10 µm) PT diameter of 60 µm (instead of 40 µm)
CV diameter of 90 µm (instead of 60 µm)                Lobule diameter of 0.5 mm 
                        (instead of 1 mm)
Figure 10.10: Pressures and streamlines (coloured according to the magnitude of the projec-
tion of the velocity into the plane ∥v⃗rθ∥) obtained on the middle cross-section (z=0) using
variations of the geometrical features compared to the baseline model: vascular septal thick-
ness of 5 µm (M100A_6), portal tract diameter of 60 µm (M100A_7), central venous diameter
of 90 µm (M100A_8) and a lobule circumferential diameter of 0.5 mm (M100A_9).
10.7). Again, this is especially relevant for the relatively poorly perfused zone
midway between neighbouring PTs. However, one has to be cautious with
this interpretation, since the inuence of anisotropy depends on the applied
boundary conditions, in particular on the longitudinal pressure gradient. To
the authors’ knowledge, there are no data available in literature on the lon-
gitudinal pressure gradient over a lobule (dened in our model as 1 mmHg
per mm; see section 10.2.2). erefore, we performed a parameter study in
which variations of the longitudinal pressure gradient showed as expected
dierences in the z-components of the velocities, but the lobule and total
liver ow did not change (Table 10.1 and 10.2).
In addition, the sensitivity of other parameters was analysed (Table 10.1
and 10.2), showing that the total liver outow was most sensitive to changes
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in the lobule cross-sectional size (determined by the lobule circumferential
diameter) and the PT-CV pressure drop. In contrast, the total liver outow
was not or only slightly sensitive to some other parameters (such as the lon-
gitudinal pressure gradient in the z-direction and the PT diameter). Esti-
mations of the ow rate and resistance of both a single lobule and the liver
as a whole for M100A resulted in Qlobul e = 6.79⋅10−5 ml/min, Ql iver = 157
ml/min, Rlobul e = 1.40⋅104mmHg⋅min/ml and Rl iver = 6.06⋅10−3mmHg⋅min
/ml, respectively (Table 10.2). However, physiological values of Ql iver are
around 1500 ml/min, which our baseline model underestimates.is is due
to the assumptions we made in our modelling, which is not surprising since
there are signicant variations of certain parameters reported in the liter-
ature (PT and CV pressures and diameters, lobule dimensions, liver weight
and ow rate etc.). We anticipate that, as better estimates of these parame-
ters become available, themodelwill becomemore realistic and can be tuned
based on these parameters so that it eectively leads to realistic whole-liver
ow characteristics. For example, with a lobule diameter of 0.5 mm and
a pressure in the PTs of 0.5 mmHg or 1 mmHg above the default values,
the ow rate through the whole liver is 1380 ml/min (M100A_10) or 1850
ml/min (M100A_11), respectively, and these values are within the physiolo-
gical range (Table 10.2). It is important to stress that we did not perform
a direct validation of the proposed models, which would require measure-
ments of pressures or ows at the liver microcirculation level, which is very
challenging. However, our results correspond to values that have been de-
scribed in the literature, and we expect the qualitative predictions of our
model to be valid.e demonstrated dierences in the ow patterns, espe-
cially in the presence of VS, are independent of the assumed sets of bound-
ary conditions. As such, our models incorporating VS and anisotropic per-
meabilities are probably more accurate since they result in more homogene-
ous ow patterns compared to previous models.
When comparing the outcomes of our models to literature, the highest
magnitudes of velocity were found near the inow from the PTs and near
the CV, which agrees with the ndings of Bonglio et al. and Ricken et al.
[43, 402]. Cohen et al. [76] also stated that the velocity near the CV is higher,
resulting in a region of hepatocytes near the CV that have amuch higher ux
of blood passing them, as compared with hepatocytes that are located nearer
the periphery.e ow patterns in the longitudinal sections through the PTs
shown in Fig. 10.5 are also similar to those reported earlier by Ricken et al.
[402]. However, in their study, the streamlines are closer to those we ob-
tained in our isotropic models, and they are orientated further from the axis
than the streamlines we obtained in our anisotropic models. is seems to
be a logical consequence of the fact that Ricken et al. [402] used a permeabil-
ity that is isotropic over the longitudinal cross-section in his 2D model.e
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ow patterns in the hexagonal cross-sectional plane of the models without
VS (shown in Fig. 10.4 a, b), are also qualitatively similar to those obtained
by Bonglio et al. [43]. Furthermore, the results obtained by Siggers et al.
[433] in their 2D model including VS were comparable with our models in-
cluding VS (projection into the hexagonal cross-sectional plane). Note that
the 3D lobule model obtained in this study could also be interpreted and
solved as a combination of a 2D porousmodel [43, 433] with a superimposed
pressure gradient in the z direction and the corresponding z-component of
the velocity, since our model uses a prescribed longitudinal pressure drop.
Comparing our model with the 3D model of Rani et al. [393], some major
dierences exist regarding the modelling approach. Rani et al. [393] based
the uid domain of their model on the 3D structure of a liver acinus, while
in this study we used the classic schematic hexagonal lobule to represent
the functional unit of the liver microcirculation (Fig. 10.1). Which model is
most appropriate to represent the functional unit of the liver (e.g. the classic
lobule, primary lobule, liver acinus, choleohepaton etc.) is still a matter of
debate [117–119, 409, 465, 466]. Furthermore, the model of Rani et al. [393]
included a terminal HA, PV and CV as well as two sinusoids having a 23.5
µm radius and fenestrations. ese sinusoidal diameter values seem to be
high, since sinusoidal diameters are typically reported as being in the order
of magnitude of 10 µm (which we also observed in a previous study [98];
see also chapter 9). Larger sinusoids will result in lower vascular resistances
and higher permeability compared to our model geometry. Another dier-
ence is that Rani et al. [393] used non-Newtonian uid properties, while we
modelled blood as an incompressible Newtonian uid. Non-Newtonian ef-
fects (such as the Fahraeus-Lindqvist eect [28] and the shear thinning eect
[393]) are important on the scale of the microscopic sinusoids. Neverthe-
less, Bonglio et al. [43] reported pressure dierences of less than 4% when
comparing the results of a Newtonian model with those of a shear thinning
model. is seems to suggest that non-Newtonian eects are of minor im-
portance for our models. As for the boundary conditions, Rani et al. [393]
applied a pressure drop from 95 mmHg to 20 mmHg along the terminal HA
and from 25 mmHg to 15 mmHg along the terminal PV, which seems quite
high (a PV pressure of 15-25 mmHg is considered indicating portal hyper-
tension). us, combining higher pressure(s) (drops) with lower vascular
resistances (due to higher sinusoidal diameters) leads to signicant dier-
ences in the order of magnitude of the predicted velocities with our data.
Furthermore, the model of Rani et al. [393] explicitly accounts neither for
the eect of more than two tortuous sinusoids, nor for the presence of VS.
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10.5 Conclusion
In this study, we developed a 3D mathematical model of a liver lobule, us-
ing a porous medium approach, incorporating the eect of vascular septa
and anisotropic permeability.e inclusion of vascular septa leads to better
perfusion of the zones lying between portal tracts as well as a more spa-
tially homogeneous perfusion of the lobule. e inclusion of anisotropic
permeability results in clearly dierent ow patterns, with streamlines that
are oriented closer to the lobule axes. A parameter study revealed that the
lobule and total liver ow is most sensitive to variations of the lobule cir-
cumferential diameter and the radial pressure drop. In conclusion, the nd-
ings suggest that especially the presence of vascular septa results in a more
physiologically realistic model of the hepatic microcirculation, and that the
model can be tuned to correspond with physiological ows and pressures.
Future work should aim at direct validation of the model and to explore
applications for a better understanding of liver pathophysiology as well as
improved diagnosis and treatment of liver disease.
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Conclusions and future
perspectives
is chapter recapitulates the most important conclusions of this manu-
script.
11.1 Where are we now?
In the introduction of this dissertation, three specic research goals were
formulated. We strived to meet these goals with the original research of
this PhD work. Below, the key ndings are summarised according to each
research goal, as well as the innovation of this work, some methodological
considerations and future perspectives.
11.1.1 Key ndings
Goal 1. Development of a methodology for the quantitative analysis of the
human liver vasculature from the macro- down to the microscopic level.
e combination of vascular corrosion casting and high-resolution micro-
CT scanning with image processing provided novel and unique data on the
human hepatic vasculature of the macro-, meso- and microcirculation of
one and the same liver (see chapters 5 and 9).is new multilevel approach
allows (digitally) visualising the complex liver vasculature at dierent length
scales in 3D and performing a detailed quantitative analysis of the topology
and geometrical features, such as vessel radii and lengths. e generated
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datasets formed the basis of the computer models of liver perfusion as dis-
cussed below (chapters 6 and 9).
Goal 2. Development of computer models to study the intrahepatic
haemodynamics and quantify biomechanical stressors on the macro- and
microscale level.
Based on the quantitative morphological analysis of the hepatic macrovas-
culature, an initial electrical analog model of the human liver was estab-
lished (chapter 6).emodel is able to predict pressure and ow parameters
throughout the liver vasculature while perfusion is in regime (steady state).
It is applicable not only to natural blood ow, but also to machine perfusion
(MP). In the case of pressure-controlled hypothermic MP (HMP) with low
pressures, themodel predicts lower sinusoidal shear stresses than in the case
of natural blood ow, and hence no shear-related endothelial damage (dur-
ing regime perfusion). However, there may be other non-biomechanical
factors that contribute to endothelial damage, such as biochemical inu-
ences evoked by using synthetic perfusion uids instead of blood. ough
the results of the initial electrical models are promising, additional experi-
mental research was necessary to validate and tune the electrical liver model
(see Goal 3).
Image processing of the micro-CT datasets of human liver microvascu-
lar samples provided more insight into structural-related perfusion charac-
teristics (e.g. porosity) of the microcirculation. A 3D numerical microcircu-
lation model of a sample from a human liver was constructed (chapter 9).
e resulting data indicate that the human hepatic microcirculation clearly
displays anisotropic behaviour in terms of permeability, which was quan-
tied by means of a permeability tensor. In particular, a higher permea-
bility was demonstrated along the direction of the central vein, and about
two times lower but approximately equal permeabilities along the radial and
circumferential directions of the liver lobule. Since the permeability coe-
cients depend on the ow direction, liver microcirculation models should
thus take into account sinusoidal anisotropy.
With these new insights, we developed a 3D porous mediummodel of a
liver lobule, incorporating anisotropic permeability as well as vascular septa
(chapter 10).e inclusion of vascular septa leads to better perfusion of the
zones lying between portal tracts as well as a more spatially homogeneous
perfusion of the lobule.e inclusion of anisotropic permeability results in
clearly dierent owpatterns, with streamlines that are oriented closer to the
lobule axes. In conclusion, our ndings suggest that especially the presence
of vascular septa results in a more physiologically plausible model of the
hepatic microcirculation, and that the model can be tuned to correspond
with physiological ows and pressures.
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Goal 3. Validation and application of the acquired models.
To test the electrical analog model against experimental data, we presented
a methodology to validate and tune the initial electrical analog model of he-
patic perfusion (developed in chapter 6) to a specic liver (to one liver in par-
ticular in chapter 7). To do so, HMP experiments were used to capture the
perfusion behaviour of two human liver gras by simultaneously measuring
pressures and ows at the hepatic in- and outlet vessels. Experimentally ac-
quired HA and PV input impedances were used to t compact Windkessel
(WK) models in order to mathematically capture the global hepatic perfu-
sion behaviour. Subsequently, the WK properties were distributed over the
extended liver-specic electrical analog model.
In chapter 8, we used the electrical analog liver model to assess the hae-
modynamic eects of partial hepatectomy procedures (e.g. in the case of
living donor liver transplantation). e model was tuned to the rat liver to
allow for comparisonwith existing experimental data. Results gave evidence
of hyperperfusion eects such as portal hypertension and elevated lobe-
specic portal venous ows. For example, the model predicts that a 90%
partial hepatectomy leads to an approximately fourfold increase in portal
pressure and a fourfold rise of the lobe-specic portal venous and hepatic
venous ow, which may severely damage the microvasculature.
11.1.2 Methodological considerations
One of the major limitations of this dissertation is the limited number of
human livers that were used. Consequently, one has to be careful when gen-
eralising ndings and results should rather be interpreted as those of a spe-
cic liver.is inevitably has to do with the fact that human livers, available
for research, are extremely scarce and their availability depends on the mo-
ment that a donor liver is discarded aer failed reallocation. It is important
to stress that, although discarded, the organs did not show any macroscopic
abnormalities compared to healthy subjects. It remains, however, important
to do this kind of research in human livers because of well-known limita-
tions of animal models (e.g. anatomical dierences). In the end, more livers
should thus be investigated in order to provide a more generic dataset of the
human liver vascular architecture and perfusion characteristics. At the same
time, however, many processing steps are laborious and extremely time de-
manding, limiting the feasibility of extended research.
As vascular geometrical data are the input for our hepatic computer
models, it is important to address how HMP and vascular corrosion cast-
ing might aect the vasculature. While HMP has the advantage of keeping
the microvasculature open and intact, the disadvantage is that high shear
stresses may arise and damage endothelial cells (although this is contra-
dicted by our resultswhenperforming pressure-controlledHMPat lowpres-
sures). Moreover, vascular corrosion casting may lead to slight shrinkage of
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the resin. Nevertheless, the casting procedure was executed according to
standardised procedures by a team having many years of expertise and our
diameter measurements were comparable with literature data.
Ideally, complete liver casts should be scanned at once at a sucient res-
olution to allow visualising all vessels down to the sinusoids. However, this is
practically impossible due to computational and soware limitations. Con-
sequently, a multilevel approach had to be used to consecutively study the
macro-, meso- and microcirculation. As there is still a gap of a few blood
vessel generations between the meso- and microcirculation, additional data
on these missing generations may be helpful to describe the full spectrum
of the hepatic vasculature. However, image processing becomes extremely
complicated at this level due to an exponential increase of the number of
(touching) vessels when moving towards higher generation numbers.
e developed electrical analog model is a lumped parameter model,
meaning that it is a concise model to analyse complicated vascular networks
based on a simplication of the actual anatomical reality. However, we re-
garded its use justied to model the overall hepatic haemodynamic param-
eters, as we are mainly interested in relative dierences (e.g. natural liver
versusHMP), and as it is practically impossible - at thismoment - to develop
models taking into account all anatomical features of the complete liver vas-
culature due to computational and soware limitations. Nonetheless, fur-
ther renements may be relevant, especially at the level of the microcircu-
lation.is is why we focused on modelling the perfusion behaviour of the
hepatic microcirculation in chapters 9 and 10. Furthermore, the electrical
model simulates steady state hepatic perfusion, while transient phenomena
(for instance when starting up perfusion) may induce dierent biomechan-
ical stressors in the vasculature compared to steady state perfusion, possibly
leading to endothelial damage.
e PV hydraulic input impedances, acquired in chapter 7, showed a re-
latively low frequency content due to a small amount of coherent points be-
tween pressure and ow signals. Caution is thus recommended when inter-
preting the PV results. Ideally, more frequency content should be acquired
to more accurately t Windkessel models and extended electrical models to
PV impedance data. is might be achieved by inducing analysing perfu-
sion perturbations (such as transient phenomena, e.g. starting or stopping
the pumps as was done during the experiments of chapter 7) or adjusting
the HMP control circuit.
e electrical analog rat liver model of chapter 8 was solely based on
vascular resistances (simplication of the original model in chapter 6), not
taking into account (visco-)elasticity and inertial eects. Since pulsatility
is heavily damped when reaching the hepatic microcirculation, our main
interest was analysing the DCmodel to obtain time-averaged pressures and
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ows, as we believed this to be sucient to quantify overall hyperperfusion
eects at the level of the microvasculature.
e microcirculatory perfusion characteristics were acquired based on
onemicrovascular sample of a human liver (chapter 9). Again, results should
be interpreted as indicative. More samples might allow a better estimation
of these characteristics, but imply a labour-intensive procedure to acquire
good geometries and meshes. Consequently, only one sample was studied,
of which subsamples were used to characterise the permeability of liver tis-
sue. Care was taken tomake sure that the sinusoidal heterogeneity was su-
ciently coveredwhen selecting the studied sample. Furthermore, it was di-
cult to dene accurate boundary conditions, especially for the lobule model
of chapter 10, as literature data on the microvasculature (dimensions, pres-
sures etc.) are scarce and vary substantially (e.g. for the diameter of central
veins). Due to a lack of accurate measurement techniques to acquire pres-
sures and ow data at the microcirculation level, the obtained micromod-
els were not (yet) validated. However, we showed that our lobule model
(chapter 10) can be tuned to predict physiological liver ows and pressures.
As this PhD work focused on modelling the hepatic vasculature and
blood perfusion, other vessel systems (the biliary systemand the lymphatics)
as well as mass transport (e.g. between the vascular compartment and the
space of Disse) were not taken into account. We believe that these phenom-
ena only slightly aect hepatic perfusion (e.g. approximately 0.5 ml lymph
production for every litre of blood ow; section 1.2.2). However, these sys-
tems as well as other factors (such as biological and metabolic factors) play
an important role in the homeostasis of the organ and may be involved in
the process of (endothelial) damage.
11.1.3 Innovation
is PhD thesis is innovative both at the level of liver morphology research
as well as at the level of hemodynamic modelling of hepatic blood ow.
11.1.3.1 Morphology-related novelties
We applied an innovative combination of state of-the-art techniques (vas-
cular corrosion casting, micro-CT imaging, image processing and vascular
architecture analysis) to generate detailed and unique morphological data
on the vasculature of human livers. Both the combination and integration
of these techniques, as well as the use of human liver samples, was unpre-
cedented. Most other studies are indeed based on animal models (rat livers,
porcine livers etc.). Furthermore, we analysed the geometrical features of the
three hepatic vascular trees (the hepatic arterial, portal venous and hepatic
venous tree) simultaneously, spanning the micro-, meso- and the microvas-
culature for one and the same liver, where previous work oen addressed
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only one (or two) vascular trees and focused on only one length scale. e
acquired data are thus truly unique.
11.1.3.2 Modelling-related novelties
While the modelling techniques (lumped parameter modelling and compu-
tational uid dynamics) as such are not novel, the applications and the level
of detail of implementation are (fairly) new. We are the rst to generate the
data to develop a liver-specic extended electrical analog model for human
livers. A previous model was based on dog liver data. More important, we
also validated and calibrated the electrical livermodel by performing human
liver HMP experiments.ese experiments revealed that literature values of
one of the critical model parameters is actually a few orders of magnitude
o, with important consequences for computed (pulsatile) hemodynamic
variables. We also applied an extended lobe-specic version of the model to
assess the hemodynamic eects immediately aer partial hepatectomy.
In addition to the electrical model, the perfusion characteristics of the
human liver microcirculation were studied using a computational uid dy-
namics micromodel based on eective 3D imaging data of the human he-
patic microcirculation instead of an idealised geometry as in existing liter-
ature.is allowed us to convincingly demonstrate the anisotropic nature of
the microcirculation, and to provide quantitative values for the anisotropic
permeability tensor which can be used in future research. We used this in-
formation to construct a 3D porous media liver lobule model. Besides the
extension to 3D, other novelties over existing models were the inclusion of
the anisotropic permeability tensor as well as vascular septa.
11.2 Where to go from here?
Future research may focus on optimising and extending the methodologies
and models developed in this dissertation. Although the original research
of this PhD work is mainly fundamental, future research may also include
(new) applications.
First of all, it would be relevant to enlarge the data pool by repeating
the presented methodology for more livers. In addition, developing an al-
gorithm to (semi-)automate the geometrical data acquisition of the hepatic
vasculaturemay signicantly speed up this procedure (for some preliminary
results: see [96, 97]).
e electrical analog model of the hepatic perfusion may be extended
from modelling steady state perfusion to transient behaviour, and the mi-
crocirculation models may be coupled to the electrical model. e (tuned)
electrical model may be useful to test and compare dierentMP settings be-
fore performing animal or human liverMP experiments, as well as to predict
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- in the longer term - liver-specic optimal perfusion settings. Furthermore,
the monitoring system ofMP devices may potentially benet from incorpo-
rating real-time calculations of input impedances and Windkessel models,
giving the user information on the perfusion properties of the organ (such
as its vascular resistance and stiness).
e models, developed within this PhD, may also be useful in other do-
mains of hepatology, in which liver perfusion plays an important role (e.g.
liver cirrhosis with pulmonary hypertension, the prediction of the outcome
of transjugular intrahepatic portosystemic shunt procedures etc.).
In the longer term, surgery may benet from more detailed models of
hepatic perfusion as they allow taking the haemodynamics of functional
liver tissue into account during surgical planning besides information on
the anatomy of the macro- and microcirculation. As such, these models
may be helpful to predict patient-specic outcomes aer e.g. a partial hepa-
tectomy due to living donor liver transplantation, split liver transplantation,
a resection due to hepatocellular carcinoma, the placement of a transjugular
intrahepatic portosystemic shunt and the prediction of its potential failure
etc. Another possible model application in surgery is to simulate the eect
of the paediatric Fontan procedure (whichmay result in severe hepatic com-
plications in the longer term) on the liver haemodynamics. As a matter of
fact, H. Ho et al. recently used a simplied version of our electrical model to
simulate the eect of a right lobectomy [195] and transjugular intrahepatic
portosystemic shunts [197], as well as to enlighten the hepatic arterial buer
response eect [196].
In several liver pathologies, alterations in the vasculature and hepatic
haemodynamics seem to be important markers of disease progression (e.g.
for cirrhosis, hepatocellular carcinoma etc.) and complications (e.g. portal
hypertension, collateral formation etc.).is eld is largely unexplored. Our
methodologies can thus also be applied to diseased organs (e.g. liver cir-
rhosis) in order to compare them to normal organs and to enlighten the un-
derlying disease processes. Liver cirrhosis is characterised by liver brosis
and the formation of regenerative nodules, which severely alters the hepatic
microarchitecture by inducing a step-by-step loss of normal lobular struc-
ture with abnormal branching patterns, the capillarisation of sinusoids, the
formation of shunt vessels etc. (see also section 2.1.4). We are actually plan-
ning a study on the development of cirrhotic liver disease by means of a rat
model and by applying our methodologies. At certain time steps, rats will
be sacriced to image and model their hepatic perfusion.
e detailed hepatic angioarchitectural data, obtained in this work, may
also be of interest to anatomists andmorphologists, e.g. to better understand
the topographical hepatic vascular anatomy and function. In this respect, it
may be interesting to also take into account the anatomical segmental sub-
division when analysing the hepatic vasculature of new human liver casts.
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Furthermore, the generated 3D visualisations of the liver vasculature at dif-
ferent scales may be applicable for educational purposes (and potentially for
surgical training).
Our approach of quantifying andmodelling the hepatic vasculature and
perfusion, may analogously be applied to the biliary tree and bile ow, or to
other organs (e.g. kidneys). Furthermore, our approach oers the possibility
to compare the hepatic vasculature of dierent species (e.g. human versus
rat livers).
ese applications thus illustrate that this PhD resulted in a number of
methodologies, forming the building blocks for dierent future research di-
rections.
11.3 Take home message
e take homemessage of this work is that a multi-level framework of mod-
els was developed to simulate hepatic perfusion at dierent scales.is ver-
satile framework was applied in the context of liver transplantation and re-
sulted in unique 3D morphological and geometrical data on human and rat
livers, as well as novel models and insights into the haemodynamic impact
of machine perfusion preservation of donor livers, partial hepatectomy pro-
cedures (such as living donor liver transplantation), and into the perfusion
characteristics of the liver microcirculation. Doing so, we were able to nd
some missing pieces of the puzzle on liver perfusion. However, further re-
search is necessary to reveal the complete picture. . .
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Calculation of the principal axes of
the permeability tensor
To determine the principal axes and principal permeabilities of tensorK, the
eigenvalues as well as the eigenvectors had to be calculated. As illustrated in
Liakopoulos et al. [286], a permeability tensor has to be a symmetric matrix.
Accordingly, a real symmetric matrix has real eigenvalues and real eigen-
vectors corresponding to an orthogonal coordinate system representing the
principal axes [33]. As such, the symmetric part of K was dened by calcu-
lating the mean values of the o-diagonal coecients as illustrated for krθ
and kθr in eq. A.1.is operation resulted in a symmetric matrix Ksymm as
dened in eq. A.2.
ksymm,rθ = krθ + kθr2 (A.1)
Ksymm = ⎡⎢⎢⎢⎢⎢⎣
krr ksymm,rθ ksymm,rz
ksymm,rθ kθθ ksymm,θz
ksymm,rz ksymm,θz kzz
⎤⎥⎥⎥⎥⎥⎦ (A.2)
Subsequently, the eigenvalues (λ1, λ2, λ3) were calculated by solving the
characteristic polynomial of Ksymm (eq. A.3), and accordingly, the eigen-
vectors (e⃗1, e⃗2, e⃗3), being the directions of the principal axes belonging to
Ksymm, were determined (eq. A.4).
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det(Ksymm − λI) = ⎡⎢⎢⎢⎢⎢⎣
krr − λ ksymm,rθ ksymm,rz
ksymm,rθ kθθ − λ ksymm,θz
ksymm,rz ksymm,θz kzz − λ
⎤⎥⎥⎥⎥⎥⎦ = 0 (A.3)(Ksymm − λI) ⋅ e⃗ = 0 (A.4)
Using the eigenvectors (columns of matrix V ; eq. A.5), Ksymm was di-
agonalised resulting in the diagonal matrix Kd (eq. A.6).is matrix repre-
sents the principal permeabilities belonging to the principal axes dened by
the eigenvectors.
Kd = VTKsymmV = ⎡⎢⎢⎢⎢⎢⎣
e⃗1
e⃗2
e⃗3
⎤⎥⎥⎥⎥⎥⎦Ksymm [e⃗1 e⃗2 e⃗3] (A.5)
= ⎡⎢⎢⎢⎢⎢⎣
kd ,11 0 0
0 kd ,22 0
0 0 kd ,33
⎤⎥⎥⎥⎥⎥⎦ (A.6)
Knowing the eigenvectors and accompanying diagonal matrix, we were
able to calculate the angles between the predened coordinate system (r,
θ, z) and the resulting principal axes (dened by the eigenvectors). is is
illustrated in eq. A.7 for the angle α between the r axis and e⃗1.
α = acos ( r⃗ ⋅ e⃗1∥r⃗∥ ∥e⃗1∥) (A.7)
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Estimation of the lobe-specific and
total liver flow and resistance
Based on the simulation results, the ow rate in a single lobule, Qlobul e
[m3/s], can be estimated by multiplying the surface area of the CV by a typ-
ical normal velocity component of the ux entering the CV:
Qlobul e = ∥v⃗CV∥ ⋅ ACV = ∥v⃗CV∥ ⋅ 2pirCV ⋅ llobul e (B.1)
where v⃗CV [m/s] is the radial velocity at the CV outow, ACV [m2] is the
surface area of the CV lumen, rCV [3⋅10−5 m] is the CV radius, and llobul e
[10−3 m] the lobule length. e total liver ow, Ql iver [m3/s], is calculated
by multiplying Qlobul e by the number of lobules, n, which is estimated by
dividing a typical volume of the liver by the volume of a lobule (hexagonal
prism volume):
Ql iver = Qlobul e ⋅ n (B.2)
n = Vl iver
Vlobul e
= m l iv erρ l iv er
3rlobul e
√3r l obul e
2 llobul e
(B.3)
where Vl iver [m3] is the liver volume, Vlobul e [m3] is the lobule volume,
ml iver [1.5 kg] is the mass of the liver [311], ρl iver [103 kg/m3; equal to water]
the liver density and rlobul e is the length of a side of the lobule hexagonal
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cross-section. e lobule-specic hydraulic resistance, Rlobul e [Pa⋅s/m3], is
estimated by dividing the pressure dierence between the inowandoutow
(along the streamlines running from PT to CV) by the lobule-specic ow:
Rlobul e = ∆Plobul eQlobul e (B.4)
Since the lobules are arranged in parallel with respect to the blood ow,
the total hydraulic resistance of themicrovasculature of the liver is calculated
as the lobule resistance divided by the estimated number of lobules n:
Rl iver = Rlobul en (B.5)
248
Bibliography
[1] epa.gov/ncct/virtual_liver.
[2] histologyatlas.wisc.edu.
[3] web.williams.edu/biology/Faculty_Sta/sswoap/site/ratmousepic.
[4] www.adamimages.com.
[5] www.arizonatransplant.com/healthtopics/liver.
[6] www.eltr.org/spip.php?article161.
[7] www.eurotransplant.org.
[8] www.fresenius.com/586.htm.
[9] www.gambro.com/en/global/Products/Acute-Care/Acute-
Monitors/MARS.
[10] www.nlm.nih.gov/frankenstein/preface.html.
[11] www.organ-assist.nl.
[12] www.passport-liver.eu.
[13] www.scienticamerican.com/slideshow.cfm?id=placenta-capturing-
inner-beauty.
[14] www.transplantliverindia.com/node/13.
[15] www.virtual-liver.de.
[16] M. Abdolrazaghi, M. Navidbakhsh, and K. Hassani. Mathematical
modelling and electrical analog equivalent of the human cardiovas-
cular system. Cardiovascular Engineering, 10(2):45–51, 2010.
249
Bibliography
[17] P. Abt, M. Crawford, N. Desai, J. Markmann, K. Oltho, and
A. Shaked. Liver transplantation from controlled non-heart-beating
donors: An increased incidence of biliary complications. Transplan-
tation, 75(10):1659–1663, 2003.
[18] S. Aharinejad, W. Schreiner, and F. Neumann. Morphometry of hu-
man coronary arterial trees. e Anatomical Record, 251(1):50–59,
1998.
[19] M.A. Aller, L. Lorente, I. Prieto, L.M. Moquillaza, and J. Arias. Hep-
atectomies in the rat: A look at the caudate process throughmicrosur-
gery. Digestive and Liver Disease, 41(10):695–699, 2009.
[20] G. Almeida-Porada, E.D. Zanjani, and C.D. Porada. Bone mar-
row stem cells and liver regeneration. Experimental Hematology,
38(7):574–580, 2010.
[21] R. Anaya-Prado and J.A. Delgado-Vazquez. Scientic basis of organ
preservation. Current Opinion in Organ Transplantation, 13(2):129–
134, 2008.
[22] P.P. Anthony, K.G. Ishak, N.C. Nayak, H.E. Poulsen, P.J. Scheuer, and
L.H. Sobin. Morphology of cirrhosis. Journal of Clinical Pathology,
31(5):395–414, 1978.
[23] M.M. Augustine, I.R. Kamel, and T.M. Pawlik. Morphometric ima-
ging techniques and the functional liver remnant. In D.C. Mado,
M. Makuuchi, M. Nagino, and J.-N. Vauthey, editors, Venous embol-
ization of the liver, chapter 11, pages 95–105. Springer, London, 2011.
[24] R. Avritscher, K.C. Wright, S. Javadi, R. Uthamanthil, S. Gupta,
M. Gagea, R.L. Bassett, R. Murthy, M.J. Wallace, and D.C. Mado.
Development of a large animal model of cirrhosis and portal hyper-
tension using hepatic transarterial embolization: A study in swine.
Journal of Vascular and Interventional Radiology, 22(9):1329–1334,
2011.
[25] C. Bae, S.D. Henry, and J.V. Guarrera. Is extracorporeal hypothermic
machine perfusion of the liver better than the ‘good old icebox’? Cur-
rent Opinion in Organ Transplantation, 17(2):137–142, 2012.
[26] D. Balfoussia, D. Yerrakalva, K. Hamaoui, and V. Papalois. Advances
in machine perfusion gra viability assessment in kidney, liver, pan-
creas, lung, and heart transplant. Experimental and Clinical Trans-
plantation, 10(2):87–100, 2012.
250
Bibliography
[27] R. Banares, F. Nevens, F.S. Larsen, R. Jalan, A. Albillos, M. Dollinger,
F. Saliba, T. Sauerbruch, S. Klammt, J. Ockenga, A. Pares, J. Wendon,
T. Brunnler, L. Kramer, P. Mathurin, M. de la Mata, A. Gasbarrini,
B. Mullhaupt, A. Wilmer, W. Laleman, M. Eefsen, S. Sen, A. Zip-
prich, T. Tenorio, M. Pavesi, H.H. Schmidt, S. Mitzner, R. Williams,
and V. Arroyo. Extracorporeal albumin dialysis with the molecular
adsorbent recirculating system in acute-on-chronic liver failure:e
RELIEF trial. Hepatology, 57(3):1153–1162, 2013.
[28] J.H. Barbee and G.R. Cokelet. e Fahraeus eect. Microvascular
Research, 3(1):6–16, 1971.
[29] A. Baretta, C. Corsini, W. Yang, I.E. Vignon-Clementel, A.L.
Marsden, J.A. Feinstein, T.Y. Hsia, G. Dubini, F. Migliavacca, and
G. Pennati. Virtual surgeries in patients with congenital heart dis-
ease: A multi-scale modelling test case. Philosophical Transactions of
the Royal Society A: Mathematical, Physical & Engineering Sciences,
369(1954):4316–4330, 2011.
[30] C.A. Basciano. Computational particle-hemodynamics analy-
sis applied to an abdominal aortic aneurysm with thrombus and
microsphere-targeting of liver tumors. PhD thesis, North Carolina
State University, 2010.
[31] C.A. Basciano, C. Kleinstreuer, A.S. Kennedy, W.A. Dezarn, and
E. Childress. Computer modeling of controlled microsphere release
and targeting in a representative hepatic artery system. Annals of Bio-
medical Engineering, 38(5):1862–1879, 2010.
[32] E. Bavu, J.-L. Gennisson, M. Couade, J. Berco, V. Mallet, M. Fink,
A. Badel, A. Vallet-Pichard, B. Nalpas, M. Tanter, and S. Pol. Non-
invasive in vivo liver brosis evaluation using supersonic shear ima-
ging: A clinical study on 113 hepatitis C virus patients. Ultrasound in
Medicine and Biology, 37(9):1361–1373, 2011.
[33] R.A. Beezer. Arst course in linear algebra. University of Puget Sound,
Tacoma, Washington, USA, 2010.
[34] S. Beloucif, N. Brienza, K. Andreoni, T. Ayuse, M. Takata, C.P. Odon-
nell, and J.L. Robotham. Distinct behavior of portal venous and ar-
terial vascular waterfalls in porcine liver. Journal of Critical Care,
10(3):104–114, 1995.
251
Bibliography
[35] M. Bessems, B.M. Doorschodt, J.L.P. Kolkert, R.L. Vetelainen, A.K.
van Vliet, H. Vreeling, J. vanMarle, and T.M. van Gulik. Preservation
of steatotic livers: A comparison between cold storage and machine
perfusion preservation. Liver Transplantation, 13(4):497–504, 2007.
[36] M. Bessems, B.M. Doorschodt, A.K. van Vliet, and T.M. van Gulik.
Improved rat liver preservation by hypothermic continuous machine
perfusion using Polysol, a new, enriched preservation solution. Liver
Transplantation, 11(5):539–546, 2005.
[37] J. Bézy-Wendling, M. Kretowski, and Y. Rolland. Hepatic tumor en-
hancement in computed tomography: Combinedmodels of liver per-
fusion and dynamic imaging. Computers in Biology and Medicine,
33(1):77–89, 2003.
[38] H. Bismuth. Surgical anatomy and anatomical surgery of the liver.
World Journal of Surgery, 6(1):3–9, 1982.
[39] P.J. Blanco and R.A. Feijoo. A dimensionally-heterogeneous closed-
loopmodel for the cardiovascular systemand its applications.Medical
Engineering & Physics, 2012.
[40] E. Bloch.e termination of hepatic arterioles and the functional unit
of the liver as determined by microscopy of the living organ. Annals
of the New York Academy of Sciences, 170:78–87, 1970.
[41] I. Bockx. Neurohepatology:e role of the vagus nerve in liver disease.
PhD thesis, Katholieke Universiteit Leuven, 2010.
[42] H.G. Bohlen, R. Maass-Moreno, and C.F. Rothe. Hepatic venular
pressures of rats, dogs, and rabbits. American Journal of Physiology,
261(3):G539–G547, 1991.
[43] A. Bonglio, K. Leungchavaphongse, R. Repetto, and J.H. Siggers.
Mathematical modeling of the circulation in the liver lobule. Journal
of Biomechanical Engineering, 132(11):111011, 2010.
[44] C. Booth, T. Soker, P. Baptista, C.L. Ross, S. Soker, U. Farooq, R.J.
Stratta, and G. Orlando. Liver bioengineering: Current status and
future perspectives. World Journal of Gastroenterology, 18(47):6926–
34, 2012.
[45] H. Bourquain, A. Schenk, andH.O. Peitgen. Computer-assisted plan-
ning and decision-making in living-donor liver transplantation. In
Kaihara S I.Y. Tanaka K, editor, Living-donor liver transplantation -
surgical techniques and innovations, pages 23–28. Prous Science, Bar-
celona, 2003.
252
Bibliography
[46] E.M. Boyle and E.D. Verrier. Rheologic considerations in organ pre-
servation. Annals oforacic Surgery, 69(1):12–13, 2000.
[47] D.J. Breen, E.E. Rutherford, B. Stedman, C. Lee-Elliott, and C.N.
Hacking. Intrahepatic arterioportal shunting and anomalous venous
drainage: Understanding the CT features in the liver. European Radi-
ology, 14(12):2249–2260, 2004.
[48] L. Brettschneider, J. Kol, G.V. Smith, A.J. Martin, P. Taylor, and T.E.
Starzl. An evaluation of perfusion constituents in liver preservation.
Surgical Forum, 19:354–356, 1968.
[49] J. Brockmann, S. Reddy, C. Coussios, D. Pigott, D. Guirriero,
D. Hughes, A. Morovat, D. Roy, L. Winter, and P.J. Friend. Normo-
thermic perfusion A new paradigm for organ preservation. Annals of
Surgery, 250(1):1–6, 2009.
[50] J.G. Brockmann, A. Vaidya, S. Reddy, and P.J. Friend. Retrieval of
abdominal organs for transplantation. British Journal of Surgery,
93(2):133–146, 2006.
[51] A. Brunon, K. Bruyere-Garnier, andM. Coret. Mechanical character-
ization of liver capsule through uniaxial quasi-static tensile tests until
failure. Journal of Biomechanics, 43(11):2221–2227, 2010.
[52] J. Op Den Buijs, Z. Bajzer, and E.L. Ritman. Branching morphology
of the rat hepatic portal vein tree: A micro-CT study. Annals of Bio-
medical Engineering, 34(9):1420–1428, 2006.
[53] W.E. Burkel.e ne structure of the terminal branches of the hepatic
arterial system of the rat. Anatomical Record, 167(3):329–349, 1970.
[54] P. Burra and R. Freeman. Trends in liver transplantation 2011. Journal
of Hepatology, 56:S101–S111, 2012.
[55] A.K. Burroughs. e hepatic artery, portal venous system and portal
hypertension: e hepatic veins and liver in circulatory failure. In
Sherlock’s diseases of the liver and biliary system, pages 152–209.Wiley-
Blackwell, 2011.
[56] A.J. Butler, M.A. Rees, D.G.D. Wight, N.D. Casey, G. Alexander,
D.J.G. White, and P.J. Friend. Successful extracorporeal porcine liver
perfusion for 72 hr. Transplantation, 73(8):1212–1218, 2002.
253
Bibliography
[57] F. Ariza Cadena, L.F. Carmona Serna, I.F. Quintero C, L.A. Caicedo,
C.A. Vidal Perdomo, and L.F. González. Sistemas de soporte hep-
ático extracorpóreo. Revista Colombiana de Anestesiología, 39:528–
543, 2011.
[58] R.Y. Calne, K. Rolles, D.J. White, S.iru, D.B. Evans, P. McMaster,
D.C. Dunn, G.N. Craddock, R.G. Henderson, S. Aziz, and P. Lewis.
Cyclosporin A initially as the only immunosuppressant in 34 recipi-
ents of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet,
2(8151):1033–1036, 1979.
[59] E.M. Carlisle and G. Testa. Adult to adult living related liver trans-
plantation: Where do we currently stand? World Journal of Gastroen-
terology, 18(46):6729–6736, 2012.
[60] J.C. Carr, A.A. Nemcek, M. Abecassis, A. Blei, L. Clarke, F.S. Pereles,
R. McCarthy, and J.P. Finn. Preoperative evaluation of the entire he-
patic vasculature in living liver donors with use of contrast-enhanced
MR angiography and true fast imaging with steady-state precession.
Journal of Vascular and Interventional Radiology, 14(4):441–449, 2003.
[61] A. Carrel and C.A. Lindbergh. e culture of whole organs. Science,
81(2112):621–623, 1935.
[62] C. Casteleyn. Vascular anatomy of the mouse visualized by the corro-
sion casting technique. master thesis, Ghent University, 2008.
[63] C. Casteleyn, B. Trachet, D. Van Loo, D.G.H. Devos, W. Van den
Broeck, P. Simoens, and P. Cornillie. Validation of the murine aortic
arch as amodel to study human vascular diseases. Journal of Anatomy,
216(5):563–571, 2010.
[64] S.C. Chan, C.M. Lo, and S.T. Fan. Simplifying living donor liver trans-
plantation. Hepatobiliary & Pancreatic Diseases International, 9(1):9–
14, 2010.
[65] S.C. Chan, C.M. Lo, K.K.C. Ng, I.O.L. Ng, B.H. Yong, and S.T. Fan.
Portal inow and pressure changes in right liver living donor liver
transplantation including the middle hepatic vein. Liver Transplanta-
tion, 17(2):115–121, 2011.
[66] S. Chatelin, J. Oudry, N. Perichon, L. Sandrin, P. Allemann, L. Soler,
and R. Willinger. In vivo liver tissue mechanical properties by tran-
sient elastography: Comparison with dynamic mechanical analysis.
Biorheology, 48(2):75–88, 2011.
254
Bibliography
[67] C.Y. Chen, S.C. Shiesh, M.C. Wu, and X.Z. Lin. e eects of bile
duct obstruction on the biliary secretion of ciprooxacin in piglets.
American Journal of Gastroenterology, 94(9):2408–2411, 1999.
[68] H. Chen, Y. Zhang, L. Zhou, H.-Y. Xie, and S.-S. Zheng. Role of basic
studies in expanding the donor pool for liver transplantation. Hep-
atobiliary & Pancreatic Diseases International, 7(6):571–580, 2008.
[69] M.L. Chen, Q.Y. Zeng, J.W. Huo, X.M. Yin, B.P. Li, and J.X. Liu. As-
sessment of the hepatic microvascular changes in liver cirrhosis by
perfusion computed tomography. World Journal of Gastroenterology,
15(28):3532–3537, 2009.
[70] Z. Chen, L. Yan, B. Li, Y. Zeng, T. Wen, J. Zhao, W. Wang, M. Xu, and
J. Yang. Prevent small-for-size syndrome using dual gras in living
donor liver transplantation. Journal of Surgical Research, 155(2):261–
267, 2009.
[71] T.M. Chu and N.P. Reddy. A lumped parameter mathematical model
of the splanchnic circulation. Journal of Biomechanical Engineering -
Transactions of the ASME, 114(2):222–226, 1992.
[72] C. Chui, E. Kobayashi, X. Chen, T. Hisada, and I. Sakuma. Combined
compression and elongation experiments and non-linear modelling
of liver tissue for surgical simulation. Medical & Biological Engineer-
ing & Computing, 42(6):787–798, 2004.
[73] C. Chui, E. Kobayashi, X. Chen, T. Hisada, and I. Sakuma. Trans-
versely isotropic properties of porcine liver tissue: Experiments and
constitutive modelling. Medical & Biological Engineering & Comput-
ing, 45(1):99–106, 2007.
[74] R. Ciria, J. Briceno, S. Ruan, A. Luque, and P. Lopez-Cillero. Dona-
tion aer cardiac death: Where, when, and how? Transplantation
Proceedings, 44(6):1470–1474, 2012.
[75] E.C. Clarke, S. Cheng, M. Green, R. Sinkus, and L.E. Bilston. Using
static preload with magnetic resonance elastography to estimate large
strain viscoelastic properties of bovine liver. Journal of Biomechanics,
44(13):2461–2465, 2011.
[76] R.D. Cohen, C.L. Brown, C. Nickols, P. Levey, B.J. Boucher, S.E. Gre-
enwald, andW.Wang. Inbuiltmechanisms for overcoming functional
problems inherent in hepatic microlobular structure. Computational
and Mathematical Methods in Medicine, 2011:185845, 2011.
255
Bibliography
[77] P. Cornillie, W. Van den Broeck, and P. Simoens. Origin of the in-
frarenal part of the caudal vena cava in the pig. Anatomia Histologia
Embryologia, 37(5):387–393, 2008.
[78] C. Couinaud. Le foie: Études anatomiques et chirurgicales. Masson et
Cie, 1957.
[79] C. Couinaud. Liver anatomy: Portal (and suprahepatic) or biliary
segmentation. Digestive Surgery, 16(6):459–467, 1999.
[80] F.G. Court, S.A. Wemyss-Holden, C.P. Morrison, B.D. Teague, P.F.
Laws, J. Kew, A.R. Dennison, and G.J. Maddern. Segmental nature
of the porcine liver and its potential as a model for experimental par-
tial hepatectomy. British Journal of Surgery, 90(4):440–444, 2003.
[81] A.R. Crawford, X.Z. Lin, and J.M.Crawford.e normal adult human
liver biopsy: a quantitative reference standard. Hepatology, 28(2):323–
331, 1997.
[82] J.M. Crawford. Development of the intrahepatic biliary tree. Seminars
in Liver Disease, 22(3):213–226, 2002.
[83] J.M. Crawford. Vascular disorders of the liver. Clinical Liver Disease,
14(4):635–650, 2010.
[84] S. Cui, T. Shibamoto, W. Zhang, H. Takano, and Y. Kurata. Venous
resistance increases during rat anaphylactic shock. Shock, 29(6):733–
739, 2008.
[85] M.H. Dahlke, H. Aselmann, D. Ceylan, T. Bellin, P. Flemming, P.N.
Meier, K. Oldhafer, J. Klempnauer, H.J. Schlitt, and P. Piso. Eec-
tiveness of peripheral hepatogastrostomy versus hepatojejunostomy
in the treatment of obstructive cholestasis: Results of an experimental
model. Surgery Today, 34(4):349–353, 2004.
[86] U. Dahmen, C.A. Hall, N. Madrahimov, V. Milekhin, and O. Dirsch.
Regulation of hepatic microcirculation in stepwise liver resection.
Acta Gastro-Enterologica Belgica, 70(4):345–351, 2007.
[87] U. Dahmen, N. Madrahimov, F. Madrahimova, Y. Ji, A. Schenk, and
O. Dirsch. Small-for-size syndrome in the rat: Does size or technique
matter? Journal of Surgical Research, 149(1):15–26, 2008.
[88] U. Dahmen, A. Radtke, T. Schroeder, H. Chi, N. Madrahimov, M. Lu,
A. Schenk, K.H. Peitgen, and O. Dirsch. Median liver lobe of wood-
chuck as a model to study hepatic outow obstruction: A pilot study.
Liver International, 28(9):1236–1244, 2008.
256
Bibliography
[89] C. Rodriguez de Lope, S. Tremosini, A. Forner, M. Reig, and J. Bruix.
Management of HCC. Journal of Hepatology, 56:S75–S87, 2012.
[90] L. de Pater. An electrical analogue of the entire human circulatory
system.Medical electronics and biological engineering, 2:161–166, 1964.
[91] L. de Pater. An electrical analogue of the human circulatory system.
PhD thesis, University of Groningen, 1966.
[92] O. de Rougemont, S. Breitenstein, B. Leskosek, A.Weber, R. Graf, P.A.
Clavien, and P. Dutkowski. One hour hypothermic oxygenated per-
fusion (hope) protects nonviable liver allogras donated aer cardiac
death. Annals of Surgery, 250(5):674–683, 2009.
[93] C. Debbaut, D. Monbaliu, C. Casteleyn, P. Cornillie, D. Van Loo,
B. Masschaele, J. Pirenne, P. Simoens, L. Van Hoorebeke, and
P. Segers. From vascular corrosion cast to electrical analog model for
the study of human liver hemodynamics and perfusion. IEEE Trans-
actions on Biomedical Engineering, 58(1):25–35, 2011.
[94] C. Debbaut, D. Monbaliu, and P. Segers. Validation and calibration of
an electrical analog model of hepatic perfusion based on human liver
hypothermic machine perfusion experiments. Submitted for publica-
tion.
[95] C. Debbaut, P. Segers, P. Cornillie, C. Casteleyn, M. Dierick, W. Lale-
man, and D. Monbaliu. Analyzing the human liver vascular archi-
tecture by combining vascular corrosion casting and micro-CT scan-
ning: a feasibility study. Submitted for publication.
[96] C. Debbaut, J.G. Sled, D. Monbaliu, and P. Segers. Semi-automatic
morphological analysis of vascular trees: Application to the human
liver. 11th Belgian National Day on Biomedical Engineering, 2012.
[97] C. Debbaut, J.G. Sled, D. Monbaliu, and P. Segers. Semi-automatic
analysis of the branching topology and geometrical characteristics
of hepatic vascular trees. e International Liver Congress (EASL),
Journal of Hepatology, 58:S230, 2013.
[98] C. Debbaut, J. Vierendeels, C. Casteleyn, P. Cornillie, D. Van Loo,
P. Simoens, L. Van Hoorebeke, D. Monbaliu, and P. Segers. Perfu-
sion characteristics of the human hepatic microcirculation based on
three-dimensional reconstructions and computational uid dynamic
analysis. Journal of Biomechanical Engineering, 134(1):011003, 2012.
257
Bibliography
[99] C. Debbaut, J. Vierendeels, J. Siggers, R. Repetto, D. Monbaliu, and
P. Segers. A 3D porous media liver lobule model : the importance of
vascular septa and anisotropic permeability for homogeneous perfu-
sion. ComputerMethods in Biomechanics and Biomedical Engineering,
e-publication ahead of print, 2012.
[100] C. Debbaut, D. De Wilde, C. Casteleyn, P. Cornillie, D. Van Loo,
L. Van Hoorebeke, D. Monbaliu, Y.-D. Fan, and P. Segers. Model-
ing the impact of partial hepatectomy on the hepatic hemodynam-
ics using a rat model. IEEE Transactions on Biomedical Engineering,
59(12):3293–3303, 2012.
[101] T.Deeux, G.Montaldo,M.Tanter, andM. Fink. Shearwave spectro-
scopy for in vivo quantication of human so tissues visco-elasticity.
IEEE Transactions on Medical Imaging, 28(3):313–322, 2009.
[102] K. Derveaux, D.Monbaliu, T. Crabbe, D. Schein, J. Brassil, D. Kravitz,
J. Fevery, L. Jacobbi, T. Roskams, and J. Pirenne. Does ex vivo vascular
resistance reect viability of non-heart-beating donor livers? Trans-
plantation Proceedings, 37(1):338–339, 2005.
[103] V.J. Desmet. e amazing universe of hepatic microstructure. Hep-
atology, 50(2):333–344, 2009.
[104] V.J. Desmet. Ductal plates in hepatic ductular reactions. Hypothesis
and implications. II. Ontogenic liver growth in childhood. Virchows
Archiv, 458(3):261–270, 2011.
[105] O. Dirsch, J. Li, Q. He, Y. Ji, Y.L. Gu, and U. Dahmen. Induction of re-
jection aer small-for-size liver transplantation: Size matters. Journal
of Investigative Surgery, 21(5):288–298, 2008.
[106] O. Dirsch, N. Madrahimov, N. Chaudri, M. Deng, F. Madrahimova,
A. Schenk, and U. Dahmen. Recovery of liver perfusion aer focal
outow obstruction and liver resection. Transplantation, 85(5):748–
756, 2008.
[107] G. Donati, G. La Manna, G. Cianciolo, V. Grandinetti, E. Carretta,
M. Cappuccilli, L. Panicali, M. Iorio, F. Piscaglia, L. Bolondi, L. Coli,
and S. Stefoni. Extracorporeal detoxication for hepatic failure us-
ing molecular adsorbent recirculating system: Depurative eciency
and clinical results in a long-term follow-up. Articial Organs, e-
publication ahead of print, 2013.
258
Bibliography
[108] R.E. Drake, S.J. Allen, J. Katz, J.C. Gabel, and G.A. Laine. Equivalent
circuit technique for lymph ow studies. American Journal of Physi-
ology, 251(5 Pt 2):H1090–H1094, 1986.
[109] P. Dutkowski, O. de Rougemont, and P.A. Clavien. Alexis Carrel:
Genius, innovator and ideologist. American Journal of Transplanta-
tion, 8(10):1998–2003, 2008.
[110] P. Dutkowski, O. de Rougemont, and P.A. Clavien. Machine perfu-
sion for ’marginal’ liver gras. American Journal of Transplantation,
8(5):917–924, 2008.
[111] P. Dutkowski, K. Furrer, Y.H. Tian, R. Graf, and P.A. Clavien. Novel
short-term hypothermic oxygenated perfusion (HOPE) system pre-
vents injury in rat liver gra from non-heart beating donor. Annals
of Surgery, 244(6):968–977, 2006.
[112] P. Dutkowski, B. Odermatt, T. Heinrich, S. Schonfeld, M. Watzka,
V. Winkelbach, M. Krysiak, and T. Junginger. Hypothermic oscillat-
ing liver perfusion stimulates ATP synthesis prior to transplantation.
Journal of Surgical Research, 80(2):365–372, 1998.
[113] P. Dutkowski, S. Schonfeld, B. Odermatt, T. Heinrich, and
T. Junginger. Rat liver preservation by hypothermic oscillating liver
perfusion compared to simple cold storage. Cryobiology, 36(1):61–70,
1998.
[114] C. Eipel, K. Abshagen, J. Ritter, D. Cantre, M.D. Menger, and B. Voll-
mar. Splenectomy improves survival by increasing arterial blood sup-
ply in a rat model of reduced-size liver. Transplant International,
23(10):998–1007, 2010.
[115] R.M. Eisele, W. Meissner, N.C. Nussler, K.P. Platz, U. Settmacher,
and P. Neuhaus. Hepatic artery resistance as a marker for preserva-
tion/reperfusion injury. Transplantation Proceedings, 33(1-2):959–961,
2001.
[116] W. Ekataksin. Microanatomy of the bile secretory epithelium and vas-
culature:e identication of mammalian livers. In M.P. Manns, J.L.
Boyer, P.L.M. Jansen, and J. Reichen, editors,Cholestatic liver diseases,
pages 46–61. Kluwer Academic Publishers, Dordrecht, 1998.
[117] W. Ekataksin. e isolated artery: An intrahepatic arterial pathway
that can bypass the lobular parenchyma in mammalian livers. Hep-
atology, 31:269–279, 2000.
259
Bibliography
[118] W. Ekataksin and K. Wake. Liver units in 3 dimensions: 1. Or-
ganization of argyrophilic connective-tissue skeleton in porcine liver
with particular reference to the compound hepatic lobule. American
Journal of Anatomy, 191(2):113–153, 1991.
[119] W. Ekataksin and K.Wake. New concepts in biliary and vascular ana-
tomy of the liver. Progress in Liver Diseases, 15:1–30, 1997.
[120] S. Ekins, A.J.Williams, and J.J. Xu. A predictive ligand-based bayesian
model for human drug-induced liver injury. Drug Metabolism and
Disposition, 38(12):2302–2308, 2010.
[121] B. Ekser, B. Gridelli, M. Veroux, and D.K.C. Cooper. Clinical pig liver
xenotransplantation: How far do we have to go? Xenotransplantation,
18(3):158–167, 2011.
[122] H. Ellis. Anatomy of the liver. Surgery (Oxford), 29(12):589–592, 2011.
[123] B.G. Ericzon, M. Larsson, andH.E.Wilczek. Domino liver transplan-
tation: Risks and benets. Transplantation Proceedings, 40(4):1130–
1131, 2008.
[124] European Association for the Study of the Liver. EASL postgraduate
course: Alcoholic liver disease, 2012.
[125] Eurotransplant International Foundation. Annual report, 2008.
[126] Eurotransplant International Foundation. Annual report, 2010.
[127] Eurotransplant International Foundation. Annual report, 2012.
[128] R. Fahraeus and T. Lindqvist. e viscosity of the blood in narrow
capillary tubes. American Journal of Physiology – Legacy Content,
96(3):562–568, 1931.
[129] S.T. Fan. Live donor liver transplantation in adults. Transplantation,
82(6):723–732, 2006.
[130] S.T. Fan. Living donor liver transplantation. World Scientic Publish-
ing Co. Pte. Ltd., Singapore, 2nd edition, 2007.
[131] Y.D. Fan, E.Vanheule, D.Meester, J. VanHuysse, K.Olievier,M. Praet,
I. Colle, and B. de Hemptinne. Hepatic stellate cell activation: An
important contributor to persistent hepatic resistance in small-for-
size livers aer extended partial hepatectomy in the rat. Journal of
Hepatology, 52:S59–S60, 2010.
260
Bibliography
[132] G.C. Farrell and C.Z. Larter. Nonalcoholic fatty liver disease: From
steatosis to cirrhosis. Hepatology, 43(S1):S99–S112, 2006.
[133] J.H.D. Fasel. Portal venous territorieswithin the human liver: An ana-
tomical reappraisal. Anatomical Record-Advances in Integrative Ana-
tomy and Evolutionary Biology, 291(6):636–642, 2008.
[134] J. Fernandez and T. Gustot. Management of bacterial infections in
cirrhosis. Journal of Hepatology, 56:S1–S12, 2012.
[135] P. Fiaschetti, R. Pretagostini, D. Stabile, D. Peritore, A. Oliveti, F. Gab-
brielli, S. Cenci, A. Ricci, F. Vespasiano, and W.F. Grigioni. e use
of neoplastic donors to increase the donor pool. Transplantation Pro-
ceedings, 44(7):1848–1850, 2012.
[136] D.R. Fine, D. Glasser, D. Hildebrandt, J. Esser, R.E. Lurie, and
N. Chetty. An anatomic and physiological model of hepatic vascu-
lar system. Journal of Applied Physiology, 79(3):1008–1026, 1995.
[137] G. Finet, M. Gilard, B. Perrenot, G. Rioufol, P. Motre, L. Gavit, and
R. Prost. Fractal geometry of arterial coronary bifurcations: A quant-
itative coronary angiography and intravascular ultrasound analysis.
EuroInvention, 3(4):490–498, 2007.
[138] C.D. Fingas, S. Wu, Y. Gu, J. Wohlschlaeger, A. Scherag, U. Dah-
men, A. Paul, H. de Groot, and U. Rauen. Assessment of a
chloride-poor versus a chloride-containing version of a modied
histidine-tryptophan-ketoglutarate solution in a rat liver transplan-
tation model. Liver Transplantation, 17(6):650–660, 2011.
[139] R.A. Fisher, L.M. Kulik, C.E. Freise, A.S.F. Lok, T.H. Shearon, Jr.
R.S. Brown, R.M. Ghobrial, J.H. Fair, K.M. Oltho, I. Kam, C.L. Berg,
and the A2ALL Study Group. Hepatocellular carcinoma recurrence
and death following living and deceased donor liver transplantation.
American Journal of Transplantation, 7(6):1601–1608, 2007.
[140] C. Fondevila. Is extracorporeal support becoming the new standard
for the preservation of DCD gras? American Journal of Transplan-
tation, 10(6):1341–1342, 2010.
[141] C. Fondevila, A.J. Hessheimer, M.-H.J. Maathuis, J. Munoz, P. Taura,
D. Calatayud, H. Leuvenink, A. Rimola, J.C. Garcia-Valdecasas, and
R.J. Ploeg. Hypothermic oxygenated machine perfusion in porcine
donation aer circulatory determination of death liver transplant.
Transplantation, 94(1):22–29, 2012.
261
Bibliography
[142] S. Francque,W. Laleman, L. Verbeke, C. Van Steenkiste, C. Casteleyn,
W. Kwanten, C. Van Dyck, M. D’Hondt, A. Ramon, W. Vermeu-
len, B. De Winter, E. Van Marck, V. Van Marck, P. Pelckmans, and
P. Michielsen. Increased intrahepatic resistance in severe steatosis:
endothelial dysfunction, vasoconstrictor overproduction and altered
microvascular architecture. Laboratory Investigation, 92(10):1428–
1439, 2012.
[143] S.L. Friedman. Molecular regulation of hepatic brosis, an integ-
rated cellular response to tissue injury. Journal of Biological Chem-
istry, 275(4):2247–2250, 2000.
[144] P.J. Friend, C. Imber, S. St Peter, I. Lopez, A.J. Butler, and M.A. Rees.
Normothermic perfusion of the isolated liver. Transplantation Pro-
ceedings, 33(7-8):3436–3438, 2001.
[145] T. Fukuchi, H. Hirose, A. Onitsuka, M. Hayashi, S. Senga, N. Imai,
M. Shibata, K. Yamauchi, N. Futamura, and Y. Sumi. Eects of portal-
systemic shunt following 90% partial hepatectomy in rats. Journal of
Surgical Research, 89(2):126–131, 2000.
[146] B.J. Fuller and C.Y. Lee. Hypothermic perfusion preservation: e
future of organ preservation revisited? Cryobiology, 54(2):129–145,
2007.
[147] L.A. Furchtgott, C.C. Chow, and V. Periwal. A model of liver regen-
eration. Biophysical Journal, 96(10):3926–3935, 2009.
[148] I.T. Gabe. Arterial blood ow by analogue solution of Navier-Stokes
equation. Physics in Medicine and Biology, 10(2):271–280, 1965.
[149] E. Gabrys, M. Rybaczuk, and A. Kedzia. Fractal models of circulatory
system. Symmetrical and asymmetrical approach comparison. Chaos
Solitons & Fractals, 24(3):707–715, 2005.
[150] Z. Gao, K. Lister, and J.P. Desai. Constitutive modeling of liver tissue:
Experiment and theory. Annals of Biomedical Engineering, 38(2):505–
516, 2010.
[151] G. Garcea and G.J. Maddern. Liver failure aer major hepatic re-
section. Journal of Hepato-Biliary-Pancreatic Surgery, 16(2):145–155,
2009.
[152] G. Garcea, H. Nabi, and G.J. Maddern. Russell strong and the his-
tory of reduced-size liver transplantation. World Journal of Surgery,
33(8):1575–1580, 2009.
262
Bibliography
[153] G.Garcea, S.L.Ong, andG.J.Maddern. Predicting liver failure follow-
ing major hepatectomy. Digestive and Liver Disease, 41(11):798–806,
2009.
[154] G. Garcia-Tsao, S. Friedman, J. Iredale, and M. Pinzani. Now there
are many (stages) where before there was one: In search of a patho-
physiological classication of cirrhosis. Hepatology, 51(4):1445–1449,
2010.
[155] J.C. García-Valdecasas. Split and living donor liver transplantation.
Digestive and Liver Disease Supplements, 3(4):93–95, 2009.
[156] J.C. Garcia-Valdecasas and C. Fondevila. In-vivo normothermic re-
circulation: An update. Current Opinion in Organ Transplantation,
15(2):173–176, 2010.
[157] C. Gennings, D. Heuman, O. Fulton, and A.J. Sanyal. Use of de-
sirability functions to evaluate health status in patients with cirrhosis.
Journal of Hepatology, 52(5):665–671, 2010.
[158] S. George. Hemodynamic investigation of the liver using magnetic res-
onance imaging and computational uid dynamics. PhD thesis, Geor-
gia Institute of Technology, 2008.
[159] R.M. Ghobrial, C.E. Freise, J.F. Trotter, L. Tong, A.O. Ojo, J.H. Fair,
R.A. Fisher, J.C. Emond, A.J. Koron, T.L. Pruett, K.M. Oltho, and
the A2ALL Study Group. Donor morbidity aer living donation for
liver transplantation. Gastroenterology, 135(2):468–476, 2008.
[160] C. Gille, C. Boelling, A. Hoppe, S. Bulik, S. Homann, K. Huebner,
A. Karlstaedt, R. Ganeshan, M. Koenig, K. Rother, M. Weidlich,
J. Behre, andH.-G.Holzhuetter. HepatoNet1: A comprehensivemeta-
bolic reconstruction of the human hepatocyte for the analysis of liver
physiology. Molecular Systems Biology, 6:411, 2010.
[161] P. Gines, J. Fernandez, F. Durand, and F. Saliba. Management of
critically-ill cirrhotic patients. Journal of Hepatology, 56:S13–S24,
2012.
[162] I. Giuvarasteanu. Scanning electronmicroscopy of vascular corrosion
casts–standard method for studying microvessels. Romanian Journal
of Morphology and Embryology, 48(3):257–261, 2007.
[163] M. Glanemann, C. Eipel, A.K. Nussler, B. Vollmar, and P. Neuhaus.
Hyperperfusion syndrome in small-for-size livers. European Surgical
Research, 37(6):335–341, 2005.
263
Bibliography
[164] F. Glisson. Anatomia hepatis. London, 1654.
[165] N. Goldaracena, E. Quinonez, P. Mendez, M. Anders, F. Orozco
Ganem, R. Mastai, and L. McCormack. Extremely marginal liver
gras from deceased donors have outcome similar to ideal gras.
Transplantation Proceedings, 44(7):2219–2222, 2012.
[166] R.F.M. Gomes and J.H.T. Bates. Geometric determinants of airway
resistance in two isomorphic rodent species. Respiratory Physiology
& Neurobiology, 130(3):317–325, 2002.
[167] Z. Gordon, D. Elad, R. Almog, Y. Hazan, A.J. Jaa, and O. Eytan. An-
thropometry of fetal vasculature in the chorionic plate. Journal of
Anatomy, 211(6):698–706, 2007.
[168] D.N. Granger. Ischemia-reperfusion: Mechanisms of microvascular
dysfunction and the inuence of risk factors for cardiovascular dis-
ease. Microcirculation, 6(3):167–178, 1999.
[169] C.V. Greenway and R.D. Stark. Hepatic vascular bed. Physiological
Reviews, 51(1):23–65, 1971.
[170] E. Gringeri, P. Bonsignore, D. Bassi, F.E. D’Amico, C. Mescoli, M. Po-
lacco, M. Buggio, R. Luisetto, R. Boetto, G. Noaro, A. Ferrigno,
E. Boncompagni, I. Freitas, M.P. Vairetti, A. Carraro, D. Neri, and
U. Cillo. Subnormothermicmachine perfusion for non-heart-beating
donor liver gras preservation in a swine model: A new strategy to
increase the donor pool? Transplantation Proceedings, 44(7):2026–
2028, 2012.
[171] M. Gronbaek, M.K. Jensen, D. Johansen, T.I.A. Sorensen, and
U. Becker. Intake of beer, wine and spirits and risk of heavy drinking
and alcoholic cirrhosis. Biological Research, 37(2):195–200, 2004.
[172] S. Gruttadauria, C.S. Foglieni, C. Doria, A. Luca, A. Lauro, and I.R.
Marino.e hepatic artery in liver transplantation and surgery: Vas-
cular anomalies in 701 cases. Clinical Transplantation, 15(5):359–363,
2001.
[173] J.V. Guarrera, J. Estevez, J. Boykin, R. Boyce, J. Rashid, S. Sun, and
B. Arrington. Hypothermic machine perfusion of liver gras for
transplantation: Technical development in human discard and mini-
ature swine models. Transplantation Proceedings, 37(1):323–325, 2005.
264
Bibliography
[174] J.V. Guarrera, S.D. Henry, B. Samstein, R. Odeh-Ramadan, M. Kinkh-
abwala, M.J. Goldstein, L.E. Ratner, J.F. Renz, H.T. Lee, Jr. R.S. Brown,
and J.C. Emond. Hypothermic machine preservation in human liver
transplantation: e rst clinical series. American Journal of Trans-
plantation, 10(2):372–381, 2010.
[175] J.V. Guarrera and N.A. Karim. Liver preservation: Is there anything
new yet? Current Opinion in Organ Transplantation, 13(2):148–154,
2008.
[176] S.C. Gupta, C.D. Gupta, and A.K. Arora. Subsegmentation of the hu-
man liver. Journal of Anatomy, 124(2):413–423, 1977.
[177] S.C. Gupta, C.D. Gupta, and S.B. Gupta. Hepatovenous segments in
the human liver. Journal of Anatomy, 133(1):1–6, 1981.
[178] H.K. Hahn, C.J.G. Evertsz, H.-O. Peitgen, and J.H.D. Fasel. Fractal
properties, segment anatomy, and interdependence of the human
portal vein and the hepatic vein in 3D. Fractals, 11(01):53–62, 2003.
[179] H.K. Hahn, M. Georg, and H.-O. Peitgen. Fractal aspects of three-
dimensional vascular constructive optimization. In G. Losa, D. Mer-
lini, T. Nonnenmacher, and E. Weibel, editors, Fractals in biology
and medicine, Mathematics and biosciences in interaction, chapter 5,
pages 55–66. Birkhäuser Basel, 2005.
[180] J.T. Halavaara, L.M. Hamberg, F.S. Leong, G.J. Hunter, G.S. Gazelle,
and G.L. Wolf. Functional CT with an experimental intravascular
contrast agent in the assessment of liver vascular physiology. Aca-
demic Radiology, 3(11):946–952, 1996.
[181] H. Hano and S. Takasaki. ree-dimensional observations on the al-
terations of lobular architecture in chronic hepatitis with special refer-
ence to its angioarchitecture for a better understanding of the formal
pathogenesis of liver cirrhosis. Virchows Archiv, 443(5):655–663, 2003.
[182] C. Hansen, S. Zidowitz, A. Schenk, K.J. Oldhafer, H. Lang, and H.O.
Peitgen. Risk maps for navigation in liver surgery. In K.H. Wong and
M.I. Miga, editors, Proceedings of SPIE, Medical Imaging 2010: Visu-
alization, Image-Guided Procedures, and Modeling, 2010.
[183] T.R.Harring, C.A.O’Mahony, and J.A.Goss. Extended donors in liver
transplantation. Clinics in Liver Disease, 15(4):879–900, 2011.
265
Bibliography
[184] K. Hashimoto, C.M. Miller, C. Quintini, F.N. Aucejo, K. Hirose, T.D.
Uso, L. Trenti, D.M. Kelly, C.G. Winans, D.P. Vogt, B. Eghtesad, and
J.J. Fung. Is impaired hepatic arterial buer response a risk factor for
biliary anastomotic stricture in liver transplant recipients? Surgery,
148(3):582–588, 2010.
[185] R.H. Haynes. Physical basis of the dependence of blood viscosity
on tube radius. American Journal of Physiology – Legacy Content,
198(6):1193–1200, 1960.
[186] M.Hennenberg, J. Trebicka, T. Sauerbruch, and J.Heller. Mechanisms
of extrahepatic vasodilation in portal hypertension. Gut, 57(9):1300–
1314, 2008.
[187] S.D. Henry and J.V. Guarrera. Protective eects of hypothermic ex
vivo perfusion on ischemia/reperfusion injury and transplant out-
comes. Transplantation Reviews, 26(2):163–175, 2012.
[188] A.J. Hessheimer, C. Fondevila, and J.C. Garcia-Valdecasas. Extracor-
porealmachine liver perfusion: Arewewarming up? CurrentOpinion
in Organ Transplantation, 17(2):143–147, 2012.
[189] A.J. Hessheimer, C. Fondevila, P. Taura, J. Munoz, O. Sanchez,
J. Fuster, A. Rimola, and J. Carlos Garcia-Valdecasas. Decompression
of the portal bed and twice-baseline portal inow are necessary for
the functional recovery of a "small-for-size" gra. Annals of Surgery,
253(6):1201–1210, 2011.
[190] A.J. Hessheimer, D. Parramon, A. Guimera, I. Erill, A. Rimola, J.C.
Garcia-Valdecasas, R. Villa, and C. Fondevila. A rapid and reliable
means of assessing hepatic steatosis in vivo via electrical bioimped-
ance. Transplantation, 88(5):716–722, 2009.
[191] W. Hillewaert, Q. Liu, K. Vekemans, P. Segers, P. Verdonck, J. Pirenne,
J. Brassil, and D. Monbaliu. Hepatic artery/portal vein ow compe-
tition during hypothermic machine perfusion of the liver. European
Society for Articial Organs (ESAO) congress, International Journal of
Articial Organs, 30(8):710, 2007.
[192] N. Hirooka, I. Iwasaki, H. Horie, and G. Ide. Hepatic microcircu-
lation of liver cirrhosis studied by corrosion cast/scanning electron
microscope examination. Acta Pathologica Japonica, 36(3):375–387,
1986.
266
Bibliography
[193] C.-M. Ho, R.-K. Lin, S.-F. Tsai, R.-H. Hu, P.-C. Liang, T.W.-H. Sheu,
and P.-H. Lee. Simulation of portal hemodynamic changes in a
donor aer right hepatectomy. Journal of Biomechanical Engineering-
Transactions of the ASME, 132(4):041002, 2010.
[194] H. Ho, A. Bartlett, and P. Hunter. Hemodynamic simulation for an
anatomically realistic portal system. Medical image computing and
computer-assisted intervention, MICCAI 2011, 14(Pt 1):347–354, 2011.
[195] H.Ho, K. Sorrell, A. Bartlett, and P. Hunter. Blood ow simulation for
the liver aer a virtual right lobe hepatectomy,MICCAI 2012.Medical
Image Computing and Computer-Assisted Intervention, 15(Pt 3):525–
532, 2012.
[196] H. Ho, K. Sorrell, A. Bartlett, and P. Hunter. Modeling the hepatic
arterial buer response in the liver. Medical Engineering & Physics,
35(8):1053–1058, 2013.
[197] H. Ho, K. Sorrell, L. Peng, Z. Yang, A. Holden, and P. Hunter. Hemo-
dynamic analysis for transjugular intrahepatic portosystemic shunt
(tips) in the liver based on a CT-image. IEEE Transactions onMedical
Imaging, 32(1):92–98, 2013.
[198] S. Hoehme, M. Brulport, A. Bauer, E. Bedawy, W. Schormann,
M. Hermes, V. Puppe, R. Gebhardt, S. Zellmer, M. Schwarz,
E. Bockamp, T. Timmel, J.G. Hengstler, and D. Drasdo. Prediction
and validation of cell alignment along microvessels as order prin-
ciple to restore tissue architecture in liver regeneration. Proceedings
of the National Academy of Sciences of the United States of America,
107(23):10371–10376, 2010.
[199] S.Hoehme andD.Drasdo. A cell-based simulation soware formulti-
cellular systems. Bioinformatics, 26(20):2641–2642, 2010.
[200] S. Hoehme, J.G. Hengstler, M. Brulport, M. Schaefer, A. Bauer,
R. Gebhardt, and D. Drasdo. Mathematical modelling of liver regen-
eration aer intoxication with CCl4. Chemico-Biological Interactions,
168(1):74–93, 2007.
[201] R.M. Homann, J.H. Southard, M. Lutz, A. Mackety, and F.O. Belzer.
Synthetic perfusate for kidney-preservation - its use in 72-hour pre-
servation of dog kidneys. Archives of Surgery, 118(8):919–921, 1983.
267
Bibliography
[202] A. Hofmann. e choleohepatic circulation of unconjugated bile
acids: An update. In G. Paumgartner, A. Stiehl, and W. Gerok, edit-
ors, Bile acids and the hepatobiliary system: from basic science to clini-
cal practice, pages 143–160. Kluwer Academic Publishers, Dordrecht,
1993.
[203] J.P. Holt, E.A. Rhode, W.W. Holt, and H. Kines. Geometric similar-
ity of aorta, venae cavae, and certain of their branches in mammals.
American Journal of Physiology, 241(1):100–104, 1981.
[204] H.-G. Holzhütter, D. Drasdo, T. Preusser, J. Lippert, and A.M. Hen-
ney. e virtual liver: A multidisciplinary, multilevel challenge for
systems biology. Wiley Interdisciplinary Reviews: Systems Biology and
Medicine, 4(3):221–235, 2012.
[205] J.C. Hong, H. Yersiz, and R.W. Busuttil. Where are we today in split
liver transplantation? Current Opinion in Organ Transplantation,
16(3):269–273, 2011.
[206] K. Horseld and G. Cumming. Morphology of the bronchial tree in
man. Journal of Applied Physiology, 24(3):373–383, 1968.
[207] K. Horseld, G. Dart, D.E. Olson, G.F. Filley, and G. Cumming.
Models of the human bronchial tree. Journal of Applied Physiology,
31(2):207–217, 1971.
[208] T.L. Hsu, H. Hsiu, P.T. Chao, S.P. Li, W.K. Wang, and Y.Y.L. Wang.
ree-block electrical model of renal impedance. Physiological Meas-
urement, 26(4):387–399, 2005.
[209] H. Huang, M. Deng, H. Jin, O. Dirsch, and U. Dahmen. Intra-
operative vital and haemodynamic monitoring using an integrated
multiple-channelmonitor in rats. Laboratory Animals, 44(3):254–263,
2010.
[210] H. Huang, M. Deng, H. Jin, A. Liu, O. Dirsch, and U. Dahmen. He-
patic arterial perfusion is essential for the spontaneous recovery from
focal hepatic venous outow obstruction in rats. American Journal of
Transplantation, 11(11):2342–2361, 2011.
[211] H. Huang, M. Deng, H. Jin, A. Liu, O. Dirsch, and U. Dahmen.
A novel end-to-side anastomosis technique for hepatic rearterializa-
tion in rat orthotopic liver transplantation to accommodate size mis-
matches between vessels. European Surgical Research, 47(2):53–62,
2011.
268
Bibliography
[212] P.M. Huet, G. Pomier-Layrargues, J.P. Villeneuve, F. Varin, and A. Vi-
allet. Intrahepatic circulation in liver-disease. Seminars in Liver Dis-
ease, 6(4):277–286, 1986.
[213] A. Humar, A.J. Matas, andW.D. Payne. Atlas of organ transplantation.
Springer-Verlag, London, 2006.
[214] A. Humar and W.D. Payne. Liver transplantation. In A. Humar,
A.J. Matas, and W.D. Payne, editors, Atlas of organ transplantation.
Springer-Verlag, London, 2006.
[215] L. Huwart, C. Sempoux, E. Vicaut, N. Salameh, L. Annet, E. Danse,
F. Peeters, L.C. ter Beek, J. Rahier, R. Sinkus, Y. Horsmans, and
B.E. Van Beers. Magnetic resonance elastography for the noninvasive
staging of liver brosis. Gastroenterology, 135(1):32–40, 2008.
[216] S. Hwang. Microcirculation of the liver. In D.C. Mado, M. Makuu-
chi, M. Nagino, and J.-N. Vauthey, editors,Venous embolization of the
liver, chapter 2, pages 9–13. Springer, London, 2011.
[217] S. Ijaz, W. Yang, M.C. Winslet, and A.M. Seifalian. Impairment of
hepatic microcirculation in fatty liver. Microcirculation, 10(6):447–
456, 2003.
[218] T. Ikegami, M. Shimada, S. Imura, Y. Arakawa, A. Nii, Y. Morine, and
H. Kanemura. Current concept of small-for-size gras in living donor
liver transplantation. Surgery Today, 38(11):971–982, 2008.
[219] C.J. Imber, S.D. St Peter, I.L. de Cenarruzabeitia, D. Pigott, T. James,
R. Taylor, J. McGuire, D. Hughes, A. Butler, M. Rees, and P.J. Friend.
Advantages of normothermic perfusion over cold storage in liver pre-
servation. Transplantation, 73(5):701–709, 2002.
[220] C.M. Ionescu, I. Muntean, J.A. Tenreiro-Machado, R. De Keyser, and
M. Abrudean. A theoretical study on modeling the respiratory tract
with ladder networks by means of intrinsic fractal geometry. IEEE
Transactions on Biomedical Engineering, 57(2):246–253, 2010.
[221] Y. Ito, K.K. Sorensen, N.W. Bethea, D. Svistounov, M.K. McCuskey,
B.H. Smedsrod, and R.S. McCuskey. Age-related changes in the he-
paticmicrocirculation inmice. Experimental Gerontology, 42(8):789–
797, 2007.
[222] Y. Iwakiri. Endothelial dysfunction in the regulation of cirrhosis and
portal hypertension. Liver International, 32(2):199–213, 2012.
269
Bibliography
[223] H. Iwamoto, N.Matsuno, Y.Narumi,M.Uchiyama, K. Kozaki, H.De-
gawa, K. Hama, K. Kikuchi, H. Takeuchi, M. Kozaki, and T. Nagao.
Benecial eect of machine perfusion preservation on liver trans-
plantation from non-heart-beating donors. Transplantation Proceed-
ings, 32(7):1645–1646, 2000.
[224] J. Jack, J.F. Wambaugh, and I. Shah. Simulating quantitative cellular
responses using asynchronous threshold boolean network ensembles.
BMC Systems Biology, 5:109, 2011.
[225] G.N. Jager, N. Westerhof, and A. Noordergraaf. Oscillatory ow
impedance in electrical analog of arterial system - representation of
sleeve eect and non-Newtonian properties of blood. Circulation Re-
search, 16(2):121–133, 1965.
[226] S. Jain, C.Y. Lee, S. Baicu, H. Duncan, H. Xu, J.W. Jones, M.G. Clem-
ens, J. Brassil, M.J. Taylor, and K.G.M. Brockbank. Hepatic func-
tion in hypothermically stored porcine livers: Comparison of hypo-
thermic machine perfusion vs cold storage. Transplantation Proceed-
ings, 37(1):340–341, 2005.
[227] S. Jain, H.Z. Xu, H. Duncan, J.W. Jones, J.X. Zhang, M.G. Clemens,
and C.Y. Lee. Ex-vivo study of ow dynamics and endothelial cell
structure during extended hypothermicmachine perfusion preserva-
tion of livers. Cryobiology, 48(3):322–332, 2004.
[228] R.W. Jamieson, M. Zilvetti, D. Roy, D. Hughes, A. Morovat, C.C.
Coussios, and P.J. Friend. Hepatic steatosis and normothermic
perfusion-preliminary experiments in a porcine model. Transplan-
tation, 92(3):289–295, 2011.
[229] L. Jerby, T. Shlomi, and E. Ruppin. Computational reconstruction of
tissue-specic metabolic models: Application to human liver meta-
bolism. Molecular Systems Biology, 6:401, 2010.
[230] Z.L. Jiang, G.S. Kassab, and Y.C. Fung. Diameter-dened Strahler
systemand connectivitymatrix of the pulmonary arterial tree. Journal
of Applied Physiology, 76(2):882–892, 1994.
[231] H. Jin, U.Dahmen, A. Liu, H.Huang, Y.Gu, andO.Dirsch. Prolonged
cold ischemia does not trigger lethal rejection or accelerate the acute
rejection in two allogeneic rat liver transplantation models. Journal
of Surgical Research, 175(2):322–332, 2012.
270
Bibliography
[232] I. Jochmans, C. Moers, J.M. Smits, H.G.D. Leuvenink, J. Treckmann,
A. Paul, A. Rahmel, J.P. Squiet, E. van Heurn, D. Monbaliu, R.J.
Ploeg, and J. Pirenne.e prognostic value of renal resistance during
hypothermic machine perfusion of deceased donor kidneys. Amer-
ican Journal of Transplantation, 11(10):2214–2220, 2011.
[233] L.C. Junqueira and J. Carneiro. Functionele histologie. Elsevier
Gezondheidszorg, 10th edition, 2004.
[234] K. Jurczuk, M. Kretowski, and J. Bezy-Wendling. Vascular system
modeling in parallel environment - distributed and shared memory
approaches. IEEETransactions on InformationTechnology in Biomedi-
cine, 15(4):668–672, 2011.
[235] A. Kamarainen, I. Virkkunen, and J. Tenhunen. Hypothermic pre-
conditioning of donor organs prior to harvesting and ischaemia using
ice-cold intravenous uids. Medical Hypotheses, 73(1):65–66, 2009.
[236] P.S. Kamath, R.H. Wiesner, M. Malinchoc, W. Kremers, T.M.
erneau, C.L. Kosberg, G. D’Amico, E.R. Dickson, and W.R. Kim.
A model to predict survival in patients with end-stage liver disease.
Hepatology, 33(2):464–470, 2001.
[237] Z. Kan andD.C.Mado. Liver anatomy: Microcirculation of the liver.
Seminars in Interventional Radiology, 25(2):77–85, 2008.
[238] M. Kanamoto, M. Shimada, T. Utsunomiya, S. Imura, Y. Morine,
T. Ikemoto, H. Mori, and J. Hanaoka. Impact of a new refrigerator
on the preservation of hepatic gras. Hepatology Research, 42(8):798–
805, 2012.
[239] A.N. Kandilis, J. Koskinas, D.G. Tiniakos, N. Nikiteas, and D.N. Per-
rea. Liver regeneration: Focus on cell types and topographic dier-
ences. European Surgical Research, 44(1):1–12, 2010.
[240] M.K. Kapanen, J.T. Halavaara, and A.M. Hakkinen. Open four-
compartmentmodel in themeasurement of liver perfusion. Academic
Radiology, 12(12):1542–1550, 2005.
[241] M.M. Kaplan and M.E. Gershwin. Primary biliary cirrhosis. New
England Journal of Medicine, 353(12):1261–1273, 2005.
[242] S.J. Karran, C.J. Eagles, J.S. Fleming, and D.M. Ackery. In vivo meas-
urement of liver perfusion in the normal and partially hepatectom-
ized rat using TC-99M sulfur colloid. Journal of Nuclear Medicine,
20(1):26–31, 1979.
271
Bibliography
[243] M. Kasahara, Y. Takada, K. Kozaki, K. Uryuhara, Y. Ogura, K. Ogawa,
Y. Fujimoto, and K. Tanaka. Functional portal ow competition
aer auxiliary partial orthotopic living donor liver transplantation
in noncirrhotic metabolic liver disease. Journal of Pediatric Surgery,
39(7):1138–1141, 2004.
[244] G.S. Kassab. Scaling laws of vascular trees: Of form and func-
tion. American Journal of Physiology-Heart and Circulatory Physiol-
ogy, 290(2):H894–H903, 2006.
[245] G.S. Kassab and Y.C.B. Fung. e pattern of coronary arteriolar bi-
furcations and the uniform shear hypothesis. Annals of Biomedical
Engineering, 23(1):13–20, 1995.
[246] I. Kassissia, A. Brault, and P.M. Huet. Hepatic-artery and portal-
vein vascularization of normal and cirrhotic rat-liver. Hepatology,
19(5):1189–1197, 1994.
[247] R. Kavlock and D. Dix. Computational toxicology as implemented
by the US EPA: Providing high throughput decision support tools for
screening and assessing chemical exposure, hazard and risk. Journal
of Toxicology and Environmental Health-Part B-Critical Reviews, 13(2-
4):197–217, 2010.
[248] E.B. Keee. Liver transplantation: Current status and novel ap-
proaches to liver replacement. Gastroenterology, 120(3):749–762,
2001.
[249] A.R. Kemper, A.C. Santago, J.D. Stitzel, J.L. Sparks, and S.M. Duma.
Biomechanical response of human liver in tensile loading. Annals of
Advances in Automotive Medicine, 54:15–26, 2010.
[250] A.S. Kennedy, C. Kleinstreuer, C.A. Basciano, and W.A. Dezarn.
Computer modeling of yttrium-90-microsphere transport in the he-
patic arterial tree to improve clinical outcomes. International Journal
of Radiation Oncology Biology Physics, 76(2):631–637, 2010.
[251] V.O. Kheyfets, W. O’Dell, T. Smith, J.J. Reilly, and E.A. Finol. Con-
siderations for numerical modeling of the pulmonary circulation - a
review with a focus on pulmonary hypertension. Journal of Biomech-
anical Engineering, 135(6):061011, 2013.
[252] F. Kiernan. e anatomy and physiology of the liver. Transactions of
the royal society of London, 123:711–770, 1883.
272
Bibliography
[253] R.D. Kim, J.-S. Kim, and K.E. Behrns. Liver regeneration and
the atrophy-hypertrophy complex. In D.C. Mado, M. Makuuchi,
M. Nagino, and J.-N. Vauthey, editors, Venous embolization of the
liver, chapter 6, pages 37–47. Springer, London, 2011.
[254] Y. Kishi, T. Hashimoto, and M. Makuuchi. Portal and hepatic vein
anatomy. In D.C. Mado, M. Makuuchi, M. Nagino, and J.-N. Vau-
they, editors, Venous embolization of the liver, chapter 3, pages 15–22.
Springer, London, 2011.
[255] Y. Kishi, H. Imamura, Y. Sugawara, K. Sano, J. Kaneko, N. Kokudo,
andM.Makuuchi. Evaluation of donor vasculobiliary anatomic vari-
ations in liver gra procurements. Surgery, 147(1):30–39, 2010.
[256] T.L. Kline,M. Zamir, and E.L. Ritman. Relating function to branching
geometry: A micro-CT study of the hepatic artery, portal vein, and
biliary tree. Cells Tissues Organs, 194(5):431–442, 2011.
[257] K. Kogure, M. Ishizaki, M. Nemoto, H. Kuwano, and M. Makuuchi.
A comparative study of the anatomy of rat and human livers. Journal
of Hepato-Biliary-Pancreatic Surgery, 6(2):171–175, 1999.
[258] A. Koo, I.Y.S. Liang, and K.K. Cheng. Terminal hepatic microcircu-
lation in the rat. Quarterly Journal of Experimental Physiology and
Cognate Medical Sciences, 60(4):261–266, 1975.
[259] G. Kootstra, J.H. Daemen, and A.P. Oomen. Categories of non-heart-
beating donors. Transplantation Proceedings, 27(5):2893–2894, 1995.
[260] R.G. Kratky and M.R. Roach. Shrinkage of Batsons and its relevance
to vascular casting. Atherosclerosis, 51(2-3):339–341, 1984.
[261] M.Kretowski, J. Bezy-Wendling, andP. Coupe. Simulation of biphasic
CT ndings in hepatic cellular carcinoma by a two-level physiological
model. IEEE Transactions on Biomedical Engineering, 54(3):538–542,
2007.
[262] M. Kretowski, Y. Rolland, J. Bezy-Wendling, and J.L. Coatrieux. Fast
algorithm for 3-D vascular tree modeling. Computer Methods and
Programs in Biomedicine, 70(2):129–136, 2003.
[263] A. Kribben, G. Gerken, S. Haag, S. Herget-Rosenthal, U. Treichel,
C. Betz, C. Sarrazin, E. Hoste, H. Van Vlierberghe, A. Escorsell,
273
Bibliography
C.Hafer, O. Schreiner, P.R. Galle, E.Mancini, P. Caraceni, C.J. Karvel-
las, H. Salmhofer, M. Knotek, P. Gines, J. Kozik-Jaromin, and K. Ri-
fai. Eects of fractionated plasma separation and adsorption on sur-
vival in patients with acute-on-chronic liver failure. Gastroenterology,
142(4):782–789, 2012.
[264] W. Kroon, W. Huberts, M. Bosboom, and F. van de Vosse. A numer-
ical method of reduced complexity for simulating vascular hemody-
namics using coupled 0D lumped and 1D wave propagation models.
Computational and Mathematical Methods in Medicine, 2012.
[265] J.W.C. Kung, I.S. Currie, S.J. Forbes, and J.A. Ross. Liver develop-
ment, regeneration, and carcinogenesis. Journal of Biomedicine and
Biotechnology, 2010:984248, 2010.
[266] Q. Lai, F. Melandro, G.B.L. Sandri, G. Mennini, S.G. Corradini,
M. Merli, P.B. Berloco, and M. Rossi. Use of elderly donors for liver
transplantation: Has the limit been reached? Journal of Gastrointesti-
nal and Liver Diseases, 20(4):383–387, 2011.
[267] W. Laleman. Role of hepatic stellate cells and vascular mediators in the
pathophysiology of cirrhotic portal hypertension. PhD thesis, Kath-
olieke Universiteit Leuven, 2006.
[268] W. Laleman, I.V. Elst, M. Zeegers, R. Servaes, L. Libbrecht,
T. Roskams, J. Fevery, and F. Nevens. A stable model of cirrhotic
portal hypertension in the rat: ioacetamide revisited. European
Journal of Clinical Investigation, 36(4):242–249, 2006.
[269] W. Laleman, L. Van Landeghem, A. Wilmer, J. Fevery, and F. Nevens.
Portal hypertension: From pathophysiology to clinical practice. Liver
International, 25(6):1079–1090, 2005.
[270] P. Lamata, A. Jalote-Parmar, F. Lamata, and J. Declerck. e resec-
tion map, a proposal for intraoperative hepatectomy guidance. In-
ternational Journal of Computer Assisted Radiology and Surgery, 3(3-
4):299–306, 2008.
[271] W.H. Lamers, A. Hilberts, E. Furt, J. Smith, G.N. Jonges, C.J.F. Van-
noorden, J.W.G. Janzen, R. Charles, and A.F.M. Moorman. Hepatic
enzymic zonation - a reevaluation of the concept of the liver acinus.
Hepatology, 10(1):72–76, 1989.
[272] B.H. Landing and T.R. Wells. Considerations of some architectural
properties of the biliary tree and liver in childhood. Perspectives in
pediatric pathology, 14:122–142, 1991.
274
Bibliography
[273] M. Lara, C.Y. Chen, P. Mannor, O. Dur, P.G. Menon, A.P. Yoganathan,
and K. Pekkan. Hemodynamics of the hepatic venous three-vessel
conuences using particle image velocimetry. Annals of Biomedical
Engineering, 39(9):2398–2416, 2011.
[274] H. Lauschke, M. Kotting, S. Akbar, and T. Minor. Use of taurine as
antioxidant in resuscitating livers from non-heart-beating donors by
gaseous oxygen persuation. Journal of Investigative Surgery, 16(1):7–
11, 2003.
[275] W.W. Lautt. Mechanism and role of intrinsic regulation of hepatic ar-
terial blood ow: Hepatic arterial buer response. American Journal
of Physiology, 249(5):G549–G556, 1985.
[276] W.W. Lautt. Regulatory processes interacting to maintain hepatic
blood ow constancy: Vascular compliance, hepatic arterial buer re-
sponse, hepatorenal reex, liver regeneration, escape from vasocon-
striction. Hepatology Research, 37(11):891–903, 2007.
[277] W.W. Lautt.Hepatic circulation: Physiology and pathophysiology. Mor-
gan & Claypool Life Sciences., San Rafael CA, 2010.
[278] W.W. Lautt and C.V. Greenway. Conceptual review of the hepatic vas-
cular bed. Hepatology, 7(5):952–963, 1987.
[279] C.Y. Lee, J.X. Zhang, J.W. Jones, J.H. Southard, and M.G. Clemens.
Functional recovery of preserved livers following warm ischemia:
Improvement by machine perfusion preservation. Transplantation,
74(7):944–951, 2002.
[280] S.S. Lee, A. Hadengue, C. Girod, A. Braillon, and D. Lebrec. Re-
duction of intrahepatic vascular space in the pathogenesis of portal-
hypertension - invitro and invivo studies in the rat. Gastroenterology,
93(1):157–161, 1987.
[281] T.C. Lee, K.F. Huang, M.L. Hsiao, S.T. Tang, and S.T. Young. Elec-
trical lumped model for arterial vessel beds. Computer Methods and
Programs in Biomedicine, 73(3):209–219, 2004.
[282] K. Lehmann and P.-A. Clavien. History of hepatic surgery. Surgical
Clinics of North America, 90(4):655–664, 2010.
[283] J. Lemasters, H. Bunzendahl, and R.urman. Preservation of the
liver. In W.C. Maddrey and M.F. Sorrell, editors, Transplantation of
the liver. Appleton & Lange, Connecticut, 1991.
275
Bibliography
[284] J. Li, Y. Hou, J. Liu, B. Liu, and L. Li. A better way to do small-for-size
liver transplantation in rats. Frontier Medical, 5(1):106–110, 2011.
[285] Q. Li, D.-W. Liu, L.-M. Zhang, B. Zhu, Y.-T. He, and Y.-H. Xiao. Ef-
fects of augmentation of liver regeneration recombinant plasmid on
rat hepatic brosis. World Journal of Gastroenterology, 11(16):2438–
2443, 2005.
[286] A.C. Liakopoulos. Darcy’s coecient of permeability as symmetric
tensor of second rank. International Association of Scientic Hydro-
logy, 10(3):41–48, 1965.
[287] R.-H. Lin and C.-L. Chuang. A hybrid diagnosis model for determin-
ing the types of the liver disease. Computers in Biology and Medicine,
40(7):665–670, 2010.
[288] K.D. Lindor,M.E.Gershwin, R. Poupon,M.Kaplan, N.V. Bergasa, and
E.J. Heathcote. Primary biliary cirrhosis. Hepatology, 50(1):291–308,
2009.
[289] A. Liu, H. Fang, O. Dirsch, H. Jin, and U. Dahmen. Early release
of macrophage migration inhibitory factor aer liver ischemia and
reperfusion injury in rats. Cytokine, 57(1):150–157, 2012.
[290] J.P. Liu, L.L. Gluud, B. Als-Niesen, and C. Gluud. Articial and bioar-
ticial support systems for liver failure. Cochrane Database of System-
atic Reviews, 2004(1):CD003628, 2004.
[291] G.J. Lueck, T.K. Kim, P.N. Burns, and A.L. Martel. Hepatic perfusion
imaging using factor analysis of contrast enhanced ultrasound. IEEE
Transactions on Medical Imaging, 27(10):1449–1457, 2008.
[292] Y. Ma, G.D. Wang, L.W. Wu, and R.D. Hu. Dynamical changing pat-
terns of histological structure and ultrastructure of liver gra under-
going warm ischemia injury from non-heart-beating donor in rats.
World Journal of Gastroenterology, 12(30):4902–4905, 2006.
[293] R. Maass-Moreno and C.F. Rothe. Contribution of the large hepatic
veins to postsinusoidal vascular resistance. American Journal of Phys-
iology, 262(1 Pt 1):G14–G22, 1992.
[294] R. Maass-Moreno and C.F. Rothe. Nonlinear resistances in hepatic
microcirculation. American Journal of Physiology, 269(6 Pt 2):H1922–
H1930, 1995.
276
Bibliography
[295] R. Maass-Moreno and C.F. Rothe. Distribution of pressure gradients
along hepatic vasculature. American Journal of Physiology-Heart and
Circulatory Physiology, 272(6):H2826–H2832, 1997.
[296] M.-H.J. Maathuis, H.G.D. Leuvenink, and R.J. Ploeg. Perspectives in
organ preservation. Transplantation, 83(10):1289–1298, 2007.
[297] M.H.J. Maathuis, S. Manekeller, A. van der Plaats, H.G.D. Leuven-
ink, N.A. ’t Hart, A.B. Lier, G. Rakhorst, R.J. Ploeg, and T. Minor.
Improved kidney gra function aer preservation using a novel hy-
pothermic machine perfusion device. Annals of Surgery, 246(6):982–
991, 2007.
[298] N. Madrahimov, O. Dirsch, C. Broelsch, and U. Dahmen. Marginal
hepatectomy in the rat - from anatomy to surgery. Annals of Surgery,
244(1):89–98, 2006.
[299] F. Maes, P. Ransbeeck, H. Van Oosterwyck, and P. Verdonck. Mod-
eling uid ow through irregular scaolds for perfusion bioreactors.
Biotechnology and Bioengineering, 103(3):621–630, 2009.
[300] J.F. Magliocca, J.C. Magee, S.A. Rowe, M.T. Gravel, R.H. Chenault,
R.M.Merion, J.D. Punch, R.H. Bartlett, andM.R.Hemmila. Extracor-
poreal support for organ donation aer cardiac death eectively ex-
pands the donor pool. Journal of Trauma-Injury Infection and Critical
Care, 58(6):1095–1101, 2005.
[301] A.V. Maker, W.R. Jarnagin, and A.M. Covey. Liver anatomy: Vari-
ant venous anatomy and implications for resection. In D.C. Mado,
M. Makuuchi, M. Nagino, and J.-N. Vauthey, editors, Venous embol-
ization of the liver, chapter 5, pages 29–36. Springer, London, 2011.
[302] S.M.Maksan, H. Paulo, E. Ryschich, C.Kuntz,M.M.Gebhard, E. Klar,
and J. Schmidt. In vivo assessment of angioarchitecture andmicrocir-
culation in experimental liver cancer - a new model in rats. Digestive
Diseases and Sciences, 48(2):279–290, 2003.
[303] D.E.Malarkey, K. Johnson, L. Ryan, G. Boorman, andR.R.Maronpot.
New insights into functional aspects of liver morphology. Toxicologic
Pathology, 33(1):27–34, 2005.
[304] M. Malinchoc, P.S. Kamath, F.D. Gordon, C.J. Peine, J. Rank, and
P.C.J. ter Borg. Model to predict poor survival in patients undergoing
transjugular intrahepatic portosystemic shunts (TIPS). Hepatology,
43(2):S11–S12, 2000.
277
Bibliography
[305] F.P. Mall. A study of the structural unit of the liver. American Journal
of Anatomy, 5:244–249, 1906.
[306] J. Mann andD.A.Mann. Transcriptional regulation of hepatic stellate
cells. Advanced Drug Delivery Reviews, 61(7-8):497–512, 2009.
[307] R.E.Mann, R.G. Smart, andR.Govoni.e epidemiology of alcoholic
liver disease. Alcohol Research & Health, 27(3):209–219, 2003.
[308] S. Marchesseau, T. Heimann, S. Chatelin, R. Willinger, and H. De-
lingette. Fast porous visco-hyperelastic so tissue model for surgery
simulation: Application to liver surgery. Progress in Biophysics &Mo-
lecular Biology, 103(2-3):185–196, 2010.
[309] G. Mareels. Experimental and numerical modeling of ow and mass
transport in a bio-articial liver. PhD thesis, Ghent University, 2008.
[310] Y.K. Mariappan, K.J. Glaser, and R.L. Ehman. Magnetic resonance
elastography: A review. Clinical Anatomy, 23(5):497–511, 2010.
[311] E. N. Marieb and K. Hoehn. Anatomy & physiology. Pearson Educa-
tion, San Francisco, 3rd edition edition, 2008.
[312] P.N.A. Martins and P. Neuhaus. Surgical anatomy of the liver, hepatic
vasculature and bile ducts in the rat. Liver International, 27(3):384–
392, 2007.
[313] P.N.A. Martins, T.P.eruvath, and P. Neuhaus. Rodent models of
partial hepatectomies. Liver International, 28(1):3–11, 2008.
[314] S. Marubashi, M. Sakon, H. Nagano, K. Gotoh, K. Hashimoto,
M.Kubota, S. Kobayashi, S. Yamamoto, A.Miyamoto, K.Dono, S. Na-
kamori, K. Umeshita, and M. Monden. Eect of portal hemodynam-
ics on liver regeneration studied in a novel portohepatic shunt rat
model. Surgery, 136(5):1028–1037, 2004.
[315] T.V. Masyuk, E.L. Ritman, and N.F. LaRusso. Hepatic artery and
portal vein remodeling in rat liver - vascular response to select-
ive cholangiocyte proliferation. American Journal of Pathology,
162(4):1175–1182, 2003.
[316] P. Mathurin and M.R. Lucey. Management of alcoholic hepatitis.
Journal of Hepatology, 56:S39–S45, 2012.
[317] T. Matsumoto andM. Kawakami.e unit-concept of hepatic paren-
chyma - a re-examination based on angioarchitectural studies. Acta
Pathologica Japonica, 32(2):285–314, 1982.
278
Bibliography
[318] T.Matsumoto, R. Komori, T.Magara, T. Ui, M. Kawakami, T. Tokuda,
S. Takasaki, H. Hayashi, K. Jo, H. Hano, H. Fujino, and H. Tanaka. A
study on the normal structure of the human liver, with special refer-
ence to its angioarchitecture. Jikeikai Medical, 26:1–40, 1979.
[319] E. Mazza, A. Nava, D. Halmloser, W. Jochum, and M. Bajka. e
mechanical response of human liver and its relation to histology: An
in vivo study. Medical Image Analysis, 11(6):663–672, 2007.
[320] R. McCuskey. Hepatic microcirculation. In P. Bioulac-Sage and
C. Balabaud, editors, Sinusoids in human liver: Health and disease,
pages 151–164. Kuper Cell Foundation, Rijswijk, 1988.
[321] R.S. McCuskey. A dynamic and static study of hepatic arterioles
and hepatic sphincters. American Journal of Anatomy, 119(3):455–477,
1966.
[322] R.S.McCuskey. Morphologicalmechanisms for regulating blood ow
through hepatic sinusoids. Liver, 20(1):3–7, 2000.
[323] R.S. McCuskey, W. Ekataksin, A.V. LeBouton, J. Nishida, M.K. Mc-
Cuskey, D. McDonnell, C. Williams, N.W. Bethea, B. Dvorak, and
O. Koldovsky. Hepatic microvascular development in relation to the
morphogenesis of hepatocellular plates in neonatal rats.e anatom-
ical record. Part A, Discoveries in molecular, cellular, and evolutionary
biology, 275(1):1019–30, 2003.
[324] R.S. McCuskey and F.D. Reilly. Hepatic microvasculature: Dynamic
structure and its regulation. Seminars in LiverDisease, 13(1):1–12, 1993.
[325] T.J.McKenzie, J.B. Lillegard, and S. Nyberg. Articial and bioarticial
liver support. Seminars in liver disease, 28:210–217, 2008.
[326] A.J. McLaren and P.J. Friend. Trends in organ preservation. Trans-
plant International, 16(10):701–708, 2003.
[327] M. Meguro, T. Katsuramaki, H. Kimura, M. Isobe, M. Nagayama,
K. Kukita, A. Nui, and K. Hirata. Apoptosis and necrosis aer warm
ischemia-reperfusion injury of the pig liver and their inhibition by
ONO-1714. Transplantation, 75(5):703–710, 2003.
[328] M. Mescam, M. Kretowski, and J. Bezy-Wendling. Multiscale model
of liver DCE-MRI towards a better understanding of tumor complex-
ity. IEEE Transactions on Medical Imaging, 29(3):699–707, 2010.
279
Bibliography
[329] G.K. Michalopoulos. Liver regeneration. Journal of Cellular Physiol-
ogy, 213(2):286–300, 2007.
[330] G.K. Michalopoulos. Liver regeneration aer partial hepatectomy
critical analysis of mechanistic dilemmas. American Journal of Patho-
logy, 176(1):2–13, 2010.
[331] G.K. Michalopoulos and M.C. DeFrances. Liver regeneration. Sci-
ence, 277(5331):1423–1423, 1997.
[332] V. Milisic and A. Quarteroni. Analysis of lumped parameter models
for blood ow simulations and their relationwith 1Dmodels. ESAIM-
MathematicalModelling andNumerical Analysis, 38(4):613–632, 2004.
[333] J.M. Millis, D.C. Cronin, R. Johnson, H. Conjeevaram, C. Conlin,
S. Trevino, and P. Maguire. Initial experience with the modied ex-
tracorporeal liver-assist device for patients with fulminant hepatic
failure: System modications and clinical impact. Transplantation,
74(12):1735–1746, 2002.
[334] G.Millonig, S. Friedrich, S. Adolf, H. Fonouni,M.Golriz, A.Mehrabi,
P. Stiefel, G. Poeschl, M.W. Buechler, H.K. Seitz, and S. Mueller. Liver
stiness is directly inuenced by central venous pressure. Journal of
Hepatology, 52(2):206–210, 2010.
[335] T. Minor, P. Olschewski, R.H. Tolba, S. Akbar, M. Kocalkova, and
F. Dombrowski. Liver preservation with HTK: Salutary eect of hy-
pothermic aerobiosis by either gaseous oxygen ormachine perfusion.
Clinical Transplantation, 16(3):206–211, 2002.
[336] G.Y. Minuk. Hepatic regeneration: If it ain’t broke, don’t x it. Cana-
dian Journal of Gastroenterology, 17(7):418–424, 2003.
[337] N. Mittal, Y. Zhou, S. Ung, C. Linares, S. Molloi, and G.S. Kassab.
A computer reconstruction of the entire coronary arterial tree based
on detailed morphometric data. Annals of Biomedical Engineering,
33(8):1015–1026, 2005.
[338] C. Moers, J.M. Smits, M.H.J. Maathuis, J. Treckmann, F. van Gelder,
B.P. Napieralski, M. van Kasterop-Kutz, J.J.H. van der Heide, J.P.
Squiet, E. van Heurn, G.R. Kirste, A. Rahmel, H.G.D. Leuvenink,
A. Paul, J. Pirenne, and R.J. Ploeg. Machine perfusion or cold storage
in deceased-donor kidney transplantation. New England Journal of
Medicine, 360(1):7–19, 2009.
280
Bibliography
[339] M.M. Molla and M.C. Paul. LES of non-Newtonian physiological
blood ow in a model of arterial stenosis. Medical Engineering &
Physics, 34(8):1079–1087, 2012.
[340] D. Monbaliu. Tolerance of livers to warm ischemia in a preclinical
model of liver transplantation from non-heart-beating donors. PhD
thesis, Katholieke Universiteit Leuven, 2007.
[341] D. Monbaliu and J. Brassil. Machine perfusion of the liver: Past,
present and future. Current Opinion in Organ Transplantation,
15(2):160–166, 2010.
[342] D. Monbaliu, C. Debbaut, W. Hillewaert, J. Brassil, W. Laleman,
M. Sainz-Barriga, D. Kravitz, J. Pirenne, and P. Segers. Flow com-
petition between hepatic arterial and portal venous ow during hy-
pothermicmachine perfusion preservation of porcine livers. Interna-
tional Journal of Articial Organs, 35(2):119–131, 2012.
[343] D. Monbaliu, Q. Liu, L. Libbrecht, R. De Vos, K. Vekemans,
C. Debbaut, O. Detry, T. Roskams, J. van Pelt, and J. Pirenne. Pre-
serving the morphology and evaluating the quality of liver gras by
hypothermicmachine perfusion: A proof-of-concept study using dis-
carded human livers. Liver Transplantation, 18(12):1495–1507, 2012.
[344] D. Monbaliu, Q. Liu, K. Vekemans, T. Roskams, and J. Pirenne. Po-
tentiation of adverse eects of cold by warm ischemia in circulatory
death donors for porcine liver transplantation. Transplantation Pro-
ceedings, 44(9):2874–2879, 2012.
[345] D. Monbaliu, J. Pirenne, and D. Talbot. Liver transplantation using
donation aer cardiac death donors. Journal ofHepatology, 56(2):474–
485, 2012.
[346] D. Monbaliu, L. Qiang, K. Vekemans, and J. Pirenne. History
of organ perfusion in organ transplantation. In D. Talbot and
A. D’Alessandro, editors, Organ donation and transplantation aer
cardiac death, chapter 3, pages 31–49. Oxford press, 2009.
[347] D. Monbaliu, J. Vandersmissen, G. De Hertogh, G. Van Assche,
I. Homan, N. Knops, C.Debbaut, S. Heye, J. Pirenne, andG.Maleux.
Portal hypertension aer combined liver and intestinal transplanta-
tion, a diagnostic and therapeutic challenge? Pediatric Transplanta-
tion, 16(7):E301–E305, 2012.
281
Bibliography
[348] E. Morsiani, A. Aleotti, and D. Ricci. Haemodynamic and ultrastruc-
tural observations on the rat liver aer two-thirds partial hepatec-
tomy. Journal of Anatomy, 192:507–515, 1998.
[349] K.E. Mortensen, L.N. Conley, J. Hedegaard, T. Kalstad, P. Sorensen,
C. Bendixen, and A. Revhaug. Regenerative response in the pig liver
remnant varieswith the degree of resection and rise in portal pressure.
American Journal of Physiology-Gastrointestinal and Liver Physiology,
294(3):G819–G830, 2008.
[350] U. Motosugi, T. Ichikawa, F. Amemiya, H. Sou, K. Sano, A. Muhi,
N. Enomoto, and T. Araki. Cross-validation of MR elastography and
ultrasound transient elastography in liver stinessmeasurement: Dis-
crepancy in the results of cirrhotic liver. Journal of Magnetic Reson-
ance Imaging, 35(3):607–610, 2012.
[351] P.M. Motta. e three-dimensional microanatomy of the liver.
Archivum Histologicum Japonicum, 47(1):1–30, 1984.
[352] M.F. Mozes, R.B. Skolek, and B.C. Korf. Use of perfusion parameters
in predicting outcomes of machine-preserved kidneys. Transplanta-
tion Proceedings, 37(1):350–351, 2005.
[353] S. Mueller, G. Millonig, L. Sarovska, S. Friedrich, F.M. Reimann,
M. Pritsch, S. Eisele, F. Stickel, T. Longerich, P. Schirmacher, andH.K.
Seitz. Increased liver stiness in alcoholic liver disease: Dierenti-
ating brosis from steatohepatitis. World Journal of Gastroenterology,
16(8):966–972, 2010.
[354] S.A. Müller, F. Pianka, M. Schoebinger, A. Mehrabi, H. Fonouni,
B. Radele, H.-P. Meinzer, and B.M. Schmied. Computer-based liver
volumetry in the liver perfusion simulator. Journal of Surgical Re-
search, 171(1):87–93, 2011.
[355] B. Mullhaupt, D. Dimitroulis, J.T. Gerlach, and P.A. Clavien. Hot
topics in liver transplantation: Organ allocation – extended criteria
donor – living donor liver transplantation. Journal of Hepatology, 48
Suppl 1:S58–67, 2008.
[356] D.Mutter, B.Dallemagne, C. Bailey, L. Soler, and J.Marescaux. 3D vir-
tual reality and selective vascular control for laparoscopic le hepatic
lobectomy. Surgical Endoscopy and Other Interventional Techniques,
23(2):432–435, 2009.
282
Bibliography
[357] J.P. Mynard. Computer modelling and wave intensity analysis of peri-
natal cardiovascular function and dysfunction. PhD thesis, University
of Melbourne, 2011.
[358] K.Nakata, G.F. Leong, andR.W. Brauer. Directmeasurement of blood
pressures in minute vessels of the liver. American Journal of Physiol-
ogy, 199(6):1181–1188, 1960.
[359] K. Naruse. Articial liver support: Future aspects. Journal of Articial
Organs, 8:71–76, 2005.
[360] K.Naruse,W.Tang, andM.Makuuchi. Articial and bioarticial liver
support: A review of perfusion treatment for hepatic failure patients.
World Journal of Gastroenterology, 13(10):1516–1521, 2007.
[361] P. Neuhaus and G. Blumhardt. Extracorporeal liver perfusion - ap-
plications of an improved model for experimental studies of the liver.
International Journal of Articial Organs, 16(10):729–739, 1993.
[362] J.O. Neumann, M. orn, L. Fischer, M. Schobinger, T. Heimann,
B. Radele, J. Schmidt, H.P.Meinzer, M.W. Buehler, and P. Schemmer.
Branching patterns and drainage territories of themiddle hepatic vein
in computer-simulated right living-donor hepatectomies. American
Journal of Transplantation, 6(6):1407–1415, 2006.
[363] F. Nevens and W. Laleman. Articial liver support devices as treat-
ment option for liver failure. Best Practice & Research in Clinical Gas-
troenterology, 26(1):17–26, 2012.
[364] G.A. Nibourg, R. Hoekstra, T.V. van der Hoeven, M.T. Ackermans,
T.B. Hakvoort, T.M. van Gulik, and R.A. Chamuleau. Increased he-
patic functionality of the human hepatoma cell line hepaRG cultured
in the AMC bioreactor. International Journal of Biochemistry & Cell
Biology, 45(8):1860–1868, 2013.
[365] D.A. Nordsletten, S. Blackett, M.D. Bentley, E.L. Ritman, and N.P.
Smith. Structural morphology of renal vasculature. American Journal
of Physiology-Heart and Circulatory Physiology, 291(1):H296–H309,
2006.
[366] P.G. Northup and C.L. Berg. Living donor liver transplantation:e
historical and cultural basis of policy decisions and ongoing ethical
questions. Health Policy, 72(2):175–185, 2005.
[367] S. Ogawa and S. Miyagawa. Potentials of regenerative medicine for
liver disease. Surgery Today, 39(12):1019–1025, 2009.
283
Bibliography
[368] H. Ohno, Y. Naito, H. Nakajima, and M. Tomita. Construction of
a biological tissue model based on a single-cell model: A computer
simulation of metabolic heterogeneity in the liver lobule. Articial
Life, 14(1):3–28, 2008.
[369] O. Ohtani and Y. Ohtani. Lymph circulation in the liver. Anatom-
ical Record-Advances in Integrative Anatomy and Evolutionary Bio-
logy, 291(6):643–652, 2008.
[370] J.G. O’Leary, R. Lepe, and G.L. Davis. Indications for liver transplan-
tation. Gastroenterology, 134(6):1764–1776, 2008.
[371] P. Olschewski, P. Gass, V. Ariyakhagorn, K. Jasse, G.Hunold,M.Men-
zel, W. Schoening, V. Schmitz, P. Neuhaus, and G. Puhl. e in-
uence of storage temperature during machine perfusion on preser-
vation quality of marginal donor livers. Cryobiology, 60(3):337–343,
2010.
[372] M.S. Olufsen and A. Nadim. On deriving lumped models for blood
ow and pressure in the systemic arteries. Mathematical Biosciences
and Engineering, 1(1):61–80, 2004.
[373] R.C. Ooi, X.Y. Luo, S.B. Chin, A.G. Johnson, and N.C. Bird. e ow
of bile in the human cystic duct. Journal of Biomechanics, 37(12):1913–
1922, 2004.
[374] G.D. Pan and L.N. Yan. Problems in adult living donor liver trans-
plantation using the right hepatic lobe. Hepatobiliary & Pancreatic
Diseases International, 5(3):345–9, 2006.
[375] V. Papp, K. Dezso, V. Laszlo, P. Nagy, and S. Paku. Architectural
changes during regenerative and ontogenic liver growth in the rat.
Liver Transplantation, 15(2):177–183, 2009.
[376] D. Parramon, I. Erill, A. Guimera, A. Ivorra, A. Munoz, A. Sola,
C. Fondevila, J.C. Garcia-Valdecasas, and R. Villa. In vivo detection of
liver steatosis in rats based on impedance spectroscopy. Physiological
Measurement, 28(8):813–828, 2007.
[377] A.W. Paulsen. Hepatic anatomy, physiology, and assessment of he-
patic function. In W.B. Ronald and B.K. Goran, editors, Transplanta-
tion of the liver, pages 43–64. Saunders, Philadelphia, 1996.
[378] S.D. St Peter, C.J. Imber, andP.J. Friend. Liver and kidney preservation
by perfusion. Lancet, 359(9306):604–613, 2002.
284
Bibliography
[379] T.C. Peterson and M. Neumeister. Eect of pentoxifylline in rat and
swinemodels of hepatic brosis, role of broproliferation in itsmech-
anism. Immunopharmacology, 31(2-3):183–193, 1996.
[380] S. Petkova, A. Hossain, J. Naser, and E. Palombo. CFD modelling of
blood ow in portal vein hypertension with and without thrombosis.
ird International Conference on CFD in the Minerals and Process
Industries, 2006.
[381] J. Phua and K.H. Lee. Liver support devices. Current Opinion in
Critical Care, 14(2):208–215, 2008.
[382] M. Pinzani and F. Vizzutti. Anatomy and vascular biology of the cells
in the portal circulation. In A.J. Sanyal and V.H. Shah, editors, Portal
hypertension: Pathobiology, evaluation and treatment, Clinical gastro-
enterology, chapter 2. Humana Press, Totowa, New Jersey, 2005.
[383] J. Pirenne, F. Van Gelder, R. Aerts, D. Monbaliu, D. Van Hees,
J. de Roey, B. Desschans, L. De Pauw, andW. Coosemans. Abdominal
transplant surgery and transplant coordination university hospitals
leuven 1997-2007: An overview. Acta Chirurgica Belgica, 108(1):15–21,
2008.
[384] J. Pirenne, F. Van Gelder, W. Coosemans, R. Aerts, B. Gunson,
T. Koshiba, I. Fourneau, D. Mirza, W. Van Steenbergen, J. Fevery,
F. Nevens, and P. McMaster. Type of donor aortic preservation solu-
tion andnot cold ischemia time is amajor determinant of biliary stric-
tures aer liver transplantation. Liver Transplantation, 7(6):540–545,
2001.
[385] A. Plessier, P.-E. Rautou, and D.-C. Valla. Management of hepatic
vascular diseases. Journal of Hepatology, 56:S25–S38, 2012.
[386] E. Polat, S. Topaloglu, C. Sokmensuer, E. Topaloglu, F.M. Avsar,
H. Ozel, O. Saygun, I. Yildiz, G. Ucar, and S. Hengirmen. Hetero-
geneity of damage between segments of rat liver aer inow-outow
obstruction. Transplantation Proceedings, 38(9):3075–3081, 2006.
[387] I.C.J.H. Post, M.C. Dirkes, M. Heger, R. Bezemer, J. van ’t Leven, and
T.M. van Gulik. Optimal ow and pressure management in machine
perfusion systems for organ preservation. Annals of Biomedical Engi-
neering, 40(12):2698–2707, 2012.
[388] T. Poynard, P. Bedossa, and P. Opolon. Natural history of liver
brosis progression in patients with chronic hepatitis C. Lancet,
349(9055):825–832, 1997.
285
Bibliography
[389] M.Y. Rady, J.L. Verheijde, and J. McGregor. Organ donation aer cir-
culatory death:e forgotten donor? Critical Care, 10(5):166, 2006.
[390] S. Raghunathan, D. Evans, and J.L. Sparks. Poroviscoelastic modeling
of liver biomechanical response in unconned compression. Annals
of Biomedical Engineering, 38(5):1789–1800, 2010.
[391] G. Ramadori, F. Moriconi, I. Malik, and J. Dudas. Physiology and
pathophysiology of liver inammation, damage and repair. Journal of
Physiology and Pharmacology, 59:107–117, 2008.
[392] S. Ran, T.-F. Wen, L.-N. Yan, B. Li, Y. Zeng, Z.-Y. Chen, Y. Zhang, Z.-
X. Liao, G.-L. Liang, G. Li, and X.-H. Zhang. Risks faced by donors
of right lobe for living donor liver transplantation. Hepatobiliary &
Pancreatic Diseases International, 8(6):581–585, 2009.
[393] H.P. Rani, T.W.H. Sheu, T.M. Chang, and P.C. Liang. Numerical in-
vestigation of non-Newtonianmicrocirculatory blood ow in hepatic
lobule. Journal of Biomechanics, 39(3):551–563, 2006.
[394] A.M. Rappaport, Z.J. Borowy, W.M. Lougheed, andW.N. Lotto. Sub-
division of hexagonal liver lobules into a structural and functional
unit; role in hepatic physiology and pathology. Anatomical record,
119(1):11–33, 1954.
[395] S.P. Reddy, J. Brockmann, and P.J. Friend. Normothermic perfusion:
A mini-review. Transplantation, 87(5):631–632, 2009.
[396] B. Reitinger, A. Bornik, R. Beichel, and D. Schmalstieg. Liver surgery
planning using virtual reality. IEEE Computer Graphics and Applica-
tions, 26(6):36–47, 2006.
[397] M.Y. Rennie, J. Detmar, K.J. Whiteley, J. Yang, A. Jurisicova, S.L.
Adamson, and J.G. Sled. Vessel tortuousity and reduced vasculariza-
tion in the fetoplacental arterial tree aer maternal exposure to poly-
cyclic aromatic hydrocarbons. American Journal of Physiology-Heart
and Circulatory Physiology, 300(2):H675–H684, 2011.
[398] J.F. Renz, H. Yersiz, P.R. Reichert, G.M. Hisatake, D.G. Farmer, J.C.
Emond, and R.W. Busuttil. Split-liver transplantation: A review.
American Journal of Transplantation, 3(11):1323–1335, 2003.
[399] A.L. Richards, C. Kleinstreuer, A.S. Kennedy, E. Childress, and G.D.
Buckner. Experimental microsphere targeting in a representative he-
patic artery system. IEEE Transactions on Biomedical Engineering,
59(1):198–204, 2012.
286
Bibliography
[400] P.D.I. Richardson and P.G.Withrington. Liver blood ow. 1. Intrinsic
and nervous control of liver blood ow. Gastroenterology, 81(1):159–
173, 1981.
[401] S. Richter, B. Vollmar, I. Mucke, S. Post, and M.D. Menger. Hepatic
arteriolo-portal venular shunting guarantees maintenance of nutri-
tional microvascular supply in hepatic arterial buer response of rat
livers. Journal of Physiology-London, 531(1):193–201, 2001.
[402] T. Ricken and J. Bluhm. Remodeling and growth of living tissue: A
multiphase theory. Archive of AppliedMechanics, 80(5):453–465, 2010.
[403] K.J. Riehle, Y.Y. Dan, J.S. Campbell, and N. Fausto. New concepts
in liver regeneration. Journal of Gastroenterology and Hepatology, 26
Suppl 1:203–12, 2011.
[404] E. Roan and K. Vemaganti. Strain rate-dependent viscohyperelastic
constitutive modeling of bovine liver tissue. Medical & Biological En-
gineering & Computing, 49(4):497–506, 2011.
[405] D.C. Rockey. Cell and molecular mechanisms of increased intrahe-
patic resistance and hemodynamic correlates. In A.J. Sanyal and V.H.
Shah, editors, Portal hypertension. Humana Press, New Jersey, 2005.
[406] L. Ro. Liver in mythology: A dierent version of Tityos’ myth.
Journal of Hepatology, 57(3):710–711, 2012.
[407] A. Rojas-Pena, J.L. Reoma, E. Krause, E.L. Boothman, N.P. Padiyar,
K.E. Cook, R.H. Bartlett, and J.D. Punch. Extracorporeal support:
Improves donor renal gra function aer cardiac death. American
Journal of Transplantation, 10(6):1365–1374, 2010.
[408] S. Rosenstengel, S. Stoeppeler, R. Bahde, H.U. Spiegel, and D. Palmes.
Type of steatosis inuences microcirculation and brogenesis in dif-
ferent rat strains. Journal of Investigative Surgery, 24(6):273–282, 2011.
[409] T. Roskams, V.J. Desmet, and C. Verslype. Development, structure
and function of the liver. In A.D. Burt, B.C. Portmann, and L.D. Fer-
rell, editors, MacSween’s pathology of the liver, chapter 1, pages 1–72.
Churchill Livingstone, 2007.
[410] Jr. R.S. Brown. Live donors in liver transplantation. Gastroenterology,
134(6):1802–1813, 2008.
287
Bibliography
[411] E.B. Rypins, K.M. Rosenberg, I.J. Sarfeh, J. Houck, R.M. Conroy, and
N. Milne. Computer-analysis of portal hemodynamics aer small-
diameter portacaval H-gras - the theoretical basis for partial shunt-
ing. Journal of Surgical Research, 42(4):354–361, 1987.
[412] M.E. Safar and P. Laurent. Pulse pressure and arterial stiness in rats:
Comparison with humans. American Journal of Physiology-Heart and
Circulatory Physiology, 285(4):H1363–H1369, 2003.
[413] S. Sahin and M. Rowland. Application of the dispersion model to
describe disposition kinetics of markers in the dual perfused rat liver.
Drug Metabolism and Disposition, 35(7):1119–1125, 2007.
[414] S. Saito, J. Yamanaka, K. Miura, N. Nakao, T. Nagao, T. Sugimoto,
T. Hirano, N. Kuroda, Y. Iimuro, and J. Fujimoto. A novel 3D he-
patectomy simulation based on liver circulation: Application to liver
resection and transplantation. Hepatology, 41(6):1297–1304, 2005.
[415] Y. Sato, K. Tsukada, and K. Hatakeyama. Role of shear stress and
immune responses in liver regeneration aer a partial hepatectomy.
Surgery Today-the Japanese Journal of Surgery, 29(1):1–9, 1999.
[416] I.M. Sauer and J.C. Gerlach. Modular extracorporeal liver support.
Articial Organs, 26(8):703–706, 2002.
[417] R. Saxena, N.D.eise, and J.M. Crawford. Microanatomy of the hu-
man liver - exploring the hidden interfaces. Hepatology, 30(6):1339–
1346, 1999.
[418] A. Schenk, S. Zidowitz, H. Bourquain, M. Hindennach, C. Hansen,
H.K. Hahn, and H.-O. Peitgen. Clinical relevance of model
based computer-assisted diagnosis and therapy. In M.L. Giger and
N. Karssemeijer, editors, Medical imaging 2008: Computer-aided di-
agnosis, Proceedings of the society of photo-optical instrumentation
engineers (spie), page 91502, 2008.
[419] A. Schlegel, O.d. Rougemont, R. Graf, P.-A. Clavien, and
P. Dutkowski. Protective mechanisms of end-ischemic cold
machine perfusion in DCD liver gras. Journal of Hepatology,
58(2):278–286, 2013.
[420] M.R. Schon, O. Kollmar, S. Wolf, H. Schrem, M. Matthes, N. Akkoc,
N.C. Schnoy, and P. Neuhaus. Liver transplantation aer organ pre-
servation with normothermic extracorporeal perfusion. Annals of
Surgery, 233(1):114–123, 2001.
288
Bibliography
[421] K. Schregel, E. Wuerfel née Tysiak, P. Garteiser, I. Gemeinhardt,
T. Prozorovski, O. Aktas, H. Merz, D. Petersen, J. Wuerfel, and
R. Sinkus. Demyelination reduces brain parenchymal stiness quan-
tied in vivo by magnetic resonance elastography. Proceedings of
the National Academy of Sciences of the United States of America,
109(17):6650–6655, 2012.
[422] P. Segers, E.R. Rietzschel, M.L. De Buyzere, N. Stergiopulos, N.West-
erhof, L.M. Van Bortel, T. Gillebert, and P.R. Verdonck. ree- and
four-elementwindkesselmodels: Assessment of their tting perform-
ance in a large cohort of healthymiddle-aged individuals. Proceedings
of the Institution of Mechanical Engineers Part H-Journal of Engineer-
ing in Medicine, 222(H4):417–428, 2008.
[423] D. Selle, B. Preim, A. Schenk, and H.-O. Peitgen. Analysis of vas-
culature for liver surgical planning. IEEE Transactions on Medical
Imaging, 21(11):1344–1357, 2002.
[424] D. Selle, W. Spindler, B. Preim, and H.-O. Peitgen. Mathematical
methods in medical imaging: Analysis of vascular structures for liver
surgery planning. In B. Enquist andW. Schmid, editors,Mathematics
unlimited - 2001 and beyond. Springer Verlag, Berlin, 2000.
[425] M.A. Selver, A. Kocaoglu, G.K. Demir, H. Dogan, O. Dicle, and
C. Guezelis. Patient oriented and robust automatic liver segmenta-
tion for pre-evaluation of liver transplantation. Computers in Biology
and Medicine, 38(7):765–784, 2008.
[426] H. Shah, K. Kuehl, and A.H. Sherker. Liver disease aer the Fontan
procedure what the hepatologist needs to know. Journal of Clinical
Gastroenterology, 44(6):428–431, 2010.
[427] V. Shah, G. Garcia-Cardena,W.C. Sessa, and R.J. Groszmann.e he-
patic circulation in health and disease: Report of a single-topic sym-
posium. Hepatology, 27(1):279–288, 1998.
[428] Y. Shi, P. Lawford, and R. Hose. Review of zero-D and 1-D models
of blood ow in the cardiovascular system. Biomedical Engineering
Online, 10, 2011.
[429] T. Shigeta, N. Matsuno, H. Huai-Che, H. Obara, H. Mizunuma,
T. Hirano, S. Uemoto, and S. Enosawa. A basic consideration for por-
cine liver preservation using a novel continuous machine perfusion
device. Transplantation Proceedings, 44(4):942–945, 2012.
289
Bibliography
[430] K.C. Shih and K. Man. Small-for-size liver gra injury–impact on
tumor behavior. Transplantation Reviews (Orlando), 24(1):1–10, 2010.
[431] T. Shimamura, M. Taniguchi, M.B. Jin, T. Suzuki, M. Matsushita,
H. Furukawa, and S. Todo. Excessive portal venous inow as a cause
of allogra dysfunction in small-for-size living donor liver transplan-
tation. Transplantation Proceedings, 33(1-2):1331, 2001.
[432] W. Shirai, T. Sato, H. Shibuya, K. Naito, and A. Tsukise. ree-
dimensional vasculature of the bovine liver. Anatomia Histologia
Embryologia-Journal of Veterinary Medicine Series C, 34(6):354–363,
2005.
[433] J.H. Siggers, A. Bonglio, K. Leungchavaphongse, and R. Repetto.
Mathematical modeling of blood circulation in the liver. 6th World
Congress of Biomechanics (WCB 2010) in conjunction with 14th In-
ternational Conference on Biomedical Engineering (ICBME) and 5th
Asia Pacic Conference on Biomechanics (APBiomech): IFMBE Pro-
ceedings, 31:454–457, 2010.
[434] S. Silbernagl and A. Despopoulos. Atlas van de fysiologie. HB uit-
gevers, Baarn, Nederland, 2007.
[435] M. Silveira and K. Lindor. Primary sclerosing cholangitis. In S.P.S.
Monga, editor,Molecular pathology of liver diseases, volume 5 ofMo-
lecular pathology library, chapter 50, pages 741–752. Springer US, 2011.
[436] C. Skagen, M. Lucey, and A. Said. Liver transplantation: An update
2009. Current Opinion in Gastroenterology, 25(3):202–208, 2009.
[437] J.E. Skandalakis, L.J. Skandalakis, P.N. Skandalakis, and P. Miri-
las. Hepatic surgical anatomy. Surgical Clinics of North America,
84(2):413–435, 2004.
[438] S.W. Smye, C.J. Evans, M.P. Robinson, and B.D. Sleeman. Modelling
the electrical properties of tissue as a porousmedium. Physics inMedi-
cine and Biology, 52(23):7007–7022, 2007.
[439] V. Smyrniotis, G. Kostopanagiotou, A. Kondi, E. Gamaletsos,
K.eodoraki, D. Kehagias, K. Mystakidou, and J. Contis. Hemo-
dynamic interaction between portal vein and hepatic artery ow in
small-for-size split liver transplantation. Transplant International,
15(7):355–360, 2002.
290
Bibliography
[440] J.H. Southard and M. Ametani. Organ preservation. In L.C. Ginns
and A.B. Cosimi, editors, Organ transplantation. Wiley-Blackwell,
1999.
[441] J.H. Southard and F.O. Belzer. Principles of organ preservation. In
R.W.Busuttil andG.B.Klintmalm, editors,Transplantation of the liver.
Elsevier Saunders, 1996.
[442] J.H. Southard, S. Lindell, M. Ametani, J.P. Richer, and A.W.F. Vos.
Kuper cell activation in liver preservation: Cold storage vs machine
perfusion. Transplantation Proceedings, 32(1):27–28, 2000.
[443] P. Soyer. Segmental anatomy of the liver: Utility of a nomenclature
accepted worldwide. American Journal of Roentgenology, 161(3):572–
573, 1993.
[444] M.M. Spannbauer, A. Oleszczuk, A. Tannapfel, M. Bluher, U.C.
Pietsch, J. Hengstler, B. Donaubauer, P. Madaj-Sterba, M. Furll,
A. Schuhmacher, J. iery, J.P. Hauss, and M.R. Schon. Micro-
and macrovesicular steatotic liver model for transplantation induced
by ethanol and protein-decient diet. Transplantation Proceedings,
37(1):210–211, 2005.
[445] B. Spronck, E.G. Martens, E.D. Gommer, and F.N. van de Vosse.
A lumped parameter model of cerebral blood ow control com-
bining cerebral autoregulation and neurovascular coupling. Amer-
ican Journal of Physiology - Heart and Circulatory Physiology,
303(9):H1143–53, 2012.
[446] T.E. Starzl. e long reach of liver transplantation. Nature Medicine,
18(10):1489–1492, 2012.
[447] T.E. Starzl and J.J. Fung.emes of liver transplantation. Hepatology,
51(6):1869–1884, 2010.
[448] T.E. Starzl, C.G. Groth, L. Brettschneider, I. Penn, V.A. Fulginiti, J.B.
Moon, H. Blanchard, Jr. A.J. Martin, and K.A. Porter. Orthotopic ho-
motransplantation of the human liver. Annals of Surgery, 168(3):392–
415, 1968.
[449] T.E. Starzl, G.B. Klintmalm, K.A. Porter, S. Iwatsuki, and G.P.
Schroter. Liver transplantation with use of cyclosporin A and pred-
nisone. New England Journal of Medicine, 305(5):266–269, 1981.
291
Bibliography
[450] T.E. Starzl, T.L. Marchioro, K.N. Vonkaulla, G. Hermann, R.S. Brit-
tain, andW.R.Waddell. Homotransplantation of the liver in humans.
Surgery, gynecology & obstetrics, 117:659–676, 1963.
[451] N. Stergiopulos, B.E. Westerhof, and N. Westerhof. Total arterial in-
ertance as the fourth element of the windkessel model. American
Journal of Physiology-Heart and Circulatory Physiology, 276(1):H81–
H88, 1999.
[452] R.H. Stewart and G.A. Laine. Flow in lymphatic networks: Interac-
tion between hepatic and intestinal lymph vessels. Microcirculation,
8(4):221–227, 2001.
[453] A.N. Strahler. Quantitative analysis of watershed geomorphology.
Transactions of the American Geophysical Union, 8(6):913–920, 1957.
[454] M.L. Sturdevart and A. Human. Multiorgan procurement from the
deceased donor. In A. Humar, A.J. Matas, and W.D. Payne, editors,
Atlas of organ transplantation. Springer-Verlag, London, 2006.
[455] K.C. Sudhamshu, S. Matsutani, H. Maruyama, T. Akiike, and
H. Saisho. Doppler study of hepatic vein in cirrhotic patients: Cor-
relation with liver dysfunction and hepatic hemodynamics. World
Journal of Gastroenteroly, 12(36):5853–5858, 2006.
[456] T.M. Suszynski, M.D. Rizzari, III W.E. Scott, L.A. Tempelman, M.J.
Taylor, and K.K. Papas. Persuation (or gaseous oxygen perfusion)
as a method of organ preservation. Cryobiology, 64(3):125–143, 2012.
[457] N.A. ’t Hart, A. van der Plaats, A. Faber, H.G.D. Leuvenink, P. Olinga,
J. Wiersema-Buist, G.J. Verkerke, G. Rakhorst, and R.J. Ploeg. Oxy-
genation during hypothermic rat liver preservation: An in vitro slice
study to demonstrate benecial or toxic oxygenation eects. Liver
Transplantation, 11(11):1403–1411, 2005.
[458] N.A. ’t Hart, A. van der Plaats, H.G.D. Leuvenink, H. van Goor,
J. Wiersema-Buist, G.J. Verkerke, G. Rakhorst, and R.J. Ploeg. De-
termination of an adequate perfusion pressure for continuous dual
vessel hypothermic machine perfusion of the rat liver. Transplant In-
ternational, 20(4):343–352, 2007.
[459] L. Taelman, J. Degroote, P. Verdonck, J. Vierendeels, and P. Segers.
Modeling hemodynamics in vascular networks using a geometrical
multiscale approach: Numerical aspects. Annals of Biomedical Engi-
neering, 41(7):1445–1458, 2013.
292
Bibliography
[460] K. Takasaki and M. Yamamoto. Surgical anatomy of the liver in the
glissonean pedicle approach: What we need to know. In D.C. Mado,
M. Makuuchi, M. Nagino, and J.-N. Vauthey, editors, Venous embol-
ization of the liver, chapter 4, pages 23–27. Springer, London, 2011.
[461] H.K. Tan. Molecular adsorbent recirculating system (MARS). Annals
Academy of Medicine Singapore, 33(3):329–335, 2004.
[462] K. Tanaka and Y. Ogura. "Small-for-size gra" and "small-for-size
syndrome" in living donor liver transplantation. Yonsei Medical
Journal, 45(6):1089–1094, 2004.
[463] L. Tariciotti, C. Rocha, M.T.P.R. Perera, B.K. Gunson, S.R. Bramhall,
J. Isaac, J.A.C. Buckels, A.D. Mayer, P. Muiesan, and D.F. Mirza. Is
it time to extend liver acceptance criteria for controlled donors aer
cardiac death? Transplantation, 92(10):1140–1146, 2011.
[464] R. Taub. Liver regeneration: From myth to mechanism. Nature Re-
views Molecular Cell Biology, 5(10):836–847, 2004.
[465] H.F. Teutsch. e modular microarchitecture of human liver. Hep-
atology, 42(2):317–325, 2005.
[466] H.F. Teutsch, D. Schuerfeld, and E. Groezinger. ree-dimensional
reconstruction of parenchymal units in the liver of the rat. Hepato-
logy, 29(2):494–505, 1999.
[467] D.abut and V. Shah. Intrahepatic angiogenesis and sinusoidal re-
modeling in chronic liver disease: New targets for the treatment of
portal hypertension? Journal of Hepatology, 53(5):976–980, 2010.
[468] D.G. Tiniakos, A. Kandilis, and S.A. Geller. Tityus: a forgotten myth
of liver regeneration. Journal of Hepatology, 53(2):357–361, 2010.
[469] T. Tojimbara, W.N. Wicomb, R. Garcia-Kennedy, W. Burns, M. Hay-
ashi, G. Collins, and C.O. Esquivel. Liver transplantation from non-
heart beating donors in rats: Inuence of viscosity and temperature
of initial ushing solutions on gra function. Liver Transplantation
and Surgery, 3(1):39–45, 1997.
[470] U. Töx, I. Scheller, N. Kociok, M.A. Kern, D. Klanac, S.M. Daudi,
O. Laue, P. Schirmacher, T. Goeser, S. Schulte, and H.M. Steen. Ex-
pression of angiotensin II receptor type 1 is reduced in advanced rat
liver brosis. Digestive Diseases and Sciences, 52(8):1995–2005, 2007.
293
Bibliography
[471] G. Troianowski, C.A. Taylor, J.A. Feinstein, and I.E. Vignon-
Clementel. ree-dimensional simulations in Glenn patients: Clini-
cally based boundary conditions, hemodynamic results and sensitiv-
ity to input data. Journal of Biomechical Engineering, 133(11):111006,
2011.
[472] R. Troisi, S. Ricciardi, P. Smeets, M. Petrovic, G. Van Maele, I. Colle,
H. VanVlierberghe, and B. deHemptinne. Eects of hemi-portocaval
shunts for inow modulation on the outcome of small-for-size gras
in living donor liver transplantation. American Journal of Transplan-
tation, 5(6):1397–1404, 2005.
[473] J.E. Tsitlik, H.R. Halperin, A.S. Popel, A.A. Shoukas, F.C.P. Yin, and
N.Westerhof. Modeling the circulationwith 3-terminal electrical net-
works containing special nonlinear capacitors. Annals of Biomedical
Engineering, 20(6):595–616, 1992.
[474] O.N. Tucker and N. Heaton. e ’small for size’ liver syndrome. Cur-
rent Opinion in Critical Care, 11(2):150–155, 2005.
[475] M. Uchiyama, K. Kozaki, T. Nemoto, H. Degawa, N. Matsuno,
K. Kubota, H. Takeuchi, E. Sakurai, M. Kozaki, T. Ikeda, N. Asuwa,
S. Masuda, and T. Nagao. Liver transplantation from non-heart-
beating donors: Eect ofmachine perfusion preservation andpentox-
ifylline. Transplantation Proceedings, 30(7):3798–3800, 1998.
[476] M. Uchiyama, N. Matsuno, K. Hama, H. Iwamoto, Y. Narumi,
K.Kikuchi, H.Degawa, K.Kozaki, K.Kubota, H. Takeuchi, E. Sakurai,
N. Asuwa, S.M.T. Hirano, and T. Nagao. Comparison between non-
pulsatile and pulsatile machine perfusion preservation in liver trans-
plantation from non-heart-beating donors. Transplantation Proceed-
ings, 33(1-2):936–938, 2001.
[477] M. Vairetti, A. Ferrigno, F. Carlucci, A. Tabucchi, V. Rizzo,
E. Boncompagni, D. Neri, E. Gringeri, I. Freitas, andU. Cillo. Subnor-
mothermicmachine perfusion protects steatotic livers against preser-
vation injury: A potential for donor pool increase? Liver Transplan-
tation, 15(1):20–29, 2009.
[478] A. van der Plaats. e Groningen hypothermic liver perfusion system
for improved preservation in organ transplantation. PhD thesis, Uni-
versity of Groningen, 2005.
294
Bibliography
[479] A. van der Plaats, M.H.J. Maathuis, N.A. ’t Hart, A.A. Bellekom,
H.S. Hofker, E.B. van der Houwen, G.J. Verkerke, H.G.D. Leuven-
ink, P. Verdonck, R.J. Ploeg, and G. Rakhorst. e Gronin-
gen hypothermic liver perfusion pump: Functional evaluation of a
new machine perfusion system. Annals of Biomedical Engineering,
34(12):1924–1934, 2006.
[480] A. van der Plaats, N.A. ’t Hart, A.M. Morariu, G.J. Verkerke, H.G.D.
Leuvenink, R.J. Ploeg, and G. Rakhorst. Eect of University of Wis-
consin organ-preservation solution on haemorheology. Transplant
International, 17(5):227–233, 2004.
[481] A. van der Plaats, N.A. ’t Hart, G.J. Verkerke, H.G.D. Leuvenink, R.J.
Ploeg, and G. Rakhorst. Hypothermic machine preservation in liver
transplantation revisited: Concepts and criteria in the new millen-
nium. Annals of Biomedical Engineering, 32(4):623–631, 2004.
[482] A. van der Plaats, N.A. ’t Hart, G.J. Verkerke, H.G.D. Leuvenink,
P. Verdonck, R.J. Ploeg, and G. Rakhorst. Numerical simulation of
the hepatic circulation. International Journal of Articial Organs,
27(3):222–230, 2004.
[483] C. Van Steenkiste. e role of placental growth factor (PlGF) in the
pathophysiology of portal hypertension and cirrhosis. PhD thesis,
Ghent University, 2011.
[484] C. Van Steenkiste, B. Trachet, C. Casteleyn, D. Van Loo, L. Van Hoo-
rebeke, P. Segers, A.Geerts, H.VanVlierberghe, and I. Colle. Vascular
corrosion casting: Analyzing wall shear stress in the portal vein and
vascular abnormalities in portal hypertensive and cirrhotic rodents.
Laboratory Investigation, 90(11):1558–1572, 2010.
[485] E. Vanheule, Y.-D. Fan, J. Van Huysse, D. Meester, K. Olievier,
M. Praet, B. de Hemptinne, and I. Colle. Expression of placental
growth factor in regenerating livers aer partial hepatectomy in the
rat. European Journal of Gastroenterology & Hepatology, 23(1):66–75,
2011.
[486] E. Vanheule, A.M. Geerts, J. Van Huysse, D. Schelfhout, M. Praet,
H. Van Vlierberghe, M. De Vos, and I. Colle. An intravital micro-
scopic study of the hepaticmicrocirculation in cirrhoticmicemodels:
Relationship between brosis and angiogenesis. International Journal
of Experimental Pathology, 89(6):419–432, 2008.
295
Bibliography
[487] K. Vekemans, Q. Liu, J. Brassil, M. Komuta, J. Pirenne, and D. Mon-
baliu. Inuence of ow and addition of oxygen during porcine
liver hypothermic machine perfusion. Transplantation Proceedings,
39(8):2647–2651, 2007.
[488] K. Vekemans, Q. Liu, J. Pirenne, and D. Monbaliu. Articial circula-
tion of the liver: Machine perfusion as a preservation method in liver
transplantation. Anatomical Record-Advances in Integrative Anatomy
and Evolutionary Biology, 291(6):735–740, 2008.
[489] J. Vermehren, A. Polta, O. Zimmermann, E. Herrmann, T. Poynard,
W.P. Hofmann, J. Bojunga, C. Sarrazin, S. Zeuzem, andM. Friedrich-
Rust. Comparison of acoustic radiation force impulse imaging with
transient elastography for the detection of complications in patients
with cirrhosis. Liver International, 32(5):852–858, 2012.
[490] C. Vicas, M. Lupsor, R. Badea, and S. Nedevschi. Usefulness of tex-
tural analysis as a tool for noninvasive liver brosis staging. Journal
of Medical Ultrasonics, 38(3):105–117, 2011.
[491] I.E. Vignon-Clementel, C.A. Figueroa, K.E. Jansen, and C.A. Taylor.
Outow boundary conditions for 3D simulations of non-periodic
blood owandpressure elds in deformable arteries. ComputerMeth-
ods in Biomechanics and Biomedical Engineering, 13(5):625–640, 2010.
[492] I.E.Vignon-Clementel, A.L.Marsden, and J.A. Feinstein. Aprimer on
computational simulation in congenital heart disease for the clinician.
Progress in Pediatric Cardiology, 30(1-2):3–13, 2010.
[493] S. Vilarinho and Richard P. Lion. Liver transplantation: From in-
ception to clinical practice. Cell, 150(6):1096–1099, 2012.
[494] T. Vogel, J.G. Brockmann, C. Coussios, and P.J. Friend. e role
of normothermic extracorporeal perfusion in minimizing ischemia
reperfusion injury. Transplantation Reviews, 26(2):156–162, 2012.
[495] T. Vogel, J.G. Brockmann, and P.J. Friend. Ex-vivo normothermic
liver perfusion: An update. Current Opinion in Organ Transplanta-
tion, 15(2):167–172, 2010.
[496] B. Vollmar and M.D. Menger. e hepatic microcirculation: Mech-
anistic contributions and therapeutic targets in liver injury and repair.
Physiological Reviews, 89(4):1269–1339, 2009.
296
Bibliography
[497] B. Vollmar, B. Wolf, S. Siegmund, A.D. Katsen, and M.D. Menger.
Lymph vessel expansion and function in the development of hepatic
brosis and cirrhosis. American Journal of Pathology, 151(1):169–175,
1997.
[498] R. Wagner, D. Van Loo, F. Hossler, K. Czymmek, E. Pauwels, and
L.VanHoorebeke. High-resolution imaging of kidney vascular corro-
sion casts with nano-CT.Microscopy andMicroanalysis, 17(2):215–219,
2011.
[499] J. Wambaugh and I. Shah. Simulating microdosimetry in a virtual
hepatic lobule. Plos Computational Biology, 6(4):e1000756, 2010.
[500] S.Y.Wan, A.P. Kiraly, E.L. Ritman, andW.E.Higgins. Extraction of the
hepatic vasculature in rats using 3-D micro-CT images. IEEE Trans-
actions on Medical Imaging, 19(9):964–971, 2000.
[501] A. Warren, S. Chaberek, K. Ostrowski, V.C. Cogger, S.N. Hilmer, R.S.
McCuskey, R. Fraser, and D.G. Le Couteur. Eects of old age on vas-
cular complexity and dispersion of the hepatic sinusoidal network.
Microcirculation, 15(3):191–202, 2008.
[502] E. Weibel. Mandelbrot’s fractals and the geometry of life: A tribute
to Benoît Mandelbrot on his 80th birthday. In G. Losa, D. Mer-
lini, T. Nonnenmacher, and E. Weibel, editors, Fractals in biology
and medicine, Mathematics and biosciences in interaction, chapter 1,
pages 3–16. Birkhäuser Basel, 2005.
[503] M. Weiss, T.C. Krejcie, and M.J. Avram. A physiologically based
model of hepatic ICG clearance: Interplay between sinusoidal uptake
and biliary excretion. European Journal of Pharmaceutical Sciences,
44(3):359–65, 2011.
[504] C.Welch. A note on transplantation of the whole liver in dogs. Trans-
plant Bull, 1955(2):54–55, 1955.
[505] M.J.Welsh, C.S. Rogers, D.A. Stoltz, D.K.Meyerholz, andR.S. Prather.
Development of a porcine model of cystic brosis. Transactions of the
American Clinical and Climatological Association, 120:149–162, 2009.
[506] J.R.Welty, C.E.Wicks, R.E.Wilson, andG.L. Rorrer. Fundamentals of
momentum, heat, andmass transfer. JohnWiley and sons, 4th edition,
2001.
297
Bibliography
[507] T.-F. Wen, Z.-Y. Chen, L.-N. Yan, B. Li, Y. Zeng, J.-C. Zhao, W.-T.
Wang, J.-Y. Yang, Y.-K. Ma, M.-Q. Xu, J.-W. Liu, Z.-G. Deng, and
H. Wu. Measures for increasing the safety of donors in living donor
liver transplantation using right lobe gras. Hepatobiliary & Pancre-
atic Diseases International, 6(6):590–595, 2007.
[508] D. Werner, T. Ricken, U. Dahmen, and O. Dirsch. A biphasic FEM
model for the microperfusion in liver lobules. Proceedings in Applied
Mathematics and Mechanics, 12(1):89–90, 2012.
[509] E. Wisse, F. Braet, D.Z. Luo, R. De Zanger, D. Jans, E. Crabbe, and
A. Vermoesen. Structure and function of sinusoidal lining cells in
the liver. Toxicologic Pathology, 24(1):100–111, 1996.
[510] A.M. Wolthuis, D. Monbaliu, W. Coosemans, and J. Pirenne. De-
ceased donor retrieval. In Handbook of renal and pancreatic trans-
plantation, pages 91–107. John Wiley & Sons, Ltd, 2012.
[511] W. Xing, M. Deng, J. Zhang, H. Huang, O. Dirsch, and U. Dah-
men. Quantitative evaluation and selection of reference genes in a
rat model of extended liver resection. Journal of Biomolecular Tech-
niques, 20(2):109–115, 2009.
[512] X. Xu, K. Man, S.S. Zheng, T.B. Liang, T.K. Lee, K.T. Ng, S.T. Fan,
and C.M. Lo. Attenuation of acute phase shear stress by somatostatin
improves small-for-size liver gra survival. Liver Transplantation,
12(4):621–627, 2006.
[513] S. Yagi, T. Lida, K. Taniguchi, T. Hori, T. Hamada, K. Fujii, S. Mizuno,
and S. Uemoto. Impact of portal venous pressure on regeneration and
gradamage aer living-donor liver transplantation. Liver Transplan-
tation, 11(1):68–75, 2005.
[514] J. Yamanaka, S. Saito, Y. Iimuro, T.Hirano, T.Okada, N.Kuroda, T. Su-
gimoto, and J. Fujimoto.e impact of 3-D virtual hepatectomy simu-
lation in living-donor liver transplantation. Journal of Hepato-Biliary-
Pancreatic Surgery, 13(5):363–369, 2006.
[515] L.N. Yan, B. Li, Y. Zeng, T.F. Wen, J.C. Zhao, W.T. Wang, J.Y. Yang,
M.Q. Xu, Y.K. Ma, Z.Y. Chen, J.W. Liu, and H. Wu. Modied tech-
niques for adult-to-adult living donor liver transplantation. Hepato-
biliary & Pancreatic Diseases International, 5(2):173–9, 2006.
[516] Y. Yang, S. George, D.R.Martin, A.R. Tannenbaum, andD.P. Giddens.
3D modeling of patient-specic geometries of portal veins using MR
images, 2006.
298
Bibliography
[517] H. Yokomori, M. Oda, K. Yoshimura, and T. Hibi. Recent advances in
liver sinusoidal endothelial ultrastructure and ne structure immun-
ocytochemistry. Micron, 43(2-3):129–134, 2012.
[518] F. Yuan, Y. Chi, S. Huang, and J. Liu. Modeling n-furcated liver vessels
from a 3-D segmented volume using hole-making and subdivision
methods. IEEE Transactions on Biomedical Engineering, 59(2):552–
561, 2012.
[519] X. Yuan, A.J.eruvath, X. Ge, B. Floerchinger, A. Jurisch, G. Garcia-
Cardena, and S.G. Tullius. Machine perfusion or cold storage in or-
gan transplantation: Indication, mechanisms, and future perspect-
ives. Transplant International, 23(6):561–570, 2010.
[520] T. Yzet, R. Bouzerar, J.-D. Allart, F. Demuynck, C. Legallais, B. Robert,
H. Deramond, M.-E. Meyer, and O. Baledent. Hepatic vascular ow
measurements by phase contrast MRI and Doppler echography: A
comparative and reproducibility study. Journal ofMagnetic Resonance
Imaging, 31(3):579–588, 2010.
[521] M. Zambelli, E. Andorno, L. De Carlis, G. Rossi, U. Cillo, T. De
Feo, A. Carobbio, A. Giacomoni, G. Bottino, and M. Colledan. Full-
right-full-le split liver transplantation:e retrospective analysis of
an early multicenter experience including gra sharing. American
Journal of Transplantation, 12(8):2198–2210, 2012.
[522] M. Zamir. On fractal properties of arterial trees. Journal ofeoretical
Biology, 197(4):517–526, 1999.
[523] M. Zamir. Arterial branching within the connes of fractal L-system
formalism. Journal of General Physiology, 118(3):267–275, 2001.
[524] M. Zamir. Fractal dimensions and multifractility in vascular branch-
ing. Journal ofeoretical Biology, 212(2):183–190, 2001.
[525] M. Zamir and S. Phipps. Network analysis of an arterial tree. Journal
of Biomechanics, 21(1):25–34, 1988.
[526] D.J. Zanchet and E.F. de Souza Montero. Pig liver sectorization and
segmentation and virtual reality depiction. Acta Cirúrgica Brasileira,
17(6):381–387, 2002.
[527] J.J. Zhang, X.K. Meng, C. Dong, J.L. Qiao, R.F. Zhang, G.Q. Yue, and
H.Y. Zhong. Development of a new animal model of liver cirrhosis in
swine. European Surgical Research, 42(1):35–39, 2009.
299
Bibliography
[528] L. Zhang, J. Yin, Y. Duan, Y. Yang, L. Yuan, and T. Cao. Assessment
of intrahepatic blood ow by Doppler ultrasonography: Relationship
between the hepatic vein, portal vein, hepatic artery and portal pres-
sure measured intraoperatively in patients with portal hypertension.
BMC Gastroenterology, 11, 2011.
[529] W. Zhang, L. Tucker-Kellogg, B.C. Narmada, L. Venkatraman,
S. Chang, Y. Lu, N. Tan, J.K. White, R. Jia, S.S. Bhowmick, S. Shen,
Jr. C.F. Dewey, and H. Yu. Cell-delivery therapeutics for liver regen-
eration. Advanced Drug Delivery Reviews, 62(7-8):814–826, 2010.
[530] Y. Zhang, Y. He, R.K. Praseedom, S. Zheng, J. Dong, and H. Chen.
Establishment of animal model of dual liver transplantation in rat.
PLoS One, 7(7):e40818, 2012.
[531] A. Zipprich, M.R. Loureiro-Silva, I. D’Silva, and R.J. Groszmann.
e role of hepatic arterial ow on portal venous and hepatic ve-
nous wedged pressure in the isolated perfused CCl4-cirrhotic liver.
American Journal of Physiology-Gastrointestinal and Liver Physiology,
295(1):G197–G202, 2008.
[532] Z. Zou, W. Ekataksin, and K. Wake. Zonal and regional dierences
identied from precisionmapping of vitamin A-storing lipid droplets
of the hepatic stellate cells in pig liver : A novel concept of addressing
the intralobular area of heterogeneity. Hepatology, 27(4):1098–1108,
1998.
[533] R. Zuchini, H.W. Tsai, C.Y. Chen, C.H. Huang, S.C. Huang, G.B. Lee,
C.F. Huang, and X.Z. Lin. Electromagnetic thermotherapy using ne
needles for hepatoma treatment. European Journal of Surgical Onco-
logy (EJSO), 37(7):604–610, 2011.
300
